21329 of IN:21322 UNKNOWN:7 
19890 the CT:1 DT:19878 UNKNOWN:11 
18422 . .:18419 FW:2 NN:1 
17682 , ,:17677 .:1 NN:3 UNKNOWN:1 
13192 and CC:13191 UNKNOWN:1 
12871 in DT:14 FW:634 IN:12201 NN:10 RB:1 RP:4 UNKNOWN:7 
7341 to TO:7341 
6544 a CC:1 DT:6522 LS:7 NN:5 RB:1 UNKNOWN:6 VBG:1 XT:1 
6425 ) ):6420 NN:3 UNKNOWN:2 
6381 ( (:6379 NN:2 
5641 cells JJ:1 NNS:5640 
5180 that DT:217 IN:3668 UNKNOWN:3 WDT:1292 
4750 by IN:4748 UNKNOWN:2 
4321 with IN:4320 UNKNOWN:1 
3966 is UNKNOWN:3 VBD:1 VBZ:3962 
3074 expression NN:3073 UNKNOWN:1 
2934 was VBD:2934 
2878 cell JJ:4 NN:2873 NNS:1 
2837 for IN:2830 UNKNOWN:7 
2780 B DT:1 JJ:68 NN:2710 NNS:1 
2542 The DT:2538 NNP:2 UNKNOWN:2 
2526 T JJ:4 NN:2522 
2305 gene JJ:1 NN:2303 UNKNOWN:1 
2298 human JJ:2296 NN:2 
2276 activation NN:2276 
2228 transcription NN:2228 
1892 protein JJ:4 NN:1888 
1872 as IN:1547 RB:323 UNKNOWN:2 
1837 not RB:1836 UNKNOWN:1 
1797 binding JJ:13 NN:1476 UNKNOWN:1 VBG:307 
1775 from IN:1772 JJ:1 UNKNOWN:2 
1705 factor IN:3 JJ:4 NN:1698 
1677 were VBD:1677 
1671 an CC:1 CT:1 DT:1667 JJ:1 UNKNOWN:1 
1666 or CC:1666 
1641 activity NN:1641 
1541 are VBP:1541 
1536 on IN:1534 JJ:1 UNKNOWN:1 
1418 In FW:71 IN:1347 
1373 this DT:1372 UNKNOWN:1 
1368 receptor JJ:21 NN:1346 UNKNOWN:1 
1334 promoter JJ:15 NN:1319 
1322 which WDT:1321 WP:1 
1291 we PRP:1291 
1223 NF-kappa JJ:1 NN:1222 
1197 be UNKNOWN:1 VB:1196 
1151 We PRP:1150 UNKNOWN:1 
1136 nuclear JJ:1136 
1092 these DT:1092 
1089 have UNKNOWN:1 VB:96 VBP:992 
1066 but CC:1066 
959 at IN:959 
936 both CC:671 DT:262 PDT:1 RB:2 
919 proteins NNS:919 
892 genes NNS:892 
888 alpha JJ:13 NN:875 
858 also RB:858 
848 factors NN:1 NNS:847 
837 IL-2 JJ:68 NN:769 
826 lymphocytes NNS:826 
818 mRNA JJ:2 NN:816 
815 differentiation NN:814 UNKNOWN:1 
813 may MD:811 NN:2 
807 These DT:806 UNKNOWN:1 
788 induced JJ:71 UNKNOWN:1 VBD:239 VBN:477 
777 site JJ:4 NN:773 
764 response NN:763 VBP:1 
761 induction NN:761 
753 patients NNS:753 
752 results NNS:617 VBZ:135 
752 levels NNS:752 
744 DNA NN:744 
734 : ::733 NN:1 
730 A DT:430 JJ:19 NN:276 NNP:5 
720 role NN:720 
707 activated JJ:32 UNKNOWN:1 VBD:78 VBN:596 
698 kappa JJ:1 NN:697 
696 transcriptional JJ:696 
685 NF-kappaB JJ:44 NN:641 
651 1 CD:586 JJ:14 LS:42 NN:9 
640 been UNKNOWN:1 VBN:639 
633 kinase JJ:6 NN:627 
631 has UNKNOWN:1 VBZ:630 
630 virus JJ:16 NN:614 
629 can MD:629 
621 its PRP$:621 
609 two CD:609 
581 This CT:1 DT:579 UNKNOWN:1 
577 region NN:577 
572 lines NNS:572 
570 monocytes NNS:570 
570 effect NN:565 UNKNOWN:1 VB:4 
551 found VBD:133 VBN:418 
544 sites NNS:542 UNKNOWN:2 
543 between IN:543 
533 expressed VBD:82 VBN:451 
532 regulation NN:532 
531 I CD:180 JJ:6 LS:1 NN:340 PRP:4 
521 -induced JJ:520 NN:1 
513 element JJ:2 NN:511 
511 T-cell JJ:2 NN:509 
509 HIV-1 JJ:27 NN:482 
505 other DT:1 JJ:504 
505 AP-1 JJ:21 NN:484 
501 receptors NN:1 NNS:500 
500 stimulation NN:500 
500 increased VBD:170 VBN:330 
498 normal JJ:498 
498 complex JJ:60 NN:438 
496 through IN:496 
496 sequence JJ:1 NN:495 
496 ; ::496 
493 phosphorylation NN:493 
492 signaling JJ:4 NN:447 VBG:41 
491 effects NNS:491 
489 suggest UNKNOWN:1 VB:10 VBP:478 
485 line NN:485 
480 specific JJ:480 
476 during IN:476 
473 blood NN:473 
467 production NN:467 
456 after IN:455 RB:1 
452 enhancer JJ:3 NN:449 
438 domain JJ:8 NN:430 
437 study NN:390 VB:46 VBD:1 
431 show VB:28 VBP:403 
430 analysis NN:430 
429 IL-4 JJ:50 NN:379 
424 type JJ:1 NN:423 
419 inhibited JJ:2 VBD:246 VBN:171 
418 their PRP$:418 
417 than IN:417 
408 LPS JJ:94 NN:311 NNS:3 
406 apoptosis JJ:5 NN:400 NNS:1 
404 observed VBD:61 VBN:343 
403 tyrosine JJ:17 NN:385 VBN:1 
402 peripheral JJ:402 
396 control JJ:65 NN:269 VB:23 VBP:39 
395 only JJ:15 RB:380 
395 cytokine JJ:23 NN:372 
393 function NN:350 VB:31 VBP:12 
392 II CD:387 JJ:3 NN:1 NNS:1 
391 important JJ:391 
390 treatment NN:390 
390 regulatory JJ:390 
389 vitro FW:389 
388 family NN:388 
388 % NN:388 
387 involved JJ:1 VBD:12 VBN:374 
382 2 CD:333 JJ:6 LS:41 NN:2 
381 required JJ:2 VBD:34 VBN:345 
379 showed VBD:377 VBN:2 
368 it PRP:368 
367 pathway NN:367 
365 studies NNS:364 VBZ:1 
365 inhibition NN:365 
360 glucocorticoid JJ:12 NN:348 
360 associated JJ:12 VBD:10 VBN:338 
359 tumor JJ:2 NN:357 
359 proliferation NN:359 
355 different JJ:355 
353 demonstrate VB:23 VBP:330 
353 cellular JJ:353 
352 using VBG:352 
348 signal JJ:7 NN:332 VB:6 VBP:3 
348 shown VBN:348 
348 -mediated JJ:348 
347 beta JJ:2 NN:344 NNS:1 
346 leukemia NN:346 
346 growth NN:346 
345 present JJ:313 NN:2 UNKNOWN:1 VB:5 VBP:24 
345 identified VBD:97 VBN:248 
345 addition NN:345 
343 within IN:342 UNKNOWN:1 
340 data NN:1 NNS:337 UNKNOWN:2 
339 well NN:1 RB:338 
337 mechanism NN:337 
333 increase NN:265 VB:48 VBP:20 
333 acid JJ:11 NN:322 
332 level NN:331 UNKNOWN:1 
330 class NN:330 
329 elements NNS:329 
329 Jurkat NN:329 
323 mediated JJ:39 VBD:21 VBN:263 
323 HIV JJ:24 NN:298 VBP:1 
320 demonstrated VBD:193 VBN:127 
316 presence NN:316 
315 no DT:305 RB:10 
315 did UNKNOWN:1 VBD:314 
314 However RB:313 WRB:1 
313 into IN:313 
312 TNF-alpha JJ:27 NN:285 
303 erythroid JJ:303 
303 assays NN:1 NNS:302 
302 such IN:3 JJ:295 PDT:4 
301 contrast NN:301 
299 To TO:299 
295 one CD:287 NN:6 PRP:2 
292 infection NN:292 
290 whereas IN:290 
290 immune JJ:290 
290 early JJ:265 RB:25 
290 PMA JJ:39 NN:250 NNS:1 
289 monocytic JJ:289 
287 either CC:251 DT:31 RB:5 
287 adhesion NN:287 
286 viral JJ:286 
284 mechanisms NNS:284 
284 development NN:284 
281 induce VB:209 VBP:72 
279 cytokines NNS:279 
279 EBV JJ:37 NN:241 NNS:1 
275 functional JJ:275 
272 including VBG:272 
272 complexes NNS:272 
271 primary JJ:271 
271 could MD:271 
270 vivo FW:270 
267 detected JJ:1 VBD:25 VBN:241 
266 several JJ:266 
266 IFN-gamma JJ:28 NN:237 UNKNOWN:1 
264 high JJ:264 
264 all DT:237 PDT:27 
264 -dependent JJ:264 
262 replication NN:262 
260 stimulated JJ:16 VBD:44 VBN:200 
260 pathways NNS:260 
259 molecular JJ:257 NN:2 
258 significantly RB:258 
256 +/- CC:252 JJ:4 
255 antigen JJ:4 NN:251 
254 inhibitor NN:254 
254 induces VBZ:254 
252 phorbol NN:252 
252 DNA-binding JJ:223 NN:29 
251 distinct IN:1 JJ:250 
250 suggesting UNKNOWN:1 VBG:249 
250 reporter NN:250 
250 NFAT JJ:16 NN:234 
249 when WRB:249 
249 used VBD:39 VBN:210 
248 novel JJ:248 
247 synthesis JJ:1 NN:246 
246 indicate VB:5 VBP:241 
244 examined VBD:96 VBN:148 
244 C JJ:10 NN:234 
241 shift NN:239 VB:2 
241 necrosis NN:241 
241 mononuclear JJ:240 NN:1 
241 TCR JJ:40 NN:201 
240 translocation NN:240 
240 major JJ:240 
239 sequences NNS:235 VBZ:4 
237 signals NNS:235 VBZ:2 
237 containing NN:3 VBG:234 
236 assay NN:233 VB:3 
235 number NN:235 
235 TNF JJ:13 NN:222 
234 similar JJ:234 
234 known JJ:50 VBN:184 
233 myeloid JJ:232 NN:1 
232 immunodeficiency NN:232 
231 system JJ:2 NN:229 
230 surface NN:230 
230 activate VB:180 VBP:50 
228 bind VB:127 VBP:101 
228 Furthermore RB:228 
228 3 CD:197 JJ:1 LS:28 NN:1 TO:1 
227 revealed VBD:199 VBN:28 
227 RA JJ:24 NN:202 NNS:1 
223 investigated VBD:110 VBN:113 
222 Tax JJ:35 NN:186 VBG:1 
221 more JJR:64 RBR:157 
220 lymphocyte JJ:2 NN:217 NNS:1 
220 interaction NN:220 
220 enhanced JJ:1 VBD:82 VBN:137 
218 previously RB:218 
216 IL-10 JJ:8 NN:208 
215 regulated JJ:12 VBD:5 VBN:198 
215 molecules NNS:215 
215 intracellular JJ:215 
214 compared VBD:24 VBN:190 
212 three CD:211 UNKNOWN:1 
212 reduced JJ:2 VBD:70 VBN:140 
212 had VBD:212 
212 ability NN:212 
211 active JJ:211 
211 NF-AT JJ:12 NN:199 
209 responses NNS:209 
208 negative JJ:208 
206 IL-6 JJ:17 NN:189 
205 while IN:204 UNKNOWN:1 
205 transduction NN:205 
204 mobility NN:204 
204 macrophages NNS:204 
204 inflammatory JJ:204 
201 report NN:80 VBP:121 
201 gamma JJ:1 NN:199 VB:1 
201 form IN:1 NN:137 VB:40 VBP:23 
201 decreased JJ:1 VBD:84 VBN:116 
200 activator NN:200 
199 inducible JJ:198 NN:1 
198 upstream JJ:133 RB:65 
198 endothelial JJ:196 NN:2 
198 Thus RB:198 
198 Here RB:198 
197 Our PRP$:197 
196 LTR JJ:17 NN:175 NNS:4 
195 further JJ:58 RB:115 RBR:22 
194 significant JJ:194 
194 mice NNS:194 
194 extracts NNS:193 VBZ:1 
193 findings NNS:192 UNKNOWN:1 
192 p65 JJ:4 NN:187 NNS:1 
192 chain JJ:1 NN:191 
191 target NN:176 UNKNOWN:3 VB:6 VBP:6 
191 lymphoid JJ:191 
191 isolated VBD:24 VBN:167 
191 P JJ:2 NN:189 
190 play NN:1 VB:123 VBP:66 
190 motif JJ:1 NN:189 
190 low JJ:189 UNKNOWN:1 
190 binds VBZ:190 
189 via IN:189 
189 potential JJ:130 NN:59 
189 GM-CSF JJ:7 NN:182 
188 those DT:188 
187 murine JJ:169 NN:18 
187 disease JJ:1 NN:186 
186 U937 NN:186 
185 p50 JJ:1 NN:184 
185 events NNS:185 
184 terminal JJ:183 NN:1 
184 c-fos NN:184 
183 evidence NN:183 
183 GR JJ:10 NN:158 NNS:15 
181 upon IN:181 
181 studied VBD:51 VBN:130 
181 dependent JJ:181 
181 cycle JJ:1 NN:180 
181 contains VBZ:181 
181 It PRP:181 
180 transactivation NN:180 
178 promoters NNS:178 
178 mutant JJ:104 NN:74 
178 h NN:178 
178 [ (:160 NN:18 
175 positive JJ:175 
175 inhibits VBZ:175 
175 PKC JJ:17 NN:158 
174 mouse NN:174 
174 essential JJ:173 UNKNOWN:1 
174 CD40 JJ:32 NN:142 
173 critical JJ:173 
173 affinity NN:173 
173 B-cell JJ:1 NN:171 UNKNOWN:1 
172 infected JJ:117 VBN:55 
171 related JJ:169 VBN:2 
171 first JJ:143 RB:28 
170 c-jun JJ:1 NN:169 
170 CD28 JJ:35 NN:135 
169 most JJ:1 JJS:70 RBS:98 
167 whether CC:1 IN:166 
167 NK NN:167 
167 NF JJ:1 NN:166 
166 constitutive JJ:166 
166 = JJ:165 VBD:1 
166 10 CD:166 
165 transfected JJ:7 VBD:5 VBN:153 
165 monocyte JJ:1 NN:162 NNS:2 
165 located JJ:165 
165 following JJ:3 NN:5 VBG:157 
165 determined VBD:28 VBN:137 
165 concentrations NNS:165 
164 blocked VBD:69 VBN:95 
164 GATA-1 JJ:5 NN:159 
163 various JJ:163 
163 ] ):162 NN:1 
160 types NNS:160 
160 inhibit VB:100 VBP:60 
160 does VBZ:160 
158 members NNS:158 
158 cortisol JJ:5 NN:153 
158 changes NNS:155 VBZ:3 
158 acute JJ:158 
157 resulted VBD:157 
157 repeat JJ:6 NN:151 
157 express NN:1 VB:56 VBP:100 
157 IL-1 JJ:12 NN:145 
157 's NNS:1 POS:156 
155 same JJ:154 UNKNOWN:1 
155 interleukin JJ:1 NN:154 
155 antibody JJ:4 NN:151 
154 plasma NN:154 
154 Although IN:154 
153 inhibitory JJ:153 
152 membrane NN:152 
152 hematopoietic JJ:152 
152 RNA JJ:3 NN:149 
151 subunit NN:151 
151 cDNA NN:151 
151 Sp1 JJ:3 NN:148 
150 long JJ:144 RB:6 
150 cytoplasmic JJ:150 
150 clones NNS:150 
149 multiple JJ:149 
149 formation NN:149 
149 experiments NNS:149 
148 leukocytes NNS:148 
148 antibodies NNS:148 
147 provide VB:52 VBP:95 
147 new JJ:147 
147 absence NN:147 
145 subjects NNS:145 
145 some DT:145 
144 dexamethasone JJ:5 NN:139 
143 regulate VB:80 VBP:63 
143 encoding JJ:4 NN:10 VBG:129 
143 Epstein-Barr JJ:143 
142 without IN:142 
142 respectively RB:142 
142 molecule JJ:1 NN:141 
142 group NN:142 
142 controls NNS:112 VBZ:30 
142 4 CD:130 LS:11 NN:1 
141 regions NNS:141 
141 peptide JJ:1 NN:140 
141 HTLV-I JJ:23 NN:118 
140 potent JJ:140 
140 kinases NNS:140 
140 6 CD:137 JJ:3 
139 motifs NNS:139 
139 box JJ:3 NN:136 
139 MHC JJ:4 NN:135 
138 secretion NN:138 
138 nucleus NN:138 
138 mutation NN:138 
138 functions NNS:105 VBZ:33 
138 domains NNS:138 
138 Using VBG:138 
137 specifically RB:137 
137 action NN:137 
137 IL-12 JJ:9 NN:128 
136 transient JJ:135 NN:1 
136 our PRP$:136 
136 lineage NN:136 
136 appears VBZ:136 
136 adult JJ:132 NN:4 
136 IL-2R JJ:1 NN:135 
134 model JJ:5 NN:127 VB:2 
134 interleukin-2 NN:134 
134 interactions NNS:134 
134 constructs NNS:133 VBZ:1 
134 analyzed VBD:43 VBN:91 
133 mutations NNS:131 UNKNOWN:2 
133 constitutively RB:133 
133 chronic JJ:133 
132 ligand JJ:2 NN:130 
132 bound JJ:3 VBD:81 VBN:48 
132 amino NN:132 
132 CIITA JJ:10 NN:122 
131 transcripts NNS:131 
131 they PRP:131 
131 least JJS:129 RBS:2 
131 activities NNS:131 
131 activates VBZ:131 
131 THP-1 NN:131 
130 - -:3 ::23 CC:2 CD:2 JJ:28 NN:71 NNS:1 
129 degradation NN:129 
129 alone RB:129 
129 Ca2+ JJ:16 NN:113 
128 here RB:127 UNKNOWN:1 
128 able JJ:128 
128 STAT JJ:4 NN:122 NNS:2 
127 manner NN:127 
127 expressing JJ:1 NN:10 VBG:116 
127 against IN:127 
127 CD4 JJ:18 NN:109 
126 purified JJ:1 VBD:2 VBN:123 
126 plays VBZ:126 
126 inhibitors NNS:126 
126 however RB:126 
126 due IN:6 JJ:120 
126 correlated JJ:1 VBD:65 VBN:60 
126 characterized VBD:17 VBN:109 
125 transfection NN:125 
125 lipopolysaccharide JJ:23 NN:102 
125 healthy JJ:125 
125 calcium JJ:12 NN:113 
124 higher JJR:124 
124 decrease NN:107 VB:13 VBP:4 
124 calcineurin JJ:10 NN:114 
124 Activation NN:124 
124 " '':62 ``:62 
123 together RB:123 
123 tissue NN:123 
123 tested VBD:22 VBN:101 
123 result NN:55 VB:48 VBP:20 
123 requires VBZ:123 
123 recently RB:123 
123 less CC:1 JJR:65 RBR:57 
123 cases NNS:123 
123 PU.1 JJ:5 NN:118 
123 < JJR:123 
122 hormone NN:122 
122 determine VB:113 VBN:1 VBP:8 
121 cAMP JJ:14 NN:107 
121 approximately RB:121 
120 indicating VBG:120 
120 glucocorticoids NNS:120 
119 derived JJ:4 VBD:1 VBN:114 
119 cancer NN:119 
119 bp JJ:1 NN:118 
118 cell-specific JJ:118 
118 IL-5 JJ:10 NN:108 
117 strongly RB:117 
117 clinical JJ:117 
117 5 CD:114 LS:3 
116 tissues NNS:116 
116 part NN:116 
116 electrophoretic JJ:116 
116 Both CC:70 DT:45 PDT:1 
115 there EX:113 RB:2 
115 neutrophils NNS:115 
115 many JJ:115 
115 Moreover RB:115 
114 suggests VBZ:114 
114 produced VBD:40 VBN:74 
114 D3 JJ:4 NN:110 
113 suppression NN:113 
113 serum JJ:1 NN:112 
113 reported VBD:20 VBN:93 
113 rapid JJ:113 
113 leads VBZ:113 
113 CD4+ JJ:113 
112 responsible JJ:112 
112 release NN:103 VB:7 VBP:2 
112 immunoglobulin JJ:2 NN:110 
112 conserved JJ:4 VBD:1 VBN:107 
111 pattern NN:111 
111 leukemic JJ:110 NN:1 
111 breast NN:111 
110 therapy NN:110 
110 retinoic JJ:110 
110 process NN:109 VB:1 
110 might MD:109 UNKNOWN:1 
110 mature JJ:105 VB:3 VBP:2 
110 culture NN:110 
110 common JJ:109 NN:1 
110 although IN:110 
110 Human JJ:110 
110 1,25(OH)2D3 JJ:5 NN:105 
109 wild-type JJ:108 NN:1 
109 under IN:109 
109 regulating NN:4 VBG:105 
109 lower JJR:104 RBR:3 VB:2 
109 TPA JJ:26 NN:83 
108 increases NNS:55 VBZ:53 
108 death NN:108 
108 When WRB:108 
107 suggested UNKNOWN:2 VBD:48 VBN:57 
107 second JJ:103 NN:2 RB:2 
107 fusion NN:107 
107 described VBD:3 VBN:104 
106 chromosome NN:106 
106 ICAM-1 JJ:2 NN:104 
106 Expression NN:106 
106 5' JJ:98 NN:5 RB:3 
106 -stimulated JJ:106 
105 consensus NN:105 
105 ER JJ:5 NN:100 
104 caused VBD:65 VBN:39 
103 patient NN:103 
103 independent JJ:102 UNKNOWN:1 
103 differences NNS:103 
103 PBMC NN:82 NNS:21 
103 IFN JJ:14 NN:89 
102 highly RB:102 
102 concentration NN:102 
102 c-Jun JJ:1 NN:101 
102 basal JJ:102 
101 therefore RB:101 
101 proximal JJ:99 NN:2 
101 obtained VBD:5 VBN:96 
101 do VB:3 VBP:98 
101 STAT3 JJ:2 NN:99 
100 mutants NNS:100 
100 inflammation NN:100 
100 indicated VBD:85 VBN:15 
100 directly RB:100 
100 component NN:100 
100 capacity NN:100 
100 affect NN:1 VB:83 VBP:16 
100 STAT1 JJ:3 NN:97 
99 endogenous JJ:99 
99 construct NN:98 VB:1 
99 combination NN:99 
99 c-Rel JJ:1 NN:98 
99 anti- FW:5 JJ:80 NN:14 
99 agents NNS:99 
99 CsA JJ:19 NN:80 
98 sufficient JJ:98 
98 specificity NN:98 
98 product NN:98 
98 mediate VB:60 VBP:38 
98 deletion NN:98 
98 any DT:98 
98 affected JJ:2 VBD:15 VBN:81 
97 treated JJ:11 VBD:1 VBN:85 
97 resting JJ:6 NN:1 VBG:90 
97 resistance NN:97 
97 regulates VBZ:97 
97 member NN:97 
97 mAb JJ:2 NN:95 
97 interferon JJ:3 NN:94 
97 direct JJ:87 VB:8 VBP:2 
97 VDR NN:96 NNS:1 
97 GC JJ:14 NN:76 NNS:7 
97 -binding JJ:89 NN:8 
96 s JJ:1 NN:3 NNS:91 VBZ:1 
96 phenotype NN:96 
96 conditions NNS:95 VBZ:1 
96 X NN:96 
95 variety NN:95 
95 macrophage JJ:3 NN:92 
95 kappaB JJ:12 NN:83 
95 detectable JJ:95 
95 cloned VBD:11 VBN:84 
95 HeLa NN:95 
94 vitamin NN:94 
94 thus RB:94 
94 phase JJ:2 NN:92 
94 overexpression NN:94 
94 measured VBD:14 VBN:80 
94 markedly RB:94 
94 blot NN:94 
94 accumulation NN:94 
94 VCAM-1 JJ:4 NN:90 
94 HL-60 NN:94 
94 By IN:94 
93 very RB:93 
93 octamer JJ:3 NN:90 
93 necessary JJ:93 
93 monoclonal JJ:93 
93 individuals NNS:93 
93 ester JJ:13 NN:80 
93 D JJ:7 NN:86 
92 single JJ:92 
92 locus NN:92 
92 four CD:92 
92 each DT:92 
92 downstream JJ:68 RB:24 
92 contribute VB:62 VBP:30 
92 colony-stimulating JJ:92 
92 C/EBP JJ:1 NN:91 
91 seen VBN:91 
91 rapidly RB:91 
91 natural JJ:91 
91 initiation NN:91 
91 contain VB:29 VBP:62 
91 LMP1 JJ:6 NN:85 
91 An DT:91 
90 stimuli NNS:90 
90 properties NNS:90 
90 phosphorylated JJ:23 VBD:2 VBN:65 
90 likely JJ:57 RB:33 
90 identify VB:62 VBP:28 
90 diseases NNS:90 
90 cyclosporin JJ:2 NN:88 
89 transformation NN:89 
89 putative JJ:89 
89 isoforms NNS:88 VBZ:1 
89 forms NNS:79 VBZ:10 
89 estrogen JJ:4 NN:85 
89 contained VBD:77 VBN:12 
89 conclude VB:2 VBP:87 
88 min NN:88 
88 cultured VBD:2 VBN:86 
88 bone NN:88 
87 unknown JJ:87 
87 steroid JJ:3 NN:84 
87 markers NNS:87 
87 Th2 NN:87 
87 Oct-2 JJ:5 NN:82 
86 responsiveness NN:86 
86 lymphoma NN:86 
86 globin NN:86 
86 CREB NN:86 
86 > JJ:9 JJR:44 RBR:2 TO:31 
85 phosphatase JJ:1 NN:84 
85 pathogenesis NN:85 
85 fibroblasts NNS:85 
85 differential JJ:85 
85 clone NN:84 VB:1 
85 IL-8 NN:85 
85 Finally RB:85 
85 E2F JJ:13 NN:72 
84 time NN:84 
84 thymocytes NNS:84 
84 survival JJ:1 NN:83 
84 neutrophil JJ:6 NN:78 
84 maturation NN:84 
84 leading VBG:84 
84 Ig DT:1 JJ:2 NN:81 
84 ' '':27 POS:31 ``:26 
83 transgenic JJ:83 
83 resulting VBG:83 
83 reduction NN:83 
83 possible JJ:83 
83 nM NN:83 
83 analyses NNS:83 
83 Tat JJ:13 NN:70 
82 syndrome NN:82 
82 suppressed VBD:43 VBN:39 
82 peptides NNS:82 
82 loss NN:82 
82 exposure NN:82 
82 completely RB:82 
82 because IN:82 
82 antigens NNS:82 
82 CAT NN:82 
81 use NN:66 VB:6 VBP:9 
81 support NN:24 VB:11 VBP:46 
81 sensitive JJ:81 
81 generated VBD:16 VBN:65 
81 STAT5 JJ:2 NN:79 
80 women NNS:80 
80 occurs VBZ:80 
80 kDa JJ:3 NN:77 
80 interact NN:1 VB:43 VBP:36 
80 implicated VBD:3 VBN:77 
80 activating JJ:3 NN:16 VBG:61 
80 acids NNS:80 
80 TCF-1 JJ:1 NN:79 
80 One CD:80 
80 K562 NN:80 
80 Inhibition NN:80 
80 CD3 JJ:17 NN:63 
80 As IN:76 RB:4 
80 / ::5 JJ:41 NN:33 NNS:1 
79 serine JJ:6 NN:73 
79 correlation NN:79 
79 block NN:28 VB:37 VBP:14 
79 NFkappaB JJ:2 NN:77 
79 IL-13 JJ:10 NN:69 
78 products NNS:78 
78 observations NNS:78 
78 little JJ:77 RB:1 
78 involvement NN:78 
78 investigate VB:70 VBP:8 
78 influence NN:28 VB:39 VBP:11 
78 dominant JJ:78 
78 association NN:78 
78 aldosterone NN:78 
78 Northern JJ:7 NN:71 
78 Ets NN:74 NNS:4 
78 + CC:32 JJ:43 NN:3 
77 latent JJ:77 
77 identical JJ:77 
77 basis NN:77 
76 subunits NNS:76 
76 structure NN:76 
76 stress NN:76 
76 effector NN:76 
76 delta NN:75 NNS:1 
76 cultures NNS:76 
76 capable JJ:76 
76 asthma NN:76 
76 Two CD:76 
76 TF JJ:1 NN:75 
76 IL-1beta JJ:1 NN:75 
76 50 CD:76 
76 20 CD:76 
75 recombinant JJ:74 NN:1 
75 lack NN:48 UNKNOWN:1 VB:1 VBP:25 
75 N-terminal JJ:75 
75 -infected JJ:75 
74 shock JJ:1 NN:73 
74 recognized VBD:17 VBN:57 
74 reaction NN:74 
74 enzyme NN:74 
74 Therefore RB:74 
73 strong JJ:73 
73 stage JJ:1 NN:72 
73 factor-alpha JJ:5 NN:68 
73 epithelial JJ:70 NN:3 
73 elevated JJ:62 VBD:4 VBN:7 
73 anti-CD3 JJ:53 NN:20 
73 activators NNS:73 
73 RAR JJ:5 NN:66 NNS:2 
73 Nuclear JJ:73 
72 whose WP$:72 
72 since IN:72 
72 regulator NN:72 
72 precursor JJ:3 NN:69 
72 nor CC:72 
72 genetic JJ:68 UNKNOWN:4 
72 established JJ:14 VBD:17 VBN:41 
72 cross-linking JJ:11 NN:60 VBG:1 
72 biological JJ:72 
72 Stat3 JJ:3 NN:69 
71 up-regulation NN:71 
71 small JJ:71 
71 selective JJ:71 
71 rate NN:71 
71 linked JJ:1 VBD:3 VBN:67 
71 eosinophils NNS:71 
71 c-myc JJ:1 NN:70 
71 c-Fos NN:71 
70 status NN:70 
70 restricted JJ:67 VBN:3 
70 fragment NN:70 
70 failed JJ:1 VBD:67 VBN:2 
70 before IN:70 
70 additional JJ:70 
70 Th1 NN:70 
70 IgE NN:70 
70 FK506 JJ:6 NN:64 
70 24 CD:70 
70 13-acetate JJ:4 NN:66 
69 stimulate VB:52 VBP:17 
69 responsive JJ:67 NN:2 
69 relative JJ:68 NN:1 
69 lead NN:3 VB:34 VBD:2 VBN:1 VBP:29 
69 key JJ:69 
69 gel NN:69 
69 Since IN:69 
69 E1A JJ:10 NN:59 
68 residues NNS:68 
68 marrow JJ:2 NN:66 
68 genomic JJ:68 
68 defined VBD:3 VBN:65 
68 certain JJ:68 
68 and/or CC:68 
68 act VB:43 VBP:25 
68 about IN:39 RB:27 RP:2 
68 T-cells NNS:68 
68 Oct-1 JJ:3 NN:65 
68 Fas JJ:13 NN:55 
68 DC JJ:3 NN:41 NNS:24 
67 repression NN:67 
67 recognition NN:67 
67 progression NN:67 
67 now NN:1 RB:66 
67 involves VBZ:67 
67 fetal JJ:67 
67 correlates NNS:1 VBZ:66 
67 core NN:67 
67 Taken VBN:67 
67 Bcl-2 JJ:2 NN:65 
66 zinc JJ:2 NN:64 
66 tissue-specific JJ:66 
66 subsequent JJ:66 
66 heterodimers NNS:66 
66 generation NN:66 
66 controlled JJ:3 VBN:63 
66 confirmed VBD:26 VBN:40 
66 components NNS:66 
66 CD14 JJ:5 NN:61 
65 unique JJ:65 
65 transcript NN:65 
65 propose VB:1 VBP:64 
65 progesterone JJ:5 NN:60 
65 plus CC:64 JJ:1 
65 microM NN:64 NNS:1 
65 interacts UNKNOWN:1 VBZ:64 
65 hybridization NN:65 
65 host NN:65 
65 even JJ:1 RB:64 
65 -specific JJ:65 
64 progenitors NNS:64 
64 patterns NNS:64 
64 partially RB:64 
64 lytic JJ:64 
64 ligation NN:64 
64 leukocyte JJ:3 NN:61 
64 inducing NN:1 VBG:63 
64 impaired JJ:57 VBD:5 VBN:2 
64 encodes VBZ:64 
64 difference NN:64 
64 consistent JJ:64 
64 combined JJ:52 VBD:2 VBN:10 
64 apoptotic JJ:64 
64 IkappaBalpha JJ:1 NN:63 
64 Egr-1 JJ:3 NN:61 
64 8 CD:63 NN:1 
63 state NN:63 
63 start NN:61 VBP:2 
63 selectively RB:63 
63 promyelocytic JJ:63 
63 latency NN:63 
63 late JJ:59 RB:4 
63 killer NN:63 
63 inactivation NN:63 
63 homology NN:63 
63 exhibited VBD:62 VBN:1 
63 among IN:63 
63 altered JJ:36 VBD:5 VBN:22 
63 M-CSF JJ:2 NN:61 
63 Induction NN:63 
63 30 CD:63 
62 termed VBD:1 VBN:61 
62 sensitivity NN:62 
62 samples NNS:62 
62 roles NNS:62 
62 progenitor NN:62 
62 performed VBD:10 VBN:52 
62 minimal JJ:62 
62 led VBD:55 VBN:7 
62 kb NN:62 
62 involving NN:1 VBG:61 
62 intact JJ:62 
62 accompanied VBD:1 VBN:61 
62 PHA JJ:20 NN:42 
62 NFATp JJ:2 NN:60 
62 IL-3 JJ:6 NN:56 
62 15 CD:62 
62 12-myristate NN:62 
61 yet CC:4 RB:57 
61 transformed JJ:8 VBD:2 VBN:51 
61 species NNS:61 
61 repressor NN:61 
61 polymerase NN:61 
61 nuclei NNS:61 
61 modulation NN:61 
61 lacking JJ:1 NN:1 VBG:59 
61 inhibiting JJ:1 NN:2 VBG:58 
61 hours NNS:61 
61 heterodimer NN:61 
61 functionally RB:61 
61 bacterial JJ:61 
61 acetate JJ:5 NN:56 
61 BSAP JJ:2 NN:59 
61 -treated JJ:60 NN:1 
60 tumors NNS:60 
60 still RB:60 
60 protein-1 JJ:3 NN:57 
60 particular JJ:60 
60 factor-kappa NN:60 
60 characterization NN:60 
60 acts VBZ:60 
60 Ras JJ:5 NN:54 NNS:1 
60 GATA NN:60 
59 transactivator NN:59 
59 reactive JJ:59 
59 order NN:59 
59 mediates VBZ:59 
59 localization NN:59 
59 inactive JJ:59 
59 groups NNS:59 
59 greater JJR:59 
59 granulocytes NNS:59 
59 effective JJ:59 
59 cis-acting JJ:57 NN:1 VBG:1 
59 adenovirus JJ:4 NN:55 
59 abolished VBD:39 VBN:20 
59 GATA-3 JJ:1 NN:58 
59 Analysis NN:59 
59 All DT:54 PDT:5 
58 up CD:1 IN:14 NN:1 RB:35 RP:7 
58 proliferative JJ:57 NN:1 
58 platelets NNS:58 
58 interleukin-1 NN:58 
58 if IN:58 
58 beta-globin IN:1 JJ:1 NN:56 
58 alterations NNS:58 
58 Regulation NN:58 
58 CD2 JJ:5 NN:53 
58 APL JJ:1 NN:57 
58 -- ::27 TO:31 
57 vascular JJ:57 
57 understanding NN:44 UNKNOWN:1 VBG:12 
57 therapeutic JJ:57 
57 stages NNS:57 
57 stably RB:57 
57 population NN:57 
57 p NN:57 
57 mutated JJ:2 VBD:1 VBN:54 
57 large JJ:57 
57 heat NN:57 
57 followed VBD:4 VBN:53 
57 drug NN:57 
57 differentiated JJ:1 VBD:4 VBN:52 
57 defective JJ:57 
57 another DT:57 
57 RelA JJ:2 NN:55 
57 Interestingly RB:57 
57 IL NN:57 
57 IFN-alpha JJ:4 NN:53 
57 Because IN:57 
57 ATRA JJ:11 NN:46 
57 AIDS JJ:2 NN:53 NNP:2 
57 12 CD:56 NN:1 
56 stimulates VBZ:56 
56 situ FW:56 
56 signalling NN:55 VBG:1 
56 range NN:56 
56 produce VB:39 VBP:17 
56 previous JJ:56 
56 oxidative JJ:56 
56 over IN:55 RP:1 
56 lineages NNS:56 
56 importance NN:56 
56 extracellular JJ:56 
56 closely RB:56 
56 characteristics NNS:56 
56 Treatment NN:56 
56 Stimulation NN:56 
56 3-kinase JJ:2 NN:54 
56 -responsive JJ:55 NN:1 
55 where UNKNOWN:1 WRB:54 
55 targets NNS:45 UNKNOWN:1 VBZ:9 
55 suppress VB:38 VBP:17 
55 resistant JJ:55 
55 prevented VBD:45 VBN:10 
55 occur VB:34 VBP:21 
55 mitogen-activated JJ:55 
55 hypothesis NN:55 
55 heterologous JJ:55 
55 enhance VB:33 VBP:22 
55 androgen JJ:2 NN:53 
55 alternative JJ:53 NN:2 
55 RESULTS NNS:55 
55 NAC NN:55 
55 M NN:55 
55 Jun JJ:1 NN:52 NNP:2 
55 Fc NN:55 
55 C-terminal JJ:55 
55 BCL-6 JJ:9 NN:46 
55 -like JJ:55 
55 -independent JJ:55 
54 repeats NNS:54 
54 processes NNS:53 VBZ:1 
54 point NN:45 VBP:9 
54 oncogene JJ:1 NN:53 
54 luciferase NN:54 
54 ionophore NN:54 
54 involve VB:40 VBP:14 
54 cytosol NN:54 
54 cytoplasm NN:54 
54 corresponding JJ:30 VBG:24 
54 chimeric JJ:54 
54 cascade NN:54 
54 being VBG:54 
54 assessed VBD:6 VBN:48 
54 Western JJ:4 NN:50 
54 U-937 NN:54 
54 PML JJ:1 NN:53 
54 HLA NN:54 
54 EC NN:44 NNS:10 
53 values NNS:53 
53 predominantly RB:53 
53 p105 NN:53 
53 occurred VBD:50 VBN:3 
53 neither CC:41 DT:12 
53 maximal JJ:53 
53 helper NN:53 
53 granulocyte-macrophage JJ:52 NN:1 
53 dose-dependent JJ:53 
53 appear VB:14 VBP:39 
53 apparent JJ:53 
53 Stat NN:50 NNS:3 
53 7 CD:52 NN:1 
52 variant JJ:26 NN:26 
52 thought VBN:52 
52 synthetic JJ:52 
52 switch NN:48 VB:2 VBP:2 
52 series NN:48 NNS:4 
52 naive JJ:52 
52 molecule-1 NN:52 
52 immunosuppressive JJ:52 
52 evaluated VBD:19 VBN:33 
52 enhances VBZ:52 
52 drugs NNS:52 
52 down-regulation NN:52 
52 developed VBD:21 VBN:31 
52 cytotoxic JJ:52 
52 allele JJ:3 NN:49 
52 ZEBRA JJ:6 NN:46 
52 TNFalpha JJ:3 NN:49 
52 Rel JJ:6 NN:46 
51 upregulation NN:51 
51 staining NN:45 VBG:6 
51 shows VBZ:51 
51 relationship NN:51 
51 probe NN:49 VB:2 
51 oxygen NN:51 
51 oligonucleotides NNS:51 
51 megakaryocytic JJ:51 
51 mediating VBG:51 
51 localized JJ:36 VBD:10 VBN:5 
51 incubation NN:51 
51 immediate-early JJ:51 
51 histocompatibility NN:51 
51 factor-kappaB JJ:2 NN:49 
51 differentiate VB:38 VBP:13 
51 defect NN:51 
51 days NNS:51 
51 crucial JJ:51 
51 basic JJ:51 
51 arrest NN:49 VB:2 
51 antagonist NN:51 
51 Stat1 JJ:2 NN:49 
51 STAT6 JJ:3 NN:48 
51 No DT:51 
51 HTLV-1 JJ:7 NN:44 
51 3' JJ:48 NN:1 RB:2 
51 11 CD:50 NN:1 
50 tuberculosis FW:7 JJ:2 NN:41 
50 transiently RB:50 
50 then RB:50 
50 marked JJ:49 VBN:1 
50 ligands NNS:50 
50 ionomycin JJ:7 NN:43 
50 germline NN:50 
50 genome NN:50 
50 finger NN:50 
50 exon NN:50 
50 epsilon NN:50 
50 encoded VBD:3 VBN:47 
50 efficiently RB:50 
50 central JJ:50 
50 along IN:50 
50 IRF-1 JJ:2 NN:48 
50 Further IN:1 JJ:17 RB:32 
50 CD8+ JJ:50 
50 Binding NN:45 VBG:5 
49 useful JJ:49 
49 reverse JJ:39 NN:7 VB:3 
49 remains VBZ:49 
49 rather RB:49 
49 platelet NN:49 
49 lung NN:49 
49 kinetics NN:6 NNS:43 
49 flow NN:49 
49 enhancement NN:49 
49 designated JJ:1 VBD:1 VBN:47 
49 chloramphenicol JJ:5 NN:44 
49 biochemical JJ:49 
49 appeared VBD:49 
49 Recent JJ:49 
49 HL60 NN:49 
49 G1 NN:49 
49 Epo JJ:8 NN:41 
49 AML NN:49 
48 vector NN:48 
48 structural JJ:48 
48 secondary JJ:48 
48 recruitment NN:48 
48 physiological JJ:48 
48 malignant JJ:48 
48 like IN:44 JJ:4 
48 individual JJ:40 NN:8 
48 immediate JJ:48 
48 hr NN:48 
48 granulocytic JJ:48 
48 differ VB:18 VBP:30 
48 context NN:48 
48 change NN:39 VB:7 VBP:2 
48 amounts NNS:48 
48 Transcriptional JJ:48 
48 Kd NN:48 
48 JNK JJ:2 NN:46 
48 JAK3 JJ:3 NN:45 
48 IkappaB NN:48 
48 H2O2 JJ:4 NN:44 
47 remained VBD:43 VBN:4 
47 provides VBZ:47 
47 processing NN:47 
47 precursors NNS:47 
47 myristate JJ:1 NN:46 
47 formed VBD:16 VBN:31 
47 fashion NN:47 
47 extent NN:47 
47 antisense JJ:46 NN:1 
47 alter VB:42 VBP:5 
47 acetyltransferase JJ:2 NN:45 
47 There EX:47 
47 IL-7 JJ:4 NN:43 
46 ubiquitous JJ:46 
46 truncated JJ:7 VBN:39 
46 thyroid JJ:2 NN:44 
46 soluble JJ:46 
46 six CD:46 
46 proinflammatory JJ:46 
46 oligonucleotide JJ:3 NN:43 
46 memory NN:46 
46 increasing VBG:46 
46 implications NNS:46 
46 how WRB:46 
46 exogenous JJ:46 
46 event NN:46 
46 dissociation NN:46 
46 cause NN:10 VB:26 VBP:10 
46 blocks NNS:2 VBZ:44 
46 MAPK JJ:2 NN:44 
46 FasL JJ:2 NN:44 
46 E-selectin NN:46 
46 CRE JJ:3 NN:43 
46 AP1 JJ:2 NN:44 
45 step NN:45 
45 sodium NN:45 
45 severe JJ:45 
45 respond VB:25 VBP:20 
45 preferentially RB:45 
45 possibility NN:45 
45 p38 JJ:2 NN:43 
45 medium JJ:1 NN:44 
45 mean JJ:10 NN:35 
45 mammalian JJ:45 
45 mRNAs NNS:45 
45 lymphoblastoid JJ:44 NN:1 
45 interferon-gamma JJ:1 NN:44 
45 include VB:7 VBP:38 
45 efficient JJ:45 
45 distal JJ:45 
45 composed VBN:45 
45 comparison NN:45 
45 anti-inflammatory JJ:45 
45 abnormalities NNS:45 
45 PGE2 JJ:3 NN:42 
45 NF-kB NN:45 
45 Glucocorticoid JJ:7 NN:38 
45 B-cell-specific JJ:45 
45 After IN:45 
45 17 CD:45 
44 tumour JJ:2 NN:42 
44 transducer NN:44 
44 total JJ:37 NN:6 VBP:1 
44 thymus NN:44 
44 test NN:21 VB:23 
44 systems NNS:44 
44 require VB:33 VBP:11 
44 modulate VB:31 VBP:13 
44 initial JJ:44 
44 esters NNS:44 
44 describe VB:1 VBP:43 
44 coding NN:14 UNKNOWN:2 VBG:28 
44 case NN:44 
44 age NN:44 
44 SLP-76 JJ:3 NN:41 
44 METHODS NNS:44 
44 IgH JJ:8 NN:36 
44 Electrophoretic JJ:44 
44 E FW:1 JJ:2 NN:40 NNP:1 
44 0.05 CD:44 
44 -inducible JJ:44 
43 transcriptionally RB:43 
43 them PRP:43 
43 sustained JJ:38 VBD:3 VBN:2 
43 stem NN:42 VBP:1 
43 stable JJ:43 
43 regulators NNS:43 
43 rat NN:43 
43 p53 JJ:3 NN:40 
43 p21ras NN:43 
43 out IN:10 RB:4 RP:29 
43 granulocyte JJ:1 NN:42 
43 features NNS:43 
43 exposed JJ:1 VBD:1 VBN:41 
43 differentially RB:43 
43 costimulation NN:43 
43 clearly RB:43 
43 chromatin JJ:3 NN:40 
43 antioxidant JJ:27 NN:16 
43 agent NN:43 
43 Transcription NN:43 
43 PDTC JJ:1 NN:42 
43 HIV-2 NN:43 
43 G-CSF JJ:3 NN:40 
43 Fos JJ:1 NN:42 
43 EBNA2 JJ:3 NN:40 
43 CTL NN:43 
43 AML1 JJ:2 NN:41 
42 work NN:39 VB:1 VBP:2 
42 vectors NNS:42 
42 understand VB:42 
42 underlying JJ:7 VBG:35 
42 unaffected JJ:37 VBN:5 
42 stability NN:42 
42 prepared VBD:3 VBN:39 
42 populations NNS:42 
42 okadaic JJ:42 
42 lymphocytic JJ:42 
42 five CD:42 
42 enhancers NNS:42 
42 cyclic JJ:42 
42 content NN:42 
42 compounds NNS:42 
42 chronically RB:42 
42 PBL NN:35 NNS:7 
42 DRA NN:42 
41 uptake NN:41 
41 tax NN:41 
41 subset NN:41 
41 relevant JJ:41 
41 position NN:41 
41 plasmids NNS:41 
41 plasmid NN:41 
41 novo FW:41 
41 n NN:41 
41 much JJ:13 RB:28 
41 indicates VBZ:41 
41 homologous JJ:41 
41 failure NN:41 
41 diminished UNKNOWN:1 VBD:14 VBN:26 
41 course NN:41 
41 complete JJ:40 VB:1 
41 base NN:41 
41 approach NN:39 VB:2 
41 Recently RB:41 
41 NF-IL6 NN:41 
41 MNDA JJ:1 NN:40 
41 Janus NN:41 
41 GCR NN:41 
41 G JJ:3 NN:38 
41 CD23 JJ:2 NN:39 
41 CBF NN:41 
41 -associated JJ:41 
40 yeast NN:40 
40 up-regulated JJ:1 VBD:7 VBN:32 
40 protease NN:40 
40 possibly RB:40 
40 parameters NNS:40 
40 footprinting NN:40 
40 examine VB:37 VBP:3 
40 donors NNS:40 
40 displayed VBD:36 VBN:4 
40 directed JJ:2 VBD:3 VBN:35 
40 developmental JJ:40 
40 define VB:29 VBP:11 
40 de FW:40 
40 all-trans JJ:40 
40 Similar JJ:40 
40 SCL NN:40 
40 MCP-1 JJ:1 NN:39 
40 Elf-1 JJ:2 NN:38 
40 EBNA-2 JJ:8 NN:32 
40 DNase NN:40 
40 B1 NN:40 
40 AP-2 JJ:2 NN:38 
40 40 CD:40 
40 100 CD:40 
39 unable JJ:39 
39 synergistically RB:39 
39 susceptibility NN:39 
39 subsets NNS:39 
39 splicing NN:39 
39 secreted JJ:3 VBD:3 VBN:33 
39 rheumatoid JJ:35 NN:4 
39 redox JJ:1 NN:38 
39 promonocytic JJ:39 
39 primarily RB:39 
39 positions NNS:38 VBZ:1 
39 migration NN:39 
39 independently RB:39 
39 general JJ:39 
39 finding NN:38 VBG:1 
39 families NNS:39 
39 engagement NN:39 
39 elderly JJ:39 
39 degree NN:39 
39 cycloheximide NN:39 
39 constant JJ:12 NN:27 
39 carcinoma NN:39 
39 While IN:39 
39 On IN:39 
39 E2 JJ:1 NN:38 
39 14 CD:37 JJ:1 NN:1 
39 -driven JJ:39 
38 x CC:19 NN:19 
38 requirement NN:38 
38 relatively RB:38 
38 proteasome JJ:9 NN:29 
38 presented VBD:7 VBN:31 
38 mitogenic JJ:38 
38 integrin JJ:7 NN:31 
38 identification NN:37 UNKNOWN:1 
38 free JJ:38 
38 find VB:12 VBP:26 
38 exclusively RB:38 
38 dose NN:38 
38 display NN:10 VB:6 VBP:22 
38 disorder NN:38 
38 despite IN:38 
38 day NN:38 
38 cytotoxicity NN:38 
38 correlate NN:2 VB:22 VBP:14 
38 clonal JJ:38 
38 appearance NN:38 
38 U1 NN:38 
38 T-lymphocytes NNS:38 
38 MAP NN:38 
38 EPO JJ:10 NN:28 
38 BZLF1 JJ:2 NN:36 
38 AT IN:27 NN:11 
38 13 CD:38 
38 -resistant JJ:38 
37 thrombin IN:1 JJ:4 NN:32 
37 represent VB:24 VBP:13 
37 recent JJ:37 
37 potentially RB:37 
37 participate VB:18 VBP:19 
37 optimal JJ:37 
37 normally RB:37 
37 mineralocorticoid NN:37 
37 marker NN:37 
37 lysis NN:37 
37 leukemias NN:1 NNS:36 
37 infiltration NN:37 
37 inducibility NN:37 
37 immature JJ:37 
37 erythropoietin JJ:5 NN:32 
37 decreases NNS:14 VBZ:23 
37 cytosolic JJ:37 
37 characteristic JJ:29 NN:8 
37 carrying NN:1 VBG:36 
37 bcl-2 JJ:1 NN:36 
37 arthritis NN:37 
37 TAL1 NN:37 
37 S NN:33 NNP:4 
37 RelB JJ:1 NN:36 
37 RT-PCR JJ:1 NN:36 
37 EKLF NN:37 
37 CEM NN:37 
37 CD19 JJ:1 NN:36 
37 0.01 CD:37 
37 -activated JJ:36 NN:1 
36 who WP:36 
36 unstimulated JJ:36 
36 synergistic JJ:36 
36 switching NN:35 VBG:1 
36 supershift NN:35 VB:1 
36 set NN:30 VBD:3 VBN:2 VBP:1 
36 selection NN:36 
36 persistent JJ:36 
36 origin NN:36 
36 myelomonocytic JJ:36 
36 mutagenesis NN:36 
36 modified JJ:3 VBD:1 VBN:32 
36 liver JJ:1 NN:35 
36 initiated JJ:1 VBD:7 VBN:28 
36 hormones NNS:36 
36 costimulatory JJ:35 NN:1 
36 contributes VBZ:36 
36 cloning NN:33 VBG:3 
36 classical JJ:36 
36 alveolar JJ:35 NN:1 
36 affecting VBG:36 
36 absent JJ:36 
36 ZAP-70 JJ:1 NN:35 
36 PCR NN:36 
36 Burkitt NN:36 
36 BACKGROUND NN:36 
36 /Rel NN:36 
35 should MD:35 
35 selected JJ:2 VBD:2 VBN:31 
35 risk NN:34 VBP:1 
35 provided VBD:8 VBN:27 
35 per FW:10 IN:25 
35 modulating JJ:1 NN:3 VBG:31 
35 lymphoblastic JJ:35 
35 largely RB:35 
35 itself PRP:35 
35 i.e. FW:35 
35 greatly RB:35 
35 eosinophil NN:35 
35 demonstrates VBZ:35 
35 cytometry NN:35 
35 controlling JJ:1 VBG:34 
35 chemokine NN:35 
35 augmented JJ:14 VBD:13 VBN:8 
35 amount NN:35 
35 abnormal JJ:35 
35 UV JJ:4 NN:31 
35 Together RB:35 
35 TATA JJ:1 NN:34 
35 Nef JJ:2 NN:33 
35 Jak3 NN:35 
35 For IN:35 
35 E2A NN:35 
35 CD11b NN:35 
35 -1 CD:22 JJ:2 NN:10 NNS:1 
34 thymic JJ:34 
34 synthesized VBD:1 VBN:33 
34 synergy NN:34 
34 suppressor NN:34 
34 spleen NN:34 
34 serve VB:25 VBP:9 
34 review NN:31 VB:1 VBP:2 
34 remain VB:3 VBP:31 
34 promote VB:25 VBP:9 
34 prevents VBZ:34 
34 phenomenon NN:34 
34 numbers NNS:34 
34 nucleotides NNS:34 
34 nucleotide JJ:5 NN:29 
34 isoform NN:34 
34 heavy JJ:30 NN:4 
34 glutathione JJ:1 NN:33 
34 explain VB:32 VBP:2 
34 erythroid-specific JJ:34 
34 doses NNS:34 
34 distribution NN:34 
34 cysteine JJ:7 NN:27 
34 conclusion NN:34 
34 coactivator NN:34 
34 causes NNS:1 VBZ:33 
34 c-myb NN:34 
34 blocking NN:5 VBG:29 
34 better JJR:21 RB:1 RBR:12 
34 antioxidants NNS:34 
34 Transient JJ:34 
34 T3 CD:2 JJ:3 NN:27 NNS:2 
34 RXR JJ:4 NN:30 
34 HUVECs NNS:34 
34 HMG NN:34 
34 Characterization NN:34 
34 CONCLUSIONS NNS:34 
34 CD30 JJ:8 NN:26 
34 At IN:34 
34 9 CD:34 
34 -positive JJ:34 
33 weak JJ:33 
33 variants NNS:33 
33 triggering NN:27 VBG:6 
33 transcribed VBD:1 VBN:32 
33 transactivate VB:28 VBP:5 
33 substrates NNS:33 
33 significance NN:33 
33 seems VBZ:33 
33 proto-oncogene JJ:1 NN:32 
33 pretreatment JJ:1 NN:32 
33 polymorphism NN:33 
33 physical JJ:33 
33 mediators NNS:33 
33 mapped VBD:6 VBN:27 
33 majority NN:33 
33 lymphokine JJ:2 NN:31 
33 light JJ:16 NN:17 
33 intercellular JJ:33 
33 incubated VBD:1 VBN:32 
33 humans NNS:33 
33 herpesvirus JJ:1 NN:32 
33 fused VBD:2 VBN:31 
33 freshly RB:33 
33 fragments NNS:33 
33 fact NN:33 
33 exert VB:16 VBN:1 VBP:16 
33 epitopes NNS:33 
33 detect VB:32 VBP:1 
33 defects NNS:31 VBZ:2 
33 current JJ:31 NN:2 
33 considered VBD:2 VBN:31 
33 become VB:14 VBN:6 VBP:13 
33 based JJ:3 VBN:30 
33 almost RB:33 
33 actions NNS:33 
33 TGF-beta NN:33 
33 Stat6 JJ:2 NN:31 
33 Spi-B JJ:1 NN:32 
33 LMP-1 JJ:2 NN:31 
33 Jak1 JJ:4 NN:29 
33 Jak JJ:6 NN:27 
33 Functional JJ:33 
33 Constitutive JJ:33 
33 Consistent JJ:33 
33 CMV NN:33 
33 Ag NN:33 
32 understood JJ:1 VBN:31 
32 translation NN:32 
32 toward IN:32 
32 tandem JJ:32 
32 synovial JJ:31 NN:1 
32 substrate JJ:3 NN:29 
32 strain NN:32 
32 requirements NNS:32 
32 p50/p65 NN:32 
32 mobilization NN:32 
32 mainly RB:32 
32 lesions NNS:32 
32 latter JJ:32 
32 kD NN:32 
32 embryonic JJ:32 
32 disorders NNS:32 
32 consists VBZ:32 
32 chromosomal JJ:29 NN:3 
32 called VBD:1 VBN:31 
32 apparently RB:32 
32 Stat5 JJ:1 NN:31 
32 Rb NN:32 
32 Previous JJ:32 
32 NO DT:1 JJ:1 NN:30 
32 N NN:32 
32 HLA-DR JJ:2 NN:30 
32 GAS JJ:2 NN:30 
32 B2 NN:32 
32 AR JJ:2 NN:19 NNS:11 
31 will MD:31 
31 weight NN:31 
31 viruses NNS:31 
31 translocations NNS:31 
31 transforming JJ:1 NN:5 VBG:25 
31 slightly RB:31 
31 share NN:2 VB:4 VBP:25 
31 represents VBZ:31 
31 renal JJ:31 
31 rearrangements NNS:31 
31 probably RB:31 
31 pre-B JJ:28 NN:3 
31 phytohemagglutinin JJ:7 NN:24 
31 long-term JJ:31 
31 limited JJ:27 VBN:4 
31 insulin JJ:1 NN:30 
31 immunity NN:31 
31 germinal JJ:31 
31 fully RB:31 
31 flanking JJ:24 NN:4 VBG:3 
31 dendritic JJ:31 
31 deficiency NN:31 
31 characterize VB:25 VBP:6 
31 blasts NNS:31 
31 assembly NN:31 
31 analysed JJ:1 VBD:6 VBN:24 
31 adjacent JJ:31 
31 adherence NN:31 
31 acidic JJ:31 
31 Type NN:31 
31 Several JJ:31 
31 NFAT-1 JJ:1 NN:30 
31 J JJ:1 NN:19 NNP:11 
31 Drosophila FW:22 NN:9 
31 25 CD:31 
31 21 CD:31 
30 young JJ:30 
30 years NN:1 NNS:29 
30 variation NN:30 
30 untreated JJ:30 
30 turn NN:30 
30 transducers NNS:30 
30 size NN:30 
30 short JJ:30 
30 reveal VB:4 VBP:26 
30 prolonged JJ:26 VBD:4 
30 program NN:30 
30 polyclonal JJ:30 
30 peak JJ:7 NN:21 VB:1 VBP:1 
30 parallel JJ:12 NN:16 VB:1 VBP:1 
30 observation NN:30 
30 months NNS:30 
30 modulated JJ:1 VBD:2 VBN:27 
30 lysates NNS:30 
30 library NN:30 
30 histone NN:30 
30 hGR NN:30 
30 fraction NN:30 
30 exhibit VB:5 VBP:25 
30 establish VB:14 VBP:16 
30 entry NN:30 
30 encode VB:7 VBP:23 
30 dramatically RB:30 
30 down-regulated VBD:4 VBN:26 
30 discussed VBN:30 
30 deficient JJ:29 NN:1 
30 circulating JJ:2 VBG:28 
30 center JJ:1 NN:29 
30 Three CD:30 
30 PPARgamma NN:30 
30 PBMCs NNS:30 
30 NF-E2 NN:30 
30 NF-ATp JJ:6 NN:24 
30 NF-ATc NN:30 
30 Increased VBN:30 
30 During IN:30 
30 Copyright NN:30 
30 Cell NN:23 NNP:7 
29 variable JJ:25 NN:4 
29 transduced JJ:1 VBD:2 VBN:26 
29 systemic JJ:29 
29 superfamily NN:29 
29 rearrangement NN:29 
29 predicted VBD:3 VBN:26 
29 partial JJ:29 
29 modification NN:29 
29 messenger NN:29 
29 mass NN:29 
29 homodimers NNS:29 
29 homodimer NN:29 
29 hepatitis NN:29 
29 hematopoiesis NN:29 
29 full JJ:29 
29 frequency NN:29 
29 dominant-negative JJ:29 
29 diverse JJ:29 
29 depletion NN:29 
29 depends VBZ:29 
29 density NN:29 
29 deleted JJ:5 VBN:24 
29 delayed JJ:1 VBD:4 VBN:24 
29 cotransfection NN:29 
29 corticosteroid JJ:1 NN:28 
29 consequence NN:29 
29 comparable JJ:29 
29 catalytic JJ:29 
29 agonist NN:29 
29 aged JJ:29 
29 abrogated VBD:15 VBN:14 
29 SS JJ:3 NN:25 NNS:1 
29 SLE NN:28 NNP:1 
29 NB4 NN:29 
29 M. FW:5 NN:11 NNP:13 
29 LDL JJ:1 NN:28 
29 JAK2 NN:29 
29 IkappaB-alpha NN:29 
29 IC50 NN:29 
29 HHV-6 NN:29 
29 B-alpha NN:29 
29 ATL NN:29 
29 60 CD:29 
29 -sensitive JJ:29 
28 turnover NN:28 
28 towards IN:28 
28 thereby RB:28 
28 terminus NN:28 
28 simian JJ:28 
28 rise NN:25 VB:2 VBP:1 
28 ratio NN:28 
28 prior JJ:17 RB:11 
28 particularly RB:28 
28 pair NN:28 
28 nmol/L NN:28 
28 negatively RB:28 
28 mitogen JJ:1 NN:27 
28 method NN:28 
28 matrix JJ:1 NN:27 
28 lymphomas NNS:28 
28 link NN:19 VB:4 VBP:5 
28 intron NN:28 
28 interference NN:28 
28 deletions NNS:28 
28 commitment NN:28 
28 blotting NN:27 VBG:1 
28 aspects NNS:28 
28 account NN:1 VB:24 VBP:3 
28 TCL1 NN:28 
28 T-cell-specific JJ:28 
28 SH2 JJ:1 NN:27 
28 PAF JJ:3 NN:25 
28 Overexpression NN:28 
28 Oct2 JJ:2 NN:26 
28 OCA-B JJ:1 NN:27 
28 NF-Y JJ:2 NN:26 
28 JAK NN:28 
28 Identification NN:28 
28 Id3 JJ:1 NN:27 
28 Differential JJ:28 
28 Cp JJ:2 NN:26 
28 CLL NN:27 NNP:1 
28 9-cis JJ:28 
28 -alpha JJ:1 NN:27 
27 upregulated VBD:4 VBN:23 
27 targeted VBD:1 VBN:26 
27 stimulating JJ:1 NN:13 VBG:13 
27 segment NN:27 
27 reactivity NN:27 
27 published VBN:27 
27 positively RB:27 
27 polymorphonuclear JJ:26 NN:1 
27 pairs NNS:27 
27 often RB:27 
27 native JJ:27 
27 models NNS:27 
27 mammary JJ:27 
27 jun NN:27 
27 hybrids NNS:27 
27 few JJ:27 
27 effectively RB:27 
27 disruption NN:27 
27 dephosphorylation NN:27 
27 WORDS NNS:27 
27 They PRP:27 
27 TcR JJ:2 NN:25 
27 Tax1 JJ:4 NN:23 
27 TRUNCATED VBN:27 
27 TRAF2 NN:27 
27 Syk JJ:1 NN:26 
27 SP1 NN:27 
27 RANTES JJ:1 NN:25 NNS:1 
27 PRL JJ:3 NN:24 
27 NFATc NN:27 
27 Molecular JJ:27 
27 IL-4R NN:27 
27 HS JJ:1 NN:25 NNS:1 
27 B-cells NNS:27 
27 ABSTRACT NN:27 
27 90 CD:27 
27 5'-flanking JJ:27 
27 250 CD:27 
27 16 CD:27 
27 -2 CD:23 NN:4 
26 whole JJ:26 
26 versus CC:26 
26 undergo VB:12 VBP:14 
26 transactivating JJ:2 NN:10 VBG:14 
26 suppresses VBZ:26 
26 substantial JJ:26 
26 showing VBG:26 
26 retinoid JJ:6 NN:20 
26 respect NN:26 
26 replicative JJ:25 NN:1 
26 released VBD:7 VBN:19 
26 protein-DNA JJ:25 NN:1 
26 proposed JJ:6 VBD:1 VBN:19 
26 phosphatases NN:1 NNS:25 
26 period NN:26 
26 paper NN:26 
26 open JJ:23 NN:1 VB:1 VBP:1 
26 oncoprotein NN:26 
26 occurring NN:1 VBG:25 
26 neonatal JJ:26 
26 monocyte/macrophage JJ:4 NN:22 
26 loop NN:26 
26 infections NNS:26 
26 hybrid NN:26 
26 hand NN:26 
26 granules NNS:26 
26 glycoprotein NN:26 
26 female JJ:17 NN:9 
26 extract NN:26 
26 derivative JJ:9 NN:17 
26 demonstrating NN:1 VBG:25 
26 cytolytic JJ:26 
26 copies NNS:26 
26 cooperation NN:26 
26 confer VB:20 VBP:6 
26 concomitant JJ:25 NN:1 
26 cognate JJ:24 NN:2 
26 chemotactic JJ:24 NN:2 
26 animals NNS:26 
26 allowed VBD:19 VBN:7 
26 allergic JJ:26 
26 Whereas IN:26 
26 VitD3 JJ:2 NN:24 
26 Studies NNS:26 
26 STATs NN:3 NNS:23 
26 Rap1 NN:26 
26 Press NNP:26 
26 E. FW:21 NNP:5 
26 Deletion NN:26 
26 DNA-protein JJ:21 NN:5 
26 CD34+ JJ:26 
26 C3a JJ:1 NN:25 
26 Academic NNP:26 
26 -expressing JJ:25 VBG:1 
25 would MD:25 
25 unclear JJ:25 
25 type-specific JJ:25 
25 trigger NN:4 VB:15 VBP:6 
25 transmembrane JJ:15 NN:10 
25 tat NN:25 
25 substitution NN:25 
25 silencer JJ:1 NN:24 
25 see VB:25 
25 respiratory JJ:23 NN:2 
25 rapamycin JJ:6 NN:19 
25 pregnancy NN:25 
25 portion NN:25 
25 poorly RB:25 
25 phagocytes NNS:25 
25 percentage NN:25 
25 pRB JJ:1 NN:24 
25 oxide JJ:1 NN:24 
25 overexpressed JJ:5 VBD:4 VBN:16 
25 neoplastic JJ:25 
25 minutes NNS:25 
25 means NN:7 NNS:18 
25 maintenance NN:25 
25 lymphoid-specific JJ:25 
25 lymph NN:25 
25 interleukin-4 JJ:4 NN:21 
25 incorporation NN:25 
25 gamma-globin NN:25 
25 frequently RB:25 
25 explained VBN:25 
25 experimental JJ:25 
25 endotoxin JJ:2 NN:23 
25 end NN:25 
25 ectopic JJ:25 
25 e.g. FW:25 
25 develop VB:14 VBP:11 
25 detection NN:25 
25 clear JJ:23 VB:2 
25 bronchial JJ:25 
25 autoimmune JJ:25 
25 aspirin JJ:1 NN:24 
25 analyze VB:24 VBP:1 
25 alleles NNS:25 
25 aging NN:24 VBG:1 
25 MBP JJ:2 NN:23 
25 LEF-1 JJ:2 NN:23 
25 Ikaros NN:25 
25 IFN-beta NN:25 
25 HUVEC NN:12 NNS:13 
25 EMSA NN:22 NNS:3 
25 Cushing NN:25 
25 CD45 JJ:3 NN:22 
25 Bcl-6 JJ:6 NN:19 
25 Additionally RB:25 
25 AMP JJ:5 NN:20 
25 A-myb NN:25 
25 0.001 CD:25 
24 wide JJ:24 
24 weakly JJ:1 RB:23 
24 value NN:24 
24 transfectants NNS:24 
24 trans-activator JJ:3 NN:21 
24 subsequently RB:24 
24 stimulus NN:24 
24 reversed VBD:8 VBN:16 
24 respective JJ:24 
24 reduces VBZ:24 
24 red JJ:24 
24 quiescent JJ:24 
24 probes NNS:24 
24 priming JJ:2 NN:20 VBG:2 
24 others NNS:24 
24 monkey NN:24 
24 membranes NNS:24 
24 latently RB:24 
24 intermediate JJ:20 NN:4 
24 injury NN:24 
24 inducers NNS:24 
24 helix-loop-helix JJ:24 
24 generate VB:21 VBP:3 
24 follicular JJ:24 
24 exons NNS:24 
24 erythroblasts NNS:24 
24 driven JJ:2 VBN:22 
24 decline NN:19 VBP:5 
24 compound JJ:1 NN:23 
24 competition NN:24 
24 colony NN:24 
24 chains NNS:24 
24 carcinomas NNS:24 
24 cDNAs NNS:24 
24 antigenic JJ:24 
24 allows VBZ:24 
24 affects VBZ:24 
24 added VBN:24 
24 VZV JJ:2 NN:22 
24 Upon IN:24 
24 POU NN:24 
24 PMN NN:23 NNS:1 
24 PI NN:24 
24 PEBP2 NN:24 
24 Oct JJ:2 NN:21 NNP:1 
24 Mutation NN:24 
24 LCR JJ:1 NN:23 
24 JunB NN:24 
24 Involvement NN:24 
24 IFNs NN:2 NNS:22 
24 GSH JJ:3 NN:21 
24 ERK JJ:1 NN:23 
24 B/Rel NN:24 
24 Ad NN:24 
24 APC NN:23 NNS:1 
24 18 CD:24 
24 -containing JJ:22 NN:2 
23 typical JJ:23 
23 triggered JJ:1 VBD:4 VBN:18 
23 transport NN:22 VBP:1 
23 translocated JJ:1 VBD:3 VBN:19 
23 technique NN:23 
23 targeting NN:10 VBG:13 
23 studying VBG:23 
23 similarity NN:23 
23 restored VBD:13 VBN:10 
23 relevance NN:23 
23 recombination NN:23 
23 recognizes VBZ:23 
23 proteolytic JJ:23 
23 promotes VBZ:23 
23 prevent VB:19 VBP:4 
23 potently RB:23 
23 parental JJ:23 
23 overlapping JJ:3 VBG:20 
23 muscle NN:23 
23 morphology NN:23 
23 monocyte-derived JJ:23 
23 mediator NN:23 
23 mapping NN:19 VBG:4 
23 malignancies NNS:23 
23 main JJ:23 
23 information NN:23 
23 inducer NN:23 
23 immunoregulatory JJ:23 
23 hemopoietic JJ:23 
23 genistein NN:23 
23 exerts VBZ:23 
23 erythroleukemia NN:23 
23 equivalent JJ:22 NN:1 
23 elucidate VB:22 VBP:1 
23 elevation NN:23 
23 cord JJ:1 NN:22 
23 consisting VBG:23 
23 comments NNS:23 
23 colonies NNS:23 
23 clinically RB:23 
23 body NN:23 
23 band NN:23 
23 atopic JJ:23 
23 antagonists NNS:23 
23 anergy NN:23 
23 acting JJ:1 NN:1 VBG:21 
23 TRE JJ:4 NN:19 
23 Protein NN:23 
23 LTB4 NN:23 
23 Jak2 NN:22 NNP:1 
23 JAK1 NN:23 
23 Glucocorticoids NNS:23 
23 CD95 JJ:1 NN:22 
23 CD8 JJ:7 NN:16 
23 A/R JJ:4 NN:19 
23 80 CD:23 
23 -negative JJ:23 
22 us PRP:22 
22 unlike IN:22 
22 undergoing VBG:22 
22 umbilical JJ:22 
22 thymidine JJ:1 NN:21 
22 tal-1 NN:22 
22 stimulatory JJ:22 
22 skin NN:22 
22 seven CD:22 
22 sequence-specific JJ:22 
22 segments NNS:22 
22 reveals VBZ:22 
22 retinoblastoma NN:22 
22 residue JJ:1 NN:21 
22 reading NN:22 
22 proportion NN:22 
22 profile NN:22 
22 presentation NN:22 
22 phospholipase NN:22 
22 phenotypic JJ:22 
22 oxidant JJ:18 NN:4 
22 newly RB:22 
22 lupus NN:22 
22 leucocytes NNS:22 
22 isolate JJ:2 NN:4 VB:16 
22 intestinal JJ:22 
22 initiate VB:16 VBP:6 
22 full-length JJ:21 NN:1 
22 frame NN:22 
22 existence NN:22 
22 evident JJ:22 
22 evaluate VB:21 VBP:1 
22 developing NN:1 VBG:21 
22 damage NN:22 
22 confers VBZ:22 
22 composite JJ:21 NN:1 
22 combinations NNS:22 
22 calcitriol NN:22 
22 c-rel JJ:2 NN:20 
22 c LS:5 NN:17 
22 brain NN:22 
22 believed VBN:22 
22 attenuated VBD:14 VBN:8 
22 alpha-chain JJ:3 NN:19 
22 Within IN:22 
22 VD JJ:1 NN:21 
22 TG JJ:1 NN:21 
22 Raji NN:22 
22 ROI JJ:5 NN:12 NNS:5 
22 Mutations NNS:22 
22 Mono NN:22 
22 MZF-1 NN:22 
22 Lck JJ:3 NN:19 
22 HLF JJ:6 NN:16 
22 EGR-1 JJ:1 NN:21 
22 CONCLUSION NN:22 
22 CD36 JJ:2 NN:20 
22 CCAAT NN:22 
22 72 CD:22 
22 0.5 CD:22 
21 widely RB:21 
21 translated VBN:21 
21 transition NN:21 
21 transfer NN:20 VB:1 
21 trans-activation JJ:1 NN:20 
21 tolerance NN:21 
21 third JJ:21 
21 testosterone JJ:1 NN:20 
21 supports VBZ:21 
21 squirrel NN:21 
21 so IN:3 RB:18 
21 retardation NN:21 
21 repress VB:17 VBP:4 
21 reports NNS:20 VBZ:1 
21 reactivation NN:21 
21 rats NNS:21 
21 r JJ:1 NN:20 
21 protein-protein JJ:21 
21 programmed VBD:1 VBN:20 
21 preventing VBG:21 
21 predominant JJ:21 
21 phosphatidylinositol NN:21 
21 oncogenic JJ:21 
21 octamer-binding JJ:20 NN:1 
21 nervous JJ:21 
21 needed VBD:3 VBN:18 
21 nature NN:21 
21 mol/L NN:21 
21 methylation NN:21 
21 longer JJR:11 RB:3 RBR:7 
21 introduced VBD:3 VBN:18 
21 interleukin-6 JJ:2 NN:19 
21 initiates VBZ:21 
21 inability NN:21 
21 hsp90 JJ:1 NN:20 
21 herpes NN:21 
21 heavy-chain JJ:13 NN:8 
21 gamma(c) JJ:1 NN:20 
21 fibronectin JJ:1 NN:19 NNS:1 
21 expansion NN:21 
21 erythrocytes NNS:21 
21 endothelium NN:21 
21 dual JJ:21 
21 dithiocarbamate NN:21 
21 dimerization NN:21 
21 differentiating JJ:2 VBG:19 
21 depend VB:18 VBP:3 
21 contribution NN:21 
21 constructed VBD:9 VBN:12 
21 consequences NNS:21 
21 competitive JJ:21 
21 close JJ:18 RB:3 
21 cleavage NN:21 
21 challenge NN:21 
21 biologic JJ:21 
21 axis NN:21 
21 atherosclerosis NN:21 
21 assayed VBD:3 VBN:18 
21 anti-CD28 JJ:15 NN:6 
21 achieved VBD:3 VBN:18 
21 abundant JJ:21 
21 UT-7 NN:21 
21 Tumor NN:21 
21 Transfection NN:21 
21 T-lymphocyte NN:21 
21 T- JJ:1 NN:17 NNS:3 
21 Some DT:21 
21 Similarly RB:21 
21 R NN:21 
21 OBJECTIVE NN:21 
21 MM JJ:1 NN:20 
21 MAPk NN:21 
21 IgG NN:21 
21 HCMV NN:21 
21 Gel NN:21 
21 GATA-2 NN:21 
21 GAL4 JJ:1 NN:20 
21 Ets-1 NN:21 
21 DEX JJ:2 NN:19 
21 Cells NNS:21 
21 CD69 NN:21 
21 CD44 JJ:1 NN:20 
21 B-CLL JJ:1 NN:20 
21 Ab JJ:1 NN:16 NNS:4 
21 70 CD:21 
21 12-O-tetradecanoylphorbol-13-acetate NN:21 
21 10-fold JJ:8 RB:13 
21 -regulated JJ:21 
21 -deficient JJ:21 
20 vein NN:20 
20 undetectable JJ:20 
20 synthase NN:20 
20 supernatants NNS:20 
20 substantially RB:20 
20 somatic JJ:20 
20 sites/cell NN:3 NNS:17 
20 similarly RB:20 
20 sequenced VBD:3 VBN:17 
20 salicylate NN:20 
20 restriction NN:20 
20 relation NN:20 
20 recovered JJ:1 VBD:4 VBN:15 
20 protection NN:20 
20 paralleled VBD:9 VBN:11 
20 oxidase NN:20 
20 overall JJ:17 RB:3 
20 organs NNS:20 
20 onset NN:20 
20 occupancy NN:20 
20 non- JJ:18 NN:1 NNS:1 
20 megakaryocytes NNS:20 
20 male JJ:18 NN:2 
20 lymphotropic JJ:18 NN:2 
20 lymphocyte-specific JJ:20 
20 lipid NN:20 
20 leukaemia NN:20 
20 later JJ:9 JJR:7 RB:3 UNKNOWN:1 
20 killing NN:19 VBG:1 
20 junB NN:20 
20 intrinsic JJ:20 
20 interfere VB:16 VBP:4 
20 insights NNS:19 VBZ:1 
20 i LS:19 VBN:1 
20 hypoxia JJ:2 NN:18 
20 hypothesized VBD:12 VBN:8 
20 hypersensitive JJ:20 
20 heterodimeric JJ:20 
20 extensive JJ:20 
20 estradiol NN:20 
20 erratum NN:20 
20 eosinophilic JJ:20 
20 enzymes NNS:20 
20 dramatic JJ:20 
20 determining JJ:2 NN:1 VBG:17 
20 conferred VBD:18 VBN:2 
20 compartment NN:20 
20 coli FW:19 NN:1 
20 chromosomes NNS:20 
20 cell-mediated JJ:20 
20 c-Myb NN:20 
20 autocrine JJ:14 NN:6 
20 associates NNS:1 VBZ:19 
20 alteration NN:20 
20 alpha-globin NN:20 
20 allow VB:17 VBP:3 
20 aggregation NN:20 
20 affinities NNS:20 
20 adherent JJ:20 
20 VP16 JJ:1 NN:19 
20 Th NN:20 
20 TRADD NN:20 
20 Such JJ:18 PDT:2 
20 Raf-1 NN:20 
20 RCC NN:16 NNS:4 
20 Pretreatment NN:20 
20 Peripheral JJ:20 
20 OTF-2 NN:19 NNP:1 
20 NFAT1 NN:19 NNP:1 
20 MR NN:19 NNS:1 
20 LTRs NNS:20 
20 Its PRP$:20 
20 IL2 NN:20 
20 IL-9 JJ:8 NN:12 
20 HS-40 NN:20 
20 From IN:20 
20 Effects NNS:20 
20 E2A-HLF NN:20 
20 Dexamethasone NN:20 
20 Despite IN:20 
20 DHEA NN:20 
20 CD40L JJ:5 NN:15 
20 C. FW:12 JJ:3 NN:2 NNP:3 
20 Addition NN:20 
20 -transformed JJ:20 
20 -DNA JJ:8 NN:12 
19 wild JJ:19 
19 utilized VBD:4 VBN:15 
19 triggers NNS:1 VBZ:18 
19 transactivated VBD:6 VBN:13 
19 times NNS:19 
19 subject JJ:11 NN:8 
19 simultaneous JJ:19 
19 raised VBD:3 VBN:16 
19 quantitative JJ:19 
19 prominent JJ:19 
19 physiologic JJ:19 
19 phases NNS:19 
19 partly RB:19 
19 p52 NN:19 
19 own JJ:19 
19 originally RB:19 
19 ng/ml NN:19 
19 myelogenous JJ:19 
19 mitogens NNS:19 
19 methods NNS:19 
19 metabolism NN:19 
19 maximum JJ:6 NN:13 
19 mM NN:19 
19 lipoproteins NNS:19 
19 lesser JJR:19 
19 indistinguishable JJ:19 
19 includes VBZ:19 
19 immortalization NN:19 
19 ii LS:19 
19 high-affinity JJ:18 NN:1 
19 heterozygous JJ:18 NN:1 
19 given JJ:6 VBN:13 
19 fractions NNS:19 
19 females NNS:19 
19 eukaryotic JJ:19 
19 especially RB:19 
19 epitope NN:19 
19 elucidated VBN:19 
19 elicited JJ:1 VBD:5 VBN:13 
19 downregulation NN:19 
19 demonstration NN:19 
19 degrees NNS:19 
19 cyclin JJ:1 NN:18 
19 cooperative JJ:19 
19 concert NN:19 
19 commonly RB:19 
19 chicken NN:19 
19 beta- JJ:2 NN:17 
19 balance NN:19 
19 bHLH JJ:19 
19 available JJ:19 
19 age-related JJ:19 
19 administration NN:19 
19 YY1 JJ:1 NN:18 
19 Surprisingly RB:19 
19 Spi-1 JJ:1 NN:18 
19 SR JJ:6 NN:13 
19 Ro NN:19 
19 PR NN:19 
19 PML-RAR JJ:2 NN:17 
19 L-selectin NN:19 
19 JunD NN:19 
19 Interleukin NN:19 
19 HLA-DRA NN:19 
19 GATA-binding JJ:18 NN:1 
19 FMLP JJ:1 NN:18 
19 EBNA NN:19 
19 EBF JJ:1 NN:18 
19 DM NN:19 
19 CN NN:19 
19 CML NN:19 
19 CD20 JJ:2 NN:17 
19 C5a JJ:8 NN:11 
19 B- JJ:1 NN:16 NNS:2 
19 As2O3 JJ:3 NN:16 
19 Abs NN:1 NNS:18 
18 zeta NN:18 
18 volunteers NNS:18 
18 transcriptase JJ:4 NN:14 
18 throughout IN:16 RB:2 
18 synergize VB:6 VBP:12 
18 susceptible JJ:18 
18 steps NNS:18 
18 spontaneous JJ:18 
18 simultaneously RB:18 
18 shared JJ:7 VBD:1 VBN:10 
18 removal NN:18 
18 reflect VB:10 VBP:8 
18 recurrent JJ:18 
18 recognize VB:7 VBP:11 
18 reactions NNS:18 
18 pyrrolidine NN:18 
18 purpose NN:18 
18 promoted VBD:12 VBN:6 
18 pro-B JJ:15 NN:3 
18 precise JJ:18 
18 polymorphisms NNS:18 
18 peroxide NN:18 
18 p40 NN:18 
18 p16 JJ:1 NN:17 
18 p100 JJ:1 NN:17 
18 nt JJ:1 NN:11 NNS:6 
18 noted VBN:18 
18 mixed JJ:14 VBN:4 
18 maintained JJ:3 VBD:6 VBN:9 
18 lacks VBZ:18 
18 internal JJ:18 
18 interacting NN:3 VBG:15 
18 insight NN:18 
18 influenced VBD:3 VBN:15 
18 infectious JJ:18 
18 imply VB:1 VBP:17 
18 hypertension NN:18 
18 homologue NN:18 
18 homolog NN:18 
18 highest JJS:18 
18 fibroblast NN:18 
18 factor-1 JJ:1 NN:17 
18 exception NN:18 
18 evidenced VBN:18 
18 endocrine JJ:14 NN:4 
18 earlier JJR:9 RBR:9 
18 double-stranded JJ:18 
18 differs VBZ:18 
18 defense NN:18 
18 cyclophilin NN:18 
18 concluded VBD:4 VBN:14 
18 cofactor NN:18 
18 cluster NN:17 VBP:1 
18 chemotherapy NN:18 
18 cell-free JJ:18 
18 biphasic JJ:18 
18 beta-casein NN:18 
18 bearing NN:1 VBG:17 
18 attributed VBN:18 
18 atherosclerotic JJ:18 
18 antiinflammatory JJ:18 
18 amplified VBD:4 VBN:14 
18 amplification NN:18 
18 already RB:18 
18 adaptor NN:18 
18 activation-induced JJ:18 
18 accessory JJ:11 NN:7 
18 aberrant JJ:17 NN:1 
18 Specific JJ:18 
18 SRE JJ:1 NN:17 
18 RB JJ:5 NN:13 
18 MNL NN:12 NNS:6 
18 GSSG JJ:2 NN:16 
18 Following VBG:18 
18 E3 NN:18 
18 E2F-1 NN:18 
18 Comparison NN:18 
18 CREB/ATF NN:18 
18 B-lymphocyte NN:18 
18 Among IN:18 
18 Activated VBN:18 
18 AND CC:18 
18 48 CD:18 
18 47 CD:18 
18 42 CD:18 
18 1998 CD:18 
18 1,25-dihydroxyvitamin NN:18 
17 unidentified JJ:17 
17 symptoms NNS:17 
17 subclones NNS:17 
17 structures NNS:17 
17 spliced JJ:1 VBN:16 
17 splenic JJ:17 
17 solution NN:17 
17 simplex JJ:5 NN:12 
17 severely RB:17 
17 separated JJ:1 VBN:16 
17 screening JJ:1 NN:12 VBG:4 
17 run-on JJ:17 
17 retained VBD:8 VBN:9 
17 repertoire NN:17 
17 referred VBN:17 
17 readily RB:17 
17 rare JJ:17 
17 provirus NN:17 
17 proviral JJ:17 
17 protooncogene NN:17 
17 proteolysis NN:17 
17 protect NN:1 VB:13 VBP:3 
17 proteases NNS:17 
17 proliferate NN:1 VB:12 VBP:4 
17 producing JJ:1 NN:3 VBG:13 
17 potency NN:17 
17 phenotypes NNS:17 
17 persons NNS:17 
17 p56(lck) NN:17 
17 nodes NNS:17 
17 mast JJ:1 NN:16 
17 magnitude NN:17 
17 made VBD:3 VBN:14 
17 length NN:17 
17 interferons NNS:17 
17 instead RB:17 
17 insertion NN:17 
17 influences NNS:3 VBZ:14 
17 homeostasis NN:17 
17 herbimycin NN:17 
17 hepatic JJ:17 
17 fresh JJ:17 
17 feature NN:17 
17 facilitate VB:15 VBP:2 
17 exerted VBD:8 VBN:9 
17 exchange NN:17 
17 example NN:17 
17 downregulated JJ:1 VBD:6 VBN:10 
17 documented JJ:1 VBD:4 VBN:12 
17 coordinate JJ:13 NN:1 VB:2 VBP:1 
17 contact NN:17 
17 constitute VB:7 VBP:10 
17 confirm VB:8 VBP:9 
17 complement NN:14 VB:1 VBP:2 
17 coexpression NN:17 
17 children NNS:17 
17 chemokines NNS:17 
17 cathepsin NN:17 
17 carriers NNS:17 
17 carried VBD:6 VBN:11 
17 autoregulatory JJ:16 NN:1 
17 augments VBZ:17 
17 antigen-presenting JJ:17 
17 airway NN:17 
17 aim NN:17 
17 agonists NNS:17 
17 adults NNS:17 
17 actin JJ:1 NN:16 
17 ]i NN:17 
17 X-linked JJ:17 
17 Wp JJ:2 NN:15 
17 Vav NN:17 
17 TSC2 JJ:1 NN:16 
17 TRAF NN:17 
17 TCDD JJ:1 NN:16 
17 TAR JJ:7 NN:10 
17 SV40 NN:17 
17 STAT5A NN:17 
17 STAT4 JJ:1 NN:16 
17 Retinoic JJ:17 
17 Of IN:17 
17 NE NN:9 NNS:8 
17 L NN:17 
17 IgM JJ:3 NN:14 
17 HD NN:17 
17 FKBP NN:17 
17 EBS NN:6 NNS:11 
17 CLE0 NN:17 
17 CD4(+) JJ:17 
17 BRCA1 NN:17 
17 BL NN:14 NNS:3 
17 ? .:17 
17 1999 CD:17 
17 /threonine NN:17 
17 /p65 NN:17 
17 -kappa NN:17 
17 -directed JJ:17 
17 -derived JJ:17 
16 whereby IN:3 RB:1 WRB:12 
16 vs CC:16 
16 trans-acting JJ:16 
16 thymocyte NN:16 
16 threshold JJ:1 NN:15 
16 though IN:15 RB:1 
16 surgery NN:16 
16 suppressive JJ:16 
16 substitutions NNS:16 
16 strategy NN:16 
16 strategies NNS:16 
16 silencing JJ:1 NN:14 VBG:1 
16 sepsis NN:16 
16 reversible JJ:16 
16 retinoids NNS:16 
16 rescue NN:12 VB:3 VBP:1 
16 repressed VBD:5 VBN:11 
16 remission NN:16 
16 recruited VBD:1 VBN:15 
16 reconstituted JJ:2 VBD:2 VBN:12 
16 receptor-associated JJ:16 
16 radiation NN:16 
16 providing VBG:16 
16 pronounced JJ:15 VBN:1 
16 prognostic JJ:16 
16 productive JJ:16 
16 procedure NN:16 
16 primed JJ:3 VBD:2 VBN:11 
16 pituitary JJ:12 NN:4 
16 physically RB:16 
16 persistence NN:16 
16 pRb NN:16 
16 p24 NN:16 
16 oestrogen JJ:1 NN:15 
16 notion NN:16 
16 nonlymphoid JJ:16 
16 none DT:1 NN:15 
16 neutralizing NN:4 VBG:12 
16 must MD:16 
16 modifications NNS:16 
16 mode NN:16 
16 mCD14 JJ:6 NN:10 
16 lost VBD:4 VBN:12 
16 loci NNS:16 
16 lectin JJ:1 NN:15 
16 irradiation NN:16 
16 investigation NN:16 
16 inverse JJ:14 NN:2 
16 integration NN:16 
16 immunological JJ:16 
16 immunohistochemistry NN:16 
16 immunofluorescence NN:16 
16 identity NN:16 
16 humoral JJ:16 
16 glial JJ:16 
16 footprint NN:16 
16 focused VBD:6 VBN:10 
16 fatty JJ:14 NN:2 
16 exists VBZ:16 
16 epithelium NN:16 
16 entire JJ:16 
16 electrophoresis NN:16 
16 disrupt VB:14 VBP:2 
16 displays VBZ:16 
16 determinants NNS:16 
16 depending VBG:16 
16 cytomegalovirus NN:16 
16 currently RB:16 
16 continuous JJ:16 
16 complementary JJ:16 
16 channels NNS:16 
16 cancers NNS:16 
16 bovine JJ:14 NN:2 
16 astrocytes NNS:16 
16 appropriate JJ:16 
16 antigen-specific JJ:16 
16 anergic JJ:16 
16 amino-terminal JJ:16 
16 adrenal JJ:16 
16 adenoviral JJ:16 
16 abundance NN:16 
16 abolishes VBZ:16 
16 With IN:16 
16 WT1 NN:16 
16 VD3 NN:16 
16 Tyrosine NN:16 
16 TGF-beta1 NN:16 
16 TBP JJ:2 NN:14 
16 Southern NN:16 
16 SMX NN:16 
16 SHP1 NN:16 
16 ROS NN:9 NNS:7 
16 PKC-zeta NN:16 
16 OKT3 NN:16 
16 Neither CC:11 DT:4 RB:1 
16 NGAL JJ:1 NN:15 
16 Most JJS:13 RBS:3 
16 IV CD:16 
16 IKK NN:16 
16 III CD:15 JJ:1 
16 Hodgkin NN:16 
16 High JJ:16 
16 Hence RB:16 
16 HPA JJ:9 NN:7 
16 HLA-DQ JJ:2 NN:14 
16 Grb2 JJ:1 NN:15 
16 GRE JJ:1 NN:15 
16 G0/G1 NN:16 
16 G0 NN:16 
16 ELISA NN:16 
16 E1 JJ:1 NN:15 
16 DR NN:16 
16 Cbl NN:16 
16 Ca(2+) JJ:16 
16 CD28RE JJ:2 NN:14 
16 CD16 JJ:4 NN:12 
16 A23187 JJ:1 NN:15 
16 32 CD:16 
16 29 CD:16 
16 1,25-(OH)2D3 NN:16 
15 zinc-finger JJ:8 NN:7 
15 weeks NNS:15 
15 vs. CC:15 
15 usually RB:15 
15 urinary JJ:15 
15 ultimately RB:15 
15 transmission NN:15 
15 toxin JJ:1 NN:14 
15 tolerant JJ:15 
15 thromboxane NN:15 
15 term JJ:1 NN:13 VBP:1 
15 tail NN:15 
15 t DT:1 IN:2 NN:12 
15 summary NN:15 
15 structurally RB:15 
15 striking JJ:14 UNKNOWN:1 
15 steady-state JJ:14 NN:1 
15 stabilization NN:15 
15 specificities NNS:15 
15 sets NNS:14 VBZ:1 
15 serum-free JJ:15 
15 responded VBD:15 
15 represses VBZ:15 
15 representing VBG:15 
15 replicate VB:15 
15 replaced VBD:1 VBN:14 
15 proto-oncogenes NNS:15 
15 primitive JJ:15 
15 primers NNS:15 
15 presumably RB:15 
15 postulated VBD:2 VBN:13 
15 posttranscriptional JJ:15 
15 platelet-activating JJ:14 NN:1 
15 participates VBZ:15 
15 numerous JJ:15 
15 nitric JJ:15 
15 nearly RB:15 
15 mu NN:15 
15 modulates VBZ:15 
15 metastatic JJ:15 
15 metabolites NNS:15 
15 message NN:15 
15 maintain VB:11 VBP:4 
15 local JJ:15 
15 lipoprotein JJ:1 NN:14 
15 ligand-induced JJ:15 
15 leucine NN:15 
15 knowledge NN:15 
15 kilobases NNS:15 
15 kidney NN:15 
15 judged VBN:15 
15 isolation NN:15 
15 intermediates NNS:15 
15 interleukin-1beta NN:15 
15 interferes VBZ:15 
15 insensitivity NN:15 
15 infiltrating JJ:2 VBG:13 
15 included VBD:12 VBN:3 
15 immunoprecipitation NN:15 
15 immunomodulatory JJ:15 
15 high-level JJ:15 
15 heterogeneous JJ:15 
15 gammac NN:15 
15 forskolin NN:15 
15 fluorescence NN:15 
15 fails VBZ:15 
15 extended JJ:1 VBD:5 VBN:9 
15 exist VB:8 VBP:7 
15 ets NN:15 
15 et FW:15 
15 erythropoiesis NN:15 
15 erythrocyte NN:15 
15 enzymatic JJ:15 
15 enhancing JJ:1 NN:2 VBG:12 
15 encompassing NN:1 VBG:14 
15 efficacy NN:15 
15 discuss VB:4 VBP:11 
15 dimers NNS:15 
15 dimer JJ:1 NN:14 
15 differed VBD:13 VBN:2 
15 diagnosis NN:15 
15 derivatives NNS:15 
15 dephosphorylated JJ:3 VBN:12 
15 delivery NN:15 
15 corticosteroids NNS:15 
15 concentration-dependent JJ:15 
15 compete VB:12 VBP:3 
15 codon NN:15 
15 chaffeensis FW:15 
15 candidate NN:15 
15 boxes NNS:15 
15 bodies NNS:15 
15 blockade NN:15 
15 blast NN:15 
15 average JJ:7 NN:8 
15 autologous JJ:15 
15 attributable JJ:15 
15 asthmatic JJ:15 
15 antiviral JJ:15 
15 antiproliferative JJ:15 
15 altering VBG:15 
15 alpha- NN:15 
15 acquired JJ:1 VBD:1 VBN:13 
15 Z NN:15 
15 Unlike IN:15 
15 TFIID NN:15 
15 Stat1alpha NN:15 
15 Sequence NN:15 
15 Role NN:15 
15 RARs NNS:15 
15 PtdIns NN:15 
15 Previously RB:15 
15 Other JJ:15 
15 Oct-2a NN:15 
15 NFATx1 NN:15 
15 Mac NN:15 
15 ML-9 JJ:1 NN:14 
15 IL-7R NN:15 
15 IL-1R NN:15 
15 IFNgamma JJ:3 NN:12 
15 FDC NN:15 
15 Evidence NN:15 
15 E1B NN:15 
15 Cotransfection NN:15 
15 Conversely RB:15 
15 Cloning NN:14 VBG:1 
15 CD34 JJ:1 NN:14 
15 Bmax NN:15 
15 Based VBN:15 
15 BCL6 NN:15 
15 B29 NN:14 UNKNOWN:1 
15 B-like JJ:15 
15 36 CD:15 
15 10(-10) CD:15 
14 wall NN:14 
14 virtually RB:14 
14 upregulate VB:10 VBP:4 
14 uninfected JJ:14 
14 tumorigenesis NN:14 
14 transferase NN:14 
14 transactivators NNS:14 
14 tightly RB:14 
14 taken VBN:14 
14 suppressing JJ:1 VBG:13 
14 supported VBD:6 VBN:8 
14 stronger JJR:14 
14 stromal JJ:14 
14 strains NNS:13 VBZ:1 
14 statistically RB:14 
14 social JJ:14 
14 sex NN:14 
14 serves VBZ:14 
14 separation NN:14 
14 separate JJ:14 
14 scavenger NN:14 
14 rendered VBD:5 VBN:9 
14 ras NN:14 
14 rabbit JJ:1 NN:13 
14 pulmonary JJ:14 
14 protein- JJ:11 NN:3 
14 protected JJ:3 VBD:7 VBN:4 
14 powerful JJ:14 
14 potentiates VBZ:14 
14 potentiated JJ:2 VBD:7 VBN:5 
14 polypeptides NNS:14 
14 polypeptide NN:14 
14 pleiotropic JJ:14 
14 physiologically RB:14 
14 pH NN:14 
14 p45 NN:14 
14 oxidized VBN:14 
14 organ JJ:1 NN:13 
14 myelopoiesis NN:13 PRP$:1 
14 microscopy NN:14 
14 metabolic JJ:14 
14 mAbs NNS:14 
14 lineage-specific JJ:14 
14 laboratory JJ:3 NN:11 
14 isotype NN:14 
14 interleukin-8 NN:14 
14 implicating VBG:14 
14 immediately RB:14 
14 hydrocortisone NN:14 
14 hybridomas NN:1 NNS:13 
14 histamine JJ:3 NN:11 
14 hemoglobin NN:14 
14 help VB:14 
14 heart NN:14 
14 half-life JJ:1 NN:13 
14 half NN:13 PDT:1 
14 glucose NN:14 
14 genetically RB:14 
14 gangliosides NNS:14 
14 gain NN:4 VB:10 
14 fragmentation NN:14 
14 far JJ:1 RB:13 
14 expresses VBZ:14 
14 export NN:14 
14 expected VBN:14 
14 exhibits VBZ:14 
14 except IN:14 
14 ex FW:14 
14 disrupted VBD:5 VBN:9 
14 determinant NN:14 
14 designed VBN:14 
14 depressed JJ:10 VBD:1 VBN:3 
14 degraded VBN:14 
14 criteria NNS:14 
14 created VBD:7 VBN:7 
14 coupled JJ:1 VBN:13 
14 cotransfected VBD:1 VBN:13 
14 consistently RB:14 
14 cis JJ:6 NN:8 
14 cascades NNS:14 
14 biology NN:14 
14 beta-chain IN:1 NN:13 
14 augment VB:11 VBP:3 
14 anti-IgM JJ:8 NN:6 
14 analogs NNS:14 
14 actinomycin JJ:1 NN:13 
14 Y NN:14 
14 Various JJ:14 
14 TPO JJ:1 NN:13 
14 TNFR JJ:2 NN:12 
14 TCP NN:14 
14 Src NN:14 
14 Sp3 JJ:1 NN:13 
14 Signal NN:14 
14 SRF NN:14 
14 Rho JJ:2 NN:12 
14 Rex JJ:2 NN:12 
14 Results NNS:14 
14 RU NN:14 
14 Pax-5 JJ:1 NN:13 
14 PTK NN:13 NNS:1 
14 PPARalpha NN:14 
14 PML/RARalpha NN:14 
14 P. FW:4 NNP:10 
14 Oct-2A NN:14 
14 Multiple JJ:14 
14 Many JJ:14 
14 MRD JJ:11 NN:3 
14 LT JJ:4 NN:10 
14 Indeed RB:14 
14 ISGF3 JJ:1 NN:13 
14 IL-1ra NN:14 
14 IL-15 NN:14 
14 ICSAT NN:14 
14 HTLV-II JJ:1 NN:13 
14 HSF1 NN:14 
14 HB24 NN:14 
14 GATA3 NN:14 
14 Four CD:14 
14 Fli-1 NN:14 
14 First JJ:1 RB:13 
14 FMS NN:14 
14 FISH NN:14 
14 Estrogen NN:14 
14 ETS1 NN:14 
14 ETS JJ:1 NN:12 NNS:1 
14 ES NN:14 
14 ECs NNS:14 
14 E1a NN:14 
14 Daudi JJ:1 NN:13 
14 DMSO JJ:2 NN:12 
14 Cyclosporin NN:14 
14 CyA NN:14 
14 Changes NNS:14 
14 Cepsilon NN:14 
14 CR JJ:4 NN:10 
14 CD38 NN:14 
14 CBP NN:14 
14 C/EBPbeta NN:14 
14 BOB.1/OBF.1 NN:14 
14 B-binding JJ:12 NN:2 
14 ALD JJ:3 NN:11 
14 ACTH NN:14 
14 65 CD:14 
14 37 CD:14 
14 2A NN:14 
14 27 CD:14 
14 23 CD:14 
14 10(-7) CD:14 
14 /MAD-3 NN:14 
14 -rich JJ:14 
14 -STAT JJ:5 NN:9 
14 (+) JJ:14 
13 viability NN:13 
13 variations NNS:13 
13 underlie VB:11 VBP:2 
13 unaltered JJ:13 
13 truncation NN:13 
13 transendothelial JJ:13 
13 transducing NN:5 VBG:8 
13 toxicity NN:13 
13 tool NN:13 
13 time-dependent JJ:13 
13 syndromes NNS:13 
13 spectrum NN:13 
13 slight JJ:13 
13 signal-regulated JJ:13 
13 screen NN:8 VB:5 
13 reticulocyte JJ:1 NN:12 
13 represented VBD:3 VBN:10 
13 reduce VB:11 VBP:2 
13 prove VB:13 
13 promoting VBG:13 
13 profiles NNS:13 
13 presenting JJ:1 NN:5 VBG:7 
13 preparations NNS:13 
13 polymorphic JJ:13 
13 points NNS:11 VBZ:2 
13 pivotal JJ:13 
13 phosphorothioate JJ:3 NN:10 
13 pharmacological JJ:13 
13 panel NN:13 
13 pancreatic JJ:13 
13 palindromic JJ:13 
13 overcome VB:10 VBN:2 VBP:1 
13 outside IN:11 JJ:1 NN:1 
13 otherwise JJ:2 RB:11 
13 oral JJ:13 
13 opposite JJ:13 
13 occupied JJ:1 VBD:1 VBN:11 
13 ng/mL NN:13 
13 namely RB:13 
13 named VBD:1 VBN:12 
13 monitored VBD:3 VBN:10 
13 moderate JJ:13 
13 mimic NN:1 VB:9 VBP:3 
13 micromol/L NN:13 
13 media NNS:13 
13 machinery NN:13 
13 lysate NN:13 
13 lymphoblasts NNS:13 
13 limiting VBG:13 
13 limit NN:3 VB:8 VBP:2 
13 lavage NN:13 
13 kd JJ:1 NN:11 NNS:1 
13 interleukin-3 NN:13 
13 intensity NN:13 
13 indirectly RB:13 
13 indirect JJ:13 
13 immunosuppression NN:13 
13 immunologically RB:13 
13 immunodominant JJ:13 
13 iii LS:13 
13 hypothalamic-pituitary-adrenal JJ:13 
13 hydrogen NN:13 
13 hormonal JJ:13 
13 heterogeneity NN:13 
13 having VBG:13 
13 granule NN:13 
13 gp160 JJ:3 NN:10 
13 good JJ:13 
13 generally RB:13 
13 frequent JJ:13 
13 feedback NN:13 
13 explore VB:13 
13 evaluation NN:13 
13 enriched JJ:7 VBN:6 
13 employed VBD:2 VBN:11 
13 eliminated VBD:7 VBN:6 
13 dysregulation NN:13 
13 deprivation NN:13 
13 depleted VBD:2 VBN:11 
13 cooperate VB:5 VBP:8 
13 conformation NN:13 
13 composition NN:13 
13 chemotaxis NN:13 
13 chemoattractant JJ:2 NN:11 
13 cell-type JJ:9 NN:4 
13 caspase JJ:1 NN:12 
13 carboxyl-terminal JJ:13 
13 burst NN:13 
13 basophils NNS:13 
13 bacteria JJ:1 NNS:12 
13 augmentation NN:13 
13 associate VB:7 VBP:6 
13 ascorbate NN:13 
13 antiserum NN:13 
13 anti-CD40 JJ:8 NN:5 
13 animal JJ:3 NN:10 
13 acetyl JJ:1 NN:12 
13 abnormality NN:13 
13 Zp NN:13 
13 X2 NN:13 
13 TR NN:13 
13 TLR2 JJ:2 NN:11 
13 TCRzeta JJ:1 NN:12 
13 T-ALL NN:13 
13 RARalpha JJ:1 NN:12 
13 Qp NN:13 
13 Patients NNS:13 
13 PIH NN:13 
13 Only RB:13 
13 OTF-1 JJ:1 NN:12 
13 NRE NN:13 
13 NFKB2 NN:13 
13 NF(P) NN:13 
13 LFA-3 JJ:1 NN:12 
13 K NN:13 
13 Incubation NN:13 
13 Id2 NN:13 
13 IL-2Ralpha NN:13 
13 IL-1alpha NN:13 
13 HUMARA NN:13 
13 HSV-2 JJ:1 NN:12 
13 HML NN:9 NNS:4 
13 HIV-infected JJ:13 
13 GH JJ:1 NN:12 
13 GABP JJ:1 NN:12 
13 G. FW:6 NNP:7 
13 Escherichia FW:13 
13 Dex NN:13 
13 CD80 N:1 NN:12 
13 CD25 NN:13 
13 Also RB:13 
13 Aiolos JJ:2 NN:11 
13 Ad5 NN:13 
13 75 CD:13 
13 45 CD:13 
13 120 CD:13 
13 0.2 CD:13 
13 -beta NN:13 
13 -/- JJ:13 
13 & CC:10 NN:3 
12 zipper NN:12 
12 v-erbA JJ:1 NN:11 
12 utilizing VBG:12 
12 unit NN:12 
12 undifferentiated JJ:12 
12 two-hybrid JJ:12 
12 transplantation NN:12 
12 transduce VB:9 VBP:3 
12 totally RB:12 
12 terminally RB:12 
12 tepoxalin NN:12 
12 supporting NN:1 VBG:11 
12 substitute VB:11 VBP:1 
12 subcellular JJ:12 
12 steroid-resistant JJ:12 
12 splice NN:11 VBP:1 
12 sought VBD:11 VBN:1 
12 sera NN:7 NNS:5 
12 sequencing NN:12 
12 septic JJ:12 
12 sensitization NN:12 
12 sense JJ:1 NN:11 
12 responding VBG:12 
12 research NN:12 
12 representative JJ:10 NN:2 
12 regardless JJ:1 RB:11 
12 regard NN:12 
12 raises VBZ:12 
12 prostaglandin NN:12 
12 proliferator-activated JJ:12 
12 prolactin JJ:2 NN:10 
12 progress NN:7 VB:3 VBP:2 
12 progeny NN:12 
12 pretreated JJ:5 VBN:7 
12 preincubation NN:12 
12 preincubated JJ:2 VBN:10 
12 preceded VBD:4 VBN:8 
12 possesses VBZ:12 
12 polarized VBN:12 
12 place NN:12 
12 phosphorylate VB:9 VBP:3 
12 phosphoprotein NN:12 
12 phosphate NN:12 
12 phagocytosis NN:11 NNS:1 
12 pathological JJ:12 
12 partner NN:12 
12 particles NNS:12 
12 p95vav JJ:1 NN:11 
12 p85 NN:12 
12 p130 NN:12 
12 outcome NN:12 
12 oncogenes NNS:12 
12 neutrophilic JJ:12 
12 nervosa NN:12 
12 naturally RB:12 
12 monocytoid JJ:8 NN:4 
12 monitor NN:1 VB:11 
12 mitogenesis NN:12 
12 metabolite NN:12 
12 messengers NNS:12 
12 material JJ:2 NN:10 
12 macrophage-like JJ:12 
12 labeling NN:11 VBG:1 
12 interfering VBG:12 
12 integral JJ:12 
12 injection NN:12 
12 influx NN:12 
12 inactivated UNKNOWN:1 VBD:3 VBN:8 
12 impact NN:11 VBP:1 
12 immunologic JJ:12 
12 immunoblotting NN:7 VBG:5 
12 hypersensitivity NN:12 
12 heterodimerization NN:12 
12 gelatinase NN:12 
12 fra-1 NN:12 
12 fos JJ:1 NN:11 
12 fail VBP:12 
12 explored VBD:3 VBN:9 
12 estrogens NNS:12 
12 establishment NN:12 
12 erythematosus NN:12 
12 environmental JJ:12 
12 endometrium NN:12 
12 egr-1 NN:12 
12 dysfunction NN:12 
12 drive VB:9 VBP:3 
12 dopamine JJ:1 NN:11 
12 docking NN:12 
12 diversity NN:12 
12 divergent JJ:12 
12 distinguish VB:6 VBP:6 
12 discovered VBD:3 VBN:9 
12 directs VBZ:12 
12 differently RB:12 
12 diabetes NN:4 NNS:8 
12 determination NN:12 
12 cortex NN:12 
12 copy NN:12 
12 conventional JJ:12 
12 conjunction NN:12 
12 conducted VBN:12 
12 c-Myc NN:12 
12 breakpoints NNS:12 
12 beta-catenin JJ:2 NN:10 
12 benign JJ:12 
12 beneficial JJ:12 
12 became VBD:12 
12 baseline NN:12 
12 autosomal JJ:12 
12 autoregulation NN:12 
12 authors NNS:12 
12 atherogenesis NN:12 
12 around IN:12 
12 approaches NNS:12 
12 applied VBN:12 
12 antiapoptotic JJ:12 
12 anti-Ig JJ:9 NN:3 
12 anti JJ:12 
12 antagonize VB:10 VBP:2 
12 anorexia NN:12 
12 alters VBZ:12 
12 alternatively RB:12 
12 alpha,25-dihydroxyvitamin NN:12 
12 al. FW:12 
12 actively RB:12 
12 according VBG:12 
12 abundantly RB:12 
12 abolish VB:7 VBP:5 
12 U2 NN:12 
12 Their PRP$:12 
12 TRAF3 JJ:1 NN:11 
12 TPCK NN:12 
12 Sp NN:12 
12 Second JJ:2 RB:10 
12 SRG3 NN:12 
12 SEM NN:12 
12 S. FW:5 NNP:7 
12 RXRs NNS:12 
12 RFX JJ:1 NN:11 
12 Purified VBN:12 
12 PTF JJ:1 NN:11 
12 PPAR NN:10 NNS:2 
12 PLZF-RAR NN:12 
12 PECAM-1 NN:12 
12 PAO JJ:1 NN:11 
12 Nevertheless RB:12 
12 NH2-terminal JJ:12 
12 NF-AT1 NN:12 
12 N-acetylcysteine NN:12 
12 MIP-1 NN:12 
12 MCM NN:12 
12 Like IN:12 
12 LNCaP NN:12 
12 LMP JJ:1 NN:11 
12 LCLs NN:1 NNS:11 
12 L. FW:10 NN:1 NNP:1 
12 Interaction NN:12 
12 IkappaBbeta NN:12 
12 IRF-2 NN:12 
12 IL-13R NN:12 
12 IE JJ:4 NN:8 
12 HSV-1 NN:12 
12 HSV JJ:2 NN:10 
12 HPC NN:12 
12 HMG-I(Y) NN:12 
12 HIV1 JJ:4 NN:8 
12 HER-2/neu NN:12 
12 HBD NN:12 
12 EpoR NN:12 
12 Cross-linking JJ:3 NN:8 VBG:1 
12 Cellular JJ:12 
12 CD34(+) JJ:12 
12 CD18 JJ:3 NN:9 
12 CD15 JJ:1 NN:11 
12 CAML JJ:1 NN:11 
12 Bcl-xL NN:12 
12 BRLF1 NN:12 
12 BCL-2 JJ:1 NN:11 
12 BAT NN:12 
12 BA JJ:6 NN:6 
12 B104 NN:12 
12 Apoptosis JJ:1 NN:11 
12 Altogether RB:12 
12 Ah NN:12 
12 ALL NN:12 
12 ACH-2 NN:12 
12 33 CD:12 
12 22 CD:12 
12 200 CD:12 
12 1991 CD:12 
12 0.1 CD:12 
12 -producing JJ:12 
12 -encoded JJ:12 
11 yielded VBD:11 
11 virus-1 NN:11 
11 vimentin NN:11 
11 up-regulate VB:5 VBP:6 
11 until IN:11 
11 unresponsive JJ:11 
11 units NNS:11 
11 uninduced JJ:11 
11 undertaken VBN:11 
11 ubiquitously RB:11 
11 terms NNS:11 
11 techniques NNS:11 
11 strictly RB:11 
11 steroids NNS:11 
11 staurosporine JJ:1 NN:10 
11 specimens NNS:11 
11 spanning NN:1 VBG:10 
11 smooth JJ:7 NN:3 VB:1 
11 silent JJ:11 
11 side JJ:8 NN:3 
11 sickle JJ:6 NN:5 
11 senescence NN:11 
11 screened VBD:5 VBN:6 
11 returned VBD:11 
11 retroviral JJ:11 
11 restore VB:11 
11 responds VBZ:11 
11 residual JJ:11 
11 resembles VBZ:11 
11 repressive JJ:11 
11 replacement NN:11 
11 remaining VBG:11 
11 rel NN:11 
11 rejection NN:11 
11 regarding VBG:11 
11 reducing NN:2 VBG:9 
11 recovery NN:11 
11 recognizing VBG:11 
11 received VBD:7 VBN:4 
11 rates NNS:11 
11 protects VBZ:11 
11 prostate NN:11 
11 prognosis NN:11 
11 profound JJ:11 
11 produces VBZ:11 
11 primates NNS:11 
11 plastic JJ:6 NN:5 
11 permissive JJ:11 
11 permanent JJ:11 
11 perhaps RB:11 
11 pathophysiology NN:11 
11 pathogenic JJ:11 
11 p70 NN:11 
11 p59fyn NN:11 
11 p56 NN:11 
11 p27 NN:11 
11 overexpressing NN:1 VBG:10 
11 ovary JJ:3 NN:8 
11 non-Hodgkin JJ:11 
11 nm23 NN:11 
11 myeloma NN:11 
11 monocytes/macrophages NNS:11 
11 mimics NNS:1 VBZ:10 
11 mg NN:11 
11 megakaryocyte NN:11 
11 mAECA JJ:1 NNS:10 
11 linker NN:11 
11 linkage NN:11 
11 linear JJ:10 NN:1 
11 lies VBZ:11 
11 lck NN:11 
11 lambda NN:11 
11 lacked VBD:11 
11 jun-B NN:11 
11 issue NN:11 
11 isolates NNS:11 
11 iron NN:11 
11 interest NN:11 
11 intense JJ:11 
11 import NN:11 
11 implies VBZ:11 
11 implicate VB:1 VBP:10 
11 impairs VBZ:11 
11 immunohistochemical JJ:11 
11 immunization NN:11 
11 iNOS NN:11 
11 iNO NN:11 
11 homeodomain NN:11 
11 homeobox NN:11 
11 hence RB:11 
11 hemin JJ:2 NN:9 
11 helix NN:11 
11 hGATA-3 NN:11 
11 guanine JJ:2 NN:9 
11 great JJ:11 
11 gp120 JJ:4 NN:7 
11 gland NN:11 
11 genital JJ:11 
11 fmol/mg NN:11 
11 fmol/10(7) NN:11 
11 fluid JJ:1 NN:10 
11 fibrosis NN:11 
11 fate NN:11 
11 factor-beta NN:11 
11 extensively RB:11 
11 evolutionarily RB:11 
11 epidermal JJ:11 
11 eosinophilia NN:11 
11 envelope NN:11 
11 efficiency NN:11 
11 duration NN:11 
11 down IN:1 JJ:5 RB:3 RP:2 
11 dose-dependently RB:11 
11 donor NN:11 
11 directing VBG:11 
11 dependence NN:11 
11 delivered VBN:11 
11 delineate VB:10 VBP:1 
11 cytokine-induced JJ:11 
11 cyclin-dependent JJ:11 
11 crosslinking NN:9 VBG:2 
11 critically RB:11 
11 coordinated VBN:11 
11 continued JJ:6 VBD:4 VBN:1 
11 consisted VBD:8 VBN:3 
11 considerable JJ:11 
11 condition NN:11 
11 committed VBN:11 
11 clearance NN:11 
11 clarify VB:11 
11 circadian JJ:11 
11 cell-type-specific JJ:11 
11 cdc2 NN:11 
11 causing VBG:11 
11 c-fes NN:11 
11 best JJS:4 RB:3 RBS:4 
11 becomes VBZ:11 
11 bands NNS:11 
11 bZIP NN:11 
11 asymptomatic JJ:11 
11 arm NN:11 
11 area NN:11 
11 antisera NN:1 NNS:10 
11 ankyrin NN:11 
11 anemia NN:11 
11 analogous JJ:11 
11 alpha1 JJ:2 NN:9 
11 adenosine NN:11 
11 address VB:9 VBP:2 
11 activation-dependent JJ:11 
11 [3H]dexamethasone NN:11 
11 YJ NN:11 
11 Vpr NN:11 
11 Unexpectedly RB:11 
11 U/ml NN:11 
11 TIMP-1 JJ:3 NN:8 
11 TCEd NN:11 
11 Site-directed JJ:11 
11 STAT5B NN:11 
11 STAT2 JJ:1 NN:10 
11 STAT-1 JJ:1 NN:10 
11 SE NN:4 NNS:7 
11 SCF JJ:1 NN:10 
11 Rather RB:11 
11 Raf JJ:2 NN:9 
11 RAI NN:11 
11 PWM JJ:3 NN:8 
11 PRE-I NN:11 
11 PLD JJ:1 NN:10 
11 PD98059 NN:11 
11 Oct1 NN:11 
11 NF-E1 NN:11 
11 NADPH NN:11 
11 Mycobacterium FW:2 NN:9 
11 MSR JJ:1 NN:10 
11 MEK1 JJ:1 NN:10 
11 Lipopolysaccharide JJ:1 NN:10 
11 LYSP100 JJ:2 NN:9 
11 LMO NN:11 
11 Ki-67 NN:11 
11 K+ NN:11 
11 J. NNP:11 
11 IkB NN:11 
11 ISRE NN:11 
11 IM-9 NN:11 
11 IL4 NN:11 
11 IL3 NN:11 
11 IL-10R NN:11 
11 Hsp70 JJ:1 NN:10 
11 HIV-TF1 JJ:2 NN:9 
11 GTP JJ:6 NN:5 
11 GRalpha JJ:3 NN:8 
11 G(S)alpha NN:11 
11 G(Anh)MTetra JJ:4 NN:7 
11 F NN:11 
11 Exposure NN:11 
11 ERK2 NN:11 
11 EMSAs NNS:11 
11 EL-4 NN:11 
11 EGR1 JJ:2 NN:8 NNS:1 
11 Duffy NN:11 
11 Direct JJ:11 
11 Cytokine JJ:1 NN:10 
11 Costimulation NN:11 
11 Collectively RB:11 
11 CVZ JJ:1 NN:10 
11 CD56+ JJ:11 
11 CD21 NN:11 
11 C/EBP-epsilon NN:11 
11 C-terminus NN:11 
11 B7 JJ:1 NN:10 
11 AhR NN:11 
11 AML1a JJ:1 NN:10 
11 AML1/ETO NN:11 
11 AITL NN:11 
11 A6H NN:11 
11 A2 NN:11 
11 86 CD:11 
11 6TG1.1 NN:11 
11 55 CD:11 
11 5'HS3 NN:11 
11 35 CD:11 
11 3-fold JJ:6 RB:5 
11 28 CD:11 
11 264.7 CD:11 
11 1996 CD:11 
11 1995 CD:11 
11 1.8 CD:11 
11 -phosphorylated JJ:10 VBN:1 
11 -MCP NN:11 
11 -6 CD:11 
10 view NN:10 
10 viable JJ:10 
10 version NN:10 
10 variables NNS:10 
10 v-Abl JJ:2 NN:8 
10 v-abl JJ:6 NN:4 
10 unrelated JJ:10 
10 unlabeled JJ:10 
10 underwent VBD:10 
10 unchanged JJ:10 
10 twofold JJ:6 RB:4 
10 tumours NNS:10 
10 transplant NN:10 
10 translational JJ:10 
10 transgene NN:10 
10 tonsillar JJ:8 NN:2 
10 thiol JJ:1 NN:9 
10 surrogate JJ:8 NN:2 
10 surfaces NNS:10 
10 superoxide NN:10 
10 succinate JJ:1 NN:9 
10 subclone JJ:1 NN:9 
10 steady JJ:10 
10 stage-specific JJ:10 
10 speculate VB:1 VBP:9 
10 source NN:9 RB:1 
10 so-called JJ:10 
10 snRNA JJ:1 NN:9 
10 site-directed JJ:10 
10 similarities NNS:10 
10 serine/threonine NN:10 
10 seem VB:3 VBP:7 
10 se FW:10 
10 salt NN:10 
10 rodent JJ:10 
10 ring NN:10 
10 ribosomal JJ:10 
10 retroviruses NNS:10 
10 restores VBZ:10 
10 resembling VBG:10 
10 rescued VBD:6 VBN:4 
10 rearranged JJ:1 VBN:9 
10 ranging VBG:10 
10 radical JJ:4 NN:6 
10 quite RB:10 
10 protective JJ:10 
10 proline JJ:6 NN:4 
10 proliferating JJ:1 VBG:9 
10 progressively RB:10 
10 prevention NN:10 
10 prerequisite JJ:1 NN:9 
10 pp56(lck) NN:10 
10 potentiation NN:10 
10 posttranslational JJ:10 
10 post-transcriptional JJ:10 
10 porcine JJ:2 NN:8 
10 poor JJ:10 
10 polyomavirus NN:10 
10 plasmacytoma NN:10 
10 peaked VBD:10 
10 pathogens NNS:10 
10 pAT NN:10 
10 p56lck JJ:1 NN:9 
10 ovarian JJ:10 
10 organization NN:10 
10 obligatory JJ:10 
10 non-B JJ:10 
10 nine CD:10 
10 next JJ:4 RB:6 
10 neoplasms NNS:10 
10 need NN:6 VBP:4 
10 myeloproliferative JJ:10 
10 morphological JJ:10 
10 mobility-shift JJ:6 NN:4 
10 mixture NN:10 
10 minor JJ:10 
10 mineralocorticoids NNS:10 
10 mimicked VBD:4 VBN:6 
10 microglia NN:1 NNS:9 
10 microB NN:10 
10 methylprednisolone JJ:2 NN:8 
10 measuring VBG:10 
10 map NN:5 VB:2 VBP:3 
10 maintaining VBG:10 
10 ligand-binding JJ:9 NN:1 
10 just RB:10 
10 interplay NN:10 
10 interleukin-10 JJ:1 NN:9 
10 inositol JJ:1 NN:9 
10 initially RB:10 
10 index NN:10 
10 improved JJ:2 VBD:2 VBN:6 
10 immunosuppressant JJ:8 NN:2 
10 immunogenic JJ:10 
10 immortalized JJ:1 VBD:1 VBN:8 
10 identifying VBG:10 
10 hybridoma NN:10 
10 hour NN:10 
10 haplotypes NNS:10 
10 haematopoietic JJ:10 
10 hIL-5 JJ:2 NN:8 
10 grown JJ:2 VBN:8 
10 granzyme NN:10 
10 gradient JJ:1 NN:9 
10 grade NN:10 
10 galectin-3 NN:10 
10 fusions NNS:10 
10 fibrinogen JJ:2 NN:8 
10 facilitates NNS:1 VBZ:9 
10 extracted JJ:1 VBN:9 
10 extending VBG:10 
10 explanation NN:10 
10 exhibiting VBG:10 
10 exercise NN:10 
10 excess JJ:2 NN:8 
10 etoposide JJ:1 NN:9 
10 environment NN:10 
10 element-binding JJ:9 NN:1 
10 electrolyte NN:10 
10 elastase NN:10 
10 eight CD:10 
10 earliest JJS:10 
10 downregulates VBZ:10 
10 down-regulates VBZ:10 
10 double JJ:10 
10 distributed VBN:10 
10 discrete JJ:10 
10 diffuse JJ:7 NN:1 VB:1 VBP:1 
10 differentiation-inducing JJ:10 
10 developmentally RB:10 
10 depressive JJ:10 
10 depression NN:10 
10 dehydrogenase NN:10 
10 deacetylase NN:10 
10 daily JJ:3 RB:7 
10 d CC:1 FW:1 LS:3 NN:3 VBD:1 VBZ:1 
10 cytometric JJ:10 
10 cyclosporine NN:10 
10 cyclase NN:10 
10 costimulated JJ:1 VBD:3 VBN:6 
10 coordinately RB:10 
10 conditional JJ:10 
10 concomitantly RB:10 
10 complementation NN:10 
10 compare VB:9 VBP:1 
10 colon NN:10 
10 collagenase NN:10 
10 coexpressed JJ:1 VBD:1 VBN:8 
10 classes NNS:10 
10 cholesterol NN:10 
10 chimera NN:10 
10 chemical JJ:10 
10 cell-surface JJ:8 NN:2 
10 carboxy-terminal JJ:10 
10 benzene JJ:2 NN:8 
10 belonging VBG:10 
10 behavior NN:10 
10 barely RB:10 
10 background NN:10 
10 b LS:7 NN:3 
10 attention NN:10 
10 assess VB:10 
10 arachidonic JJ:10 
10 analog NN:10 
10 administered VBN:10 
10 across IN:10 
10 abrogates VBZ:10 
10 above IN:3 JJ:4 RB:3 
10 ZEB JJ:1 NN:9 
10 V CD:1 JJ:3 NN:6 
10 Transactivation NN:10 
10 Thrombin JJ:1 NN:9 
10 TSP NN:10 
10 TRAF1 NN:10 
10 TCC JJ:1 NN:9 
10 T-PLL NN:10 
10 Suppression NN:10 
10 Steel NN:10 
10 Stat4 NN:10 
10 Signaling NN:8 VBG:2 
10 Scatchard NN:10 
10 SOCS-3 NN:10 
10 SM NN:10 
10 Rac-1 NN:10 
10 RBC JJ:1 NN:3 NNS:6 
10 RAW NN:10 
10 R24 JJ:2 NN:8 
10 Proliferation NN:10 
10 Positive JJ:10 
10 Plasma NN:10 
10 Phorbol NN:10 
10 PMNs NNS:10 
10 PEL NN:10 
10 P2 NN:10 
10 P-selectin JJ:1 NN:9 
10 None NN:10 
10 New JJ:5 NN:5 
10 NOS NN:9 NNS:1 
10 NIK NN:10 
10 NHL NN:10 
10 NGFI-B/nur77 NN:10 
10 NF-GM2 NN:10 
10 N-acetyl-L-cysteine NN:10 
10 Modulation NN:10 
10 MS JJ:1 NN:9 
10 MEL NN:10 
10 MEK JJ:1 NN:9 
10 M4 NN:10 
10 Lymphocytes NNS:10 
10 Lymphocyte NN:10 
10 LOX-1 NN:10 
10 LN NN:10 
10 KBF1 NN:10 
10 Infection NN:10 
10 IP-10 NN:10 
10 IL-2Rbeta NN:10 
10 IL-12R NN:10 
10 IKKbeta NN:10 
10 ICAM-I NN:10 
10 HMG-I NN:10 
10 H9 NN:10 
10 Granulocyte-macrophage JJ:10 
10 GRbeta JJ:1 NN:9 
10 GCRbeta JJ:3 NN:7 
10 G0S2 NN:10 
10 FGF-1 JJ:2 NN:8 
10 Enhanced VBD:1 VBN:9 
10 EL4 NN:10 
10 EBV-transformed JJ:9 NN:1 
10 E47 NN:10 
10 E2F-4 NN:10 
10 Detection NN:10 
10 DSE NN:10 
10 Consequently RB:10 
10 CNS NN:9 NNS:1 
10 CD95L NN:10 
10 CD86 NN:10 
10 CD5 NN:10 
10 CD11c NN:10 
10 C/EBPalpha JJ:4 NN:6 
10 BHRF1 NN:10 
10 B7.1 JJ:1 NN:9 
10 B4 NN:10 
10 Another DT:10 
10 Acute JJ:10 
10 ALAS NN:10 
10 A1 NN:10 
10 A. FW:1 NNP:9 
10 5-fold JJ:4 NN:1 RB:5 
10 5-LOX JJ:2 NN:8 
10 5'-untranslated JJ:10 
10 31747A JJ:1 NN:9 
10 1997 CD:10 
10 1-2 CD:10 
10 /STAT NN:10 
10 .001 CD:10 
10 -insensitive JJ:10 
10 -inducing JJ:6 NN:4 
10 -70 CD:10 
10 -3 CD:10 
10 -10 CD:8 NN:2 
9 zeta-globin NN:9 
9 younger JJR:9 
9 year NN:9 
9 withdrawal NN:9 
9 whole-cell JJ:9 
9 virally RB:9 
9 unrecognized JJ:9 
9 undefined JJ:8 VBN:1 
9 two- CD:9 
9 triptolide JJ:3 NN:6 
9 triflusal JJ:1 NN:8 
9 treatments NNS:9 
9 translocate VB:7 VBP:2 
9 transactivates VBZ:9 
9 trans-activating JJ:9 
9 trans JJ:6 NN:2 VBG:1 
9 time- NN:9 
9 threonine JJ:2 NN:7 
9 threefold JJ:4 RB:5 
9 temporal JJ:9 
9 tamoxifen NN:9 
9 surrounding JJ:2 NN:1 VBG:6 
9 sulfate JJ:1 NN:8 
9 subtypes NNS:9 
9 subpopulations NNS:9 
9 standard JJ:8 NN:1 
9 squamous JJ:9 
9 spread NN:4 VBN:5 
9 spi-1 NN:9 
9 sialoadhesin NN:9 
9 shares VBZ:9 
9 select JJ:7 VB:2 
9 sarcoidosis NN:9 
9 saimiri NN:8 NNS:1 
9 rickets JJ:2 NN:7 
9 rhombotin NN:9 
9 retrovirus NN:9 
9 retarded JJ:1 VBD:1 VBN:7 
9 responders NNS:9 
9 requiring VBG:9 
9 renin JJ:1 NN:8 
9 reflects VBZ:9 
9 reflecting VBG:9 
9 redundancy NN:9 
9 reconstitution NN:9 
9 receiving VBG:9 
9 raise VB:3 VBP:6 
9 qualitative JJ:9 
9 property NN:9 
9 promyelocytes NNS:9 
9 promyelocyte JJ:6 NN:3 
9 prompted VBD:8 VBN:1 
9 proliferated VBD:7 VBN:2 
9 proenkephalin NN:9 
9 processed VBN:9 
9 problem NN:9 
9 principal JJ:9 
9 primate JJ:7 NN:2 
9 prevalence NN:9 
9 prednisolone JJ:2 NN:7 
9 plaque NN:9 
9 picture NN:9 
9 phosphotyrosine JJ:1 NN:8 
9 phosphorylates VBZ:9 
9 peroxidase NN:9 
9 paired JJ:9 
9 p75 NN:9 
9 p55 NN:9 
9 p50-p65 NN:9 
9 p49 NN:9 
9 p21 NN:9 
9 outgrowth NN:9 
9 ones NNS:9 
9 nonhematopoietic JJ:9 
9 non-erythroid JJ:9 
9 node NN:9 
9 neutral JJ:9 
9 neuronal JJ:9 
9 network NN:9 
9 neoformans FW:7 NNS:2 
9 near IN:6 JJ:3 
9 myeloid-specific JJ:9 
9 myeloid-cell-specific JJ:9 
9 mutational JJ:9 
9 multimerized JJ:9 
9 monoblastic JJ:9 
9 microbial JJ:9 
9 menstrual JJ:9 
9 membrane-proximal JJ:9 
9 malignancy NN:9 
9 males NNS:9 
9 make VB:2 VBP:7 
9 lysosomal JJ:9 
9 lysoPC NN:9 
9 lowered JJ:7 VBD:1 VBN:1 
9 lipids NNS:9 
9 lining JJ:5 NN:4 
9 life NN:9 
9 leukemogenesis NN:9 
9 knock-out JJ:8 NN:1 
9 isomerase NN:9 
9 island NN:9 
9 ion NN:9 
9 interleukin-5 NN:9 
9 interacted VBD:9 
9 integrins NNS:9 
9 inserted VBN:9 
9 influenza NN:9 
9 infects VBZ:9 
9 infect VB:9 
9 ineffective JJ:9 
9 indomethacin NN:9 
9 immunotherapy NN:9 
9 immunosuppressants NNS:9 
9 ie FW:8 NN:1 
9 hypermutation NN:9 
9 history NN:9 
9 hTR NN:9 
9 growing VBG:9 
9 gre NN:9 
9 gp41 JJ:3 NN:6 
9 glands NNS:9 
9 genotype NN:9 
9 generates VBZ:9 
9 gamma-IFN NN:9 
9 functioning NN:1 VBG:8 
9 fold JJ:6 NN:2 RB:1 
9 flavonoids NNS:9 
9 fingers NNS:9 
9 extinction NN:9 
9 expanded VBD:1 VBN:8 
9 exclusive JJ:9 
9 excluded VBN:9 
9 examination NN:9 
9 exact JJ:8 NN:1 
9 ethanol NN:9 
9 essentially RB:9 
9 erythrocytic JJ:9 
9 equal JJ:9 
9 endometriosis NN:9 
9 endometrial JJ:9 
9 emergence NN:9 
9 elongation NN:9 
9 elk-1 JJ:1 NN:8 
9 eliminate VB:4 VBP:5 
9 eTh2 NN:9 
9 ductal JJ:9 
9 dispensable JJ:9 
9 discovery NN:9 
9 dex JJ:7 NN:2 
9 design NN:8 VB:1 
9 describes VBZ:9 
9 dense JJ:9 
9 date NN:8 VB:1 
9 cross-linked JJ:6 VBN:3 
9 coupling NN:9 
9 counterpart NN:9 
9 corresponds VBZ:9 
9 cooperates VBZ:9 
9 conditioned JJ:8 VBN:1 
9 competed VBD:4 VBN:5 
9 classic JJ:9 
9 ciprofloxacin NN:9 
9 centers NNS:9 
9 cell-derived JJ:9 
9 catalase NN:9 
9 cap NN:9 
9 c-Maf NN:9 
9 blots NNS:9 
9 beta-galactosidase NN:9 
9 belongs VBZ:9 
9 bases NNS:9 
9 asthmatics NNS:9 
9 antitumor JJ:6 NN:3 
9 anti-CD2 JJ:6 NN:3 
9 antagonistic JJ:9 
9 antagonism NN:9 
9 analogues NNS:9 
9 always RB:9 
9 alpha,25-(OH)2D3 NN:9 
9 allowing VBG:9 
9 agreement NN:9 
9 again RB:9 
9 advantage NN:9 
9 advanced JJ:9 
9 abrogate VB:5 VBP:4 
9 Under IN:9 
9 U NN:5 NNP:4 
9 Tyk2 NN:9 
9 Tpl-2 JJ:1 NN:8 
9 TRAF6 NN:9 
9 TNFR1 JJ:1 NN:8 
9 TFIIA NN:9 
9 TEC NN:5 NNS:4 
9 T3SO4 NN:9 
9 T. FW:6 NNP:3 
9 T-helper NN:9 
9 Selective JJ:9 
9 STAT5b NN:9 
9 SP-1 JJ:2 NN:7 
9 SDS-PAGE NN:9 
9 S6 NN:9 
9 Rel/ NN:9 
9 Recombinant JJ:9 
9 RXR-alpha NN:9 
9 RI NN:9 
9 RBP-Jkappa JJ:2 NN:7 
9 Promoter NN:9 
9 Pit-1 NN:9 
9 PTPase NN:9 
9 PNU156804 NN:9 
9 PML/RAR NN:9 
9 PMA- JJ:4 NN:5 
9 PKA NN:9 
9 PI3-K NN:9 
9 PG490 NN:9 
9 PDBu JJ:2 NN:7 
9 OBF-1 NN:9 
9 Notch NN:9 
9 NSAIDs NN:1 NNS:8 
9 NF-kappaB/Rel NN:9 
9 NF-KB NN:9 
9 NDP NN:9 
9 Mutational JJ:9 
9 MZF-2 NN:9 
9 MP NN:9 
9 MNC NN:9 
9 MDS1/EVI1 NN:9 
9 MDMs NNS:9 
9 MDHM JJ:4 NN:5 
9 MDD NN:9 
9 Low JJ:9 
9 Levels NNS:9 
9 LR1 JJ:1 NN:8 
9 LIF JJ:1 NN:8 
9 LAM NN:9 
9 LAI NN:9 
9 Kruppel-like JJ:9 
9 Itk JJ:1 NN:8 
9 Isolation NN:9 
9 Interleukin-10 NN:9 
9 Interferon NN:9 
9 Importantly RB:9 
9 Ii NN:9 
9 IRAK NN:9 
9 IL-4Ralpha NN:9 
9 IL-1RI JJ:4 NN:5 
9 IKKalpha NN:9 
9 IE62 NN:9 
9 IBD NN:9 
9 HU NN:9 
9 HSF3 NN:9 
9 HS2 NN:9 
9 HPCs NNS:9 
9 HOCl JJ:1 NN:8 
9 HBxAg JJ:2 NN:7 
9 Grf40 NN:9 
9 GcR NN:9 
9 GS NN:9 
9 GCs NNS:9 
9 FKBP51 NN:9 
9 Eed JJ:3 NN:6 
9 EVI1 JJ:1 NN:8 
9 ERK1 NN:9 
9 EPOR NN:9 
9 E3330 NN:9 
9 Cytokines NNS:9 
9 Compared VBN:9 
9 Coexpression NN:9 
9 Chinese JJ:8 NN:1 
9 CTCF NN:9 
9 CSF-1 JJ:1 NN:8 
9 CRH NN:9 
9 COOH-terminal JJ:9 
9 CF NN:9 
9 CD8(-) JJ:9 
9 CD8(+) JJ:9 
9 CD3+ JJ:9 
9 CD11b/CD18 NN:9 
9 CAG NN:9 
9 Bob1 NN:9 
9 Biol NNP:9 
9 BMRF1 NN:9 
9 BFU-E JJ:3 NN:6 
9 BCR JJ:3 NN:6 
9 BCL2 JJ:1 NN:8 
9 B-lymphoid JJ:9 
9 B-lymphocytes NNS:9 
9 B-1 NN:9 
9 Activity NN:8 NNP:1 
9 Accordingly RB:9 
9 ATP NN:9 
9 ATF-1 NN:9 
9 AM580 NN:9 
9 70Z/3 JJ:2 NN:7 
9 486 CD:9 
9 26 CD:9 
9 2.3 CD:9 
9 1beta NN:9 
9 19 CD:9 
9 15-lipoxygenase NN:9 
9 133 CD:9 
9 105 CD:9 
9 1,25D3 JJ:2 NN:7 
9 0.0001 CD:9 
9 /macrophages NNS:9 
9 /calmodulin-dependent JJ:9 
9 -restricted JJ:9 
9 -receptor JJ:2 NN:7 
8 zone NN:8 
8 what WP:8 
8 week NN:8 
8 way NN:8 
8 volume NN:8 
8 varied JJ:1 VBD:7 
8 vaginalis FW:8 
8 v-erb NN:8 
8 uterine JJ:5 NN:3 
8 uses VBZ:8 
8 unusual JJ:8 
8 unrearranged JJ:8 
8 unexpected JJ:8 
8 ubiquitin JJ:4 NN:4 
8 twins NNS:8 
8 true JJ:8 
8 therapies NNS:8 
8 testing NN:6 VBG:2 
8 tax1 JJ:1 NN:7 
8 synergism NN:8 
8 supernatant JJ:3 NN:5 
8 superantigen NN:8 
8 substances NNS:8 
8 subpopulation NN:8 
8 strand NN:8 
8 starting VBG:8 
8 staphylococcal JJ:7 NN:1 
8 sphingomyelinase NN:8 
8 signal-transducing JJ:8 
8 sensitized VBD:1 VBN:7 
8 self NN:8 
8 sections NNS:8 
8 sIgM NN:8 
8 rich JJ:8 
8 reservoir NN:8 
8 repressors NNS:8 
8 render VB:3 VBP:5 
8 removed VBD:1 VBN:7 
8 recipients NNS:8 
8 receptor-1 JJ:1 NN:7 
8 reached VBD:6 VBN:2 
8 radiotherapy NN:8 
8 radiolabeled JJ:1 VBN:7 
8 purification NN:8 
8 protein-binding JJ:8 
8 progressive JJ:8 
8 pro-inflammatory JJ:8 
8 presents VBZ:8 
8 pregnant JJ:8 
8 predominance NN:8 
8 pre-existing JJ:8 
8 postmenopausal JJ:8 
8 pool NN:8 
8 placed JJ:1 VBD:1 VBN:6 
8 phagocyte NN:8 
8 peroxisome JJ:1 NN:7 
8 participation NN:8 
8 parent JJ:2 NN:6 
8 p70(s6k) NN:8 
8 p40tax NN:8 
8 p39c-jun NN:8 
8 p27Kip1 NN:8 
8 oxidants NNS:8 
8 oriP NN:8 
8 organisms NNS:8 
8 oncogenesis NN:8 
8 occurrence NN:8 
8 objective JJ:1 NN:7 
8 nucleolin NN:8 
8 nonspecific JJ:8 
8 nmol/l NN:8 
8 neuroblastoma NN:8 
8 mutually RB:8 
8 mumol/L NN:8 
8 mostly RB:8 
8 moiety NN:8 
8 modulator NN:8 
8 moderately RB:8 
8 mild JJ:8 
8 menopausal JJ:8 
8 men NNS:8 
8 mechanical JJ:8 
8 measurement NN:8 
8 manifested VBN:8 
8 loss-of-function JJ:4 NN:4 
8 location NN:8 
8 limits NNS:3 VBZ:5 
8 leukaemic JJ:8 
8 lesion NN:8 
8 inversely RB:8 
8 insufficient JJ:8 
8 insert NN:8 
8 inoculated VBN:8 
8 initiating VBG:8 
8 individually RB:8 
8 immunophilins JJ:1 NNS:7 
8 immobilized JJ:2 VBN:6 
8 hydrophobic JJ:8 
8 homologues NNS:8 
8 hLH-2 NN:8 
8 gold NN:8 
8 give VB:5 VBP:3 
8 germ-line JJ:1 NN:7 
8 gel-shift JJ:7 NN:1 
8 gamma- JJ:2 NN:5 NNS:1 
8 fundamental JJ:8 
8 foreign JJ:8 
8 focus NN:5 VB:2 VBP:1 
8 extremely RB:8 
8 extension NN:8 
8 excretion NN:8 
8 evolved VBD:2 VBN:6 
8 evolution NN:8 
8 eutopic JJ:8 
8 ets-1 NN:8 
8 etiology NN:8 
8 estrogenic JJ:8 
8 establishing VBG:8 
8 enhancer-binding JJ:8 
8 engineered VBN:8 
8 embryogenesis NN:8 
8 eTh1 NN:8 
8 down-regulate VB:6 VBP:2 
8 diverged JJ:6 VBD:1 VBN:1 
8 diurnal JJ:8 
8 disulfide NN:8 
8 dissociated VBD:1 VBN:7 
8 dissect VB:8 
8 dioxin NN:8 
8 dimethyl JJ:5 NN:3 
8 difficult JJ:8 
8 dibutyryl JJ:3 NN:5 
8 detailed JJ:7 VBN:1 
8 definitive JJ:8 
8 defining VBG:8 
8 defines VBZ:8 
8 defensin NN:8 
8 deduced VBN:8 
8 cysteamine NN:8 
8 curcumin NN:8 
8 counts NNS:8 
8 cooperatively RB:8 
8 contributed VBD:7 VBN:1 
8 conservation NN:8 
8 consequently RB:8 
8 consequent JJ:8 
8 confirming VBG:8 
8 confined VBN:8 
8 configuration NN:8 
8 comprising VBG:8 
8 comprised VBD:4 VBN:4 
8 complexed VBN:8 
8 compatible JJ:8 
8 collagenase-1 NN:8 
8 cold JJ:7 NN:1 
8 co-transfection NN:8 
8 co-transfected JJ:1 VBN:7 
8 clusters NNS:8 
8 clustering NN:7 VBG:1 
8 classified VBD:1 VBN:7 
8 cis-elements NNS:8 
8 chemically RB:8 
8 cerevisiae FW:7 NN:1 
8 caspases NNS:8 
8 carry VBP:8 
8 cardiac JJ:8 
8 carboxyl JJ:1 NN:7 
8 canonical JJ:8 
8 calyculin NN:8 
8 cAMP-dependent JJ:8 
8 breakpoint NN:8 
8 bipolar JJ:8 
8 bipartite JJ:8 
8 bare JJ:8 
8 availability NN:8 
8 autoimmunity NN:8 
8 atypical JJ:8 
8 atrophy NN:8 
8 arteritis NN:8 
8 alpha-tcp JJ:1 NN:7 
8 alpha-lipoic JJ:8 
8 albicans FW:5 NNS:3 
8 alanine JJ:1 NN:7 
8 agonist-induced JJ:8 
8 adhesive JJ:8 
8 acutely RB:8 
8 acted VBD:8 
8 abnormally RB:8 
8 aa NN:3 NNS:5 
8 [3H]thymidine NN:8 
8 YM268 JJ:1 NN:7 
8 XPB NN:8 
8 X2-box NN:8 
8 X1 NN:8 
8 X-inactivation JJ:1 NN:7 
8 X-chromosome NN:8 
8 X-SCID NN:8 
8 WAF1/CIP1 NN:8 
8 Viral JJ:8 
8 VDRE JJ:1 NN:7 
8 U3 NN:8 
8 Tissue NN:8 
8 Thrombopoietin IN:1 NN:7 
8 TSHR NN:8 
8 TSH NN:8 
8 TSG101 NN:8 
8 TREp JJ:1 NN:7 
8 TRE-1 NN:8 
8 TRAFs NNS:8 
8 TP1 NN:8 
8 TMD NN:8 
8 TK NN:8 
8 TAM JJ:1 NN:6 NNP:1 
8 T4 NN:8 
8 Stat3alpha NN:8 
8 Stat-3 NN:8 
8 Spi-C JJ:1 NN:7 
8 Smad6 NN:8 
8 Six CD:8 
8 Serum NN:8 
8 STAT1alpha JJ:2 NN:6 
8 SRY NN:8 
8 SR-BP NN:8 
8 SML NNS:8 
8 SL3 NN:8 
8 SEA JJ:1 NN:7 
8 Rev NN:8 
8 Receptor NN:8 
8 Ramos NN:8 
8 RIP NN:8 
8 RII JJ:3 NN:5 
8 RFX5 NN:8 
8 Phosphorylation NN:8 
8 Pb JJ:2 NN:6 
8 Pan NN:8 
8 PTSD NN:8 
8 PKB/Akt NN:8 
8 PEBP2/CBF NN:8 
8 PDGF(B) NN:8 
8 PC4 JJ:1 NN:7 
8 PBM NN:1 NNS:7 
8 PAFR NN:8 
8 P4 NN:8 
8 P1 NN:8 
8 P0 JJ:1 NN:7 
8 P- JJ:6 NN:2 
8 ORF NN:8 
8 Neutrophil NN:8 
8 NLS NN:8 
8 NK3.3 NN:8 
8 NF-M JJ:1 NN:7 
8 NF- NN:8 
8 More JJR:3 RBR:5 
8 Monocytes NNS:8 
8 MPL NN:8 
8 MNP NN:7 NNS:1 
8 MIP-1alpha NN:8 
8 MAD3 NN:8 
8 MAD-3 NN:8 
8 M7 NN:8 
8 LPS-induced JJ:8 
8 LAZ3/BCL6 NN:8 
8 LAK NN:8 
8 KIP1 NN:8 
8 Interleukin-6 NN:8 
8 Interferon-gamma NN:8 
8 Instead RB:8 
8 IRF JJ:1 NN:7 
8 IL-2- JJ:2 NN:6 
8 IL-11 NN:8 
8 HSF2 NN:8 
8 HIE NN:8 
8 HEL NN:8 
8 HB9 NN:8 
8 H7 NN:8 
8 Gy NN:8 
8 GrpL NN:8 
8 GDSP NN:8 
8 GCS JJ:1 NNS:7 
8 GC-box NN:8 
8 G28-5 NN:8 
8 G-CSFR NN:8 
8 Flow NN:8 
8 Five CD:8 
8 FP NN:8 
8 FOS JJ:1 NN:6 NNS:1 
8 FN JJ:3 NN:5 
8 FL NN:8 
8 FHIT NN:8 
8 Examination NN:8 
8 Each DT:7 JJ:1 
8 ERP JJ:1 NN:7 
8 ELAM-1 NN:8 
8 EBV-positive JJ:8 
8 EBNA3C NN:8 
8 Different JJ:8 
8 Data NN:1 NNS:7 
8 DQ NN:8 
8 DMDTC JJ:2 NN:6 
8 Control NN:8 
8 CoCl2 JJ:2 NN:6 
8 Chr NN:8 
8 Cbl-b JJ:1 NN:7 
8 CTLs NNS:8 
8 CTLL-2 NN:8 
8 CTLA-4 JJ:2 NN:6 
8 CR1 JJ:1 NN:7 
8 CHO NN:8 
8 CD JJ:2 NN:6 
8 CBP/p300 JJ:1 NN:7 
8 Blood NN:5 NNP:3 
8 Bcl-3 NN:8 
8 Bcd NN:8 
8 Ba/F3 NN:8 
8 BM NN:5 NNS:3 
8 BHA NN:8 
8 B95-8 NN:8 
8 B-related JJ:8 
8 B-2 NN:8 
8 Association NN:8 
8 Anti- FW:1 JJ:4 NN:3 
8 Aldh1 NN:8 
8 Additional JJ:8 
8 Abnormal JJ:8 
8 APCs NNS:8 
8 AP3-L NN:8 
8 AML1b NN:8 
8 ALY NN:8 
8 AIR-1 JJ:1 NN:7 
8 AD NN:8 
8 A-T JJ:3 NN:5 
8 A-MYB NN:8 
8 92 CD:8 
8 50-kDa JJ:8 
8 5-lipoxygenase JJ:1 NN:7 
8 5'-UTR NN:8 
8 47.10 CD:8 
8 41 CD:8 
8 38 CD:7 NN:1 
8 32Dcl3 NN:8 
8 293 CD:8 
8 29-kDa JJ:8 
8 24-hydroxylase NN:8 
8 150 CD:8 
8 1.0 CD:8 
8 09-2210 CD:8 
8 0.9 CD:8 
8 0.02 CD:8 
8 /p50 NN:8 
8 -triggered JJ:8 
8 -related JJ:8 
8 -bearing JJ:8 
8 -based JJ:7 NN:1 
8 -7 CD:8 
8 -4 CD:7 NN:1 
7 yield NN:2 VB:4 VBP:1 
7 white JJ:7 
7 virus-infected JJ:7 
7 virtue NN:7 
7 ventilation NN:7 
7 varying JJ:1 VBG:6 
7 vary VB:2 VBP:5 
7 vanadate NN:7 
7 vaccine NN:7 
7 upregulates VBZ:7 
7 up-regulates VBZ:7 
7 tryptophan NN:7 
7 transrepression NN:7 
7 translocates VBZ:7 
7 transfections NNS:7 
7 transcription-polymerase JJ:1 NN:6 
7 toxic JJ:7 
7 tight JJ:7 
7 tg NN:7 
7 synthetase NN:7 
7 synergizes VBZ:7 
7 synergized VBD:7 
7 syn-1 JJ:5 NN:2 
7 surfactant JJ:3 NN:4 
7 supplemented VBD:1 VBN:6 
7 supplementation NN:7 
7 superantigens NNS:7 
7 successful JJ:7 
7 subtle JJ:7 
7 substituted VBD:2 VBN:5 
7 subgroup NN:7 
7 subfamily NN:7 
7 strikingly RB:7 
7 stress-induced JJ:7 
7 stress-activated JJ:7 
7 states NNS:7 
7 sporadic JJ:7 
7 spontaneously RB:7 
7 spite NN:7 
7 span NN:4 VBP:3 
7 somewhat RB:7 
7 smaller JJR:7 
7 slowly RB:7 
7 slow JJ:7 
7 skeletal JJ:7 
7 signs NNS:7 
7 short-term JJ:7 
7 shear NN:7 
7 sequestered JJ:1 VBN:6 
7 sequential JJ:7 
7 secrete VB:5 VBP:2 
7 sclerosis NN:7 
7 sIgD NN:7 
7 sFv NN:7 
7 runt JJ:1 NN:6 
7 rhythm NN:7 
7 rhinitis NN:7 
7 rex NN:7 
7 rest NN:7 
7 resolution NN:7 
7 repeated JJ:3 VBN:4 
7 repair NN:7 
7 remarkable JJ:7 
7 reflected VBD:2 VBN:5 
7 reconstitute VB:7 
7 receptor-mediated JJ:7 
7 reacted VBD:5 VBN:2 
7 purine-rich JJ:7 
7 profoundly RB:7 
7 pressure NN:7 
7 premature JJ:7 
7 preferential JJ:7 
7 preeclampsia NN:7 
7 predict VB:3 VBP:4 
7 preactivated JJ:7 
7 possess VB:5 VBP:2 
7 pneumophila FW:4 NN:3 
7 placebo NN:7 
7 phosphoinositide JJ:2 NN:5 
7 phi NN:7 
7 perforin NN:7 
7 percent JJ:1 NN:6 
7 paracrine JJ:3 NN:4 
7 pCD41 NN:7 
7 p80c-rel NN:7 
7 p62c-fos NN:7 
7 p13MTCP1 NN:7 
7 p107 NN:7 
7 oxidation NN:7 
7 overlaps VBZ:7 
7 osteocalcin NN:7 
7 ongoing JJ:7 
7 oncoproteins NNS:7 
7 oleate NN:7 
7 nur77 NN:6 NNS:1 
7 nucleoprotein NN:7 
7 nongenomic JJ:7 
7 nonerythroid JJ:7 
7 non-T JJ:7 
7 non JJ:7 
7 nef NN:7 
7 myb NN:7 
7 multipotential JJ:7 
7 multipotent JJ:7 
7 morphologically RB:7 
7 month NN:7 
7 monolayers NNS:7 
7 monocyte-like JJ:7 
7 modes NNS:7 
7 mitotic JJ:7 
7 migrating JJ:2 VBG:5 
7 migrated VBD:7 
7 microenvironment NN:7 
7 membrane-bound JJ:7 
7 megakaryoblastic JJ:7 
7 measure NN:1 VB:6 
7 matched JJ:1 VBD:3 VBN:3 
7 marrow-derived JJ:7 
7 mantle NN:7 
7 lymphokines NNS:7 
7 low-density JJ:7 
7 lineage-restricted JJ:7 
7 ligand-dependent JJ:7 
7 leukotriene NN:7 
7 labile JJ:6 NN:1 
7 labeled JJ:1 VBN:6 
7 kill VB:4 VBP:3 
7 iv LS:6 NN:1 
7 inverted JJ:3 VBN:4 
7 intronic JJ:7 
7 introduction NN:7 
7 interfollicular JJ:7 
7 interferon-alpha NN:7 
7 integrated JJ:1 VBN:6 
7 insufficiency NN:7 
7 inheritance NN:7 
7 influencing JJ:1 VBG:6 
7 infiltrates NNS:7 
7 incidence NN:7 
7 impair VB:5 VBP:2 
7 immunosorbent JJ:7 
7 immunoreactive JJ:7 
7 immunoprecipitated VBD:2 VBN:5 
7 immunophilin NN:7 
7 immunocytochemistry NN:7 
7 hypoxic JJ:7 
7 hypothesize VBP:7 
7 hypertensive JJ:6 NN:1 
7 hyperparathyroidism NN:7 
7 hsp70 NN:7 
7 homozygous JJ:7 
7 homo- JJ:6 NN:1 
7 heterozygosity NN:7 
7 herein RB:7 
7 heparin JJ:2 NN:5 
7 hematopoietic-specific JJ:7 
7 harbor VB:2 VBP:5 
7 hamster NN:7 
7 gut NN:7 
7 granulocyte/macrophage JJ:6 NN:1 
7 glucocorticosteroid NN:7 
7 generating VBG:7 
7 gamma/delta NN:7 
7 fourfold JJ:2 RB:5 
7 forming NN:1 VBG:6 
7 footprints NNS:7 
7 follicles NNS:7 
7 fluticasone NN:7 
7 flank JJ:1 NN:5 VBP:1 
7 fat JJ:1 NN:6 
7 fasL NN:7 
7 familial JJ:7 
7 exposures NNS:7 
7 exogenously RB:7 
7 euthyroid JJ:5 NN:2 
7 estimated VBN:7 
7 erythropoietic JJ:7 
7 epsilon26 NN:7 
7 enterotoxin NN:7 
7 endogenously RB:7 
7 emphasize VBP:7 
7 electromobility NN:7 
7 dose- JJ:1 NN:6 
7 distinguished VBN:7 
7 disease-free JJ:7 
7 disappeared VBD:7 
7 devoid JJ:7 
7 detail NN:7 
7 desArg NN:7 
7 deregulated VBN:7 
7 depended VBD:7 
7 delay NN:4 VB:2 VBP:1 
7 definition NN:7 
7 dPRL NN:7 
7 cytopathic JJ:7 
7 cytochrome NN:7 
7 cross-talk NN:7 
7 correspond VB:2 VBP:5 
7 correlations NNS:7 
7 converted VBD:4 VBN:3 
7 contributing VBG:7 
7 constitutes VBZ:7 
7 competent JJ:7 
7 comparing VBG:7 
7 collagen JJ:1 NN:6 
7 coagulation NN:7 
7 co-stimulatory JJ:7 
7 clonality NN:7 
7 choice NN:7 
7 changed VBD:4 VBN:3 
7 carboxy JJ:1 NN:6 
7 c-erbA/TR JJ:1 NN:6 
7 burden NN:7 
7 bufalin JJ:1 NN:6 
7 budesonide NN:7 
7 broad JJ:7 
7 blk NN:7 
7 biologically RB:7 
7 beta-like JJ:7 
7 benefit NN:6 VB:1 
7 bcl-xL JJ:1 NN:6 
7 augmenting VBG:7 
7 attachment NN:7 
7 aspect NN:7 
7 arsenic JJ:5 NN:2 
7 arrested VBD:1 VBN:6 
7 aortic JJ:7 
7 alpha2 CD:1 NN:6 
7 alpha-tocopherol NN:7 
7 allergen-specific JJ:7 
7 alkaline NN:7 
7 aimed VBD:2 VBN:5 
7 adenylate JJ:3 NN:4 
7 acquisition NN:7 
7 accounted VBN:7 
7 abilities NNS:7 
7 Zta NN:7 
7 Yet RB:7 
7 XSCID JJ:1 NN:6 
7 Wurzburg NN:7 
7 World NN:7 
7 UDG NN:7 
7 Toll NN:7 
7 Takayasu NN:7 
7 TRAMP JJ:1 NN:6 
7 TNFRI NN:7 
7 TH JJ:1 NN:6 
7 TGF JJ:1 NN:6 
7 TFIIH NN:7 
7 Smad7 NN:7 
7 Sjogren NN:7 
7 Science NNP:7 
7 STAT5a NN:7 
7 SSB NN:7 
7 SP-A JJ:1 NN:6 
7 SOX9 NN:7 
7 SOD NN:7 
7 SIVsmmPBj14 NN:7 
7 SIT NN:7 
7 Rta NN:7 
7 Ro(SSA) JJ:4 NN:3 
7 Reporter NN:7 
7 Rac JJ:1 NN:6 
7 RWLeu-4 NN:7 
7 RU486 NN:7 
7 RU38486 NN:7 
7 RNase NN:7 
7 RJ2.2.5 NN:7 
7 RFX1 NN:7 
7 RBTN-2 NN:7 
7 RAW264.7 NN:7 
7 RALDH2 NN:7 
7 Proteins NNS:7 
7 Point JJ:1 NN:6 
7 PT NN:7 
7 PSA NN:7 
7 PRDII NN:7 
7 PP2A NN:7 
7 POU-specific JJ:7 
7 PGG-Glucan NN:6 TO:1 
7 PF NN:7 
7 PCD/DCoH NN:7 
7 PBSC NNS:7 
7 PB NN:7 
7 PA JJ:1 NN:6 
7 Overall RB:7 
7 Okadaic JJ:7 
7 OM10.1 NN:7 
7 Nmi NN:7 
7 NPC NN:7 
7 NM23 CD:1 NN:6 
7 NLPHD NN:7 
7 NIP JJ:1 NN:6 
7 NH2 JJ:1 NN:6 
7 NF-kappaB/NFAT NN:7 
7 NF-chi NN:7 
7 N-WASP NN:7 
7 MyD88 JJ:1 NN:6 
7 Mononuclear JJ:7 
7 Maximal JJ:7 
7 ManLAM JJ:2 NN:5 
7 MTBE NN:7 
7 MT-2 NN:7 
7 MMTV NN:7 
7 META(D+) NN:7 
7 MBC NN:7 
7 Lymphoid JJ:6 NN:1 
7 Likewise RB:7 
7 LCL JJ:1 NN:3 NNS:3 
7 LBP NN:7 
7 KOX NN:7 
7 Ipr NN:7 
7 Interleukin-4 NN:7 
7 Interleukin-2 NN:7 
7 Interferons NNS:7 
7 Inducible JJ:7 
7 IRE NN:7 
7 IL-16 NN:7 
7 IFN-U937 NN:7 
7 IBR NN:7 
7 IARC NN:7 
7 I/Y NN:7 
7 Hsp60 JJ:1 NN:6 
7 Hox11 NN:7 
7 HePTP NN:7 
7 Hb JJ:1 NN:6 
7 HUAECs NNS:7 
7 HSF2-beta NN:7 
7 HSF JJ:1 NN:6 
7 HS1 NN:7 
7 HL-60/vinc NN:7 
7 HL NN:4 NNS:3 
7 HBV NN:7 
7 H4 NN:7 
7 H-7 NN:7 
7 Gel-shift JJ:5 NN:2 
7 GT NN:7 
7 GP NN:7 
7 GM-kappa NN:7 
7 GG NNS:7 
7 Friend NN:7 
7 Freshly RB:7 
7 FcR JJ:3 NNS:4 
7 Factor NN:7 
7 FY*B NN:7 
7 FTOC NN:7 
7 FOSB NN:7 
7 Experiments NNS:7 
7 Erythropoietin JJ:1 NN:6 
7 Eosinophils NNS:7 
7 Elk-1 NN:7 
7 EB1 JJ:3 NN:4 
7 E2A- JJ:7 
7 E-box NN:7 
7 DZA NN:7 
7 DQB NN:7 
7 DQ2 JJ:1 NN:6 
7 DLCL NN:7 
7 DG NNS:7 
7 DCs NNS:7 
7 D2 NN:7 
7 CpG NN:7 
7 Clinical JJ:7 
7 Calcineurin NN:7 
7 CSF NN:7 
7 CS JJ:4 NN:3 
7 CRF NN:7 
7 COX-2 NN:7 
7 COS-7 NN:7 
7 CNI-1493 NN:7 
7 CIF NN:7 
7 CHEMR1 NN:7 
7 CD43 JJ:2 NN:5 
7 CD4-8- NN:7 
7 CD27 NN:7 
7 CALM NN:7 
7 CAEV NN:7 
7 CACCC NN:7 
7 CAAT NN:7 
7 Bcl-x NN:7 
7 BQ JJ:1 NN:6 
7 BMT NN:7 
7 BMLF1 NN:7 
7 BCR1/25 NN:7 
7 BAL NN:7 
7 B4-2 NN:7 
7 B/MAD-3 NN:7 
7 B-myb NN:7 
7 B-lymphoblastoid JJ:7 
7 Azeptin JJ:1 NN:6 
7 Antigen NN:7 
7 Antibodies NNS:7 
7 Analyses NNS:7 
7 Alternative JJ:7 
7 Abnormalities NNS:7 
7 AUC NN:7 
7 ATF-2 NN:7 
7 AS JJ:7 
7 AIDS-related JJ:7 
7 ADT NN:7 
7 96 CD:6 JJ:1 
7 95 CD:7 
7 76 CD:7 
7 727 CD:7 
7 62 CD:7 
7 59 CD:7 
7 57 CD:7 
7 52 CD:7 
7 3T3 NN:7 
7 3BP2 NN:7 
7 31 CD:7 
7 2-fold JJ:4 RB:3 
7 19K NN:7 
7 1993 CD:7 
7 18C7 NN:7 
7 10(-6) CD:7 
7 10(-5) CD:7 
7 1.5 CD:7 
7 1.3E2 NN:7 
7 0.8 CD:7 
7 /beta NN:7 
7 /CD3 NN:7 
7 -zeta NN:7 
7 -transfected JJ:7 
7 -signaling JJ:6 NN:1 
7 -secreting JJ:5 NN:2 
7 -kappaB NN:7 
7 -gamma NN:7 
7 -defective JJ:7 
7 -CAT JJ:2 NN:5 
7 -73 CD:7 
7 -65 CD:7 
6 weaker JJR:6 
6 venous JJ:6 
6 variance NN:6 
6 vaccination NN:6 
6 vWf JJ:1 NN:5 
6 utilize VB:3 VBP:3 
6 untranslated JJ:6 
6 unprimed JJ:6 
6 unlikely JJ:6 
6 unactivated JJ:6 
6 ulcerative JJ:6 
6 ubiquitinylation NN:6 
6 tyrosines NNS:6 
6 type-1 NN:6 
6 tumor-draining JJ:6 
6 trimer NN:6 
6 transplanted VBN:6 
6 transdominant JJ:6 
6 transcription-PCR NN:6 
6 toxoid NN:6 
6 topoisomerase JJ:1 NN:5 
6 tonsils NNS:6 
6 tonsil NN:6 
6 thymoma NN:6 
6 tetanus NN:6 
6 testis NN:6 
6 temperature NN:6 
6 tegument JJ:2 NN:4 
6 takes VBZ:6 
6 syncytia NN:5 NNS:1 
6 survive VB:5 VBP:1 
6 suffering VBG:6 
6 sucrose NN:6 
6 successfully RB:6 
6 submitted VBN:6 
6 stringent JJ:6 
6 sterol NN:6 
6 steroid/thyroid JJ:3 NN:3 
6 stat3 NN:6 
6 stained VBD:1 VBN:5 
6 single-chain JJ:6 
6 signal-induced JJ:6 
6 sideroblasts NNS:6 
6 shifts NNS:4 VBZ:2 
6 shed NN:1 VB:3 VBD:1 VBN:1 
6 senescent JJ:6 
6 semiquantitative JJ:6 
6 selenium JJ:1 NN:5 
6 selectivity NN:6 
6 score NN:6 
6 salicylates NNS:6 
6 rpoS NN:6 
6 rhesus NN:6 
6 reversal JJ:2 NN:4 
6 retention NN:6 
6 retain VBP:6 
6 resides VBZ:6 
6 resembled VBD:6 
6 resection NN:6 
6 reproduced VBN:6 
6 reporters NNS:6 
6 replicated VBD:3 VBN:3 
6 remote JJ:6 
6 remodeling NN:6 
6 relapse NN:6 
6 regimen NN:3 NNS:3 
6 refractory JJ:6 
6 reciprocal JJ:6 
6 reacts VBZ:6 
6 reactivities NNS:6 
6 reactivated VBN:6 
6 react VB:5 VBP:1 
6 reach VB:3 VBP:3 
6 random JJ:6 
6 question NN:6 
6 pulsed JJ:4 VBN:2 
6 pulse NN:6 
6 protecting VBG:6 
6 propionate JJ:1 NN:5 
6 promoter-reporter JJ:3 NN:3 
6 promoter-proximal JJ:6 
6 promoter-enhancer JJ:2 NN:4 
6 proliferations NNS:6 
6 proapoptotic JJ:6 
6 principally RB:6 
6 primer NN:6 
6 preparation NN:6 
6 preliminary JJ:6 
6 pre-B-cell JJ:3 NN:3 
6 ppt NN:6 
6 pp90rsk NN:6 
6 pp52 NN:6 
6 post-GC JJ:6 
6 post- JJ:6 
6 possessed VBD:5 VBN:1 
6 positioned JJ:5 VBN:1 
6 placental JJ:6 
6 phoP JJ:2 NN:4 
6 phenotypically RB:6 
6 phenomena NNS:6 
6 pg/ml NN:6 
6 pervanadate NN:6 
6 pertussis NN:6 
6 peritoneal JJ:5 NN:1 
6 periods NNS:6 
6 perceived VBN:6 
6 peaks NNS:2 VBZ:4 
6 pathology NN:6 
6 pathologic JJ:6 
6 partners NNS:6 
6 parents NNS:6 
6 parasite JJ:1 NN:5 
6 p50/p50 NN:6 
6 p47phox JJ:1 NN:5 
6 p38alpha NN:6 
6 p23 NN:6 
6 p15 NN:6 
6 oxLDLs NNS:6 
6 ovulation NN:6 
6 osteoblast-specific JJ:6 
6 orphan NN:6 
6 operate VB:4 VBP:2 
6 oligomerization NN:6 
6 oligomer NN:6 
6 nucleated JJ:6 
6 nonstimulated JJ:6 
6 nonmyeloid JJ:6 
6 nonatopic JJ:6 
6 nitrogen NN:6 
6 networks NNS:6 
6 nested JJ:4 VBD:2 
6 neoplasia NN:6 
6 nasopharyngeal JJ:5 NN:1 
6 nNOS NN:6 
6 myeloperoxidase JJ:1 NN:5 
6 mycobacterial JJ:6 
6 mucosa NN:6 
6 morphologic JJ:6 
6 morning NN:6 
6 monophosphate NN:6 
6 monocyte-specific JJ:6 
6 monocyte-macrophage JJ:6 
6 monoblastoid JJ:6 
6 modify VB:6 
6 modest JJ:6 
6 mitogen-inducible JJ:6 
6 micromolar JJ:6 
6 micrograms/ml NN:1 NNS:5 
6 microgram/ml NN:6 
6 metallothionein NN:6 
6 metalloproteinase NN:6 
6 melanomas NNS:6 
6 melanoma NN:6 
6 median JJ:4 NN:2 
6 maturing JJ:1 VBG:5 
6 man NN:6 
6 malaria NN:6 
6 lymphotoxin NN:6 
6 lymphoproliferative JJ:6 
6 long-lasting JJ:6 
6 load NN:6 
6 literature NN:6 
6 liquid JJ:6 
6 lipocalin NN:6 
6 linking VBG:6 
6 libraries NNS:6 
6 leucocytic JJ:6 
6 kinds NNS:6 
6 ketone NN:6 
6 ketoconazole NN:6 
6 keratinocytes NNS:6 
6 isotypes NNS:6 
6 irreversible JJ:6 
6 irrespective JJ:4 RB:2 
6 ions NNS:6 
6 ionizing VBG:6 
6 innate JJ:6 
6 inflamed JJ:6 
6 infarction NN:6 
6 indicator NN:6 
6 indeed RB:6 
6 inappropriate JJ:6 
6 implication NN:6 
6 implicates VBZ:6 
6 immunostaining JJ:1 NN:5 
6 immunoreactivity NN:6 
6 immunocytochemical JJ:6 
6 immunoblot NN:6 
6 imbalance NN:6 
6 identifies VBZ:6 
6 idea NN:6 
6 hybridized VBD:5 VBN:1 
6 housekeeping JJ:6 
6 histologic JJ:6 
6 histogenesis NN:6 
6 heterocomplexes NNS:6 
6 her PRP$:6 
6 head NN:6 
6 haemopoietic JJ:6 
6 hRAR NN:6 
6 hMR NN:6 
6 hEpoR NN:6 
6 growth-inhibitory JJ:6 
6 granulomatous JJ:6 
6 governing VBG:6 
6 governed VBN:6 
6 glucocorticoid-induced JJ:6 
6 glioblastoma NN:6 
6 gingival JJ:6 
6 generalized JJ:1 VBN:5 
6 functioned VBD:6 
6 former JJ:6 
6 fmol/10(6) NN:6 
6 fivefold JJ:4 RB:2 
6 fewer JJR:6 
6 ferritin NN:6 
6 fast JJ:6 
6 facilitated VBD:2 VBN:4 
6 expressions NNS:6 
6 examining VBG:6 
6 eventually RB:6 
6 etiologic JJ:6 
6 equally RB:6 
6 enzyme-linked JJ:6 
6 enter VB:1 VBP:5 
6 employing VBG:6 
6 embryos NNS:6 
6 elution NN:6 
6 eicosanoid NN:6 
6 effusions NNS:6 
6 effectiveness NN:6 
6 eGLs NNS:6 
6 dyad JJ:2 NN:4 
6 drastically RB:6 
6 donovani FW:6 
6 document VB:2 VBN:1 VBP:3 
6 divided JJ:4 VBN:2 
6 disrupts VBZ:6 
6 displacement NN:6 
6 disappearance NN:6 
6 differing VBG:6 
6 diabetic JJ:6 
6 determines VBZ:6 
6 dermatitis NN:6 
6 dermal JJ:6 
6 deregulation NN:6 
6 declined VBD:6 
6 dUTPase NN:6 
6 cytolysis NN:6 
6 cytogenetic JJ:6 
6 couple VB:3 VBP:3 
6 count NN:6 
6 cooperativity NN:6 
6 cooperated VBD:6 
6 conversion NN:6 
6 contrasts VBZ:6 
6 consecutive JJ:6 
6 conjugation NN:6 
6 confocal JJ:6 
6 concerning VBG:6 
6 concept NN:6 
6 compartments NNS:6 
6 colony-forming JJ:6 
6 colitis NN:6 
6 coincubation NN:6 
6 coactivators NNS:6 
6 clonotypes NNS:6 
6 clonogenic JJ:6 
6 cis-element NN:6 
6 cis- JJ:6 
6 circumstances NNS:6 
6 chromatography NN:6 
6 chosen VBN:6 
6 chloromethyl NN:6 
6 childhood NN:6 
6 channel NN:6 
6 ceramide NN:6 
6 cepharanthine NN:6 
6 centered JJ:2 VBN:4 
6 cell-cycle JJ:6 
6 cell-associated JJ:5 VBD:1 
6 causal JJ:6 
6 capacities NNS:6 
6 candidates NNS:6 
6 calmodulin JJ:1 NN:5 
6 calculated VBD:1 VBN:5 
6 calcium-dependent JJ:6 
6 cadmium NN:6 
6 c-erbA JJ:1 NN:5 
6 bronchoalveolar JJ:6 
6 borders NNS:6 
6 biochemically RB:6 
6 beta-estradiol NN:6 
6 below IN:6 
6 begin VB:3 VBP:3 
6 bandshift NN:6 
6 avidity NN:6 
6 avian JJ:6 
6 autoantigen NN:6 
6 assumed VBN:6 
6 artificial JJ:6 
6 arterial JJ:6 
6 array NN:6 
6 arginine NN:6 
6 areas NNS:6 
6 application NN:6 
6 antiandrogen JJ:6 
6 anti-apoptotic JJ:6 
6 antagonized VBD:2 VBN:4 
6 anergized VBN:6 
6 analyzing VBG:6 
6 analogue NN:6 
6 allelic JJ:6 
6 agonistic JJ:6 
6 adaptive JJ:6 
6 actual JJ:6 
6 activin NN:6 
6 achieve VB:5 VBP:1 
6 accumulated VBD:2 VBN:4 
6 accompanying VBG:6 
6 accompanies VBZ:6 
6 accelerated VBD:2 VBN:4 
6 abrogation NN:6 
6 abdominal JJ:6 
6 [3H] NN:6 
6 ZII NN:6 
6 XP-D NN:6 
6 XP-B NN:6 
6 XIST NN:6 
6 XIC/XIST NN:6 
6 Vitamin NN:6 
6 V3-BH10 NN:6 
6 V-ATPase NN:6 
6 UT-7/GM NN:6 
6 USA NN:4 NNP:2 
6 UF-1 NN:6 
6 Triggering NN:5 VBG:1 
6 That DT:1 IN:5 
6 Th2-specific JJ:6 
6 TaxI NN:6 
6 Targeted JJ:1 VBN:5 
6 TS NN:6 
6 TNF-alpha- JJ:1 NN:5 
6 TNF- JJ:3 NN:3 
6 TN NN:6 
6 THR NN:6 
6 TCR/CD3 JJ:2 NN:4 
6 TCR-mediated JJ:6 
6 TAD-A NN:6 
6 T-lymphoid JJ:2 NN:4 
6 T-lineage JJ:3 NN:3 
6 T-antigen NN:6 
6 Synergistic JJ:6 
6 Subsequently RB:6 
6 Staurosporine NN:6 
6 Stable JJ:6 
6 Sp140 NN:6 
6 Southwestern JJ:1 NN:5 
6 Site NN:6 
6 Shc NN:6 
6 Selection NN:6 
6 SP NN:6 
6 SLAP-130 NN:6 
6 SIVmac239 NN:6 
6 SIV JJ:1 NN:5 
6 SCID NN:6 
6 SCC NN:6 
6 S9a NN:6 
6 Rhom-2 NN:6 
6 Reverse JJ:5 NN:1 
6 Rel-related JJ:6 
6 Rel-A NN:6 
6 Reactive JJ:6 
6 Ran JJ:2 NN:4 
6 RT NN:6 
6 RP1 NN:6 
6 ROIs NNS:6 
6 RBP NN:6 
6 RAR-alpha JJ:1 NN:5 
6 RAKFKQLLQ JJ:3 NN:3 
6 QR JJ:1 NN:5 
6 Pax5 NN:6 
6 Pax NN:6 
6 PTT NN:6 
6 PP1 JJ:1 NN:5 
6 PKR NN:6 
6 PKC- JJ:3 NN:3 
6 PILOT NN:6 
6 PI3K JJ:1 NN:5 
6 PI3-kinase NN:6 
6 PGN JJ:1 NN:5 
6 PB1 NN:6 
6 PAS NN:6 
6 P/I JJ:1 NN:5 
6 ORFs NNS:6 
6 OKA NN:6 
6 OCT-1 NN:6 
6 Normal JJ:6 
6 Negative JJ:6 
6 NS-Meg NN:6 
6 NOTCH1 NN:6 
6 NIH NN:6 
6 NGFI-A/Egr-1 NN:6 
6 NF-X2 NN:6 
6 NF-MATp35 NN:6 
6 NF-IL-6 NN:6 
6 NB NN:6 
6 Mutagenesis NN:6 
6 Murine JJ:4 NN:2 
6 Much JJ:4 RB:2 
6 Monocyte NN:6 
6 Mobility NN:6 
6 MoAb NN:6 
6 Mo NN:6 
6 Mn JJ:1 NN:5 
6 Mice NNS:6 
6 MTCP1 NN:6 
6 MRP14 NN:6 
6 MM-LDL NN:6 
6 MLV NN:6 
6 MG NN:6 
6 METHOD NN:6 
6 MATERIALS NNS:6 
6 M(r) NN:6 
6 Latent JJ:6 
6 Large JJ:6 
6 La NN:6 
6 LSF NN:6 
6 LP NN:6 
6 LAT JJ:1 NN:5 
6 LANDs NNS:6 
6 LAL NN:6 
6 Jak/Stat NN:6 
6 Jagged1 NN:6 
6 J393 NN:6 
6 Impaired JJ:6 
6 Immunoprecipitation NN:6 
6 Immunohistochemical JJ:6 
6 Immune JJ:6 
6 IgD JJ:2 NN:4 
6 IVS1-10T NN:6 
6 ISO NN:6 
6 IRES NN:5 NNS:1 
6 IK NN:6 
6 II-negative JJ:6 
6 IFN-stimulated JJ:6 
6 IE-1 NN:6 
6 IDDM NN:6 
6 IDC NN:6 
6 ICRF-193 JJ:1 NN:5 
6 IBLP JJ:1 NN:5 
6 Hm JJ:4 NN:2 
6 Hashimoto NN:6 
6 HTB NN:6 
6 HT-2 NN:6 
6 HSF2-alpha NN:6 
6 HNF1 NN:6 
6 HMBA NN:6 
6 HLH JJ:6 
6 HLA-DO NN:6 
6 HLA-DM NN:6 
6 HB-EGF NN:6 
6 H2 NN:6 
6 H-RS NN:6 
6 H NN:6 
6 Growth NN:6 
6 Given IN:4 VBN:2 
6 Genetic JJ:6 
6 GSK-3beta NN:6 
6 GPIX NN:6 
6 GM3 NN:6 
6 GM2 NN:6 
6 GCII NN:6 
6 GC-R NN:6 
6 GATA1 NN:6 
6 GATA-4 NN:6 
6 GA-binding JJ:6 
6 FCS NN:6 
6 Exogenous JJ:6 
6 Erythroid JJ:6 
6 Erk2 NN:6 
6 Erk JJ:1 NN:5 
6 Engagement NN:6 
6 Elevated JJ:6 
6 Egr-2 NN:6 
6 Early JJ:5 RB:1 
6 ERK1/2 NN:6 
6 EMS NN:6 
6 EML NN:6 
6 EKLF-/- JJ:6 
6 EGR2 NN:5 NNS:1 
6 ECS NN:6 
6 EA-D NN:6 
6 E2a-Pbx1 NN:6 
6 Disruption NN:6 
6 Differentiation NN:6 
6 Differences NNS:6 
6 Demonstration NN:6 
6 Deletions NNS:6 
6 Decreased VBN:6 
6 DR3 NN:6 
6 DP1 NN:6 
6 DHS NN:6 
6 DFX NN:6 
6 DESIGN NN:6 
6 Cytomegalovirus NN:6 
6 Ctx NN:6 
6 Con NN:6 
6 Competition NN:6 
6 Chronic JJ:6 
6 Chem NNP:6 
6 CaM NN:6 
6 Ca(2+)-dependent JJ:6 
6 CRM1 NN:6 
6 CR3 JJ:1 NN:5 
6 CMAT NN:6 
6 CEM-C7 NN:6 
6 CD68+ JJ:6 
6 CD13 NN:6 
6 CCK(B) NN:6 
6 CAII JJ:1 NN:5 
6 C5b-9 JJ:2 NN:4 
6 C26 NN:6 
6 C1 NN:6 
6 Btk NN:6 
6 Bik NN:6 
6 Besides IN:5 RB:1 
6 BamHI NN:6 
6 Bacterial JJ:6 
6 BLS NN:6 
6 BLR1 NN:6 
6 BASH NN:6 
6 Ala JJ:3 NN:3 
6 Ags NN:2 NNS:4 
6 Adhesion NN:6 
6 Ad12 NN:6 
6 AZT NN:6 
6 ATGCAAAT NN:6 
6 AP-1- JJ:1 NN:5 
6 ANG NN:6 
6 AML1/MDS1/EVI1 NN:6 
6 AMI NN:6 
6 A20 NN:6 
6 97 CD:6 
6 94 CD:6 
6 9-cis-RA NN:6 
6 84 CD:6 
6 81 CD:6 
6 71 CD:6 
6 68 CD:6 
6 67 CD:6 
6 61 CD:6 
6 5-day JJ:6 
6 400 CD:6 
6 4.3 CD:6 
6 4-fold JJ:3 RB:3 
6 301 CD:6 
6 26S NN:6 
6 2.3-kb JJ:6 
6 2.0 CD:6 
6 1A9-M NN:6 
6 15-LO NN:6 
6 130 CD:6 
6 12-lipoxygenase NN:6 
6 12-O-tetradecanoyl NN:6 
6 100-fold RB:6 
6 10(-8) CD:6 
6 1,25-Dihydroxyvitamin NN:6 
6 0.7 CD:6 
6 /GC NN:6 
6 .01 CD:6 
6 -polymerase JJ:3 NN:3 
6 -epsilon NN:6 
6 -encoding JJ:6 
6 -differentiated JJ:6 
6 -bound JJ:6 
6 -GR NN:6 
6 -95 CD:6 
6 -76 CD:6 
5 yr NN:5 
5 yields NNS:1 VBZ:4 
5 xenogeneic JJ:5 
5 wound NN:5 
5 works NNS:1 VBZ:4 
5 widespread JJ:5 
5 well-defined JJ:5 
5 well-characterized JJ:4 VBD:1 
5 weights NNS:5 
5 water NN:5 
5 vpr NN:5 
5 virus-induced JJ:5 
5 vertebrates NNS:5 
5 vertebrate JJ:3 NN:2 
5 verified VBD:2 VBN:3 
5 varies VBZ:5 
5 varicella-zoster JJ:1 NN:4 
5 variability NN:5 
5 vaginal JJ:5 
5 vaccines NNS:5 
5 v-src JJ:1 NN:4 
5 uterus NN:5 
5 usage NN:5 
5 untransformed JJ:5 
5 unilineage JJ:5 
5 unexpectedly RB:5 
5 undergone VBN:5 
5 undergoes VBZ:5 
5 typically RB:5 
5 type-II JJ:5 
5 twin JJ:1 NN:4 
5 twice RB:5 
5 tubules NNS:5 
5 trypsin JJ:1 NN:4 
5 triiodothyronine NN:5 
5 treating VBG:5 
5 treat VB:5 
5 transforms VBZ:5 
5 trace NN:4 VB:1 
5 titres NNS:5 
5 tissue- NN:5 
5 thyroglobulin NN:5 
5 thiols NNS:5 
5 thereafter RB:5 
5 termini NNS:5 
5 temporally RB:5 
5 t(8;21) NN:5 
5 t(15;17) NN:5 
5 symmetry NN:5 
5 summarize VBP:5 
5 sulfoxide JJ:1 NN:4 
5 suitable JJ:5 
5 subtype NN:5 
5 subtractive JJ:5 
5 subregions NNS:5 
5 subjected VBN:5 
5 subgroups NNS:5 
5 stroma NN:5 
5 stresses NNS:5 
5 stores NNS:5 
5 steroid-treated JJ:5 
5 steroid-sensitive JJ:5 
5 steroid-regulated JJ:5 
5 src NN:5 
5 spreading NN:5 
5 spinal JJ:5 
5 specification NN:5 
5 special JJ:5 
5 site-specific JJ:5 
5 simply RB:5 
5 simple JJ:5 
5 signalsome JJ:5 
5 signaled VBD:2 VBN:3 
5 signal-dependent JJ:5 
5 sigma NN:5 
5 sialyltransferase NN:5 
5 sexual JJ:5 
5 separable JJ:5 
5 sedentary JJ:5 
5 secreting JJ:1 NN:2 VBG:2 
5 search NN:3 VB:2 
5 saturable JJ:5 
5 sarcoma JJ:1 NN:4 
5 sample NN:5 
5 runner NN:5 
5 rhu JJ:4 NN:1 
5 reviewed VBN:5 
5 revealing VBG:5 
5 reticulocytes NNS:5 
5 retaining VBG:5 
5 resultant JJ:5 
5 resident JJ:5 
5 renders VBZ:5 
5 remarkably RB:5 
5 reliable JJ:5 
5 relate VB:5 
5 regimens NNS:5 
5 reductase JJ:1 NN:4 
5 recessive JJ:5 
5 reasons NNS:5 
5 reagents NNS:5 
5 reaching VBG:5 
5 rate-limiting JJ:5 
5 radioligand NN:5 
5 radicals NNS:5 
5 radiation-induced JJ:5 
5 r-hTBP-1 NN:5 
5 quantitatively RB:5 
5 purine JJ:2 NN:3 
5 pseudohypoaldosteronism NN:5 
5 proved VBD:5 
5 prototypical JJ:5 
5 protooncogenes NNS:5 
5 protocols NNS:5 
5 proteolytically RB:5 
5 protein-2 NN:5 
5 prostatic JJ:5 
5 proportions NNS:5 
5 proper JJ:5 
5 propagated VBN:5 
5 promoter/enhancer NN:5 
5 prolymphocytic JJ:4 NN:1 
5 proline-rich JJ:5 
5 productively RB:5 
5 proband NN:5 
5 probability NN:5 
5 proIL-1 NN:5 
5 principle NN:5 
5 presumed JJ:1 VBN:4 
5 preleukemic JJ:5 
5 preformed JJ:5 
5 prednisone NN:5 
5 predicts VBZ:5 
5 predictive JJ:5 
5 pre-treatment NN:5 
5 pp65 JJ:1 NN:4 
5 potassium NN:5 
5 polyamine NN:5 
5 pig NN:5 
5 pi NN:5 
5 physiology NN:5 
5 phosphoproteins NNS:5 
5 phospholipids NNS:5 
5 phospholipid JJ:4 NN:1 
5 persistently RB:5 
5 persisted VBD:5 
5 peroxidation NN:5 
5 permits VBZ:5 
5 peripheral-blood JJ:4 NN:1 
5 peri-kappa NN:5 
5 pentoxifylline JJ:1 NN:4 
5 pediatric JJ:5 
5 peaking VBG:5 
5 paternal JJ:5 
5 past JJ:4 NN:1 
5 particle NN:5 
5 parathyroid JJ:5 
5 parallels NNS:1 VBZ:4 
5 pancreatitis NN:5 
5 pancreas NN:5 
5 p98 NN:5 
5 p60 NN:5 
5 p50/RelA NN:5 
5 p21(ras) NN:5 
5 oxLDL JJ:1 NN:4 
5 overproduction NN:5 
5 over-expression NN:5 
5 osteoclast JJ:3 NN:2 
5 osteoarthritis NN:5 
5 orientation NN:5 
5 opposing JJ:2 VBG:3 
5 opposed VBD:1 VBN:4 
5 onto IN:5 
5 oligomers NNS:5 
5 oligodeoxynucleotides NNS:5 
5 older JJR:5 
5 offers VBZ:5 
5 offer VB:1 VBP:4 
5 occupation NN:5 
5 obvious JJ:5 
5 obscure JJ:5 
5 obese JJ:5 
5 null JJ:4 NN:1 
5 notably RB:5 
5 nonresponders NNS:5 
5 nonpermissive JJ:5 
5 nonhuman JJ:5 
5 non-pregnant JJ:5 
5 non-genomic JJ:5 
5 nevertheless RB:5 
5 never RB:5 
5 nephropathy NN:5 
5 necessity NN:5 
5 myocardial JJ:5 
5 myelomonoblastic JJ:5 
5 myeloblastic JJ:5 
5 motor NN:5 
5 monomer NN:5 
5 monocyte-to-macrophage JJ:5 
5 monoamine NN:5 
5 monoallelic JJ:5 
5 monkeys NNS:5 
5 monitoring NN:2 VBG:3 
5 modulatory JJ:5 
5 mitogen-stimulated JJ:5 
5 mitochondrial JJ:5 
5 missing JJ:1 VBG:4 
5 minus CC:2 JJ:3 
5 mg-1 NN:5 
5 metastasis NN:5 
5 maternal JJ:5 
5 master JJ:3 NN:2 
5 massive JJ:5 
5 maps NNS:1 VBZ:4 
5 manifestations NNS:5 
5 making VBG:5 
5 macrophage-differentiation NN:5 
5 macaques NNS:5 
5 lungs NNS:5 
5 long-distance JJ:5 
5 liposomal JJ:5 
5 lipase NN:5 
5 lineage- NN:5 
5 light-chain JJ:4 NN:1 
5 ligated VBN:5 
5 ligase NN:5 
5 leukocyte-platelet JJ:5 
5 lectins NNS:5 
5 leader NN:5 
5 layer NN:5 
5 last JJ:5 
5 larger JJR:5 
5 kinase-1 NN:5 
5 kilodaltons NNS:5 
5 killed VBD:2 VBN:3 
5 karyotype NN:5 
5 joint NN:5 
5 isozymes NNS:5 
5 isoleucine JJ:2 NN:3 
5 isoenzymes NNS:5 
5 islet NN:5 
5 ionophores NNS:5 
5 introns NNS:5 
5 intrafollicular JJ:5 
5 interpretation NN:5 
5 internalization NN:5 
5 interleukin-7 NN:5 
5 interleukin-12 NN:5 
5 interdomain NN:5 
5 integrity NN:5 
5 integrate VB:3 VBP:2 
5 initiator NN:5 
5 infectivity NN:5 
5 inefficient JJ:5 
5 incorporated VBD:1 VBN:4 
5 impairments NNS:5 
5 impairment NN:5 
5 immunophenotype NN:5 
5 illness NN:5 
5 hypothyroidism NN:5 
5 hypotheses NNS:5 
5 hyponatremia NN:5 
5 hyperkalemia NN:5 
5 hypercalcemia NN:5 
5 hydrolysis NN:5 
5 hormone-dependent JJ:5 
5 homodimerization NN:5 
5 homodimeric JJ:5 
5 hexon NN:5 
5 hetero JJ:1 NN:3 NNS:1 
5 hepatocytes NNS:5 
5 heme NN:5 
5 helps VBZ:5 
5 healing NN:5 
5 hGM-CSF JJ:2 NN:3 
5 gynecomastia NN:4 NNS:1 
5 groove NN:5 
5 granulopoiesis NN:5 
5 granular JJ:5 
5 gradual JJ:5 
5 gradients NNS:5 
5 gp91phox NN:5 
5 gp130 JJ:1 NN:4 
5 glycoproteins NNS:5 
5 glycation NN:5 
5 glucuronides NNS:5 
5 glucocorticosteroids NNS:5 
5 glucocorticoid-sensitive JJ:5 
5 gives VBZ:5 
5 gave VBD:5 
5 gastric JJ:5 
5 gE NN:5 
5 gC NN:5 
5 fusing VBG:5 
5 functionality NN:5 
5 frameshift NN:5 
5 frames NNS:5 
5 forced JJ:2 VBN:3 
5 follow-up JJ:3 NN:2 
5 follow VBP:5 
5 focusing NN:1 VBG:4 
5 focuses VBZ:5 
5 foci NNS:5 
5 foam NN:5 
5 faster-migrating JJ:5 
5 fas NN:5 
5 factor-dependent JJ:5 
5 facilitating VBG:5 
5 extrinsic JJ:5 
5 extrathymic JJ:5 
5 exclusion NN:5 
5 eventual JJ:5 
5 ets-related JJ:5 
5 esterase NN:5 
5 episomal JJ:4 NN:1 
5 entirely RB:5 
5 entered VBD:5 
5 ensure VB:4 VBP:1 
5 engaged VBN:5 
5 ends NNS:5 
5 enabled VBD:4 VBN:1 
5 emerged VBN:5 
5 elicit VB:3 VBP:2 
5 elegans FW:3 NN:1 NNS:1 
5 electron NN:5 
5 effort NN:5 
5 effectors NNS:5 
5 easily RB:5 
5 dysregulated VBN:5 
5 dysplasia NN:5 
5 duplication NN:5 
5 duplicated JJ:5 
5 driving VBG:5 
5 dpm NN:5 
5 dose-response JJ:4 NN:1 
5 division NN:5 
5 divergence NN:5 
5 distress NN:5 
5 distinguishes VBZ:5 
5 dissection NN:5 
5 disrupting VBG:5 
5 displaying VBG:5 
5 disparate JJ:5 
5 discriminate VB:5 
5 dimeric JJ:5 
5 dihydroxyvitamin NN:5 
5 digestion NN:5 
5 die VB:2 VBP:3 
5 df NN:5 
5 detergent JJ:1 NN:4 
5 destruction NN:5 
5 destroyed VBD:3 VBN:2 
5 delta-domain JJ:1 NN:4 
5 deleterious JJ:5 
5 degenerate JJ:4 NN:1 
5 defence NN:5 
5 danazol NN:5 
5 cytoskeleton NN:5 
5 cytoskeletal JJ:5 
5 cytochalasin NN:5 
5 cystic JJ:5 
5 cyclins NNS:5 
5 culminating VBG:5 
5 cryptic JJ:5 
5 crude JJ:5 
5 covering VBG:5 
5 cortivazol NN:5 
5 corticosterone NN:5 
5 corrected JJ:1 VBN:4 
5 corneal NN:5 
5 converting NN:2 VBG:3 
5 contrary JJ:2 NN:3 
5 context-dependent JJ:5 
5 contacts NNS:5 
5 constituent JJ:1 NN:4 
5 considerably RB:5 
5 congenital JJ:5 
5 conformational JJ:5 
5 computer NN:5 
5 competence NN:5 
5 comedo NN:5 
5 collectively RB:5 
5 coincident JJ:5 
5 cofactors NNS:5 
5 codes VBZ:5 
5 cocultured VBN:5 
5 clustered JJ:2 VBN:3 
5 cholera NN:5 
5 chimeras NNS:5 
5 chi2 NN:5 
5 chi NN:5 
5 chemoattractants NNS:5 
5 cerebral JJ:5 
5 cell-permeable JJ:5 
5 cationic JJ:4 NN:1 
5 catecholamines NNS:5 
5 catalytically RB:5 
5 carboxylesterase NN:5 
5 c-kit NN:5 
5 c-fos/c-jun NN:5 
5 c-fms NN:5 
5 c-Raf JJ:2 NN:3 
5 butylated VBN:5 
5 bulbar JJ:5 
5 brought VBD:2 VBN:3 
5 bronchitis NN:5 
5 biopsies NNS:5 
5 belong VB:3 VBP:2 
5 behaves VBZ:5 
5 began VBD:5 
5 bcl-6 JJ:1 NN:4 
5 balanced JJ:5 
5 back JJ:2 RB:3 
5 babies NNS:5 
5 autoreactive JJ:5 
5 autophosphorylation NN:5 
5 autoantibodies NNS:5 
5 aureus FW:5 
5 attempt NN:5 
5 athletes NNS:5 
5 associations NNS:5 
5 ascertain VB:5 
5 appreciably RB:5 
5 apes NNS:5 
5 anti-estrogen JJ:2 NN:3 
5 anti-AIM JJ:2 NN:3 
5 anionic JJ:5 
5 aneuploidy NN:5 
5 androgens NNS:5 
5 alphaIIbbeta3 NN:5 
5 alpha/delta NN:5 
5 alpha-interferon NN:5 
5 alpha-helices NNS:5 
5 alpha-galactosidase NN:5 
5 alpha-IFN NN:5 
5 allogeneic JJ:5 
5 allergy NN:5 
5 all-trans-retinoic JJ:5 
5 albeit IN:5 
5 aeruginosa FW:5 
5 adjuvant JJ:5 
5 adipocytes NNS:5 
5 adipocyte JJ:1 NN:4 
5 adenoviruses NNS:5 
5 additionally RB:5 
5 accurate JJ:5 
5 accumulate VB:2 VBP:3 
5 accepted VBN:5 
5 accelerate VB:5 
5 absolutely RB:5 
5 aberrancies NNS:5 
5 Zap-70 NN:5 
5 Zap NN:5 
5 YY-1 NN:5 
5 Xenopus FW:1 NN:4 
5 XLH NN:5 
5 XCID NN:5 
5 Wnt NN:5 
5 Whether IN:5 
5 VSMCs NNS:5 
5 VCAM NN:5 
5 Understanding VBG:5 
5 UTR NN:5 
5 Trx NN:5 
5 Trident NN:5 
5 Tissue-specific JJ:5 
5 Through IN:5 
5 Third JJ:1 NNP:1 RB:3 
5 Theileria FW:5 
5 Tepoxalin NN:5 
5 Teflon NN:5 
5 Tax-expressing JJ:5 
5 TaqI NN:5 
5 Tap NN:5 
5 TSH-R NN:5 
5 TRs NNS:5 
5 TR75 NN:5 
5 TR2 NN:5 
5 TNFRp55 JJ:2 NN:3 
5 TINUR NN:5 
5 THP NN:5 
5 TGF-alpha NN:5 
5 TES2 NN:5 
5 TAL-1 NN:5 
5 T3R NN:4 NNS:1 
5 T-leukemia JJ:1 NN:4 
5 Strikingly RB:5 
5 Specifically RB:5 
5 Sp1- JJ:2 NN:3 
5 So RB:5 
5 Single JJ:5 
5 Signals NNS:5 
5 Shigella NN:5 
5 Secretion NN:5 
5 Saccharomyces FW:4 NN:1 
5 STP-C488 JJ:1 NN:4 
5 STAT3alpha NN:5 
5 SPD NN:5 
5 SNE NN:5 
5 SLA-DR NN:5 
5 SLA-DQ NN:5 
5 SHP2 NN:5 
5 SERCA NN:5 
5 SD NN:5 
5 SCMV NN:5 
5 SBMA NN:5 
5 SAC NN:5 
5 SAA NN:5 
5 RpoS NN:5 
5 Retinoid NN:5 
5 Repression NN:5 
5 Receptors NNS:5 
5 Rapid JJ:5 
5 RXR-RXR JJ:3 NN:2 
5 RPMI NN:5 
5 RNAs NNS:5 
5 RIC NN:5 
5 RGD JJ:1 NN:4 
5 REF-1 NN:5 
5 RE/AP NN:5 
5 RAR-RXR JJ:2 NN:3 
5 RANK JJ:2 NN:3 
5 Quantitative JJ:5 
5 PyG NN:5 
5 Prior JJ:4 RB:1 
5 Priming NN:3 VBG:2 
5 Primary JJ:5 
5 Possible JJ:5 
5 Platelet NN:5 
5 Philadelphia NN:5 
5 Peroxisome NN:5 
5 Pax-5b NN:5 
5 PYBF JJ:1 NN:4 
5 PTHrP NN:5 
5 POUHD NN:5 
5 PO-B NN:5 
5 PLB-985 NN:5 
5 PEBP2betaMYH11 NN:5 
5 PCOS NN:5 
5 PBSCT NN:3 NNS:2 
5 PBMo NN:5 
5 PBLs NNS:5 
5 PAHs NNS:5 
5 PAEC NNS:5 
5 P65 NN:5 
5 Oxidative JJ:5 
5 Ox NN:5 
5 Over IN:5 
5 OCIM1 NN:5 
5 Now RB:5 
5 NXS NN:5 
5 NKL NN:5 
5 NK-kappa NN:5 
5 NH2Cl JJ:1 NN:4 
5 NFATc.beta JJ:1 NN:4 
5 NFAT4 NN:5 
5 NF90 NN:5 
5 NF.kappa NN:5 
5 NF-muNR NN:5 
5 NF-YB NN:5 
5 NF-IL6beta NN:5 
5 NER NN:5 
5 NBs NNS:5 
5 Myb NN:5 
5 Molt-4 NN:5 
5 Mn-SOD NN:5 
5 Members NNS:5 
5 Mapping NN:5 
5 MTHC NN:5 
5 MPRO NN:5 
5 MPD NN:5 
5 MNP-1 NN:5 
5 MMP-9 NN:5 
5 MLL NN:5 
5 ML-1 NN:5 
5 MHC-I JJ:1 NN:4 
5 MDMac NN:5 
5 MCR NN:5 
5 MC903 NN:5 
5 MAR-BP1 NN:5 
5 M10 JJ:2 NN:3 
5 Lyn NN:5 
5 Lt-4 NN:5 
5 Little JJ:5 
5 Ligation NN:5 
5 LT-alpha1beta2 NN:5 
5 LS NN:5 
5 LITAF NN:5 
5 LIM NN:5 
5 L243 NN:5 
5 KH1060 NN:5 
5 KD NN:5 
5 KBF1/p50 NN:5 
5 JAK-1 JJ:1 NN:4 
5 Intracellular JJ:5 
5 Interleukin-12 NN:5 
5 Initiation NN:5 
5 Immunoblot NN:5 
5 IkappaB-alphaS32/36A NN:5 
5 If IN:5 
5 Ib NN:5 
5 ILFs NNS:5 
5 IL2R NN:5 
5 IL-2-R NN:5 
5 IL-1RII NN:5 
5 IKK2 NN:5 
5 IFN-alpha/beta NN:5 
5 IE2 NN:5 
5 I-hypersensitive JJ:5 
5 HSP27 NN:5 
5 HNF-1 NN:5 
5 HLA-Cw*0702 NN:5 
5 HLA-A3 NN:5 
5 HBx JJ:2 NN:3 
5 H. NNP:5 
5 Group NN:5 
5 Gene NN:5 
5 G_+_C-rich JJ:5 
5 GTPase NN:5 
5 GTP-binding JJ:5 
5 GST-pi NN:5 
5 GST NN:5 
5 GPIIb NN:5 
5 GIG18 NN:5 
5 GD NN:5 
5 GCT NN:5 
5 GCH NN:5 
5 Fusion NN:5 
5 FosB NN:5 
5 Flexi-12 NN:5 
5 Fas-mediated JJ:5 
5 FUra NN:5 
5 FECa2+ NN:5 
5 FCM NN:5 
5 Estrogens NNS:5 
5 Endothelial JJ:5 
5 Egr NN:5 
5 Ectopic JJ:5 
5 EC50 NN:5 
5 EBV-negative JJ:5 
5 EBS2 NN:5 
5 EBS1 NN:5 
5 E7 JJ:1 NN:4 
5 E6 NN:5 
5 E220K JJ:1 NN:4 
5 E1C3 NN:5 
5 Down-regulation NN:5 
5 Down NN:5 
5 Distinct JJ:5 
5 Diminished JJ:1 VBN:4 
5 Differanisole NN:5 
5 Delta NN:5 
5 Danazol NN:5 
5 DRE NN:5 
5 DP NN:5 
5 DOX JJ:2 NN:3 
5 DOR1 NN:5 
5 DND39 NN:5 
5 DN JJ:5 
5 DBF NN:5 
5 DARC NN:5 
5 Cu2+ NN:5 
5 Comparative JJ:5 
5 Clonality NN:5 
5 Class NN:5 
5 ChtM NN:5 
5 Chromosome NN:5 
5 CYP1A1 NN:5 
5 CXC NN:5 
5 CPO NN:5 
5 COS NN:5 
5 CL-01 NN:5 
5 CKII NN:5 
5 CIS NN:5 
5 CHO-CD86 NN:5 
5 CHO-CD80 NN:5 
5 CHD NN:5 
5 CDK4 NN:5 
5 CD8(+)-T-cell NN:5 
5 CD70 NN:5 
5 CD56 JJ:2 NN:3 
5 CD54 NN:5 
5 CD45RA+ JJ:5 
5 CD45R0 NN:5 
5 CD4(-) JJ:5 
5 CD33+ JJ:5 
5 CD33 NN:5 
5 CD3-epsilon NN:5 
5 CD16- JJ:4 NN:1 
5 CD11a NN:5 
5 CCK-8 JJ:1 NN:4 
5 CCAAT/enhancer JJ:1 NN:4 
5 CBF1/RBP-Jkappa NN:5 
5 CArG NN:5 
5 C7 NN:5 
5 C3/5 NN:5 
5 Bax NN:5 
5 BZLF NN:5 
5 BRCA2 NN:5 
5 BLR2 JJ:1 NN:4 
5 BDP NN:5 
5 B-specific JJ:5 
5 B*CaM-K NN:5 
5 AuTG NN:5 
5 Asp JJ:1 NN:4 
5 Ara-C NN:5 
5 Antisense JJ:5 
5 Akv NN:5 
5 Akt/PKB NN:5 
5 Administration NN:5 
5 Adenovirus NN:5 
5 Ad5E1A JJ:4 NN:1 
5 Ad2 NN:5 
5 Active JJ:5 
5 ATLL NN:5 
5 ATF/CREB NN:5 
5 ASM NN:5 
5 ASA NN:5 
5 ARNHL NN:5 
5 ALF1 NN:4 NNP:1 
5 AF10 NN:5 
5 AES NN:5 
5 ACLA JJ:1 NN:4 
5 93 CD:5 
5 85 CD:5 
5 78 CD:5 
5 729 CD:5 
5 63 CD:5 
5 600 CD:5 
5 5'HS2 NN:5 
5 5'-regulatory JJ:5 
5 4E-BP1 NN:5 
5 49 CD:5 
5 44 CD:5 
5 430-444 CD:4 NN:1 
5 40-kDa JJ:5 
5 317 CD:5 
5 300 CD:5 
5 30-fold JJ:2 RB:3 
5 3.7 CD:5 
5 3-O-methyl-D-glucose NN:5 
5 25(OH)D3 NN:5 
5 231 CD:5 
5 20q JJ:1 NN:4 
5 2.7 CD:5 
5 2.6 CD:5 
5 2.5 CD:5 
5 2-m NN:5 
5 2,3,7,8-tetrachlorodibenzo-p-dioxin NN:5 
5 1p36 NN:5 
5 128 CD:5 
5 12-bp JJ:5 
5 12-O-tetradecanoylphorbol NN:5 
5 110 CD:5 
5 1.3 CD:5 
5 1-binding JJ:5 
5 1,25 CD:5 
5 0.4 CD:5 
5 0.025 CD:5 
5 0.005 CD:5 
5 0.002 CD:5 
5 /ETO NN:5 
5 /A23187 NN:5 
5 .05 CD:5 
5 -linked JJ:5 
5 -initiated JJ:5 
5 -controlled JJ:5 
5 -NO NN:5 
5 -54 CD:5 
5 -250 CD:5 
5 -201 CD:5 
5 -20 CD:5 
5 -150 CD:5 
5 -130 CD:5 
4 zeta-chain NN:4 
4 xeroderma NN:4 
4 xanthomatosis NN:4 
4 wortmannin NN:4 
4 woman NN:4 
4 why IN:1 WRB:3 
4 whom WP:4 
4 ways NNS:4 
4 washed VBN:4 
4 von NN:4 
4 vitellogenin NN:4 
4 vital JJ:4 
4 virulence NN:4 
4 virions NNS:4 
4 vessels NNS:4 
4 vessel NN:4 
4 vera NN:4 
4 vast JJ:4 
4 varicella NN:4 
4 valuable JJ:4 
4 vacuolar JJ:3 NN:1 
4 v-myb NN:4 
4 v LS:3 NN:1 
4 utilization NN:4 
4 utility NN:4 
4 urchin NN:4 
4 upper JJ:4 
4 unusually RB:4 
4 unspliced JJ:4 
4 unresponsiveness NN:4 
4 unphosphorylated JJ:4 
4 unoccupied JJ:4 
4 unless IN:4 
4 uniquely RB:4 
4 uniformly RB:4 
4 uncertain JJ:4 
4 ubiquitination NN:4 
4 tyrosine-phosphorylated JJ:4 
4 typing NN:4 
4 type- NN:4 
4 tumor-suppressor JJ:3 NN:1 
4 trophoblast NN:4 
4 troglitazone NN:4 
4 trioxide NN:4 
4 trend NN:4 
4 transmit VB:3 VBP:1 
4 transmigration NN:4 
4 transfusion NN:4 
4 transcribe VB:3 VBP:1 
4 trans- JJ:2 NN:1 NNS:1 
4 took VBD:4 
4 tiny JJ:4 
4 thyroidectomy NN:4 
4 thrombosis NN:4 
4 thrombopoietin NN:4 
4 thioredoxin NN:4 
4 thapsigargin NN:4 
4 thalassemia JJ:3 NN:1 
4 tetrazolium NN:4 
4 tetrahydrobiopterin NN:4 
4 tetracycline JJ:1 NN:3 
4 tests NNS:4 
4 tester NN:4 
4 termination NN:4 
4 ten CD:4 
4 templates NNS:4 
4 telangiectasia NN:4 
4 tamarin NN:4 
4 take VB:2 VBP:2 
4 tTG NN:4 
4 t(17;19) NN:4 
4 t(10;11) NN:4 
4 synthesize VB:3 VBP:1 
4 synovium NN:4 
4 synovitis NN:4 
4 switched VBD:1 VBN:3 
4 sustain VB:4 
4 survival-promoting JJ:4 
4 survey NN:4 
4 surveillance NN:4 
4 surprisingly RB:4 
4 supine NN:4 
4 succinimide JJ:1 NN:3 
4 sublining JJ:3 NN:1 
4 subdominant JJ:4 
4 strength NN:4 
4 stimulus-induced JJ:4 
4 stimulators NNS:4 
4 stimulator NN:4 
4 started VBD:3 VBN:1 
4 stabilized VBD:3 VBN:1 
4 splenocytes NNS:4 
4 spleens NNS:4 
4 sperm NN:4 
4 spatial JJ:4 
4 spastic JJ:4 
4 spacing NN:4 
4 sorting NN:4 
4 soon IN:1 RB:3 
4 solely RB:4 
4 soft JJ:4 
4 slower JJR:4 
4 skewing JJ:1 NN:3 
4 situation NN:4 
4 shuttling NN:3 VBG:1 
4 shorter JJR:4 
4 shear-induced JJ:4 
4 sex-determining JJ:4 
4 severity NN:4 
4 sesquiterpene NN:4 
4 serum-supplemented JJ:4 
4 serines NNS:4 
4 sequestration NN:4 
4 separately RB:4 
4 selecting VBG:4 
4 seemed VBD:4 
4 seeking NN:1 VBG:3 
4 searched VBD:1 VBN:3 
4 sea NN:4 
4 scanning NN:4 
4 saturating JJ:4 
4 salivary JJ:4 
4 sIg NN:4 
4 robust JJ:4 
4 ringed JJ:4 
4 revert VB:4 
4 restricts VBZ:4 
4 resonance NN:4 
4 reproductive JJ:4 
4 replicates VBZ:4 
4 replace VB:4 
4 reorganization NN:4 
4 relies VBZ:4 
4 rel-related JJ:4 
4 regular JJ:4 
4 reductions NNS:4 
4 redistribution NN:4 
4 recurrence NN:4 
4 recruiting VBG:4 
4 receptor/CD3 NN:4 
4 recapitulated VBD:2 VBN:2 
4 ratios NNS:4 
4 rarely RB:4 
4 rPRL NN:4 
4 rBPI21 NN:4 
4 questioned VBD:3 VBN:1 
4 quercetin NN:4 
4 quality NN:4 
4 pyrrolidinedithiocarbamate NN:4 
4 pyrimidine JJ:1 NN:3 
4 purposes NNS:4 
4 pure JJ:4 
4 psi(m) NN:4 
4 proximity NN:4 
4 proven JJ:1 VBN:3 
4 prototypic JJ:4 
4 prototype NN:4 
4 protein/DNA NN:4 
4 propagation NN:4 
4 proof NN:4 
4 promotion NN:4 
4 promoter-driven JJ:4 
4 prolong VB:3 VBP:1 
4 proceeds VBZ:4 
4 procedures NNS:4 
4 prime JJ:3 VBP:1 
4 prevalent JJ:4 
4 preterms NNS:4 
4 prestimulated JJ:3 VBN:1 
4 presently RB:4 
4 pregnancies NNS:4 
4 preference NN:4 
4 preexisting JJ:2 VBG:2 
4 predicting VBG:4 
4 preclinical JJ:4 
4 precisely RB:4 
4 pre-T JJ:4 
4 pre- JJ:4 
4 pp NN:4 
4 potentiate VB:4 
4 post-translationally RB:4 
4 post-translational JJ:4 
4 positivity NN:4 
4 positional JJ:4 
4 pools NNS:4 
4 pombe FW:4 
4 polycythemia NN:4 
4 polyadenylation NN:4 
4 polar JJ:4 
4 pokeweed NN:4 
4 pneumoniae FW:3 JJ:1 
4 pmol/L NN:4 
4 pml/RAR NN:4 
4 pluripotent JJ:4 
4 pleural JJ:4 
4 plaques NNS:4 
4 placenta NN:4 
4 pim-1 NN:4 
4 pigmentosum NN:4 
4 phosphorylating VBG:4 
4 phosphatidic JJ:4 
4 phorbol-12-myristate NN:4 
4 phenylacetate NN:4 
4 pharmacologic JJ:4 
4 phagocytic JJ:4 
4 permit VB:3 VBP:1 
4 permanently RB:4 
4 pathophysiological JJ:4 
4 pathogen NN:4 
4 parts NNS:4 
4 pallidum FW:4 
4 pM NN:4 
4 p91 NN:4 
4 p75TNF-R NN:4 
4 p57 NN:4 
4 p50p50 NN:4 
4 p50- NN:4 
4 p48 NN:4 
4 p300 NN:4 
4 overt JJ:4 
4 overlap VB:1 VBP:3 
4 originating VBG:4 
4 organism NN:4 
4 optimized VBN:4 
4 operates VBZ:4 
4 opening NN:3 VBG:1 
4 ontogeny NN:4 
4 oligodeoxynucleotide NN:4 
4 old JJ:4 
4 octamer-dependent JJ:4 
4 observe VB:3 VBP:1 
4 nucleoside JJ:1 NN:3 
4 note NN:3 VB:1 
4 normals NNS:4 
4 nonresponsive JJ:4 
4 nonproductive JJ:4 
4 nonpregnancy JJ:1 NN:3 
4 noncomedo JJ:4 
4 nodular JJ:4 
4 nmol NN:4 
4 ng NN:4 
4 newborn JJ:4 
4 neurons NNS:4 
4 nephrotic JJ:4 
4 neonates NNS:4 
4 neighboring JJ:2 VBG:2 
4 negligible JJ:4 
4 negative-acting JJ:4 
4 necessarily RB:4 
4 nearby JJ:3 NN:1 
4 nasal JJ:3 NN:1 
4 myosin JJ:2 NN:2 
4 myometrium NN:4 
4 myelodysplastic JJ:4 
4 myeloblasts NNS:4 
4 mycobacteria NNS:4 
4 multimers NNS:4 
4 multifunctional JJ:4 
4 multi-protein JJ:4 
4 muB NN:4 
4 mother NN:4 
4 mosaic JJ:3 NN:1 
4 monokine NN:4 
4 monoblast NN:4 
4 moieties NNS:4 
4 mobilized VBN:4 
4 mobilities NNS:4 
4 mo JJ:1 NN:2 NNS:1 
4 mitogen- JJ:1 NN:3 
4 minority NN:4 
4 minimum JJ:3 NN:1 
4 minimally RB:4 
4 min/L NN:4 
4 mimicry NN:4 
4 mimicking VBG:4 
4 microtubule JJ:2 NN:2 
4 micrograms NNS:4 
4 microg/ml NN:4 
4 microbicidal JJ:3 NN:1 
4 metastases NNS:4 
4 mellitus NN:4 
4 megakaryocytopoiesis NN:3 NNS:1 
4 medicine NN:4 
4 maximally RB:4 
4 manipulation NN:4 
4 manifest VB:1 VBP:3 
4 manic JJ:4 
4 mammals NNS:4 
4 makes UNKNOWN:1 VBZ:3 
4 magnetic JJ:4 
4 mV NN:4 
4 mNFATc NN:4 
4 mBob1 NN:4 
4 lymphomagenesis NN:4 
4 low-level JJ:4 
4 localizes VBZ:4 
4 lipoxygenase NN:4 
4 lipopolysaccharide-induced JJ:4 
4 lipoarabinomannan NN:4 
4 ligand-activated JJ:4 
4 leukocyte-type NN:4 
4 leukemia/lymphoma NN:4 
4 leukaemias NNS:4 
4 lend VB:1 VBP:3 
4 lacZ NN:4 
4 lac NN:4 
4 knockout JJ:3 NN:1 
4 kinetic JJ:4 
4 kappaB3 NN:4 
4 kB NN:4 
4 juxtaposed VBD:1 VBN:3 
4 joints NNS:4 
4 joining NN:3 VBG:1 
4 involution NN:4 
4 investigations NNS:4 
4 invasive JJ:4 
4 invariant JJ:4 
4 invariably RB:4 
4 intriguing JJ:4 
4 intranuclear JJ:4 
4 intragenic JJ:4 
4 intracytoplasmic JJ:4 
4 intimately RB:4 
4 intestine NN:4 
4 intervention NN:4 
4 interphase JJ:1 NN:3 
4 interleukins NNS:4 
4 interleukin-13 NN:4 
4 interferon-stimulated JJ:4 
4 interfered VBD:3 VBN:1 
4 interestingly RB:4 
4 interesting JJ:4 
4 instillation NN:4 
4 instability NN:4 
4 insensitive JJ:4 
4 injury-induced JJ:4 
4 inherited VBN:4 
4 informative JJ:4 
4 infiltrated VBD:1 VBN:3 
4 infiltrate NN:4 
4 inducibly RB:4 
4 increasingly RB:4 
4 incomplete JJ:4 
4 inactivates VBZ:4 
4 inactivate VB:3 VBP:1 
4 imposed VBN:4 
4 implying VBG:4 
4 immunology NN:4 
4 immunolabeling NN:4 
4 immunogenicity NN:4 
4 immunized JJ:1 VBN:3 
4 hypotonic JJ:4 
4 hypothalamus NN:4 
4 hyporesponsiveness NN:4 
4 hypo JJ:3 NN:1 
4 hyperthermia NN:4 
4 hyperphosphorylation NN:4 
4 hypercalciuria NN:4 
4 hydroxyanisole NN:4 
4 hydrochloride NN:4 
4 hybridisation NN:4 
4 huGATA-3 NN:4 
4 hormone-binding JJ:3 NN:1 
4 homing JJ:2 NN:2 
4 histolytica JJ:1 NN:3 
4 hirsutism NN:4 
4 highlight VBP:4 
4 hierarchy NN:4 
4 heteromeric JJ:4 
4 heterodimerize VB:2 VBP:2 
4 hepatoma NN:4 
4 hemoglobinization NN:4 
4 heme-treated JJ:4 
4 hematopoietin NN:4 
4 hck NN:4 
4 harvests NNS:4 
4 harboring NN:1 VBG:3 
4 haploinsufficiency NN:4 
4 hampered VBN:4 
4 hallmark NN:4 
4 half-maximal JJ:4 
4 hairy JJ:4 
4 haemin NN:4 
4 hTLR2 NN:4 
4 hSIE NN:4 
4 hGATA-4 NN:4 
4 hCLEO NN:4 
4 gradually RB:4 
4 goal NN:4 
4 glycophorin NN:4 
4 glutamine-rich JJ:4 
4 glutamine NN:4 
4 gliadin NN:4 
4 glia NN:4 
4 giant JJ:4 
4 germ NN:4 
4 genuine JJ:4 
4 gels NNS:4 
4 gamma-2 NN:4 
4 gamma-1 NN:4 
4 future JJ:4 
4 front NN:4 
4 fork NN:4 
4 footprinted JJ:1 VBN:3 
4 fluorescent JJ:4 
4 fluids NNS:4 
4 fludarabine NN:4 
4 flexible JJ:4 
4 fixed JJ:4 
4 fine JJ:3 NN:1 
4 final JJ:4 
4 field NN:4 
4 fibroblastic JJ:4 
4 favor NN:1 VB:2 VBP:1 
4 faster JJR:4 
4 factor- JJ:2 NN:2 
4 extreme JJ:4 
4 extravascular JJ:4 
4 extra FW:1 JJ:3 
4 extend VB:2 VBP:2 
4 exploited VBD:1 VBN:3 
4 explants NNS:4 
4 explaining VBG:4 
4 experiment NN:4 
4 exit NN:1 VB:1 VBP:2 
4 exclude VB:3 VBP:1 
4 evolutionary JJ:4 
4 evoked VBD:1 VBN:3 
4 euthymic JJ:4 
4 etiological JJ:4 
4 ester-induced JJ:4 
4 erythroblastic JJ:4 
4 erythroblast NN:4 
4 epsilon- NN:4 
4 entity NN:4 
4 endotoxic JJ:4 
4 endemic JJ:4 
4 enables VBZ:4 
4 enable VB:2 VBP:2 
4 emphasized VBD:1 VBN:3 
4 elusive JJ:4 
4 elucidating VBG:4 
4 elimination NN:4 
4 eliminates VBZ:4 
4 electrolytes NNS:4 
4 eightfold JJ:2 RB:2 
4 e JJ:1 NN:2 VB:1 
4 doxorubicin NN:4 
4 downmodulated VBN:4 
4 down-modulation NN:4 
4 double-positive JJ:4 
4 dodecyl NN:4 
4 dividing VBG:4 
4 distinguishing JJ:1 VBG:3 
4 distinguishable JJ:4 
4 displaced JJ:1 VBD:1 VBN:2 
4 discordant JJ:4 
4 dioxyvit NN:4 
4 dinucleotide JJ:1 NN:3 
4 diminish VB:4 
4 differentiation-dependent JJ:4 
4 diamide NN:4 
4 diagnostic JJ:4 
4 description NN:4 
4 derive VB:2 VBP:2 
4 dependently RB:4 
4 denoted VBN:4 
4 denaturing VBG:4 
4 delta-globin JJ:1 NN:3 
4 delineated VBD:2 VBN:2 
4 dehydroepiandrosterone NN:4 
4 decreasing VBG:4 
4 decisions NNS:4 
4 daughter NN:4 
4 cytostasis NN:4 
4 cytosols NNS:4 
4 cyto-differentiating JJ:4 
4 cysteine-rich JJ:4 
4 cross JJ:2 NN:1 VBD:1 
4 creating VBG:4 
4 counterparts NNS:4 
4 corresponded VBD:4 
4 correlating VBG:4 
4 coronary JJ:4 
4 coreceptor NN:4 
4 coping NN:4 
4 coordination NN:4 
4 convert VB:3 VBP:1 
4 controversial JJ:4 
4 contents NNS:4 
4 constructions NNS:4 
4 constituents NNS:4 
4 consist VB:2 VBP:2 
4 concurrently RB:4 
4 concerted JJ:3 VBN:1 
4 compromised VBN:4 
4 comprise VBP:4 
4 complemented VBD:1 VBN:3 
4 compensatory JJ:4 
4 compelling JJ:4 
4 comparisons NNS:4 
4 communication NN:4 
4 comigrated VBD:3 VBN:1 
4 combinatorial JJ:4 
4 colostrum NN:4 
4 collapse NN:4 
4 coligation NN:4 
4 coimmunoprecipitated VBD:1 VBN:3 
4 coculture NN:4 
4 climacteric JJ:4 
4 classically RB:4 
4 cis-trans JJ:4 
4 cis-regulatory JJ:4 
4 cipro NN:4 
4 chloride JJ:1 NN:3 
4 checkpoint NN:4 
4 challenged VBN:4 
4 cerulein NN:4 
4 cellularity NN:4 
4 cells/mm2 NNS:4 
4 cell-restricted JJ:4 
4 cell-dependent JJ:4 
4 categories NNS:4 
4 caspase-3 JJ:1 NN:3 
4 casein NN:4 
4 carries VBZ:4 
4 captopril NN:4 
4 capability NN:4 
4 calpain JJ:1 NN:3 
4 calf NN:4 
4 c-sis/PDGF-B NN:4 
4 c-fos-positive JJ:4 
4 c-erbB2 NN:4 
4 c-erb NN:4 
4 c-Rel/ NN:4 
4 c-Raf-1 NN:4 
4 c-Mpl NN:4 
4 c-Fos/c-Jun NN:4 
4 c-ErbB NN:4 
4 bypassing VBG:4 
4 butyrate NN:4 
4 burst-forming JJ:4 
4 brief JJ:4 
4 bowel NN:4 
4 bond NN:4 
4 bolus NN:4 
4 blood-derived JJ:4 
4 blocker NN:4 
4 bipotential JJ:4 
4 biopsy NN:4 
4 biomarkers NNS:4 
4 bioavailability NN:4 
4 bifunctional JJ:4 
4 biallelic JJ:4 
4 beta2 NN:4 
4 beta1 NN:4 
4 beta-gal NN:4 
4 beta-cells NNS:4 
4 behaved VBD:4 
4 begins VBZ:4 
4 bed NN:4 
4 becoming VBG:4 
4 band-shift JJ:2 NN:2 
4 ataxia NN:4 
4 astrocytomas NNS:4 
4 assessment NN:4 
4 assessing VBG:4 
4 asparagine NN:4 
4 asked VBD:3 VBN:1 
4 article NN:4 
4 artery NN:4 
4 arrangement NN:4 
4 arise VB:2 VBP:2 
4 antiglucocorticoid JJ:3 NN:1 
4 antigen- JJ:2 NN:2 
4 anti-MHC JJ:4 
4 analyse VB:3 VBP:1 
4 amplifies VBZ:4 
4 alpha,25(OH)2D3 NN:4 
4 allograft NN:4 
4 allergies NNS:4 
4 allele-specific JJ:4 
4 algorithm NN:4 
4 airways NNS:4 
4 aims NNS:2 VBZ:2 
4 aid VB:4 
4 age-matched JJ:4 
4 adulthood NN:4 
4 adolescent JJ:4 
4 additive JJ:4 
4 acetylation NN:4 
4 acetylated VBN:4 
4 acetyl-transferase NN:4 
4 accounting NN:1 VBG:3 
4 absorptive JJ:4 
4 absolute JJ:4 
4 abortion NN:4 
4 ZRE-B NN:4 
4 ZIP NN:4 
4 YB-1 NN:4 
4 XCI NN:4 
4 X-ray JJ:1 NN:3 
4 Willebrand NN:4 
4 Wild-type JJ:4 
4 W NN:4 
4 Vmax NN:4 
4 VKC NN:4 
4 VIIa NN:4 
4 VCA JJ:1 NN:3 
4 V3 JJ:1 NN:3 
4 V14Rho NN:4 
4 Urapidil NN:4 
4 UT-7/GMT NN:4 
4 USF NN:4 
4 UP NN:4 
4 UAS1 NN:4 
4 U1A/U1B NN:4 
4 Tyloxapol NN:4 
4 Turner NN:4 
4 Translocation NN:4 
4 Transcripts NNS:4 
4 Total JJ:4 
4 Tip NN:4 
4 Thyroid NN:4 
4 Then RB:4 
4 Th2-type JJ:4 
4 Th1/Th2 NN:4 
4 Ter NN:4 
4 Tal-1 NN:4 
4 TSC NN:4 
4 TRP NN:4 
4 TRAP JJ:1 NN:3 
4 TLCK NN:4 
4 TH1 NN:4 
4 TBP7 NN:4 
4 TATA-less JJ:4 
4 TAFII32 NN:4 
4 T/NK NN:4 
4 T-lymphocytic JJ:4 
4 Surface NN:4 
4 Substitution NN:4 
4 Subsequent JJ:4 
4 Staphylococcus FW:4 
4 Spi-1/PU.1 NN:4 
4 Sox-4 NN:4 
4 Soluble JJ:4 
4 Significantly RB:4 
4 Sequencing NN:4 
4 Sci NNP:4 
4 ST JJ:4 
4 SSCP NN:4 
4 SOCS-1 NN:4 
4 SKW6.4 NN:4 
4 SH3 NN:4 
4 SH NN:4 
4 SCM-1 NN:4 
4 SB NN:4 
4 SAPK NN:4 
4 S49 NN:4 
4 S194 NN:4 
4 S-LB1 NN:4 
4 Ro-VDR NN:4 
4 Rheumatoid JJ:4 
4 Restriction NN:4 
4 Restoration NN:4 
4 Resting VBG:4 
4 Response NN:4 
4 Relative JJ:4 
4 Rel/NF-kappaB JJ:2 NN:2 
4 Rel/NF-kappa NN:4 
4 Redox NN:4 
4 Ras-related JJ:4 
4 RanQ69L NN:4 
4 RanBP1 NN:4 
4 RU-486 NN:4 
4 RS NN:4 
4 RIIA NN:4 
4 RFLPs NNS:4 
4 RFLP NN:4 
4 RFLAT-1 NN:4 
4 REV NN:4 
4 RARE JJ:3 NN:1 
4 RAG NN:4 
4 RA-induced JJ:4 
4 R7-57 NN:4 
4 R-responsive JJ:4 
4 R-PK NN:4 
4 PuF NN:4 
4 Progesterone NN:4 
4 Production NN:4 
4 Proc NNP:4 
4 Preincubation NN:4 
4 Potential JJ:4 
4 Platelet-activating JJ:4 
4 Pervanadate NN:4 
4 Pbx1 JJ:1 NN:3 
4 Pax-5e NN:4 
4 Pax-5d NN:4 
4 Pax-5a NN:4 
4 Partial JJ:4 
4 PXQXT/S NN:4 
4 PU-SF NN:4 
4 POZ NN:4 
4 POS-1 NN:4 
4 PMNCs NNS:4 
4 PMLRAR NN:4 
4 PML/ NN:4 
4 PLC NN:4 
4 PLAP JJ:1 NN:3 
4 PKC-epsilon NN:4 
4 PKC-alpha NN:4 
4 PKB JJ:1 NN:3 
4 PIF NN:4 
4 PIEC NN:4 
4 PHP NN:4 
4 PHA/ NN:4 
4 PHA-activated JJ:4 
4 PCr NN:4 
4 PC-3 NN:4 
4 PAX-5 NN:4 
4 PARP NN:4 
4 PAI-1 NN:4 
4 P3 NN:4 
4 P-like JJ:4 
4 P-CREB JJ:1 NN:3 
4 OspA NN:4 
4 Octamer NN:4 
4 OTF2 NN:4 
4 OSF2 NN:4 
4 OSE2 NN:4 
4 OM-10.1 NN:4 
4 OCTA NN:4 
4 OAP NN:4 
4 Notch-1 NN:4 
4 Notably RB:4 
4 Nonetheless RB:4 
4 Nitric JJ:4 
4 Nature NNP:4 
4 Natl NN:1 NNP:3 
4 Namalwa NN:4 
4 NWP NN:4 
4 NRDS NN:4 
4 NFATx NN:4 
4 NF-YA NN:4 
4 NF-AT-1 NN:4 
4 NAF NN:3 NNS:1 
4 Mr NN:4 
4 Monocytic JJ:4 
4 Monoclonal JJ:3 NNP:1 
4 Mol NNP:4 
4 Mechanisms NNS:4 
4 Macrophages NNS:4 
4 Mac-1 NN:4 
4 MYH11 NN:3 NNS:1 
4 MT-I NN:4 
4 MS-2 NN:4 
4 MOLT-4 NN:4 
4 MNP-2 NN:4 
4 MMP9 NN:4 
4 MKP-1 NN:4 
4 MKK3 DT:1 NN:3 
4 MIE NN:4 
4 MIBP1 NN:4 
4 MET NN:4 
4 MCM6 NN:4 
4 MCF-7 NN:4 
4 MAPKK-1 NN:4 
4 M4Eo NN:4 
4 M22 NN:4 
4 M2 NN:4 
4 M1 NN:4 
4 M-TAT NN:4 
4 M-CRF NN:4 
4 Ligand NN:4 
4 Leukotriene NN:4 
4 LT-293 NN:4 
4 LPS- NN:4 
4 LPMC NN:4 
4 LFA-I NN:4 
4 LBR NN:4 
4 L2 NN:4 
4 Kruppel-related JJ:4 
4 Km NN:4 
4 KV NN:4 
4 KG1 NN:4 
4 Jul NNP:4 
4 JNK1 NN:4 
4 JAKs NNS:4 
4 J393/ JJ:1 NN:3 
4 Interleukin-7 NN:4 
4 Interleukin-5 NN:4 
4 Interactions NNS:4 
4 Inhibitory JJ:4 
4 Induced VBD:1 VBN:3 
4 Immunofluorescence NN:4 
4 IgA NN:4 
4 Id-3 NN:4 
4 IcsA NN:4 
4 IU/mL NN:4 
4 INK4A NN:4 
4 IL1B NN:4 
4 IL13 NN:4 
4 IL-4RE NN:4 
4 IL-4- NN:4 
4 IKK1 NN:4 
4 IKK-beta NN:4 
4 IKK-alpha NN:4 
4 II-positive JJ:4 
4 II-2 NN:4 
4 IHES NN:4 
4 IFNgamma- JJ:3 NN:1 
4 IFNGR1 NN:4 
4 IFNA JJ:1 NN:3 
4 IFN-gammaR NN:4 
4 ICK-1 NN:4 
4 ICER NN:4 
4 IC50s NN:2 NNS:2 
4 I-TE NN:4 
4 Herpesvirus NN:4 
4 HVS NN:3 NNS:1 
4 HSs NNS:4 
4 HS-72 NN:4 
4 HRBC JJ:1 NN:3 
4 HOX11 NN:4 
4 HL-60/vinc/R NN:4 
4 HIVs NN:1 NNS:3 
4 HIV- NN:4 
4 HHV-8 JJ:2 NN:2 
4 HF NN:2 NNS:2 
4 HD6 NN:4 
4 HCD57-SREI NN:4 
4 HCD57 NN:4 
4 H-89 NN:4 
4 Gram-negative JJ:4 
4 Genes NNP:1 NNS:3 
4 GR6 NN:4 
4 GM-CSF-responsive JJ:4 
4 GIRE NN:4 
4 GH3 NN:4 
4 GF NN:4 
4 GD3 JJ:1 NN:3 
4 GCR-beta JJ:1 NN:3 
4 GAD NN:4 
4 G2/M NN:4 
4 G0S24 NN:4 
4 G0S NN:4 
4 Fra-1 NN:4 
4 Formation NN:4 
4 Flutamide NN:4 
4 Fluorescence NN:4 
4 Few JJ:4 
4 FcgammaRI NN:4 
4 Fabry NN:4 
4 FLCs NNS:4 
4 FK-506 NN:4 
4 FH NN:4 
4 FGF NN:4 
4 FEV1 NN:4 
4 Except IN:4 
4 Even RB:4 
4 Evaluation NN:4 
4 Ets-related JJ:4 
4 Epo-R NN:4 
4 Enhancement NN:4 
4 Eight CD:4 
4 Egr-3 NN:4 
4 Effect NN:4 
4 ERK-2 NN:4 
4 ER+ JJ:4 
4 EMCV NN:4 
4 ELAM NN:4 
4 EIC NN:4 
4 EGTA NN:4 
4 EGFR NN:4 
4 EF1 JJ:1 NN:3 
4 EC-Mn NN:4 
4 EA/S JJ:1 NN:3 
4 E74 NN:4 
4 E2F4 NN:4 
4 E2F1 NN:4 
4 Dendritic JJ:4 
4 DeltaE NN:4 
4 DTCs NNS:4 
4 DR-nm23 NN:4 
4 DQA1 NN:4 
4 DQ0302 NN:4 
4 DNAs NNS:4 
4 DNA-cellulose NN:4 
4 DNA-bound JJ:4 
4 DHA NN:4 
4 DESTs NNS:4 
4 DEP- NNS:4 
4 DDPCR NN:4 
4 D-responsive JJ:4 
4 Cryptococcus FW:2 NN:2 
4 Cortivazol NN:4 
4 Contrary JJ:4 
4 Concomitant JJ:4 
4 Complex NN:4 
4 Chloramphenicol NN:4 
4 Certain JJ:4 
4 Cell-to-cell JJ:4 
4 Cdc42 JJ:2 NN:2 
4 Candida FW:2 NN:2 
4 Calphostin NN:4 
4 CaM-K NN:4 
4 CaM-AI NN:4 
4 Ca(2+)-ATPase NN:4 
4 CSF-1R JJ:1 NN:3 
4 CRO-AP/5 NN:4 
4 CRO-AP/3 NN:4 
4 CP1 NN:4 
4 COS-1 NN:4 
4 CLEO NN:4 
4 CL JJ:1 NN:3 
4 CK-1 NN:4 
4 CHO/ NN:4 
4 CD8- JJ:3 NN:1 
4 CD71 NN:4 
4 CD48 NN:4 
4 CD45RO+ JJ:4 
4 CD45RA NN:4 
4 CD4- JJ:3 NN:1 
4 CD3epsilon NN:4 
4 CD34+Thy-1+ JJ:4 
4 CD106 NN:4 
4 CCl4 JJ:1 NN:3 
4 CCR-4 NN:4 
4 CCAAT/enhancer-binding JJ:4 
4 CB NN:4 
4 C3 NN:4 
4 C/EBPepsilon NN:4 
4 C-type JJ:4 
4 C-JUN NN:4 
4 C-C NN:4 
4 But CC:4 
4 Biochemical JJ:4 
4 Before IN:4 
4 Band NN:4 
4 Bak NN:4 
4 BZLF-1 JJ:1 NN:3 
4 BZ1 NN:4 
4 BW NN:4 
4 BSO JJ:1 NN:3 
4 BP1 NN:4 
4 BOX1 NN:4 
4 BLPs NNS:4 
4 BJA-B NN:4 
4 BEAS-2B NN:4 
4 BCP-ALL NN:4 
4 BALB/c NN:4 
4 B. FW:1 NNP:3 
4 B-dependent JJ:4 
4 Arnt NN:4 
4 Apr NN:1 NNP:3 
4 Androgen NN:4 
4 Alveolar JJ:4 
4 Alu NN:4 
4 All-trans JJ:4 
4 Ach2 NN:4 
4 Acad NNP:4 
4 Abelson NN:4 
4 ATG NN:4 
4 ATF1 NN:4 
4 ATF/CRE NN:4 
4 ATF NN:4 
4 ARDS NN:4 
4 APLs NNS:4 
4 AP-1-binding JJ:4 
4 AO JJ:1 NN:3 
4 AMP-responsive JJ:4 
4 AITL/GC NN:4 
4 AGS NN:4 
4 AG-490 NN:4 
4 ADP JJ:1 NN:2 VBZ:1 
4 ADA NN:4 
4 AC NN:4 
4 A-sensitive JJ:4 
4 A-CRF NN:4 
4 9.3 CD:4 
4 9.2 CD:4 
4 8e51 NN:4 
4 89 CD:4 
4 828 CD:4 
4 82 CD:4 
4 7-day JJ:4 
4 5b NN:4 
4 50-fold JJ:2 RB:2 
4 5- CD:4 
4 5'-most JJ:4 
4 3q21 NN:4 
4 39 CD:4 
4 32P-labeled JJ:4 
4 3.5 CD:4 
4 3-O-MG JJ:1 NN:3 
4 3'-UTR NN:4 
4 272 CD:4 
4 27-kDa JJ:4 
4 25-fold JJ:2 RB:2 
4 2418delA NN:4 
4 24-hour JJ:4 
4 21-bp JJ:4 
4 20-epi JJ:1 NN:3 
4 2/5 CD:4 
4 2.4 CD:4 
4 2.2 CD:4 
4 2- CD:3 JJ:1 
4 1E8 NN:4 
4 1D4 NN:4 
4 1994 CD:4 
4 1989 CD:4 
4 1988 CD:4 
4 19-bp JJ:4 
4 17q NN:4 
4 160 CD:3 JJ:1 
4 151 CD:4 
4 14q32.1 NN:4 
4 145 CD:4 
4 141 CD:4 
4 128-135 CD:4 
4 11p15 NN:4 
4 11p13 NN:4 
4 119 CD:4 
4 110-kDa JJ:4 
4 105-kDa JJ:4 
4 1.9 CD:4 
4 1.7 CD:4 
4 1.1 CD:4 
4 1,_25(OH)2D3 JJ:1 NN:3 
4 1,25-dihydroxycholecalciferol NN:4 
4 00 CD:4 
4 0/3 CD:4 
4 0.67 CD:4 
4 0.6 CD:4 
4 /c-Jun NN:4 
4 /RXR NN:4 
4 /NF-kappa NN:4 
4 /I NN:4 
4 /CD70 NN:4 
4 /CAT NN:4 
4 /AP-1 NN:4 
4 -to- JJ:4 
4 -signal JJ:4 
4 -selected JJ:4 
4 -reactive JJ:4 
4 -mRNA JJ:1 NN:3 
4 -luciferase JJ:2 NN:2 
4 -gene JJ:4 
4 -enhanced JJ:4 
4 -coupled JJ:4 
4 -activating JJ:4 
4 -S NNS:4 
4 -NHOH NN:4 
4 -MYH11 NN:4 
4 -DR NN:4 
4 -C NN:4 
4 -96 CD:4 
4 -92 CD:4 
4 -90 CD:4 
4 -9 CD:4 
4 -88 CD:4 
4 -8 CD:4 
4 -79 CD:4 
4 -59 CD:4 
4 -5 CD:4 
4 -417 CD:4 
4 -36 CD:4 
4 -3134 CD:4 
4 -148 CD:3 NN:1 
4 -120 CD:4 
3 zymosan JJ:1 NN:2 
3 zymogen NN:3 
3 zones NNS:3 
3 zero- JJ:3 
3 xanthine NN:3 
3 western NN:3 
3 well-known JJ:3 
3 volunteer NN:3 
3 vitro-translated JJ:2 VBN:1 
3 visualized VBN:3 
3 visible JJ:3 
3 viscosity NN:3 
3 virus-immortalized JJ:3 
3 virus-exposed JJ:3 
3 virus-I NN:3 
3 virtual JJ:3 
3 vesicles NNS:3 
3 ventilated VBN:3 
3 vasculopathy NN:3 
3 valine NN:3 
3 v-rel NN:3 
3 utilizes VBZ:3 
3 usefulness NN:3 
3 unliganded JJ:3 
3 unit-erythroid JJ:2 NN:1 
3 unfractionated JJ:3 
3 unexplained JJ:3 
3 underphosphorylated JJ:2 VBN:1 
3 underlined VBN:3 
3 underlies VBZ:3 
3 under-representation NN:3 
3 uncultured JJ:3 
3 uncovered JJ:1 VBD:1 VBN:1 
3 typhimurium FW:3 
3 tyloxapol NN:3 
3 tumorigenic JJ:3 
3 tuberous JJ:3 
3 tropical JJ:3 
3 triplex NN:3 
3 triple JJ:3 
3 trinucleotide JJ:1 NN:2 
3 trials NNS:3 
3 transrepressive JJ:3 
3 transient-transfection JJ:1 NN:2 
3 transform VB:2 VBP:1 
3 transferrin NN:3 
3 transferred VBN:3 
3 transduces VBZ:3 
3 transcriptase-polymerase JJ:1 NN:2 
3 trans-activate VB:2 VBP:1 
3 trafficking NN:3 
3 traffic JJ:1 VBP:2 
3 tract NN:3 
3 tracer NN:3 
3 toxins NNS:3 
3 tools NNS:3 
3 too RB:3 
3 toll-like JJ:3 
3 titers NNS:3 
3 thyroxine JJ:1 NN:2 
3 thyrotropin NN:3 
3 thrombospondin NN:3 
3 thrombocytopenia NN:3 
3 thresholds NNS:3 
3 thiol-reducing JJ:3 
3 thiamine NN:3 
3 thermosensitive JJ:3 
3 thereof RB:3 
3 theoretical JJ:3 
3 themselves PRP:3 
3 thalassaemia NN:3 
3 tetrahydrocortisol NN:3 
3 tethering NN:3 
3 terminate VB:3 
3 template NN:3 
3 technology NN:3 
3 tags NNS:3 
3 t1/2 NN:3 
3 t(X;14) NN:3 
3 t(14;14) NN:3 
3 synchronized JJ:1 VBD:1 VBN:1 
3 switches NNS:1 VBZ:2 
3 suspected VBN:3 
3 surrounded VBN:3 
3 surprising JJ:3 
3 suppressibility NN:3 
3 superior JJ:3 
3 superinduction NN:3 
3 superinduced VBD:1 VBN:2 
3 sulfoximine NN:3 
3 sulfhydryl NN:3 
3 sulfate-polyacrylamide JJ:3 
3 suggestive JJ:3 
3 substitutes VBZ:3 
3 suboptimal JJ:3 
3 subnuclear JJ:3 
3 subdomains NNS:3 
3 structure-function JJ:3 
3 strongest JJS:3 
3 stratified JJ:1 VBN:2 
3 stored JJ:1 VBN:2 
3 stoichiometry NN:3 
3 stocks NNS:3 
3 stimulations NNS:3 
3 statistical JJ:3 
3 stat1 NN:3 
3 stage- JJ:3 
3 stabilizes VBZ:3 
3 stabilize VB:2 VBP:1 
3 sport NN:3 
3 split JJ:3 
3 splenocyte NN:3 
3 specimen NN:3 
3 specifying VBG:3 
3 specialized JJ:1 VBN:2 
3 spans NNS:1 VBZ:2 
3 spanned VBD:3 
3 spaced JJ:1 VBN:2 
3 sources NNS:3 
3 sometimes RB:3 
3 smoking NN:3 
3 skewed JJ:3 
3 site-like JJ:3 
3 sis-inducible JJ:3 
3 single-copy JJ:3 
3 single-cell JJ:2 NN:1 
3 simplified JJ:1 VBN:2 
3 short-lived JJ:3 
3 sharp JJ:3 
3 sex-matched JJ:3 
3 setting NN:2 VBG:1 
3 served VBD:3 
3 serum-containing JJ:3 
3 serotypes NNS:3 
3 serious JJ:3 
3 sequestering VBG:3 
3 sequester VB:2 VBP:1 
3 sequence-binding JJ:1 NN:2 
3 separates VBZ:3 
3 sensitivities NNS:3 
3 selectin NN:3 
3 segregated VBD:3 
3 sedimenting NN:2 VBG:1 
3 sedimentation NN:3 
3 secretory JJ:3 
3 scavenging NN:3 
3 salicylic JJ:3 
3 sIgM- NN:3 
3 sIgD- NN:3 
3 rutin NN:3 
3 ribonucleic JJ:2 NN:1 
3 rhythms NNS:3 
3 rheumatic JJ:3 
3 reviews VBZ:3 
3 reversion NN:3 
3 reversibly RB:3 
3 return NN:3 
3 reticulum NN:3 
3 restricting NN:1 VBG:2 
3 responder NN:3 
3 resolved VBN:3 
3 resemble VB:2 VBP:1 
3 rescues VBZ:3 
3 repressing VBG:3 
3 replicating VBG:3 
3 renewal NN:3 
3 rely VB:2 VBP:1 
3 releasing NN:1 VBG:2 
3 releases VBZ:3 
3 relatives NNS:3 
3 relapsed JJ:1 NN:1 VBD:1 
3 relB NN:3 
3 reiteration NN:3 
3 regulon NN:3 
3 regularly RB:3 
3 regression NN:3 
3 reference NN:3 
3 refer VBP:3 
3 recruits VBZ:3 
3 recruit VB:2 VBP:1 
3 receptors/cell NNS:3 
3 receptor-positive JJ:3 
3 receptor-negative JJ:3 
3 receptor-ligand JJ:3 
3 receptor-dependent JJ:3 
3 receptor-alpha NN:3 
3 receptor-CD3 JJ:1 NN:2 
3 realized VBD:1 VBN:2 
3 reactivations NNS:3 
3 reactivate VB:3 
3 randomly RB:3 
3 raising VBG:3 
3 rIL-12 NN:3 
3 quantities NNS:3 
3 quantification NN:3 
3 pursued VBN:3 
3 psychiatric JJ:3 
3 proviruses NNS:3 
3 protoenhancers NNS:3 
3 protocol NN:3 
3 proto-enhancer NN:3 
3 protein-tyrosine JJ:1 NN:2 
3 protein-1alpha NN:3 
3 proportional JJ:3 
3 propidium NN:3 
3 prooxidant JJ:3 
3 promotor NN:3 
3 promoter- JJ:1 NN:2 
3 prolyl JJ:3 
3 prolongation NN:3 
3 programs NNS:3 
3 programme NN:3 
3 proceed VB:3 
3 proIL-1beta NN:3 
3 pro-IL-16 NN:3 
3 pro-B-cell JJ:3 
3 preoperatively RB:3 
3 preferred JJ:2 VBN:1 
3 predisposition NN:3 
3 predictors NNS:3 
3 predictor NN:3 
3 precipitins NNS:3 
3 precedes VBZ:3 
3 pp70S6K NN:3 
3 power NN:3 
3 potentiating NN:1 VBG:2 
3 potencies NNS:3 
3 postulate VB:1 VBP:2 
3 posttranscriptionally RB:3 
3 positioning NN:2 VBG:1 
3 position-dependent JJ:3 
3 polymerized JJ:3 
3 polymerization NN:3 
3 polyacrylamide NN:3 
3 polyA NN:3 
3 pol NN:3 
3 pocket NN:3 
3 pml/RAR-alpha NN:3 
3 played VBD:2 VBN:1 
3 platelet-like JJ:3 
3 plasmacytomas NNS:3 
3 plant NN:3 
3 pituitary-specific JJ:3 
3 pigment NN:3 
3 phytohaemagglutinin NN:3 
3 phosphatidylserine NN:3 
3 phosphatidyl JJ:2 NN:1 
3 phorbol-13-acetate NN:3 
3 phorbol-12-myristate-13-acetate NN:3 
3 phoQ JJ:1 NN:2 
3 phenylarsine NN:3 
3 phenolic JJ:3 
3 pharmacokinetics NNS:3 
3 pharmacodynamic JJ:3 
3 pg/mL NN:3 
3 perturbation NN:3 
3 pertinent JJ:2 UNKNOWN:1 
3 persists VBZ:3 
3 perpetuation NN:3 
3 peroxidase-negative JJ:3 
3 permitted VBD:3 
3 permeabilized JJ:3 
3 periphery NN:3 
3 periodontitis NN:3 
3 periodontal JJ:3 
3 performance NN:3 
3 perform VB:3 
3 perennial JJ:3 
3 paxillin NN:3 
3 pathologies NNS:3 
3 pathogenicity NN:3 
3 particulate JJ:3 
3 participating VBG:3 
3 parasitic JJ:3 
3 parasite-induced JJ:3 
3 paraparesis NN:3 
3 parameter NN:3 
3 paralleling JJ:1 VBG:2 
3 paradigm NN:3 
3 palindrome NN:3 
3 pain NN:3 
3 pag NN:3 
3 paclitaxel JJ:1 NN:2 
3 pTh NN:3 
3 pGD41 NN:3 
3 p95 NN:3 
3 p92 NN:3 
3 p70(S6)-kinase NN:3 
3 p65- JJ:1 NN:2 
3 p50B NN:3 
3 p50/c-Rel NN:3 
3 p49/p65 NN:3 
3 p37 NN:3 
3 p24rex NN:3 
3 p105/p50 NN:3 
3 owl NN:3 
3 overcomes VBZ:3 
3 osteoclasts NNS:3 
3 original JJ:3 
3 orientation-independent JJ:3 
3 organogenesis NN:3 
3 organized VBN:3 
3 orally RB:3 
3 opioid JJ:3 
3 operational JJ:3 
3 operating VBG:3 
3 olfactory JJ:3 
3 occasionally RB:3 
3 obtaining VBG:3 
3 obstacle NN:3 
3 obligate JJ:3 
3 obesity NN:3 
3 nucleosome JJ:2 NN:1 
3 noticed VBN:3 
3 noticeable JJ:3 
3 notable JJ:3 
3 nontransformed JJ:3 
3 nonresponsiveness NN:3 
3 nonreceptor JJ:2 NN:1 
3 nonproliferating JJ:3 
3 nonphlogistic JJ:3 
3 nonfunctional JJ:3 
3 nonexpressing JJ:2 VBG:1 
3 noncoding JJ:3 
3 noncanonical JJ:3 
3 non-specific JJ:3 
3 non-lymphoid JJ:3 
3 non-irradiated JJ:3 
3 non-inducible JJ:3 
3 non-clonal JJ:3 
3 nm23-H2 NN:3 
3 nitroblue JJ:3 
3 neutrophilia NN:3 
3 neuroendocrine JJ:2 NN:1 
3 neural JJ:3 
3 neotropical JJ:3 
3 narrow JJ:3 
3 name NN:3 
3 nadir NN:3 
3 myricetin NN:3 
3 myogenic JJ:3 
3 myelo- JJ:3 
3 mutagenized VBN:3 
3 mut-I NN:3 
3 musculin NN:3 
3 muscular JJ:3 
3 multimer NN:3 
3 multifactorial JJ:3 
3 mucosal JJ:3 
3 muE3 JJ:1 NN:2 
3 muA NN:3 
3 movements NNS:3 
3 mount VB:2 VBP:1 
3 mortality NN:3 
3 morphogenetic JJ:3 
3 moreover RB:3 
3 mononucleosis NN:3 
3 monomeric JJ:3 
3 monocytogenes FW:1 NNS:2 
3 monocytic/macrophage JJ:1 NN:2 
3 monocytes-macrophages NNS:3 
3 monocyte/macrophage-like JJ:3 
3 monocyte-binding JJ:3 
3 molybdate NN:3 
3 module NN:3 
3 modifying NN:1 VBG:2 
3 modestly RB:3 
3 mmol/L NN:3 
3 mmol/l NN:3 
3 ml NN:3 
3 mite JJ:1 NN:2 
3 migrates VBZ:3 
3 migrate VB:1 VBP:2 
3 microtubules NNS:3 
3 microsomes NNS:3 
3 microsomal JJ:3 
3 microsatellite NN:3 
3 microorganisms NNS:3 
3 microglial JJ:3 
3 microdissected JJ:1 VBN:2 
3 methylated VBN:3 
3 methyl NN:3 
3 methionine NN:3 
3 metalloproteinases NNS:3 
3 merely RB:3 
3 menses NNS:3 
3 membrane-associated JJ:3 
3 medullary JJ:3 
3 medication NN:3 
3 measurements NNS:3 
3 mb-1 NN:3 
3 matrices NNS:3 
3 margins NNS:3 
3 manuscript NN:3 
3 mandatory JJ:3 
3 management NN:3 
3 maintains VBZ:3 
3 macrophage-CSF NN:3 
3 mU/L NN:3 
3 m JJ:1 NN:2 
3 lysozyme NN:3 
3 lysed JJ:1 VBN:2 
3 lyn NN:3 
3 lymphokine-activated JJ:3 
3 lymphoid-restricted JJ:3 
3 lymphatic JJ:3 
3 luteal JJ:2 NN:1 
3 lowest JJS:3 
3 low-dose JJ:3 
3 low-affinity JJ:2 NN:1 
3 losses NNS:3 
3 logarithmic JJ:3 
3 locally RB:3 
3 localizing VBG:3 
3 livers NNS:3 
3 lithium NN:3 
3 lipopolysaccharides NNS:3 
3 lipopolysaccharide-stimulated JJ:3 
3 limitations NNS:3 
3 limitation NN:3 
3 ligand-inducible JJ:3 
3 life-threatening JJ:3 
3 leukoplakia NN:3 
3 leukocyte-specific JJ:3 
3 leukemia-specific JJ:3 
3 leucocyte NN:3 
3 lethal JJ:3 
3 lengths NNS:3 
3 leiomyoma NN:3 
3 lambda5 NN:3 
3 lactosylceramide NN:3 
3 lactones NNS:3 
3 laboratories NNS:3 
3 labial JJ:3 
3 labelled JJ:2 VBN:1 
3 know VB:2 VBP:1 
3 kit/IL-4R NN:3 
3 kinase-3 NN:3 
3 karyotypic JJ:3 
3 karyopherin NN:3 
3 kappaB- NN:3 
3 junD NN:3 
3 jun-D NN:3 
3 jagged1 NN:3 
3 isozyme NN:3 
3 isotype-specific JJ:3 
3 isoproterenol NN:3 
3 isolating VBG:3 
3 isogenic JJ:3 
3 irregular JJ:3 
3 irradiated JJ:3 
3 iono NN:3 
3 iodide NN:3 
3 investigators NNS:3 
3 investigating VBG:3 
3 inversions NNS:3 
3 invasion NN:3 
3 introducing VBG:3 
3 intravenous JJ:3 
3 intravascular JJ:3 
3 intrapulmonary JJ:3 
3 intranasally RB:3 
3 intranasal JJ:3 
3 intraductal JJ:3 
3 intrabodies NNS:3 
3 intervening VBG:3 
3 intervals NNS:3 
3 internucleosomal JJ:3 
3 internalized VBN:3 
3 interindividual JJ:3 
3 interferon-regulated JJ:3 
3 interferon-inducible JJ:3 
3 interested JJ:1 VBD:1 VBN:1 
3 interchangeable JJ:3 
3 integrates VBZ:3 
3 insult NN:3 
3 instances NNS:3 
3 inhibitable JJ:3 
3 inherent JJ:3 
3 infecting VBG:3 
3 industrial JJ:3 
3 inductive JJ:3 
3 indicators NNS:3 
3 indicative JJ:3 
3 inclusion NN:3 
3 inadequate JJ:3 
3 inactivity NN:3 
3 inactivating VBG:3 
3 improvement NN:3 
3 improve VB:3 
3 importantly RB:3 
3 impart VB:1 VBP:2 
3 immunorecessive JJ:3 
3 immunopoiesis NN:3 
3 immunomagnetic JJ:3 
3 immunohistochemically RB:3 
3 immunocompetent JJ:3 
3 immunizing JJ:2 VBG:1 
3 immune-mediated JJ:3 
3 immortalize VB:3 
3 idiopathic JJ:3 
3 iHIV-1 NN:3 
3 i.p. RB:3 
3 hypochlorous JJ:3 
3 hypertensives NNS:3 
3 hyperresponsiveness NN:3 
3 hyperpolarization NN:3 
3 hyperplastic JJ:3 
3 hyperplasia NN:3 
3 hypergammaglobulinemia NN:3 
3 hypereosinophilic JJ:3 
3 hypercortisolism NN:3 
3 hypercortisolemic JJ:3 
3 hyperaldosteronism NN:3 
3 hyper JJ:1 NN:2 
3 hydrolytic JJ:3 
3 hydrolase NN:3 
3 hundred CD:3 
3 hotspot NN:3 
3 hot JJ:3 
3 hosts NNS:3 
3 homotypic JJ:3 
3 homologs NNS:3 
3 homogeneous JJ:3 
3 homeotic JJ:3 
3 hitherto RB:3 
3 histological JJ:3 
3 histiocytic JJ:3 
3 hippocampus NN:3 
3 hinge NN:3 
3 highlights VBZ:3 
3 hexamethylene NN:3 
3 heterotrimeric JJ:3 
3 heterokaryons NNS:3 
3 heptamer NN:3 
3 hepatocyte NN:3 
3 heparin-binding JJ:3 
3 hemodynamic JJ:3 
3 hematologic JJ:3 
3 helpful JJ:3 
3 helicase NN:3 
3 helenalin NN:3 
3 health NN:3 
3 hardly RB:3 
3 harbouring VBG:3 
3 harbors VBZ:3 
3 haplotype NN:3 
3 hair NN:3 
3 haemoglobin NN:3 
3 hXBP-1 NN:3 
3 hToll JJ:1 NN:2 
3 hPR NN:3 
3 hMNL NN:3 
3 hIL-4R NN:3 
3 hBMP-2 JJ:2 NN:1 
3 hBCL6 NN:3 
3 hAEC NN:3 
3 guinea NN:3 
3 growth-related JJ:3 
3 gross JJ:3 
3 granulomatoses NNS:3 
3 granulocyte-colony-stimulating JJ:3 
3 granulocyte-colony JJ:2 NN:1 
3 goiter NN:3 
3 glycosphingolipid NN:3 
3 glycine NN:3 
3 glucocorticoid-resistant JJ:3 
3 glucocorticoid- JJ:1 NN:2 
3 glomerulonephritis NN:3 
3 ghost NN:3 
3 genotypes NNS:3 
3 genomes NNS:3 
3 gelatinase-associated JJ:3 
3 ganglioside NN:3 
3 gamma-interferon NN:3 
3 gamma-gene NN:3 
3 gain-of-function NN:3 
3 g NN:3 
3 fuses VBZ:3 
3 furthermore RB:2 RBR:1 
3 fungal JJ:3 
3 fundamentally RB:3 
3 frequencies NNS:3 
3 fractionation NN:3 
3 fourth JJ:3 
3 follows VBZ:3 
3 fmol/million NN:3 
3 flux NN:3 
3 flutamide NN:3 
3 fkhrl1 NN:3 
3 finally RB:3 
3 filarial JJ:3 
3 fifth JJ:3 
3 feasible JJ:3 
3 feasibility NN:3 
3 favoring VBG:3 
3 fatal JJ:3 
3 factor-IL6 JJ:1 NN:2 
3 f FW:1 IN:1 NN:1 
3 extraction NN:3 
3 explains VBZ:3 
3 expansions NNS:3 
3 exocytosis NN:3 
3 exocrine JJ:3 
3 existed VBD:3 
3 exercises NNS:3 
3 excluding VBG:3 
3 exchangeable JJ:3 
3 excessive JJ:3 
3 excellent JJ:3 
3 exceed VB:3 
3 examples NNS:3 
3 exactly RB:3 
3 every DT:2 JJ:1 
3 evasion NN:3 
3 erythroleukemic JJ:3 
3 erythroid/megakaryocytic JJ:3 
3 equilibrium NN:3 
3 epsilon-globin-encoding JJ:3 
3 epithelia NN:3 
3 eotaxin NN:3 
3 eosinophil-specific JJ:3 
3 env NN:3 
3 entering VBG:3 
3 ensuring VBG:3 
3 enhancerless JJ:2 NN:1 
3 enhancer/promoters NNS:3 
3 engages VBZ:3 
3 engage VB:2 VBP:1 
3 endowed JJ:3 
3 endotoxin-stimulated JJ:3 
3 endothelial-leukocyte JJ:3 
3 endocytic JJ:3 
3 encompassed VBD:3 
3 employ VB:2 VBP:1 
3 emphasis NN:3 
3 emerging VBG:3 
3 emerge VB:2 VBP:1 
3 embryonal JJ:3 
3 embedded JJ:3 
3 emanating VBG:3 
3 elf-2b NN:3 
3 elevate VBP:3 
3 eicosanoids NNS:3 
3 effusion NN:3 
3 effected VBD:1 VBN:2 
3 edge NN:3 
3 ectopically RB:3 
3 ds JJ:3 
3 drop NN:3 
3 drives VBZ:3 
3 downregulate VB:2 VBP:1 
3 downmodulation NN:3 
3 downmodulates VBZ:3 
3 down-regulatory JJ:3 
3 double-negative JJ:3 
3 dominantly RB:3 
3 divisions NNS:3 
3 disturbed JJ:1 VBN:2 
3 distinctly RB:3 
3 distinctive JJ:3 
3 dissociate VB:1 VBP:2 
3 displace VB:2 VBP:1 
3 dismutase NN:3 
3 discusses VBZ:3 
3 discrepancy NN:3 
3 disabling JJ:1 VBG:2 
3 diploid JJ:3 
3 diphosphate NN:3 
3 diminishes VBZ:3 
3 dilution NN:3 
3 dihydrolipoic JJ:3 
3 difficulty NN:3 
3 differentiative JJ:3 
3 differentiation-associated JJ:3 
3 differentiates VBZ:3 
3 differanisole NN:3 
3 diethylstilbestrol NN:3 
3 diesel NN:3 
3 died VBD:3 
3 diapedesis NN:3 
3 diameter NN:3 
3 diacylglycerol NN:3 
3 detrimental JJ:3 
3 deposition NN:3 
3 dependency NN:3 
3 demonstrable JJ:3 
3 deltorphin NN:3 
3 deltaSpl234 NN:2 RB:1 
3 deltaNFkappaB NN:2 RB:1 
3 delta-aminolevulinate JJ:2 NN:1 
3 delta-ALA NN:3 
3 delivers VBZ:3 
3 deliver VB:3 
3 deletional JJ:3 
3 degrade VB:3 
3 degradative JJ:3 
3 deficiency-heat JJ:3 
3 deficiency-cold JJ:3 
3 defensins NNS:3 
3 decoy NN:3 
3 declines VBZ:3 
3 decidual JJ:3 
3 decay NN:3 
3 death-promoting JJ:3 
3 deaminase NN:3 
3 dead JJ:3 
3 damage-induced JJ:3 
3 cytokine-stimulated JJ:3 
3 cyclosporin-sensitive JJ:3 
3 cyclooxygenase-2 NN:3 
3 cycling NN:3 
3 cycles NNS:3 
3 cycle-dependent JJ:3 
3 cutaneous JJ:3 
3 curve NN:3 
3 cultivation NN:3 
3 culminate VB:2 VBP:1 
3 crystal JJ:1 NN:2 
3 crucially RB:3 
3 create VB:3 
3 cover VB:1 VBP:2 
3 covalent JJ:3 
3 counting NN:2 VBG:1 
3 counteracting NN:1 VBG:2 
3 counseling NN:3 
3 cotton-top JJ:3 
3 cotreatment NN:3 
3 costimulus NN:3 
3 corroborated VBD:1 VBN:2 
3 correction NN:3 
3 correct JJ:2 VB:1 
3 conversely RB:3 
3 converge VBP:3 
3 controversy NN:3 
3 contributions NNS:3 
3 contractions NNS:3 
3 contraction NN:3 
3 continuously RB:3 
3 continuing VBG:3 
3 continue VB:1 VBP:2 
3 contaminated VBN:3 
3 constants NNS:3 
3 considering VBG:3 
3 consideration NN:3 
3 conservative JJ:3 
3 conferring VBG:3 
3 conditionally RB:3 
3 concurrent JJ:3 
3 concerned VBD:1 VBN:2 
3 concatenated JJ:1 VBN:2 
3 concanavalin NN:3 
3 complications NNS:3 
3 complicated JJ:1 VBN:2 
3 complexity NN:3 
3 competitor NN:3 
3 competitively RB:3 
3 competing VBG:3 
3 compensate VB:3 
3 comparative JJ:3 
3 come VBN:1 VBP:2 
3 combining VBG:3 
3 combine VB:2 VBP:1 
3 column NN:3 
3 colonic JJ:3 
3 colocalized VBD:3 
3 coincides VBZ:3 
3 cohort NN:3 
3 coengagement NN:3 
3 codons NNS:3 
3 coded VBD:1 VBN:2 
3 cocultures NNS:3 
3 cocultivation NN:3 
3 cocktail NN:3 
3 co-immunoprecipitation NN:3 
3 co-expressing VBG:3 
3 co-cultured VBN:3 
3 clue NN:3 
3 clonally RB:3 
3 clinic NN:3 
3 cleaved VBN:3 
3 classification NN:3 
3 cited VBN:3 
3 cis-linked JJ:3 
3 cirrhosis NN:3 
3 ciprofibrate JJ:1 NN:2 
3 chromosome-positive JJ:3 
3 chimaeric JJ:3 
3 chelator NN:3 
3 charged JJ:3 
3 characterizing VBG:3 
3 characterizes VBZ:3 
3 characteristically RB:3 
3 character NN:3 
3 changing VBG:3 
3 challenging JJ:2 VBG:1 
3 cell-cell JJ:3 
3 celiac JJ:3 
3 cdk2 NN:3 
3 cdk NN:3 
3 cavity NN:3 
3 cations NNS:3 
3 catabolism NN:3 
3 carcinogenesis NN:3 
3 capsid NN:3 
3 calcium- JJ:1 NN:2 
3 cRel NN:3 
3 cPKC-betaII NN:3 
3 cPKC-alpha NN:3 
3 cAMP-responsive JJ:3 
3 c-erbA/TR-alpha NN:3 
3 c-Rel/p65 NN:3 
3 c-Rel- JJ:3 
3 c-Kit NN:3 
3 c- NN:3 
3 buthionine NN:3 
3 bursa NN:3 
3 burgdorferi FW:3 
3 burdens NNS:3 
3 buffer NN:3 
3 brother NN:3 
3 bronchiolitis NN:3 
3 broader JJR:3 
3 breaks NN:1 NNS:2 
3 breakdown NN:3 
3 breakage NN:3 
3 boundary NN:3 
3 blunted VBD:1 VBN:2 
3 blue JJ:3 
3 black JJ:3 
3 bisacetamide NN:3 
3 biotinylated VBN:3 
3 biomedical JJ:3 
3 bioactive JJ:3 
3 binary JJ:3 
3 bimodal JJ:3 
3 beyond IN:3 
3 beta-adrenergic JJ:3 
3 benefits NNS:3 
3 behave VB:1 VBP:2 
3 beginning NN:1 VBG:2 
3 bcl-x NN:3 
3 basophilia NN:3 
3 basally RB:3 
3 barrier NN:3 
3 bait NN:3 
3 bacterium NN:3 
3 b558 NN:3 
3 auxiliary JJ:2 NN:1 
3 autoregulated JJ:1 VBN:2 
3 autoinhibitory JJ:3 
3 autoantigens NNS:3 
3 authentic JJ:3 
3 attenuates VBZ:3 
3 attenuate VB:2 VBP:1 
3 atopy NN:3 
3 asymmetric JJ:3 
3 assigned VBD:1 VBN:2 
3 assembled VBN:3 
3 assaying VBG:3 
3 ascribed VBN:3 
3 arteries NNS:3 
3 arrays NNS:3 
3 argue VBP:3 
3 architecture NN:3 
3 approaching VBG:3 
3 antithyroid JJ:2 NN:1 
3 antigen-driven JJ:3 
3 antiestrogens NNS:3 
3 antibiotic JJ:2 NN:1 
3 antiatherogenic JJ:3 
3 anti-tumor JJ:3 
3 anti-human JJ:3 
3 anti-TNF-alpha JJ:3 
3 anti-IgM-induced JJ:3 
3 anti-Fos JJ:3 
3 anti-D JJ:3 
3 anti-CD3/ JJ:2 NN:1 
3 anti-CD3-stimulated JJ:3 
3 antagonizes VBZ:3 
3 annulata FW:2 JJ:1 
3 anion NN:3 
3 angiotensin NN:3 
3 angioimmunoblastic JJ:3 
3 angiogenesis NN:3 
3 amplifying VBG:3 
3 amplify VB:3 
3 amino- NN:3 
3 amebic JJ:3 
3 alternatives NNS:3 
3 alphabeta NN:3 
3 alphaIIbH NN:3 
3 alphaCD3 JJ:1 NN:2 
3 alpha/beta NN:3 
3 alpha-subunit NN:3 
3 alpha-naphthyl JJ:2 NN:1 
3 alpha-helical JJ:3 
3 alpha-PML NN:3 
3 allergen NN:3 
3 albumin NN:3 
3 al FW:3 
3 age-associated JJ:3 
3 age- NN:3 
3 agammaglobulinemia NN:3 
3 adversely RB:3 
3 adverse JJ:3 
3 advances NNS:3 
3 adrenocorticotropic JJ:3 
3 adrenocortical JJ:3 
3 adoptive JJ:3 
3 admitted VBN:3 
3 adhesiveness NN:3 
3 adenylyl JJ:1 NN:2 
3 adenopathy JJ:1 NN:2 
3 adeno-associated JJ:3 
3 addressed VBD:1 VBN:2 
3 add VBP:3 
3 adapted VBN:3 
3 accurately RB:3 
3 accumulating VBG:3 
3 accumulates VBZ:3 
3 accounts VBZ:3 
3 accordance NN:3 
3 accomplished VBN:3 
3 accessibility NN:3 
3 accelerating VBG:3 
3 absorption NN:3 
3 abrogating VBG:3 
3 aberrantly RB:3 
3 aNF-E2 NN:3 
3 [Ca2+]i NN:3 
3 [3H]aldosterone NN:3 
3 Zhang NNP:3 
3 Zebra NN:3 
3 ZK161422 NN:3 
3 ZK157202 NN:3 
3 Z29 NN:3 
3 Z/c-myb NN:3 
3 Y319 NN:3 
3 Y315 NN:3 
3 Y292 NN:3 
3 Y-box NN:3 
3 Xi NN:3 
3 XY NN:3 
3 XP NN:3 
3 Wilms NN:3 
3 WY NN:3 
3 WIN NN:3 
3 Virus NN:3 
3 Virol NNP:3 
3 VSMC-myc JJ:1 NN:2 
3 VP22 NN:3 
3 Utilizing VBG:3 
3 Use NN:3 
3 Upregulation NN:3 
3 Uncoupling NN:2 VBG:1 
3 USF/c-Myc NN:3 
3 UAS2 NN:3 
3 U9-IIIB NN:3 
3 U373 NN:3 
3 U/mL NN:3 
3 U-373 NN:3 
3 Tyr-493 NN:3 
3 Tyr-492 NN:3 
3 Tx NN:3 
3 Truncation NN:3 
3 Transient-transfection JJ:1 NN:2 
3 Transgenic JJ:3 
3 Toll-like JJ:3 
3 Thymocytes NNS:3 
3 Thy-1 NN:3 
3 Thr NN:3 
3 Ten CD:3 
3 Tcf-1 JJ:1 NN:2 
3 TcR/CD3 NN:3 
3 Tandem JJ:3 
3 TYK2 NN:3 
3 TUR NN:3 
3 TUNEL NN:3 
3 TT JJ:2 NN:1 
3 TSAP JJ:1 NN:2 
3 TRE1 NN:3 
3 TRE-like JJ:3 
3 TRAIL NN:3 
3 TR55 NN:3 
3 TR2RE- NN:3 
3 TNF-treated JJ:2 VBN:1 
3 TNF-alpha-induced JJ:3 
3 THP1 NN:3 
3 TGase NN:3 
3 TFIIIB NN:3 
3 TF.VIIa NN:3 
3 TES1 NN:3 
3 TDAG51 NN:3 
3 TCRG NN:3 
3 TCR-induced JJ:3 
3 TCR- JJ:2 NN:1 
3 TAD-B NN:3 
3 TACI JJ:2 NN:1 
3 T/NK-cell JJ:2 NN:1 
3 T-cell-mediated JJ:3 
3 T-cell-activating JJ:3 
3 Synergism NN:3 
3 Switching NN:1 VBG:2 
3 Survanta NN:3 
3 Supershift NN:3 
3 Sub. NN:3 
3 Structure NN:3 
3 Structurally RB:3 
3 Steroid NN:3 
3 StatG NN:3 
3 Stat3gamma NN:3 
3 Stat3beta NN:3 
3 Stat2 NN:3 
3 Staphylococcal JJ:3 
3 Src-family JJ:1 NN:2 
3 Spi-1/ NN:3 
3 Sp-1 NN:3 
3 Sos1 NN:3 
3 Significant JJ:3 
3 Severe JJ:3 
3 Seventeen CD:3 
3 Ser NN:3 
3 Sequences NNS:3 
3 Sequence-specific JJ:3 
3 Sensitivity NN:3 
3 Secreted VBN:3 
3 Schneider NN:2 NNP:1 
3 Schizosaccharomyces FW:3 
3 Saimiri FW:1 NN:2 
3 SWI3 NN:3 
3 STLV-I JJ:1 NN:2 
3 STAT-1alpha NN:3 
3 SP100 NN:3 
3 SN50 JJ:2 NN:1 
3 SMase NN:3 
3 SKW NN:3 
3 SK NN:3 
3 SJO NN:3 
3 SFs NNS:3 
3 SEB NN:3 
3 SDS-polyacrylamide JJ:1 NN:2 
3 SCM-1-producer JJ:2 NN:1 
3 SBA NN:3 
3 SB203580 NN:3 
3 S1 NN:3 
3 S-phase NN:3 
3 S-X-Y NN:3 
3 Runt NN:3 
3 Richter NN:3 
3 Retroviral JJ:3 
3 Responses NNS:3 
3 Resolution NN:3 
3 Resistance NN:3 
3 Res NNP:3 
3 Requirement NN:3 
3 Replication NN:3 
3 Remarkably RB:3 
3 Relationship NN:3 
3 Rel/kappaB NN:3 
3 Reed-Sternberg NN:3 
3 Reconstitution NN:3 
3 Recognition NN:3 
3 Reactivity NN:3 
3 RT- NN:3 
3 RM NN:3 
3 RJ NN:3 
3 RIA NN:3 
3 RFX-B NN:3 
3 RCCs NNS:3 
3 RBD NN:3 
3 RAZ NN:3 
3 RARS NN:2 NNS:1 
3 RARA NN:3 
3 RANKL JJ:1 NN:2 
3 R129C NN:3 
3 R. NNP:3 
3 Pyrrolidine NN:3 
3 Purification NN:3 
3 Pu NN:3 
3 Prostaglandin NN:3 
3 Prolonged JJ:3 
3 Prog NN:3 
3 Primer NN:3 
3 Present JJ:3 
3 Preliminary JJ:3 
3 Precise JJ:3 
3 Potent JJ:2 NN:1 
3 Porphyromonas NN:3 
3 Plasmodium NN:3 
3 Pip NN:3 
3 Physical JJ:3 
3 Phosphatidylinositol NN:3 
3 PhoQ NN:3 
3 PhoP JJ:1 NN:2 
3 Phenylarsine NN:3 
3 Pertussis NN:3 
3 Percoll NN:3 
3 Peptides NNS:3 
3 Pd-C NN:3 
3 Paradoxically RB:3 
3 Pan/ NN:3 
3 PURPOSE NN:3 
3 PU.1/Spi-1 NN:3 
3 PTCA NN:3 
3 PRRIII NN:3 
3 PROBLEM NN:3 
3 PP-2A JJ:1 NN:2 
3 POS JJ:1 NN:2 
3 PMA-induced JJ:2 NN:1 
3 PMA-differentiated JJ:3 
3 PLB-IIIB NN:3 
3 PKCalpha NN:3 
3 PFP9a20 NN:3 
3 PEER NN:3 
3 PD NN:3 
3 PCVs NNS:3 
3 PCDDs/PCDFs NNS:3 
3 PBGD NN:3 
3 PAM NNS:3 
3 P3HR1 NN:3 
3 P3HR-1 NN:3 
3 P/CAF NN:3 
3 Oxidants NNS:3 
3 Once IN:2 RB:1 
3 Oestrogen NN:3 
3 OTF1 NN:3 
3 OSM NN:3 
3 ORF2 NN:3 
3 OH NN:3 
3 OAP40 CD:1 NN:2 
3 Numerous JJ:3 
3 Nuclei NNS:3 
3 Novel JJ:3 
3 Not RB:3 
3 Nmax NN:3 
3 Nm23H2 NN:3 
3 Next RB:3 
3 Nb2 NN:3 
3 NTF NN:3 
3 NT3R NN:3 
3 NRL NN:3 
3 NR2 NN:3 
3 NK- NN:3 
3 NIH3T3 NN:3 
3 NIH-3T3 NN:3 
3 NGF JJ:1 NN:2 
3 NFKB1 NN:3 
3 NFIL3/E4BP4 NN:3 
3 NFATx2 NN:3 
3 NFAT2 NN:3 
3 NFAT-like JJ:3 
3 NFAT-family NN:3 
3 NFAT-binding JJ:3 
3 NF-kappaB1 NN:3 
3 NF-kappaB- JJ:2 NN:1 
3 NF-IL4 NN:3 
3 NF-AT4 NN:3 
3 NF-AT-binding JJ:3 
3 NF(kappa)B NN:3 
3 NCL NN:3 
3 N-formyl-methionyl-leucyl-phenylalanine NN:3 
3 N-acetyl-cysteine NN:3 
3 N-Oct NN:3 
3 N- NN:3 
3 Mycoplasma NN:3 
3 Mpl NN:3 
3 Mouse NN:3 
3 Moloney NN:3 
3 MnlI-AluI NN:3 
3 Mitogen NN:3 
3 Methylation NN:3 
3 Mechanism NN:3 
3 Max NN:3 
3 Major JJ:3 
3 Maf NN:3 
3 MVEC NNS:3 
3 MPE NN:3 
3 MPC11 NN:3 
3 MO7e NN:3 
3 MLR NN:3 
3 MKK NN:3 
3 MIP-1beta NN:3 
3 MGC NN:3 
3 META NN:3 
3 MEF2C NN:3 
3 MDP NN:3 
3 MCM5 NN:3 
3 MARs NNS:3 
3 M47 NN:3 
3 M2-type JJ:3 
3 M-TAT/GM-CSF NN:3 
3 M-TAT/EPO NN:3 
3 Luc NN:3 
3 Leukocyte NN:3 
3 Leu NN:3 
3 Late JJ:3 
3 Lastly RB:3 
3 Lactobacilli NN:3 
3 Lack NN:3 
3 La/SS-B NN:3 
3 La(SSB) NN:3 
3 LY294002 NN:3 
3 LPS-stimulated JJ:3 
3 LFA-1 NN:3 
3 LEF1/BCF1 NN:3 
3 LEF1 NN:3 
3 LEF/TCF NN:3 
3 LBF7 NN:3 
3 L227 NN:3 
3 L1 NN:3 
3 Kit225 NN:3 
3 Kip1 NN:3 
3 Kinase NN:3 
3 Kasumi-1 NN:3 
3 Kappa NN:3 
3 KG-1 NN:3 
3 KCa NN:3 
3 KB NN:3 
3 K46 NN:3 
3 K. NNP:3 
3 Jun/Fos NN:3 
3 Japanese JJ:2 NN:1 
3 Is VBZ:3 
3 Introduction NN:3 
3 Intravenous JJ:3 
3 Intrafollicular JJ:3 
3 Internal JJ:3 
3 Interleukin-3 NN:3 
3 Interleukin-1 NN:3 
3 Interferon-alpha NN:3 
3 Initial JJ:3 
3 Increasing VBG:3 
3 Implications NNS:3 
3 Immunol NNP:3 
3 Immunohistochemistry NN:3 
3 Il-2 NN:3 
3 Id-3L NN:3 
3 Id NN:3 
3 ISGs NNS:3 
3 ISG15 NN:3 
3 ISG NN:3 
3 IMPDH NN:3 
3 ILs NNS:3 
3 IL-6-responsive JJ:3 
3 IL-2Rs NNS:3 
3 IL-18 JJ:1 NN:2 
3 IIb NN:3 
3 II-like JJ:3 
3 IFNalpha- JJ:1 NN:2 
3 IFNalpha NN:3 
3 IFN-gamma-activated JJ:3 
3 IFN-gamma- JJ:3 
3 ICSs NNS:3 
3 ICSBP NN:3 
3 ICR27TK.3 NN:3 
3 ICP4 NN:3 
3 ICP0 NN:3 
3 ICN NN:3 
3 ICI NN:3 
3 ICE NN:3 
3 IBR/F NN:3 
3 IBF NN:3 
3 I-restricted JJ:3 
3 Hyon NN:3 
3 Histamine NN:3 
3 Highly RB:3 
3 High-level JJ:3 
3 HbF NN:3 
3 HZF NN:3 
3 HTLV-I(+) JJ:3 
3 HT29 NN:3 
3 HSV-specific JJ:3 
3 HSP70 NN:3 
3 HRF NN:3 
3 HPV JJ:1 NNS:2 
3 HPLC NN:3 
3 HPFH NN:3 
3 HLA-B8-restricted JJ:3 
3 HL-60R NN:3 
3 HL-60-C15 NN:3 
3 HIV-LTR NN:3 
3 HEL/S NN:3 
3 HEB NN:3 
3 HDMEC NN:3 
3 HCSs NNS:3 
3 HBsAg JJ:1 NN:2 
3 HBB NN:3 
3 HAECs NNS:3 
3 HAEC NNS:3 
3 H5 NN:3 
3 H-7-sensitive JJ:3 
3 Graves NN:3 
3 Granulocyte NN:3 
3 Globin NN:3 
3 Generation NN:3 
3 Gangliosides NN:1 NNS:2 
3 GTPases NN:1 NNS:2 
3 GTP-bound JJ:3 
3 GST- NN:3 
3 GRR NN:3 
3 GPA NN:3 
3 GM5 NN:3 
3 GM-CSFRalpha NN:3 
3 GF109203X NN:3 
3 GC-insensitive JJ:3 
3 GATA-1.05 NN:3 
3 GAS-motif JJ:2 NN:1 
3 GAGs NNS:3 
3 GABPalpha NN:3 
3 G76 NN:3 
3 G75 NN:3 
3 G2S NN:3 
3 G-protein-coupled JJ:3 
3 G-CSF-R NN:3 
3 Function NN:3 
3 Fos/Jun NN:3 
3 Form NN:3 
3 Fludarabine JJ:1 NN:2 
3 Findings NNS:3 
3 Fetal JJ:3 
3 FLRE NN:3 
3 FKBP52 NN:3 
3 FKBP12 NN:3 
3 FCS- JJ:2 NN:1 
3 FCS+ JJ:2 NN:1 
3 Exosurf NN:3 
3 Esc NN:3 
3 Enhancer NN:3 
3 Endogenous JJ:3 
3 Elucidation NN:3 
3 Efficient JJ:3 
3 Edelta NN:3 
3 ETS-like JJ:3 
3 ER- JJ:1 NNS:2 
3 EM NN:3 
3 ELK-1 NN:3 
3 ELISAs NNS:3 
3 EGF NN:3 
3 EDN NN:3 
3 ED50 NN:3 
3 ECV304 NN:3 
3 ECP NN:3 
3 EBV- NN:3 
3 EBNAs NN:1 NNS:2 
3 EBNA2-dependent JJ:3 
3 EBNA-5 NN:3 
3 EBERs NNS:3 
3 E3' NN:3 
3 E2a- JJ:1 NN:2 
3 E2RE NN:3 
3 E-box-dependent JJ:3 
3 Duffy-negative JJ:3 
3 Due IN:1 JJ:2 
3 Dominant JJ:3 
3 Detailed JJ:3 
3 Dephosphorylation NN:3 
3 Delta19 NN:3 
3 Deletional JJ:3 
3 Defective JJ:3 
3 Dec NNP:3 
3 DU-145 NN:3 
3 DS NN:3 
3 DRIP NN:3 
3 DQA1*0501/DQB1*0201 NN:3 
3 DQA1*0201/DQB1*0201 NN:3 
3 DQ3.2 NN:3 
3 DPD NN:3 
3 DPA NN:3 
3 DP-1 NN:3 
3 DNA- JJ:2 NN:1 
3 DHCC NN:3 
3 DES NN:3 
3 DD NN:3 
3 DCoH NN:3 
3 DBD NN:3 
3 D5 NN:3 
3 D1 NN:3 
3 D-ribose NN:3 
3 D-dependent JJ:3 
3 Cytoplasmic JJ:3 
3 Cyclin NN:3 
3 Cutting JJ:3 
3 Currently RB:3 
3 Cross NN:3 
3 Cox NN:2 NNP:1 
3 Cortisol NN:3 
3 Corticosteroid NN:3 
3 Correlation NN:3 
3 Cooperation NN:3 
3 Constitutively RB:3 
3 Considering VBG:3 
3 Co-expression NN:3 
3 Clusters NNS:3 
3 Circulating VBG:3 
3 Chromosomal JJ:3 
3 Chemokines NNS:3 
3 Cepharanthine NN:3 
3 Cell-specific JJ:3 
3 Calcium JJ:1 NN:2 
3 Caenorhabditis FW:1 NN:2 
3 CaMKIV/Gr NN:3 
3 CaMKIV NN:3 
3 Ca2+/calmodulin-dependent JJ:3 
3 Ca(2+)- JJ:1 NN:2 
3 CXCR4 NN:3 
3 CTLA4Ig NN:3 
3 CTF NN:3 
3 CT NN:3 
3 CREF NN:3 
3 CMPD1 NN:3 
3 CLC NN:3 
3 CID NN:3 
3 CHO-CD14 NN:3 
3 CEMxl74 NN:3 
3 CDR2-loop NN:3 
3 CD7 NN:3 
3 CD62E NN:3 
3 CD40-stimulated JJ:3 
3 CD38+ JJ:2 NN:1 
3 CD3/CD28 JJ:1 NN:2 
3 CD3-CD16+ JJ:3 
3 CD3+/CD4+ JJ:3 
3 CD28RC NN:3 
3 CD26 NN:3 
3 CD23b NN:3 
3 CD11/CD18 NN:3 
3 CAV NN:3 
3 CAMs NNS:3 
3 CACCC-binding JJ:3 
3 C81-66-45 NN:3 
3 C5b-7 NN:3 
3 C5MJ2 NN:3 
3 C2H2 NN:3 
3 C1-C3 NN:3 
3 C/EBP-beta NN:3 
3 C-site NN:3 
3 C-11 NN:3 
3 Bt2cAMP NN:3 
3 BrdU NN:3 
3 Blockade NN:3 
3 Biol. NNP:3 
3 Bcl-XL NN:3 
3 Basal JJ:3 
3 BamHI-Q NN:3 
3 BV NN:3 
3 BR3 NN:3 
3 BLIN-1 NN:3 
3 BL-2 NN:3 
3 BKO NN:3 
3 BJAB NN:3 
3 BEAD-1 NN:3 
3 BCS NN:3 
3 B7-2 NN:3 
3 B7-1 NN:3 
3 B5A NN:3 
3 B3 NN:3 
3 B27 NN:3 
3 B/rel NN:3 
3 B/GC-box NN:3 
3 Associated VBN:3 
3 Arp2/3 NN:3 
3 Arg NN:3 
3 Ar-5 NN:3 
3 Alzheimer NN:3 
3 Alternatively RB:3 
3 Altered JJ:3 
3 Alteration NN:3 
3 Alone RB:3 
3 Allergen-specific JJ:3 
3 Aldosterone NN:3 
3 Adult JJ:2 NN:1 
3 Addisonian JJ:3 
3 AUG NN:3 
3 ATL-16T NN:3 
3 ATD NN:3 
3 AP2 NN:3 
3 AP NN:3 
3 AMP-dependent JJ:3 
3 AML1/ NN:3 
3 AML-1B NN:3 
3 AML-1 NN:3 
3 AFR NN:3 
3 AF-2 NN:3 
3 A1-VDR NN:3 
3 9cisRA NN:3 
3 99 CD:3 
3 94-kD JJ:3 
3 92-kDa JJ:3 
3 900 CD:3 
3 85-kDa JJ:3 
3 80-kDa JJ:3 
3 80-kD JJ:3 
3 80-90 CD:3 
3 7TD1 NN:3 
3 793 CD:3 
3 780 CD:3 
3 73 CD:3 
3 72-kDa JJ:3 
3 70-bp JJ:3 
3 7.7 CD:3 
3 66 CD:3 
3 65-kDa JJ:3 
3 65-kD JJ:3 
3 64.1 CD:3 
3 6.4 CD:3 
3 6-8 CD:3 
3 54 CD:3 
3 500 CD:3 
3 5'-end JJ:1 NN:2 
3 5'-deletion JJ:3 
3 4E-BP2 NN:3 
3 4C NN:3 
3 433-442 CD:3 
3 40-fold JJ:1 RB:2 
3 4.7 CD:3 
3 4.5 CD:3 
3 4.2 CD:3 
3 4.1 CD:3 
3 4-6 CD:3 
3 3T3-L1 NN:3 
3 38486 CD:3 
3 35-kDa JJ:3 
3 346 CD:3 
3 32Dc13 NN:3 
3 3/4 CD:3 
3 3.9 CD:3 
3 3-5 CD:3 
3 286-551 CD:3 
3 271C NN:3 
3 270 CD:3 
3 25-hydroxyvitamin NN:3 
3 25-6603 CD:3 
3 25-35 CD:3 
3 247464 CD:3 
3 240 CD:3 
3 233G NN:3 
3 20-fold JJ:1 RB:2 
3 2.5-fold JJ:1 RB:2 
3 2.2.5 CD:3 
3 2.06 CD:3 
3 2-4 CD:3 
3 1A NN:3 
3 1986 CD:3 
3 196 CD:3 
3 182 CD:3 
3 17beta-HSD NN:3 
3 17-bp JJ:3 
3 16p13.3 NN:3 
3 1640 CD:3 
3 15d-PGJ NN:3 
3 15-amino JJ:3 
3 14q11 NN:3 
3 14,643 CD:3 
3 125I-labeled JJ:3 
3 113 CD:3 
3 112 CD:3 
3 109203X NN:3 
3 106 CD:3 
3 101 CD:3 
3 10- CD:2 JJ:1 
3 10(-12) CD:3 
3 1/2 CD:3 
3 1.6 CD:3 
3 1.2 CD:3 
3 1.1-4.4 CD:3 
3 1-kb JJ:3 
3 1-4 CD:3 
3 1-3 CD:3 
3 0.73 CD:3 
3 0.35 CD:3 
3 0.33 CD:3 
3 0.3 CD:3 
3 0.23 CD:3 
3 0.04 CD:3 
3 0.029 CD:3 
3 0.003 CD:3 
3 /protein NN:3 
3 /STAT5 NN:3 
3 /IL-7R NN:3 
3 /DNA NN:3 
3 -substituted JJ:3 
3 -retinoid JJ:1 NN:2 
3 -reporter JJ:2 NN:1 
3 -protein JJ:2 NN:1 
3 -oestrogen JJ:1 NN:2 
3 -nonproducing JJ:3 
3 -mutated JJ:3 
3 -modulating JJ:3 
3 -ligand JJ:1 NN:2 
3 -generated JJ:3 
3 -enriched JJ:3 
3 -crosslinking NN:3 
3 -NF-kappa NN:3 
3 -Ile NN:3 
3 -I JJ:1 NN:2 
3 -DQ NN:3 
3 -DP NN:3 
3 -91 CD:3 
3 -85 CD:3 
3 -75 CD:3 
3 -72 CD:3 
3 -66 CD:3 
3 -64 CD:3 
3 -60 CD:3 
3 -52 CD:3 
3 -50 CD:3 
3 -4gamma NN:3 
3 -40 CD:3 
3 -3gamma NN:3 
3 -3beta NN:3 
3 -3059 CD:3 
3 -30 CD:3 
3 -286 CD:3 
3 -280 CD:3 
3 -276 CD:3 
3 -245 CD:3 
3 -230 CD:3 
3 -207 CD:3 
3 -183 CD:3 
3 -182 CD:3 
3 -176 CD:3 
3 -140 CD:3 
3 -137 CD:3 
3 -12 CD:2 NN:1 
3 -108 CD:3 
3 -103 CD:3 
3 -1-mediated JJ:3 
3 +12 CD:3 
3 (1-231)-mediated JJ:3 
3 (1-231) NN:3 
3 (-)/ JJ:3 
3 (-) JJ:3 
2 zinc-binding JJ:2 
2 zeta- NN:2 
2 zearalenone NN:2 
2 zap-70 NN:2 
2 xenotransplantation NN:2 
2 xenografts NNS:2 
2 xenograft NN:2 
2 wt JJ:1 NN:1 
2 worse JJ:1 JJR:1 
2 workers NNS:2 
2 wk NN:2 
2 wished VBD:2 
2 winged-helix JJ:2 
2 window NN:2 
2 whole-blood JJ:2 
2 wheat NN:2 
2 whatever WDT:2 
2 well-studied JJ:2 
2 wbJun NN:2 
2 wbFos NN:2 
2 wave NN:2 
2 warrants VBZ:2 
2 vulvar JJ:2 
2 voltage-gated JJ:2 
2 vivax NN:2 
2 vitro-differentiated JJ:2 
2 visualization NN:2 
2 virus-transformed JJ:2 
2 virus-long JJ:2 
2 virus-encoded JJ:2 
2 virulent JJ:2 
2 virologic JJ:2 
2 vincristine NN:2 
2 vigorously RB:2 
2 vigorous JJ:2 
2 vicinity NN:2 
2 vi LS:2 
2 versions NNS:2 
2 versatility NN:2 
2 versatile JJ:2 
2 vernal JJ:2 
2 ventilatory JJ:2 
2 vehicle NN:2 
2 vav NN:2 
2 vasoactive JJ:2 
2 vascular-specific JJ:2 
2 vWF NN:2 
2 v-Fos NN:2 
2 urine NN:2 
2 uremic JJ:2 
2 uremia NN:2 
2 uracil-DNA NN:2 
2 upregulating VBG:2 
2 up-regulating VBG:2 
2 up- JJ:1 RB:1 
2 unwanted JJ:2 
2 unstained JJ:2 
2 unprecedented JJ:2 
2 unnecessary JJ:2 
2 universal JJ:2 
2 unicellular JJ:2 
2 unfused JJ:2 
2 undesirable JJ:2 
2 undescribed JJ:2 
2 undertook VBD:2 
2 underscores VBZ:2 
2 underscore VBP:2 
2 underlining VBG:2 
2 uncover VB:1 VBP:1 
2 uncouple VB:1 VBP:1 
2 uncommitted JJ:2 
2 uncharacterized JJ:2 
2 unbound JJ:2 
2 unbalanced JJ:2 
2 ultrafiltration NN:2 
2 ubiquitinylated VBN:2 
2 tyrphostin NN:2 
2 tyrosyl NN:2 
2 tyrosine-based JJ:2 
2 type-I JJ:1 NN:1 
2 type-8 NN:2 
2 tyk2 NN:2 
2 two-step JJ:2 
2 two-fold JJ:1 RB:1 
2 two-dimensional JJ:2 
2 two-component JJ:1 NN:1 
2 turns NNS:2 
2 turned VBD:2 
2 tumorigenicity NN:2 
2 tumor-specific JJ:2 
2 tumor-infiltrating JJ:2 
2 tumor-derived JJ:2 
2 tuberculous JJ:2 
2 ttk NN:2 
2 trypan NN:2 
2 truncating JJ:2 
2 truly RB:2 
2 trough NN:2 
2 trophic JJ:2 
2 trimester NN:2 
2 triglyceride NN:2 
2 tried VBD:1 VBN:1 
2 trapping NN:2 
2 transporter NN:2 
2 transmitted VBN:2 
2 transglutaminase NN:2 
2 transfecting VBG:2 
2 transfectant JJ:1 NN:1 
2 transcription-independent JJ:2 
2 transcription-dependent JJ:2 
2 transcription-activating JJ:2 
2 transcription-6 NN:2 
2 transcription-3 NN:2 
2 trans-factors NNS:2 
2 trans-dominant JJ:2 
2 trans-activators NNS:2 
2 trans-activates VBZ:2 
2 trans-activated JJ:1 VBD:1 
2 trancriptional JJ:2 
2 toremifene NN:2 
2 topoisomerases NNS:2 
2 topography NN:2 
2 topographical JJ:2 
2 tonically RB:2 
2 toll NN:2 
2 tolerated VBN:2 
2 tolerate VB:2 
2 titer NN:2 
2 thyromimetic JJ:2 
2 thyroidism NN:2 
2 thyrocyte NN:2 
2 thymus-derived JJ:2 
2 thymopoiesis NN:2 
2 thymocyte-specific JJ:2 
2 thrombotic JJ:2 
2 thrombopoiesis NN:2 
2 thrombocytosis NN:2 
2 thrombin-stimulated JJ:2 
2 three-dimensional JJ:2 
2 thioctic JJ:2 
2 think VBP:2 
2 thiazolidinediones NNS:2 
2 theses DT:2 
2 thermal JJ:2 
2 tetrameric JJ:2 
2 tetrahexamer NN:2 
2 tetracyclines NNS:2 
2 tether VBP:2 
2 terminating VBG:2 
2 tempting JJ:2 
2 temperature-sensitive JJ:2 
2 telomeric JJ:1 NN:1 
2 tat/S NN:2 
2 tat-I NN:2 
2 tartrate-resistant JJ:2 
2 tarsal JJ:2 
2 taking VBG:2 
2 tacrolimus NN:2 
2 tachycardia NN:2 
2 t(3;3)(q21;q26) NN:2 
2 t(3;21) NN:2 
2 t(3;14)(q27;q11) NN:2 
2 t(15;_17) NN:2 
2 systematic JJ:2 
2 synthesis-independent JJ:2 
2 synteny NN:2 
2 synergizing VBG:2 
2 syndrome-associated JJ:2 
2 syndecan-1 NN:2 
2 syncytia-forming JJ:2 
2 synchronous JJ:2 
2 symptom NN:2 
2 survived VBD:2 
2 surgically RB:2 
2 suppressors NNS:2 
2 supposed VBN:2 
2 supply NN:2 
2 supplied VBN:2 
2 supershifted VBN:2 
2 summarizes VBZ:2 
2 sulphamethoxazole NN:2 
2 sulindac NN:2 
2 suicide NN:2 
2 suggestion NN:2 
2 sugar NN:2 
2 sufficiently RB:2 
2 succumb VBP:2 
2 successive JJ:2 
2 subtotal JJ:2 
2 substrate-2 NN:2 
2 substSpl234 NN:2 
2 substSpl2 NN:2 
2 substSp34 NN:2 
2 substSp23 NN:2 
2 substNFkappaB NN:2 
2 subsites NNS:2 
2 submaximal JJ:2 
2 subline NN:2 
2 sublethal JJ:2 
2 subfragment NN:2 
2 subfamilies NNS:2 
2 subendothelial JJ:2 
2 subdivided VBN:2 
2 stringency NN:2 
2 strict JJ:2 
2 stretches NNS:2 
2 stretch NN:2 
2 stressful JJ:2 
2 stressed JJ:2 
2 strengthens VBZ:2 
2 streak NN:2 
2 stranded JJ:2 
2 storage NN:2 
2 stop NN:2 
2 stock NN:2 
2 stimulus-dependent JJ:2 
2 stimulus- NN:2 
2 stimuli-specific JJ:2 
2 stimulation-dependent JJ:2 
2 steroid-responsive JJ:2 
2 steroid-induced JJ:2 
2 stem-loop JJ:2 
2 staurosporin NN:2 
2 stationary JJ:2 
2 stain VB:2 
2 stabilizing VBG:2 
2 squelching NN:2 
2 sputum NN:2 
2 spondyloarthropathies NNS:2 
2 splenomegaly NN:2 
2 spironolactones NNS:2 
2 spironolactone NN:2 
2 spirochetal JJ:2 
2 spindle-shaped JJ:2 
2 specifies VBZ:2 
2 specificity-conferring JJ:2 
2 sparing NN:2 
2 space NN:2 
2 sorter NN:2 
2 sorted VBN:2 
2 sophisticated JJ:2 
2 sooty JJ:2 
2 solid JJ:2 
2 sole JJ:2 
2 sodium/proton JJ:1 NN:1 
2 sodium-proton-antiport NN:2 
2 smokers NNS:2 
2 smoke NN:2 
2 slide NN:2 
2 slg+ JJ:2 
2 sizes NNS:2 
2 sixth JJ:2 
2 sixfold JJ:1 RB:1 
2 situations NNS:2 
2 sites/nucleus NNS:2 
2 sister NN:2 
2 single-stranded JJ:2 
2 single-strand JJ:2 
2 simplest JJS:2 
2 signal-transduction JJ:1 NN:1 
2 siblings NNS:2 
2 sibling NN:2 
2 shuffling NN:2 
2 shortly RB:2 
2 shortened VBD:1 VBN:1 
2 shifted VBN:2 
2 she PRP:2 
2 sharing VBG:2 
2 shape NN:1 VBP:1 
2 sexes NNS:2 
2 sex- NN:2 
2 sevenfold JJ:1 RB:1 
2 serving VBG:2 
2 serum-starved JJ:2 
2 serum-inducible JJ:2 
2 serum-activated JJ:2 
2 sertraline NN:2 
2 serotonin NN:2 
2 serology NN:2 
2 serine-threonine JJ:1 NN:1 
2 serine-rich JJ:2 
2 serially RB:2 
2 ser-727 NN:2 
2 sequentially RB:2 
2 sequela NN:2 
2 sensor NN:2 
2 sensitizing VBG:2 
2 semiquantitated VBN:2 
2 seminoma NN:2 
2 self-renewing JJ:2 
2 self-renewal JJ:2 
2 self-reactive JJ:2 
2 self-antigens NNS:2 
2 selector NN:2 
2 segregation NN:2 
2 segregating VBG:2 
2 seeded VBN:2 
2 secretions NNS:2 
2 seconds NNS:2 
2 second-messenger NN:2 
2 season NN:2 
2 searching VBG:2 
2 scored VBN:2 
2 scheme NN:2 
2 schedules NNS:2 
2 scavenges VBZ:2 
2 saturated JJ:2 
2 salts NNS:2 
2 safety NN:2 
2 safe JJ:2 
2 sIg-crosslinking-induced JJ:2 
2 rupture NN:2 
2 rsk NN:2 
2 routinely RB:2 
2 round JJ:1 NN:1 
2 roughly RB:2 
2 rotamase NN:2 
2 rosetting NN:1 VBG:1 
2 rolling NN:2 
2 ribosome NN:2 
2 ribonuclease NN:2 
2 rhythmicity NN:2 
2 rhabdomyosarcomas NNS:2 
2 rhabdomyosarcoma NN:2 
2 reverted VBD:2 
2 reverses VBZ:2 
2 reverse-transcriptase NN:2 
2 returning VBG:2 
2 retrodifferentiation NN:2 
2 retinoidal JJ:2 
2 retinoid-induced JJ:2 
2 retinoic-acid JJ:1 NN:1 
2 retinobenzoic JJ:2 
2 retinaldehyde NN:2 
2 reticulocyte-type JJ:1 NN:1 
2 retarding NN:2 
2 retains VBZ:2 
2 resynthesized VBN:2 
2 resynthesis NN:2 
2 resuscitated JJ:1 VBN:1 
2 restoring VBG:2 
2 restoration NN:2 
2 restimulation NN:2 
2 restimulated VBN:2 
2 response-1 NN:2 
2 resolves VBZ:2 
2 resist VB:1 VBP:1 
2 residing NN:1 VBG:1 
2 resided VBD:2 
2 reside VB:1 VBP:1 
2 reservoirs NNS:2 
2 researchers NNS:2 
2 rescuing VBG:2 
2 requisite JJ:2 
2 reportedly RB:2 
2 replication-competent JJ:2 
2 repetitive JJ:2 
2 reoxygenation NN:2 
2 renaturation NN:2 
2 remove VB:2 
2 remissions NNS:2 
2 relationships NNS:2 
2 relating VBG:2 
2 relatedness NN:2 
2 relA NN:2 
2 rel/ NN:2 
2 reiterations NNS:2 
2 reiterated VBN:2 
2 reinfusion NN:2 
2 region/leucine NN:2 
2 refs NNS:2 
2 refers VBZ:2 
2 reexpression NN:2 
2 reexamined VBD:1 VBN:1 
2 redundant JJ:2 
2 redox-sensitive JJ:2 
2 redox-regulated JJ:2 
2 recurrences NNS:2 
2 reconstitutes VBZ:2 
2 reconcile VB:2 
2 recombinase NN:2 
2 recognizable JJ:2 
2 reciprocally RB:2 
2 receptor-stimulated JJ:2 
2 receptor-specific JJ:2 
2 receptor-related JJ:2 
2 receptor-interacting JJ:2 
2 receptor-induced JJ:2 
2 receptor-effector JJ:2 
2 receptor-bearing JJ:2 
2 receptor-2 NN:2 
2 recapitulates VBZ:2 
2 reasoned VBD:1 VBN:1 
2 reason NN:2 
2 real-time JJ:2 
2 real JJ:2 
2 reacting VBG:2 
2 re-expression NN:2 
2 rays NNS:2 
2 rank NN:2 
2 ranged VBD:2 
2 ramifications NNS:2 
2 radiosensitivity NN:2 
2 radioreceptor NN:2 
2 radioligand-binding JJ:2 
2 radioassay NN:2 
2 radioactive JJ:2 
2 radio-ligand JJ:2 
2 rSSB NN:2 
2 rRNA NN:2 
2 rDNA NN:2 
2 r+ JJ:2 
2 quiescence NN:2 
2 quickly RB:2 
2 questions NNS:2 
2 quantitating VBG:2 
2 quantitated VBN:2 
2 qualitatively RB:2 
2 q34 NN:2 
2 pyruvate NN:2 
2 pyrimidine-rich JJ:2 
2 pyrilamine NN:2 
2 pyramidal JJ:2 
2 purity NN:2 
2 pulse/chase-experiments NNS:2 
2 pulse-treatment NN:2 
2 pts NNS:2 
2 psoriasis NN:2 
2 pseudoautosomal JJ:2 
2 provoked VBD:2 
2 provision NN:2 
2 proto-oncoprotein NN:2 
2 proteolysis-resistant JJ:2 
2 proteoglycan NN:2 
2 proteinases NNS:2 
2 proteinase NN:2 
2 protein_-_RNA JJ:2 
2 protein/p300 NN:2 
2 protein/activation NN:2 
2 protein-coupled JJ:2 
2 protein-coding JJ:2 
2 prostate-specific JJ:2 
2 prospective JJ:2 
2 propria NN:2 
2 propranolol NN:2 
2 properly RB:2 
2 propagate VB:2 
2 prone JJ:2 
2 promyeloid JJ:2 
2 promoter/reporter NN:2 
2 promoter-luciferase JJ:1 NN:1 
2 promoter-dependent JJ:2 
2 promoter-chloramphenicol JJ:2 
2 promoter-binding JJ:2 
2 promoter-CAT JJ:1 NN:1 
2 promising JJ:2 
2 prolongs VBZ:2 
2 prolonging VBG:2 
2 proliferator NN:2 
2 project NN:2 
2 prointerleukin NN:2 
2 progressed VBD:2 
2 programming NN:2 
2 professional JJ:2 
2 proceeded VBD:2 
2 proboscipedia NN:2 
2 problems NNS:2 
2 pro-myelocytic JJ:2 
2 pro-monocytic JJ:2 
2 pro-apoptotic JJ:2 
2 pro- JJ:1 NN:1 
2 pretranslational JJ:2 
2 preterm JJ:2 
2 pressure-stretching JJ:2 
2 preserving NN:1 VBG:1 
2 preserved JJ:1 VBN:1 
2 prenatal JJ:2 
2 premenopausal JJ:2 
2 pregnancy-induced JJ:2 
2 preeclamptic JJ:2 
2 predominates VBZ:2 
2 predominately RB:2 
2 predisposes VBZ:2 
2 predictions NNS:2 
2 prediction NN:2 
2 predetermined JJ:1 VBN:1 
2 precultured VBN:2 
2 precipitation NN:2 
2 precipitated JJ:1 VBD:1 
2 pre-cultured JJ:2 
2 pre-activation NN:2 
2 pre JJ:1 RB:1 
2 practice NN:2 
2 posttraumatic JJ:2 
2 posttranslationally RB:2 
2 postoperative JJ:2 
2 postnatally RB:2 
2 post-transcriptionally RB:2 
2 post-receptor JJ:2 
2 post-germinal JJ:2 
2 post JJ:1 RB:1 
2 positive-acting JJ:2 
2 portions NNS:2 
2 pore NN:2 
2 populated JJ:2 
2 pooled JJ:2 
2 polyunsaturated JJ:2 
2 polyposis NN:2 
2 polycystic JJ:2 
2 polyamines NNS:2 
2 polyamides NNS:2 
2 poly(A) NN:2 
2 polarity NN:2 
2 pointed VBD:1 VBN:1 
2 pmol/l NN:2 
2 plot NN:2 
2 pleiotropy NN:2 
2 pleckstrin NN:2 
2 plate NN:2 
2 plasmon NN:2 
2 plasmacytoid JJ:1 NN:1 
2 placentae NN:2 
2 pioglitazone NN:2 
2 pili NNS:2 
2 phytohemagglutinin- JJ:1 NN:1 
2 phosphotyrosine-containing JJ:2 
2 phosphoserine NN:2 
2 phosphorylation-dependent JJ:2 
2 phosphocreatine JJ:2 
2 phosphates NNS:2 
2 phorbol-di-butyrate JJ:1 NN:1 
2 phenylalanine NN:2 
2 phenol NN:2 
2 phase-1 JJ:2 
2 pharmaceutical JJ:2 
2 phagocytosing VBG:2 
2 pertussis-toxin-sensitive JJ:2 
2 perspectives NNS:2 
2 persisting JJ:1 VBG:1 
2 persist VB:1 VBP:1 
2 peroxisomal JJ:2 
2 permitting VBG:2 
2 permissivity NN:2 
2 permeable JJ:2 
2 perivascular JJ:2 
2 perforin-expressing JJ:2 
2 perfectly RB:2 
2 peptidylprolyl JJ:2 
2 peptidyl JJ:2 
2 peptidoglycan NN:2 
2 peptide-specific JJ:2 
2 peptide-loaded JJ:2 
2 peptide-binding JJ:2 
2 pentazocine NN:2 
2 pbmc NN:2 
2 pathophysiologic JJ:2 
2 passage NN:2 
2 parva-transformed JJ:2 
2 parva FW:2 
2 partitioned VBD:1 VBN:1 
2 partition NN:2 
2 participant NN:2 
2 parenchyma NN:2 
2 parasites NNS:2 
2 parasitemia NN:2 
2 paraffin-embedded JJ:2 
2 papillomaviruses NNS:2 
2 palmitate JJ:1 NN:1 
2 palmar JJ:2 
2 palindromes NNS:2 
2 pacemaker NN:2 
2 pZVH14 NN:2 
2 pZVB70 NN:2 
2 pZVB10 NN:2 
2 pIL-5(-511) NN:2 
2 p94 NN:2 
2 p93fes NN:2 
2 p90 NN:2 
2 p65/p50 NN:2 
2 p63 NN:2 
2 p55TNF-R NN:2 
2 p54 NN:2 
2 p50s NNS:2 
2 p50/RelB NN:2 
2 p50/NF-kappa NN:2 
2 p50.p65 NN:2 
2 p50-NF-kappa NN:2 
2 p42/44 NN:2 
2 p35 NN:2 
2 p300/CBP NN:2 
2 p21/Cip1 NN:2 
2 p140 NN:2 
2 p120 NN:2 
2 oxidative-stress JJ:1 NN:1 
2 oxidant-induced JJ:2 
2 ovulatory JJ:2 
2 overview NN:2 
2 overnight JJ:2 
2 overexpress VBP:2 
2 overcoming VBG:2 
2 overcame VBD:2 
2 outward JJ:2 
2 outer JJ:2 
2 ouabain NN:2 
2 osteoclast-like JJ:2 
2 osteoblast NN:2 
2 originate VB:2 
2 ori NN:2 
2 organize VB:1 VBP:1 
2 orders NNS:2 
2 ordered VBN:2 
2 orchestrated VBN:2 
2 options NNS:2 
2 optimum JJ:1 NN:1 
2 opsonized JJ:1 VBN:1 
2 operator NN:2 
2 oligos NNS:2 
2 oligopeptides NNS:2 
2 oligo JJ:2 
2 oleic JJ:2 
2 offspring NN:2 
2 octamerlike JJ:2 
2 octamer-like JJ:2 
2 occupy VBP:2 
2 occasional JJ:2 
2 obviously RB:2 
2 obtain VB:2 
2 obstructive JJ:2 
2 obstruction NN:2 
2 obliterans NNS:2 
2 objectives NNS:2 
2 o'-bismyristoyl JJ:1 NN:1 
2 o NN:2 
2 nutritionally RB:2 
2 nude JJ:2 
2 nucleotide-dependent JJ:2 
2 nucleosome-free JJ:2 
2 nucleoproteins NNS:2 
2 nucleoplasmic JJ:2 
2 nucleolar JJ:2 
2 nuclease NN:2 
2 normotensive JJ:2 
2 normocalcemic JJ:2 
2 normalizing NN:1 VBG:1 
2 normalized VBN:2 
2 nontuberculous JJ:2 
2 nontransgenic JJ:2 
2 nonthyroidal JJ:2 
2 nonstructural JJ:2 
2 nonsteroidal JJ:2 
2 nonradioactive JJ:2 
2 nonproductively RB:2 
2 nonpituitary JJ:2 
2 nonpeptidyl JJ:2 
2 nonoverlapping JJ:2 
2 nonopsonic JJ:2 
2 noninvasive JJ:2 
2 nonepithelial JJ:2 
2 nonconsensus JJ:2 
2 nonactivated JJ:2 
2 non-transformed JJ:2 
2 non-sequence-specific JJ:2 
2 non-rheumatoid JJ:2 
2 non-proliferative JJ:2 
2 non-monocytic JJ:2 
2 non-malignant JJ:2 
2 non-depressed JJ:2 
2 non-cytotoxic JJ:2 
2 non-cytokine JJ:2 
2 non-consensus JJ:2 
2 non-antigen-selected JJ:2 
2 non-Ashkenazi JJ:2 
2 nineteen CD:2 
2 ng/10(6) CD:2 
2 neutrophil-endothelial JJ:2 
2 neutralize VB:1 VBP:1 
2 neurotoxin NN:2 
2 neuron-specific JJ:2 
2 neurologic JJ:2 
2 neuroendocrine-immune JJ:2 
2 net JJ:2 
2 nerve JJ:1 NN:1 
2 nephritis NN:2 
2 neoplasias NN:1 NNS:1 
2 neomycin NN:2 
2 needs VBZ:2 
2 neck NN:2 
2 nck NN:2 
2 nail NN:2 
2 nGRE NN:2 
2 n't RB:2 
2 myristoyl NN:2 
2 myristic JJ:2 
2 myogenesis NN:2 
2 myf3 NN:2 
2 myelopathy NN:2 
2 myeloid-related JJ:2 
2 myeloid-committed JJ:2 
2 myeloid-associated JJ:2 
2 myelodysplasia NN:2 
2 mycotoxins NNS:2 
2 mutual JJ:2 
2 mutationally RB:2 
2 mutating VBG:2 
2 mut NN:2 
2 muscle-specific JJ:2 
2 murine-specific JJ:2 
2 multivariate JJ:2 
2 multiplication NN:2 
2 multinucleated JJ:2 
2 multigene JJ:2 
2 multidrug-resistant JJ:2 
2 multicopy JJ:2 
2 multicomponent JJ:2 
2 movement NN:2 
2 move VB:2 
2 motility NN:2 
2 mothers NNS:2 
2 mosaicism NN:2 
2 morphogenesis NN:2 
2 morphogen NN:2 
2 morbidity NN:2 
2 monozygotic JJ:2 
2 monovalent JJ:2 
2 monospecific JJ:2 
2 monocytes/ NNS:2 
2 monocyte/macrophage- NN:2 
2 monocyte/B-cell-specific JJ:2 
2 monocyte- NN:1 NNS:1 
2 monoblasts NNS:2 
2 molecularly RB:2 
2 molar JJ:2 
2 mol NN:2 
2 modules NNS:2 
2 modifies VBZ:2 
2 modality NN:2 
2 mobilize VB:1 VBP:1 
2 mitochondria NN:2 
2 mirrored VBD:1 VBN:1 
2 mineralization NN:2 
2 mimetic JJ:2 
2 mifepristone NN:2 
2 microvessel NN:2 
2 microtitre NN:2 
2 microsequencing NN:2 
2 microscopic JJ:2 
2 micrograms/mL NNS:2 
2 microarchitecture NN:2 
2 microE5/kappa NN:2 
2 microA NN:2 
2 mg/kg NN:2 
2 mg/dl NN:2 
2 mg/day NN:2 
2 mg/24h NN:2 
2 methodology NN:2 
2 metal-ion JJ:2 
2 metal JJ:1 NN:1 
2 metabolized VBN:2 
2 messages NNS:2 
2 menopause NN:2 
2 melanogaster FW:2 
2 megakaryocytic-specific JJ:2 
2 megakaryocyte-specific JJ:2 
2 medulla NN:2 
2 medical JJ:2 
2 mechanistic JJ:2 
2 mechanims NNS:2 
2 measures NNS:2 
2 measurable JJ:2 
2 matrix-associated JJ:2 
2 matches NNS:1 VBZ:1 
2 match NN:1 VBP:1 
2 masses NNS:2 
2 masks VBZ:2 
2 marmoset NN:2 
2 marks VBZ:2 
2 marking VBG:2 
2 marginally RB:2 
2 marginal JJ:2 
2 mannose-capped JJ:2 
2 manipulating VBG:2 
2 manifests VBZ:2 
2 manifestation NN:2 
2 mangabeys NNS:2 
2 macrovascular JJ:2 
2 macrophage-tropic JJ:2 
2 macrophage-colony NN:2 
2 macromolecule NN:2 
2 macromolecular JJ:2 
2 macrolide NN:2 
2 mEI NN:2 
2 mBCL6 NN:2 
2 lyt-10 NN:2 
2 lysophospholipid NN:2 
2 lysophosphatidylcholine NN:2 
2 lysine NN:2 
2 lymphotrophic JJ:2 
2 lymphotoxin-beta NN:2 
2 lymphopoiesis NN:2 
2 lymphoma/leukemia NN:2 
2 lymphoid-related JJ:2 
2 lumen NN:2 
2 lpr/lpr NN:2 
2 lpr NN:2 
2 lox NN:2 
2 lower-affinity JJ:2 
2 looked VBD:1 VBN:1 
2 long-range JJ:2 
2 lone JJ:1 RB:1 
2 localised JJ:2 
2 loading NN:2 
2 living VBG:2 
2 live JJ:2 
2 list NN:2 
2 lipopolysaccharide-activated JJ:2 
2 lipophilic JJ:2 
2 lipopeptides NNS:2 
2 lipid-soluble JJ:2 
2 links NNS:1 VBZ:1 
2 lineage-dependent JJ:2 
2 lineage-associated JJ:2 
2 likewise RB:2 
2 lighting NN:2 
2 ligation-mediated JJ:2 
2 lie VBP:2 
2 liberation NN:2 
2 liberates VBZ:2 
2 leukostasis NN:2 
2 leukemia-derived JJ:2 
2 leukaemogenesis NN:2 
2 leucine-zipper JJ:1 NN:1 
2 leucine-rich JJ:2 
2 lethality NN:2 
2 leiomyosarcoma NN:2 
2 leaving VBG:2 
2 lean JJ:2 
2 laser NN:2 
2 laminin NN:2 
2 lamina NN:2 
2 lamin NN:2 
2 lactate NN:2 
2 lac-Z NN:2 
2 kinases-interacting JJ:2 
2 kinase-dependent JJ:2 
2 kinase-deficient JJ:2 
2 kilobase NN:2 
2 keratoconjunctivitis NN:2 
2 keratoacanthomas NNS:2 
2 keeping VBG:2 
2 karyotypes NNS:2 
2 kappaY NN:2 
2 kappaB-responsive JJ:2 
2 kappaB-dependent JJ:2 
2 kappaB-alpha NN:2 
2 kB-like JJ:2 
2 jun/fos NN:2 
2 jacchus FW:2 
2 isotype-matched JJ:2 
2 isomers NNS:2 
2 isomer NN:2 
2 isoflavone NN:2 
2 iron-responsive JJ:2 
2 ionomycine NN:2 
2 iodine NN:2 
2 invokes VBZ:2 
2 inversion NN:2 
2 intron-exon JJ:2 
2 introduce VB:1 VBP:1 
2 intravenously RB:2 
2 intraperitoneal JJ:2 
2 intertypic JJ:2 
2 interstitial JJ:2 
2 interruption NN:2 
2 interrupting NN:1 VBG:1 
2 interpret VB:2 
2 intermediary JJ:2 
2 interleukin-4-induced JJ:2 
2 interleukin-1beta-converting JJ:2 
2 interleukin-1alpha NN:2 
2 interleukin-11 NN:2 
2 intergenic JJ:2 
2 interferon-induced JJ:2 
2 interferon-gamma-treated JJ:2 
2 interferon-gamma-induced JJ:2 
2 interassay JJ:2 
2 interactor NN:2 
2 interactive JJ:2 
2 intensive JJ:2 
2 intensely RB:2 
2 insulin-induced JJ:2 
2 insulin-gene JJ:2 
2 instance NN:2 
2 insect NN:2 
2 inoculation NN:2 
2 inner JJ:2 
2 injected VBN:2 
2 inhibin NN:2 
2 inhaled VBN:2 
2 ingestion NN:2 
2 ingested VBN:2 
2 infused VBN:2 
2 infer VB:1 VBP:1 
2 infectable JJ:2 
2 infants NNS:2 
2 infant JJ:1 NN:1 
2 inert JJ:2 
2 ineffectiveness NN:2 
2 inductions NNS:2 
2 inducer-mediated JJ:2 
2 indispensable JJ:2 
2 indices NNS:2 
2 indeterminate JJ:2 
2 independence NN:2 
2 inconsistent JJ:2 
2 incompetent JJ:2 
2 incompatible JJ:2 
2 incapable JJ:2 
2 inappropriately RB:2 
2 in-vitro-stimulated JJ:2 
2 in-situ FW:2 
2 in-frame JJ:1 RB:1 
2 imprinted JJ:1 VBN:1 
2 importin NN:2 
2 imported VBN:2 
2 implantation NN:2 
2 impedes VBZ:2 
2 imparted VBD:1 VBN:1 
2 immunotoxicity NN:2 
2 immunotherapeutic JJ:2 
2 immunoreaction NN:2 
2 immunoprecipitates NNS:2 
2 immunophenotypic JJ:2 
2 immunomodulator NN:2 
2 immunomodulation NN:2 
2 immunomodulating JJ:1 NN:1 
2 immunolabelling NN:2 
2 immunohistology NN:2 
2 immunocompromised JJ:2 
2 immunoblots NNS:2 
2 immunoassays NNS:2 
2 immune-response JJ:2 
2 immune-endocrine JJ:2 
2 immortalizing JJ:1 VBG:1 
2 immortalised JJ:1 VBN:1 
2 immobilization NN:2 
2 illustrates VBZ:2 
2 illustrate VBP:2 
2 ill RB:2 
2 ileum NN:2 
2 identically RB:2 
2 hypothesised VBN:2 
2 hypothalamic-pituitary-adrenocortical JJ:2 
2 hypothalamic-hypophyseal-adrenocortical JJ:2 
2 hypopigmented JJ:2 
2 hypophosphorylated VBN:2 
2 hypophosphatemic JJ:2 
2 hypophosphatemia NN:2 
2 hypomelanosis NN:2 
2 hypokalemia NN:2 
2 hypoglycemia NN:2 
2 hypoactivity NN:2 
2 hyperthyroidism NN:2 
2 hyperthyroid JJ:2 
2 hyperplasias NN:2 
2 hyperphosphorylated JJ:1 VBN:1 
2 hyperlipidemia NN:2 
2 hyperimmunoglobulin NN:2 
2 hypercortisolaemia NN:2 
2 hypercalciuric NN:2 
2 hyperadhesion NN:2 
2 hyperactivation NN:2 
2 hyperabsorption NN:2 
2 hyper- JJ:2 
2 hygromycin NN:2 
2 hydrogenation NN:2 
2 hybridizes VBZ:2 
2 hyaluronic JJ:2 
2 hyaluronan NN:2 
2 hrs NNS:2 
2 house NN:2 
2 host-cell JJ:2 
2 hormone/receptor NN:2 
2 hormone-related JJ:2 
2 hormone-receptor NN:2 
2 hormone-mediated JJ:2 
2 hormone-activated JJ:2 
2 homogenates NNS:2 
2 homocysteine NN:2 
2 homo JJ:2 
2 homeostatic JJ:2 
2 homeodomains NNS:2 
2 histopathological JJ:2 
2 histogenetic JJ:2 
2 histochemistry NN:2 
2 histochemical JJ:2 
2 hirsute JJ:2 
2 high-resolution JJ:2 
2 high-grade JJ:2 
2 high-density JJ:2 
2 heterozygotes NNS:2 
2 herpesviruses NNS:2 
2 hereditary JJ:2 
2 hemopoietins NNS:2 
2 hemopoiesis NN:2 
2 hemoglobinopathies NNS:2 
2 hemo-lymphoid JJ:2 
2 hemin-mediated JJ:2 
2 helped VBD:1 VBN:1 
2 heat-shock JJ:1 NN:1 
2 harvester NN:2 
2 harmful JJ:2 
2 haptenation NN:2 
2 handling NN:2 
2 hallmarks NNS:2 
2 halflife NN:2 
2 haematopoiesis NN:2 
2 haematological JJ:2 
2 hTAFII130 NN:2 
2 hTAFII105 NN:2 
2 hT86 NN:2 
2 hIRAK NN:2 
2 hEpo NN:2 
2 h5 NN:2 
2 guamerin-derived JJ:2 
2 growth-regulated JJ:2 
2 grow VB:2 
2 greatest JJS:2 
2 granuloma NN:2 
2 graft NN:2 
2 gp NN:2 
2 govern VB:1 VBP:1 
2 goals NNS:2 
2 glycosylase NN:2 
2 glycogen NN:2 
2 glycerol NN:2 
2 glutamic JJ:2 
2 glucocorticoid-mediated JJ:2 
2 global JJ:2 
2 gliotoxin JJ:1 NN:1 
2 gld/gld NN:2 
2 giving VBG:2 
2 gingivalis NN:2 
2 gentle JJ:2 
2 genotypic JJ:2 
2 genesis NN:2 
2 generality NN:2 
2 gene-targeted JJ:2 
2 gcRs NNS:2 
2 gastroenterology NN:2 
2 gammaRI NN:2 
2 gammaR1 NN:2 
2 gamma-promoter NN:2 
2 gamma-herpesvirus NN:2 
2 gamma-chain NN:2 
2 gamma-Interferon JJ:1 NN:1 
2 gaining VBG:2 
2 gag-pol NN:2 
2 gag NN:2 
2 gB NN:2 
2 g/g NN:2 
2 fyn NN:2 
2 function- NN:2 
2 frozen VBN:2 
2 freely RB:2 
2 framework NN:2 
2 fragmented JJ:2 
2 four-fold JJ:2 
2 fos-B NN:2 
2 formulation NN:2 
2 formal JJ:2 
2 folding NN:2 
2 focus-forming JJ:2 
2 fmol/micrograms NN:2 
2 fluxes NNS:2 
2 fluoroquinolone JJ:1 NN:1 
2 fluctuations NNS:2 
2 flexneri NN:2 
2 flavonoid NN:2 
2 flagellum NN:2 
2 flagella NNS:2 
2 firm JJ:2 
2 filaments NNS:2 
2 filament NN:2 
2 fide FW:2 
2 fibrosarcoma NN:2 
2 fibromyalgia NN:2 
2 fibromatosis NNS:2 
2 fibrogenesis NN:2 
2 fibric JJ:2 
2 fibre JJ:2 
2 fiber NN:2 
2 fetus NN:2 
2 fetal/adult JJ:2 
2 fertile JJ:2 
2 fermentans NNS:2 
2 fenofibrate NN:2 
2 fecal JJ:2 
2 favour NN:1 VB:1 
2 favored VBN:2 
2 favorable JJ:2 
2 false JJ:2 
2 fall VBP:2 
2 falciparum FW:1 NN:1 
2 failures NNS:2 
2 factor/oncoprotein NN:2 
2 factor-responsive JJ:2 
2 factor-like JJ:2 
2 factor-induced JJ:2 
2 factor-Stat5 NN:2 
2 factor-IL-6beta NN:2 
2 factor-DNA JJ:1 NN:1 
2 factor-B NN:2 
2 fMLP NN:2 
2 extravasation NN:2 
2 extrarenal JJ:2 
2 extract-DNA JJ:2 
2 extracellular-regulated JJ:2 
2 extra-renal JJ:2 
2 exploring VBG:2 
2 exploits VBZ:2 
2 expiratory JJ:1 NN:1 
2 experimentally RB:2 
2 experience VBP:2 
2 expanding VBG:2 
2 exhaust NN:2 
2 exemplified VBN:2 
2 excision NN:2 
2 excised VBN:2 
2 exchanges NNS:1 VBZ:1 
2 exchanger NN:2 
2 exceeding VBG:2 
2 examines VBZ:2 
2 evolve VB:1 VBP:1 
2 evidences NNS:2 
2 evaluating VBG:2 
2 evade VB:2 
2 eukaryotes NNS:2 
2 ets-binding JJ:1 NN:1 
2 estimate NN:1 VBP:1 
2 ester-inducible JJ:2 
2 erythroleukemias NNS:2 
2 erythrocyte-specific JJ:2 
2 erk2 NN:2 
2 ergometer NN:2 
2 erbA-binding JJ:2 
2 equimolar JJ:2 
2 epitheliomas NNS:2 
2 episode NN:2 
2 epinephrine NN:2 
2 eosinophilias NNS:2 
2 eosinophil-derived JJ:2 
2 eosinophil-committed JJ:2 
2 enterotoxins NN:1 NNS:1 
2 ensuing JJ:1 VBG:1 
2 enhancer/promoter NN:2 
2 enhancer/ JJ:2 
2 enhancer-like JJ:2 
2 enhancer-dependent JJ:2 
2 enhancer-blocking JJ:2 
2 enforced JJ:1 VBN:1 
2 endothelial-RAW264.7 NN:2 
2 endoplasmic JJ:2 
2 endonucleases NNS:2 
2 endometriotic JJ:2 
2 endocytosis NN:2 
2 endobronchial JJ:2 
2 encountered VBN:2 
2 encounter NN:2 
2 encompass VBP:2 
2 enabling VBG:2 
2 employs VBZ:2 
2 empirically RB:2 
2 emphasizes VBZ:2 
2 emission NN:2 
2 emerges VBZ:2 
2 embryonic/fetal JJ:2 
2 embryonic-fetal JJ:2 
2 embryoid JJ:2 
2 embryo NN:2 
2 elongated VBN:2 
2 elicits VBZ:2 
2 eliciting VBG:2 
2 elf-2a NN:2 
2 elf-2 NN:2 
2 elevating NN:1 VBG:1 
2 elevates VBZ:2 
2 element-containing JJ:2 
2 elective JJ:2 
2 elaborated VBN:2 
2 elaborate VB:1 VBP:1 
2 ehrlichiosis NN:2 
2 eed NN:2 
2 ecto-5'-nucleotidase JJ:1 NN:1 
2 ecto-5'-NT NN:2 
2 ecotropic JJ:2 
2 early-induced JJ:2 
2 dynamics NNS:2 
2 dying VBG:2 
2 dust NN:2 
2 ds-oligonucleotides NNS:2 
2 drug-induced JJ:2 
2 drug-immunophilin JJ:1 NN:1 
2 drug-free JJ:2 
2 draw VB:2 
2 drastic JJ:2 
2 downregulating VBG:2 
2 down-modulated VBN:2 
2 down-modulate VB:2 
2 doubling JJ:1 VBG:1 
2 double-blind JJ:2 
2 dots NNS:2 
2 dosing NN:2 
2 dorsal NN:2 
2 done VBN:2 
2 domain-containing JJ:2 
2 dl343 NN:2 
2 diversification NN:2 
2 divalent JJ:2 
2 dithiothreitol NN:2 
2 disulfide-linked JJ:2 
2 disturbances NNS:2 
2 disturb VBP:2 
2 distributions NNS:2 
2 distantly RB:2 
2 distant JJ:2 
2 dissecting VBG:2 
2 dissected VBD:2 
2 disproportionate JJ:2 
2 disposition NN:2 
2 dispersed JJ:1 VBN:1 
2 disomy NN:2 
2 diseased JJ:2 
2 disease-resistant JJ:2 
2 discussion NN:2 
2 discrimination NN:2 
2 discontinuous JJ:2 
2 dimethylsulfoxide NN:2 
2 dimerizes VBZ:2 
2 dimaprit NN:2 
2 dihydrotestosterone NN:2 
2 dihydropyrimidine NN:2 
2 dihydrofolate JJ:2 
2 digested JJ:1 VBN:1 
2 differentiation-promoting JJ:2 
2 diethyl NN:2 
2 diet NN:2 
2 dictating VBG:2 
2 dictated VBN:2 
2 diclofenac NN:2 
2 dibenzofurans NNS:2 
2 dibenzo-p-dioxins NNS:2 
2 diagnosed VBN:2 
2 dextran NN:2 
2 dexamethasone-induced JJ:2 
2 dex-resistant JJ:2 
2 deviations NNS:2 
2 develops VBZ:2 
2 developmental- JJ:2 
2 detectably RB:2 
2 details NNS:2 
2 destroys VBZ:2 
2 destined VBN:2 
2 designing VBG:2 
2 desferrioxamine NN:2 
2 desensitization NN:2 
2 derives VBZ:2 
2 derivation NN:2 
2 deregulate VB:1 VBP:1 
2 deranged JJ:1 VBN:1 
2 depth NN:2 
2 depletes VBZ:2 
2 deplete VB:2 
2 dephosphorylate VB:2 
2 deoxyribonuclease NN:2 
2 densitometry NN:2 
2 densely RB:2 
2 dendritic-like JJ:2 
2 delta99 NN:2 
2 delta383 NN:2 
2 delta-globin-encoding JJ:2 
2 delta-aminolaevulinic JJ:2 
2 delta- NN:1 NNS:1 
2 delineation NN:2 
2 delayed-type JJ:2 
2 delayed-early JJ:2 
2 dehydration NN:2 
2 dehydratase/dimerization NN:2 
2 definite JJ:2 
2 deficit NN:2 
2 default NN:2 
2 decisive JJ:2 
2 decidualized VBN:2 
2 decidualization NN:2 
2 decidua NN:2 
2 decarboxylase NN:2 
2 decades NNS:2 
2 decade NN:2 
2 death-inducing JJ:2 
2 deamidation NN:2 
2 deactivating VBG:2 
2 deacetylated VBN:2 
2 database NN:2 
2 dampen VB:2 
2 damaging NN:2 
2 daltons NNS:2 
2 daidzein NN:2 
2 dUTP NN:2 
2 cytospin NN:2 
2 cytokine-mediated JJ:2 
2 cyclooxygenase NN:2 
2 cyclin/cdks NN:1 NNS:1 
2 cyclin-like JJ:2 
2 cyclic-AMP JJ:1 NN:1 
2 cycle-associated JJ:2 
2 cushingoid JJ:2 
2 curves NNS:2 
2 curry NN:2 
2 cues NNS:2 
2 cryptococcal JJ:2 
2 crossreactive JJ:2 
2 crossreacting VBG:2 
2 crosslinked VBD:1 VBN:1 
2 cross-reactive JJ:2 
2 cross-priming NN:2 
2 cross-link NN:1 VBP:1 
2 crisis NN:2 
2 crises NNS:2 
2 crippled VBN:2 
2 covalently RB:2 
2 counter VB:2 
2 costimulate VB:1 VBP:1 
2 cosignaling NN:2 
2 corticotropin-releasing JJ:2 
2 corticotropin NN:2 
2 corticoid NN:2 
2 cortical JJ:2 
2 correctly RB:2 
2 cores NNS:2 
2 corepressor NN:2 
2 coregulator NN:2 
2 coregulation NN:2 
2 coreceptors NNS:2 
2 core-binding JJ:2 
2 copurified VBD:2 
2 coprecipitated VBD:2 
2 convergence NN:2 
2 convenient JJ:2 
2 contrasting JJ:1 VBG:1 
2 contradict VBP:2 
2 contiguous JJ:2 
2 contig NN:2 
2 contamination NN:2 
2 contaminant JJ:1 NN:1 
2 constraints NNS:2 
2 constitutional JJ:2 
2 constitution NN:2 
2 constituted VBD:1 VBN:1 
2 constantly RB:2 
2 consolidation NN:2 
2 considers VBZ:2 
2 consider VB:1 VBP:1 
2 connective JJ:2 
2 connection NN:2 
2 connected VBN:2 
2 conjugate NN:2 
2 conflicting VBG:2 
2 concerns VBZ:2 
2 conalbumin JJ:2 
2 comprises VBZ:2 
2 comprehensive JJ:2 
2 complement-dependent JJ:2 
2 competitors NNS:2 
2 combs NNS:2 
2 combat NN:1 VB:1 
2 colorectal JJ:2 
2 color NN:2 
2 collection NN:2 
2 collected VBN:2 
2 collaboration NN:2 
2 cold-air JJ:2 
2 coincided VBD:2 
2 coimmunoprecipitation NN:2 
2 coexpressing VBG:2 
2 coefficient NN:2 
2 codon-10-variant JJ:2 
2 codeletion NN:2 
2 code VBP:2 
2 coat NN:2 
2 co-transfections NNS:2 
2 co-transfecting VBG:2 
2 co-stimulus NN:2 
2 co-stimulation NN:2 
2 co-receptor NN:2 
2 co-migrating VBG:2 
2 co-expression NN:2 
2 co-cultivated JJ:2 
2 co-activator NN:2 
2 co-activation NN:2 
2 co- NN:1 NNS:1 
2 closest JJS:2 
2 clinics NNS:2 
2 clinicians NNS:2 
2 cleft NN:2 
2 cleave VB:2 
2 cleared VBN:2 
2 clear-cut JJ:2 
2 clarifying VBG:2 
2 cis-active JJ:2 
2 cis-activation NN:2 
2 circumvent VB:2 
2 circulation NN:2 
2 ciclosporin NN:2 
2 chymotryptic JJ:2 
2 chromatographic JJ:2 
2 chromatin-integrated JJ:2 
2 choriocarcinoma NN:2 
2 chloroquine NN:2 
2 childrens NNS:2 
2 child-bearing-age JJ:2 
2 child NN:2 
2 chickens NNS:2 
2 chick NN:2 
2 chemotherapeutic JJ:2 
2 charybdotoxin NN:2 
2 charcoal NN:2 
2 characterised VBN:2 
2 chaperone NN:2 
2 chamissonolid NN:2 
2 chamber NN:2 
2 challenges NNS:2 
2 chain-breaking JJ:2 
2 cessation NN:2 
2 cervical JJ:2 
2 certainly RB:2 
2 cercopithicine NN:2 
2 centromere NN:2 
2 centre NN:2 
2 cell-types NNS:2 
2 cell-to-cell JJ:2 
2 cell-like JJ:2 
2 cell-induced JJ:2 
2 cell-expressed JJ:2 
2 cell-death NN:2 
2 cell- JJ:1 NN:1 
2 cdk6 NN:2 
2 causative JJ:2 
2 catalyzing VBG:2 
2 catalyzes VBZ:2 
2 catalyst NN:2 
2 cat NN:2 
2 castellanii NN:2 
2 case-control JJ:2 
2 carotid JJ:1 NN:1 
2 carboxyterminal JJ:2 
2 carboxyl-terminus NN:2 
2 carboxy-terminus NN:2 
2 carboxy- JJ:2 
2 carbinolamine NN:2 
2 carbimazole NN:2 
2 caprine JJ:2 
2 capabilities NNS:2 
2 canrenone NN:2 
2 calmodulin-dependent JJ:2 
2 calcineurin- JJ:1 NN:1 
2 calcemic JJ:2 
2 cachexia NN:2 
2 ca. FW:2 
2 cAMP-response JJ:1 NN:1 
2 cAMP- JJ:1 NN:1 
2 c12 NN:2 
2 c-sis/platelet-derived JJ:2 
2 c-fps/fes NN:2 
2 c-MYC NN:2 
2 c-Jun/c-Fos NN:2 
2 bypass VB:2 
2 butyric JJ:2 
2 bulk NN:2 
2 bryostatin NN:2 
2 bromodomain NN:2 
2 brings VBZ:2 
2 bridges NNS:1 VBZ:1 
2 breast/ovarian JJ:2 
2 breast-conserving JJ:2 
2 breast-cancer JJ:1 NN:1 
2 branch NN:2 
2 brains NNS:2 
2 box-specific JJ:2 
2 boundaries NNS:2 
2 born JJ:1 VBN:1 
2 bore VBD:1 VBP:1 
2 bona FW:2 
2 boliviensis FW:2 
2 bloods NNS:2 
2 blacks NNS:2 
2 bisindolylmaleimide NN:2 
2 biscoclaurine JJ:1 NN:1 
2 bipotent JJ:2 
2 biosynthetic JJ:2 
2 biosynthesis NN:2 
2 biophysical JJ:2 
2 biomarker NN:2 
2 bindings NNS:2 
2 biliary JJ:2 
2 bi- JJ:1 RB:1 
2 beta-subunit NN:2 
2 beta-promoter NN:2 
2 beta-phorbol NN:2 
2 beta-interferon NN:2 
2 beta-hydroxysteroid NN:2 
2 beta-galactoside-binding JJ:2 
2 beta-chemokine NN:2 
2 beta-cell NN:2 
2 beta-actin NN:2 
2 beta-(1,3)-glucan NN:2 
2 benzoquinone NN:2 
2 benzidine-positive JJ:2 
2 bend NN:2 
2 believe VBP:2 
2 bears VBZ:2 
2 beads NNS:2 
2 bcr1 NN:2 
2 bcr/abl NN:2 
2 bcl-3 NN:2 
2 basophil NN:2 
2 basolateral JJ:2 
2 basic-helix-loop-helix JJ:2 
2 banding NN:2 
2 bactericidal/permeability-increasing JJ:2 
2 backbone NN:2 
2 azelastine NN:2 
2 axillary JJ:1 NN:1 
2 avidin JJ:2 
2 autosomes NNS:2 
2 autosome JJ:1 NN:1 
2 autonomous JJ:2 
2 autoinduction NN:2 
2 aurothioglucose NN:2 
2 attractive JJ:2 
2 attenuating NN:1 VBG:1 
2 attempts NNS:1 VBZ:1 
2 attempted VBD:1 VBN:1 
2 attacks NNS:2 
2 attack NN:2 
2 attached VBN:2 
2 atheroma NN:2 
2 ataxia-telangiectasia NN:2 
2 astrocytoma NN:2 
2 astrocyte-derived JJ:2 
2 assumption NN:2 
2 assume VB:2 
2 associating VBG:2 
2 assignment NN:2 
2 ascorbic JJ:2 
2 artificially RB:2 
2 arthritis-encephalitis JJ:2 
2 arresting VBG:2 
2 arranged VBN:2 
2 aromatic JJ:2 
2 arising VBG:2 
2 arises VBZ:2 
2 arachidonate NN:2 
2 aqueous JJ:2 
2 approximate JJ:2 
2 approx. RB:2 
2 appropriately RB:2 
2 appreciable JJ:2 
2 applications NNS:2 
2 appearing VBG:2 
2 apoplexy NN:2 
2 apocynin NN:2 
2 apart RB:2 
2 antiphosphotyrosine NN:2 
2 antihypertensive JJ:2 
2 antigen-induced JJ:2 
2 antibiotics NNS:2 
2 antiatherosclerotic JJ:2 
2 antiandrogens NNS:2 
2 anti-viral JJ:2 
2 anti-sense JJ:2 
2 anti-proliferative JJ:2 
2 anti-endothelial JJ:2 
2 anti-atherosclerotic JJ:2 
2 anti-STAT JJ:2 
2 anti-NF-ATp JJ:1 NN:1 
2 anti-Jun JJ:2 
2 anti-IL-1 JJ:2 
2 anti-HLA JJ:2 
2 anti-Fas-mediated JJ:2 
2 anti-Fas- JJ:2 
2 anti-Fas JJ:2 
2 anti-E-selectin JJ:2 
2 anti-CD4 JJ:2 
2 anti-CD3-induced JJ:2 
2 anti-CD3-activated JJ:2 
2 anti-CD3- JJ:2 
2 anthracycline JJ:2 
2 anterior JJ:2 
2 anoxia/reoxygenation NN:2 
2 anoxia NN:2 
2 annexin NN:2 
2 anlage FW:1 NN:1 
2 anions NNS:2 
2 anemic JJ:2 
2 anchor NN:2 
2 anaphylatoxins NNS:2 
2 analogy NN:2 
2 anaemia NN:2 
2 amyloid NN:2 
2 amylase NN:2 
2 amplicon NN:2 
2 amol NN:2 
2 aminothiol NN:2 
2 amino-acid JJ:2 
2 ameliorated VBN:2 
2 amebiasis NN:2 
2 alveoli NNS:2 
2 alphaIIb NN:2 
2 alpha2beta1 NN:2 
2 alpha/AML-1 NN:2 
2 alpha-zearalenol NN:2 
2 alpha-thrombin NN:2 
2 alpha-stimulated JJ:2 
2 alpha-like JJ:2 
2 alpha-granules NNS:2 
2 alpha-associated JJ:2 
2 alpha-LBD NN:2 
2 allosteric JJ:2 
2 alloreactive JJ:2 
2 alloimmune JJ:2 
2 alkaloid NN:2 
2 alignment NN:2 
2 albuminuria NN:2 
2 air NN:2 
2 agonism NN:2 
2 aggressive JJ:2 
2 aggregated JJ:1 VBN:1 
2 aggregate NN:1 VB:1 
2 agar NN:2 
2 affinity-purified JJ:2 
2 advance VB:1 VBP:1 
2 adrenocorticotropin NN:2 
2 adolescents NNS:2 
2 adnexal JJ:2 
2 adhesivity NN:2 
2 adhesions NNS:2 
2 adhesion-dependent JJ:2 
2 adhering JJ:2 
2 adenomatous JJ:2 
2 adenocarcinoma NN:2 
2 adds VBZ:2 
2 adding VBG:2 
2 adaptors NNS:2 
2 adapter NN:2 
2 adaptation NN:2 
2 acyclovir JJ:1 NN:1 
2 actually RB:2 
2 activations NNS:2 
2 activation-inducible JJ:2 
2 activation-deficient JJ:2 
2 acne NN:2 
2 acinar JJ:2 
2 acid-sensitive JJ:2 
2 acid- JJ:2 
2 achieving VBG:2 
2 achievable JJ:2 
2 acetyltransferases NNS:2 
2 acetonide NN:2 
2 acetate/ionomycin NN:2 
2 aborters NNS:2 
2 aborted VBD:1 VBN:1 
2 abolishing VBG:2 
2 ablating VBG:2 
2 aberrations NNS:2 
2 aP2 NN:2 
2 [3H]calcitriol/VDR NN:2 
2 [3H]1,25(OH)2D3 NN:2 
2 [3H]-dexamethasone NN:2 
2 [125I]- NN:2 
2 ZR-75-1 NN:2 
2 Z-LLL-H JJ:1 NN:1 
2 Yin-Yang NN:2 
2 Yae NN:2 
2 YT-N17 NN:2 
2 YT NN:2 
2 YLPQ NN:2 
2 YAC NN:2 
2 Y128 NN:2 
2 Y113 NN:2 
2 Xp NN:2 
2 Xenogeneic JJ:2 
2 XPD NN:2 
2 XISTE- JJ:2 
2 X2BP NN:2 
2 X-box NN:2 
2 X-_chromosome NN:2 
2 X-Y NN:2 
2 X- JJ:1 NN:1 
2 Wortmannin NN:2 
2 West JJ:1 NNP:1 
2 WGATAR NN:2 
2 W-X-Y NN:2 
2 Virtually RB:2 
2 Vbeta NN:2 
2 Variation NN:2 
2 Variants NNS:2 
2 Variant JJ:2 
2 Val NN:2 
2 VR JJ:1 NN:1 
2 VLA-5 NN:2 
2 VDRnuc NN:2 
2 VDR-RXR NN:2 
2 VDDR-II NN:2 
2 VCAM- JJ:1 NN:1 
2 VAV NN:2 
2 V-(D)-J NN:2 
2 Up-regulation NN:2 
2 Ulrich NNP:2 
2 UV-induced JJ:2 
2 USA-derived JJ:2 
2 UCSD-AML1 NN:2 
2 UAS3 NN:2 
2 U89 NN:2 
2 U86 NN:2 
2 Type-II JJ:2 
2 Two-dimensional JJ:2 
2 Twenty-two CD:2 
2 Twenty CD:2 
2 Tuberculosis NN:2 
2 Truncated JJ:1 VBN:1 
2 Treponema FW:2 
2 Translocations NNS:2 
2 Transforming VBG:2 
2 Transfectants NNS:2 
2 Tracey NNP:2 
2 Torr NN:2 
2 Toremifene NN:2 
2 Tobacco NN:2 
2 Tissues NNS:2 
2 Time-course JJ:2 
2 Thr729-Leu765 JJ:2 
2 Though IN:2 
2 Those DT:2 
2 Thirteen CD:2 
2 Thiol NN:2 
2 Thapsigargin NN:2 
2 Th2- JJ:2 
2 Th1-dominated JJ:2 
2 Th1- NN:2 
2 Th0 NN:2 
2 Terminal JJ:2 
2 Temporal JJ:2 
2 Tcells NNS:2 
2 Tcell NN:2 
2 Tax-transformed JJ:2 
2 Tax-responsive JJ:2 
2 Tat-binding JJ:2 
2 Tat-I NN:2 
2 Target NN:2 
2 Taq NN:2 
2 Tamoxifen NN:2 
2 TWHf FW:2 
2 TRAF5 NN:2 
2 TRAF-binding JJ:1 NN:1 
2 TNT NN:2 
2 TNFRp75 NN:2 
2 TNFR-1 NN:2 
2 TNF-induced JJ:2 
2 TLRs NN:1 NNS:1 
2 TL-Om1 NN:2 
2 TIS NN:2 
2 TIMP NN:1 NNS:1 
2 THF/THF NN:2 
2 THF NN:2 
2 THE/THF NN:2 
2 TH2 NN:2 
2 TH1/TH2 NN:2 
2 TGFs NNS:2 
2 TGACGTCA NN:2 
2 TFIIIB90 NN:2 
2 TFIIHwt NN:2 
2 TFIIHmut NN:2 
2 TFIIE NN:2 
2 TFE3 NN:2 
2 TFE-3 NN:2 
2 TDS NN:2 
2 TCRhigh JJ:2 
2 TCRalpha NN:2 
2 TCR-regulated JJ:2 
2 TCR-alpha NN:2 
2 TCR+ JJ:2 
2 TCF/LEF NN:2 
2 TCF-2 NN:2 
2 TCF-1/LEF-1 NN:2 
2 TCE NN:2 
2 TBP-1 NN:2 
2 TATA-box NN:2 
2 TATA-binding JJ:2 
2 TAT NN:2 
2 TAFII105 NN:2 
2 TAF NN:2 
2 T2 NN:2 
2 T1 NN:2 
2 T-lymphotropic JJ:2 
2 T-helper-cell JJ:1 NN:1 
2 T-cell-receptor-mediated JJ:2 
2 T-cell-leukemia JJ:2 
2 T-cell-expressed JJ:2 
2 Systemic JJ:2 
2 System NN:2 
2 Synthetic JJ:2 
2 Synthesis NN:2 
2 Syndrome NN:2 
2 Syk-family JJ:2 
2 Susceptibility NN:2 
2 Surfactant JJ:1 NN:1 
2 Superantigens NNS:2 
2 Substantial JJ:2 
2 Sublethal JJ:2 
2 Study NN:2 
2 Structural JJ:2 
2 Sterol NN:2 
2 Stage NN:2 
2 Spl NN:2 
2 Specificity NN:2 
2 Sp1/AP-2 NN:2 
2 Sp1-binding JJ:2 
2 Sos2 NN:2 
2 Solution NN:2 
2 Sodium NN:2 
2 Society NNP:2 
2 Smmhc NN:2 
2 Sjogrens NN:2 
2 Simultaneous JJ:2 
2 Simple JJ:2 
2 Signalling NN:2 
2 Sialoadhesin NN:2 
2 Shift NN:2 
2 Sherry NNP:2 
2 She PRP:2 
2 Sex NN:2 
2 Seven CD:2 
2 Ser184 NN:2 
2 Ser-727 NN:2 
2 Separate JJ:2 
2 Sendai NN:2 
2 Schmidtmayerova NNP:2 
2 Sc-I NN:2 
2 Salmonella FW:2 
2 Salicylates NNS:2 
2 SWI6/ankyrin NN:2 
2 SWI2 NN:2 
2 STUDY NN:2 
2 STP NN:2 
2 STAT5- JJ:1 NN:1 
2 STAT1- JJ:1 NN:1 
2 STAT-binding JJ:2 
2 STAT-6 NN:2 
2 STAT-5 NN:2 
2 SSE NN:2 
2 SRY-related JJ:2 
2 SRIs NNS:2 
2 SRI NN:2 
2 SRE- NN:2 
2 SP140 NN:2 
2 SP1/Egr-1 NN:2 
2 SP-B21 NN:2 
2 SOS1 NN:2 
2 SKF525a NN:2 
2 SK-N-Be(2) NN:2 
2 SIVmacMER NN:2 
2 SIVmac251 NN:2 
2 SIVmac NN:2 
2 SHP-1 NN:2 
2 SH2-deleted JJ:2 
2 SF NN:2 
2 SEE NN:2 
2 SCL/Tal1 NN:2 
2 SCID-HU-INT JJ:2 
2 SCD NN:2 
2 SAP NN:2 
2 SAF NN:2 
2 S107 NN:2 
2 S1' NN:2 
2 S.R. NN:1 NNP:1 
2 S-allyl JJ:2 
2 S-adenosylhomocysteine NN:2 
2 Run-on JJ:2 
2 RpoN NN:2 
2 Rpd3p NN:2 
2 Risk NN:2 
2 Ribophorin NN:2 
2 Ri-I NN:2 
2 Rho-family JJ:2 
2 Rh NN:2 
2 Retroviruses NNP:1 NNPS:1 
2 Retinoids NNS:2 
2 Retinoblastoma NN:2 
2 Replacement NN:2 
2 Repeated JJ:1 VBN:1 
2 Removal NN:2 
2 RelA/p65 NN:2 
2 Rel-B NN:2 
2 Regulatory JJ:2 
2 Regions NNS:2 
2 Reduction NN:2 
2 Reduced VBN:2 
2 Rat-1 NN:2 
2 Rat NN:2 
2 Ras(G12V) NN:2 
2 Rap NN:2 
2 RanBP2 NN:2 
2 Radiolabeled VBN:2 
2 RXR-RAR NN:2 
2 RVLP NN:2 
2 RNA-dependent JJ:2 
2 RIIIA NN:2 
2 RI- NN:2 
2 RBCs NNS:2 
2 RBA NNS:2 
2 RAREs NNS:2 
2 RAR-selective JJ:2 
2 RAR-beta NN:2 
2 RAG-1 NN:2 
2 RAD NN:2 
2 R59Z NN:2 
2 R2 NN:2 
2 R.C.Gallo NNP:2 
2 Quantitation NN:2 
2 Putative JJ:2 
2 Pseudomonas FW:2 
2 Pseudohypoaldosteronism NN:2 
2 Protein-DNA JJ:2 
2 Protease NN:2 
2 Prolactin NN:2 
2 Proinflammatory JJ:2 
2 Productive JJ:2 
2 Precursor NN:2 
2 Porcine JJ:1 NN:1 
2 Polyamines NNS:2 
2 Plus JJ:1 NN:1 
2 Platelets NNS:2 
2 Pit-1b NN:2 
2 Phytohemagglutinin NN:2 
2 Physiological JJ:2 
2 Phenotypic JJ:2 
2 Pharmacological JJ:2 
2 Pharmacologic JJ:2 
2 Perhaps RB:2 
2 Peptide NN:2 
2 Pentoxifylline NN:2 
2 Pebp2 NN:2 
2 Pax-8 NN:2 
2 Pax-2 NN:2 
2 Pathogenesis NN:2 
2 Pancreatic JJ:2 
2 Palombella NNP:2 
2 PU-box NN:2 
2 PU NN:2 
2 PTX NN:2 
2 PTPases NNS:2 
2 PTKs NN:2 
2 PSE NN:2 
2 PS NN:2 
2 PRRII NN:2 
2 PRRI NN:2 
2 PRL- JJ:1 NN:1 
2 PRDI NN:2 
2 PPE NN:2 
2 PPB NN:2 
2 PPARs NNS:2 
2 POUs NNS:2 
2 POU-homeodomain NN:2 
2 PO2 NN:2 
2 PMA-treated JJ:2 
2 PMA-mediated JJ:2 
2 PMA-activated JJ:2 
2 PMA+ NN:2 
2 PLZF NN:2 
2 PLC-gamma1 NN:2 
2 PKCs NNS:2 
2 PIBF NN:2 
2 PI-3,4,5-P3 NN:2 
2 PHA-stimulated JJ:2 
2 PHA-blasts NNS:2 
2 PHA- JJ:1 NN:1 
2 PFP5a NN:2 
2 PDN NN:2 
2 PD-135,158 NN:2 
2 PCR-based JJ:2 
2 PCNA NN:2 
2 PCDD/PCDF NN:2 
2 PCD NN:2 
2 PBL-T NN:2 
2 PATIENTS NNS:2 
2 PAR NN:2 
2 PAK NN:2 
2 PAF-receptor NN:2 
2 PAC-1 NN:2 
2 P7 NN:2 
2 P65/P50 NN:2 
2 P5 NN:2 
2 P450IA1 NN:2 
2 P3HR-1-infected JJ:2 
2 P19 NN:2 
2 P15 NN:2 
2 P10 NN:2 
2 P.Lusso NNP:2 
2 P.K. NNP:2 
2 P.G. NN:1 NNP:1 
2 Optimal JJ:2 
2 Oncogene NN:2 
2 Oligonucleotides NNS:2 
2 Olf-1 NN:2 
2 Oct2b NN:2 
2 Oct2ab NN:2 
2 Oct2a NN:2 
2 Oct2-isoform JJ:2 
2 Oct-2B NN:2 
2 OTF NN:2 
2 OS NN:2 
2 ORF-A NN:2 
2 OP NN:2 
2 OLR1 NN:2 
2 OKT8+ JJ:2 
2 OF IN:2 
2 ODNs NNS:2 
2 OBJECTIVES NNS:2 
2 OBF-1/Bob1/OCA-B NN:2 
2 O. NNP:2 
2 O-side JJ:2 
2 Nur77 NN:2 
2 Nucleolin NN:2 
2 Nov2 NN:2 
2 Nov1 NN:2 
2 Neutrophils NNS:2 
2 Neutralizing VBG:2 
2 Neutral JJ:2 
2 Native JJ:2 
2 Nasal JJ:2 
2 NaOV NN:2 
2 NaCl NN:2 
2 NaB NN:2 
2 Na+ NN:2 
2 NRE-II NN:2 
2 NRE-I NN:2 
2 NP-1 NN:2 
2 NMR NN:2 
2 NL NN:2 
2 NH2- NN:2 
2 NH(2)-terminal JJ:2 
2 NFkB NN:2 
2 NFIL2 NN:2 
2 NFIL-2B NN:2 
2 NFIL-2A NN:2 
2 NFAT3 NN:2 
2 NFAT-containing JJ:2 
2 NFAT- NN:2 
2 NF-kappaB2 NN:2 
2 NF-kappaB/ NN:2 
2 NF-kappaB-binding JJ:2 
2 NF-_kappaB NN:2 
2 NF-Y- JJ:2 
2 NF-E2/AP1 NN:2 
2 NF-ATn NN:2 
2 NF-AT3 NN:2 
2 NF-AT2 NN:2 
2 NF-AT/AP-1-binding JJ:2 
2 NF-AT-like JJ:2 
2 NF-AT-Oct NN:2 
2 NECA NN:2 
2 NBT NN:2 
2 NAD(P)H:quinone NN:2 
2 N9 NN:2 
2 N19RhoA NN:2 
2 N-Oct-3 NN:2 
2 N-Acetylcysteine NN:2 
2 MyoD NN:2 
2 Myeloid JJ:2 
2 Myc-associated JJ:2 
2 Myc NN:2 
2 Mutual JJ:2 
2 Monochloramine NN:2 
2 Monoallelic JJ:2 
2 Mol. NNP:2 
2 Moderate JJ:2 
2 Miyatake NNP:2 
2 Mineralocorticoid NN:2 
2 Mildly RB:2 
2 Microtubule NN:2 
2 Messenger NN:2 
2 Measurement NN:2 
2 Mch NN:2 
2 Martin NNP:2 
2 Marked JJ:2 
2 Mar NNP:2 
2 MZ JJ:2 
2 MTIIa NN:2 
2 MTG8 NN:2 
2 MSV NN:2 
2 MS-2gamma NN:2 
2 MS-2beta NN:2 
2 MRNA NN:2 
2 MRL-lpr/lpr NN:2 
2 MPDs NNS:2 
2 MOPC NN:2 
2 MODY NN:2 
2 MMs NNS:2 
2 MM6 NN:2 
2 MM-derived JJ:2 
2 ML-1a NN:2 
2 MHC-peptide JJ:1 NN:1 
2 MGUS NN:2 
2 MG-132 NN:2 
2 MF NN:2 
2 MEASUREMENTS NNS:2 
2 MDS NN:2 
2 MDA-MB-231 NN:2 
2 MCF-Fas NN:2 
2 MBP-HBD NN:2 
2 MAb NN:2 
2 MAZ NN:2 
2 MARCKS JJ:1 NN:1 
2 MAD3/ NN:2 
2 M32 NN:2 
2 M1-CAT NN:2 
2 M.A. NNP:2 
2 M-1 NN:2 
2 Lyt NN:2 
2 LysoPC NN:2 
2 Lyonization NN:2 
2 Lung NN:2 
2 Loss NN:2 
2 Looking VBG:2 
2 Locus NN:2 
2 Lineage-specific JJ:2 
2 Lewis NN:2 
2 Leishmania FW:2 
2 Legionella NN:2 
2 Later RB:2 
2 Lac+ JJ:2 
2 LYL-1 NN:2 
2 LTalpha NN:2 
2 LTR-modified JJ:2 
2 LTR-driven JJ:2 
2 LT-kappa NN:2 
2 LT-betaR NN:2 
2 LT-beta NN:2 
2 LSP1 NN:2 
2 LPS-responsive JJ:2 
2 LMP1s NNS:2 
2 LM-PCR NN:2 
2 LIM-only JJ:2 
2 LGL NN:2 
2 LDP NN:2 
2 LCD NNS:2 
2 LBP-1 NN:2 
2 LBF6 NN:2 
2 LBF5 NN:2 
2 LBF4 NN:2 
2 LBF3 NN:2 
2 LBF2 NN:2 
2 LAMPf NN:2 
2 L929 NN:2 
2 L23 NN:2 
2 L132 NN:2 
2 Ku NN:2 
2 Kruppel-type JJ:2 
2 Komatsu NN:2 
2 Kinetics NNS:2 
2 Kinetic JJ:2 
2 Kcat NN:2 
2 Kaposi NN:2 
2 Ka NN:2 
2 KSHV NN:2 
2 KS NN:2 
2 KN-62 NN:2 
2 KA NN:2 
2 K.J. NNP:2 
2 K-RAS NN:2 
2 K-562 NN:2 
2 Jurkat-T NN:2 
2 Jeg-3 NN:2 
2 January NNP:2 
2 Jak/STAT NN:2 
2 JY25 NN:2 
2 JUN NN:2 
2 JPX-9 NN:2 
2 JNKs NNS:2 
2 JN NN:2 
2 JCam NN:2 
2 JCaM1 NN:2 
2 JAK/STAT NN:2 
2 JAK-3 NN:2 
2 J2 NN:2 
2 J.M.Hardwick NNP:2 
2 J.Jhan NN:2 
2 Ito NN:2 
2 Isoforms NNS:2 
2 Irrespective JJ:1 RB:1 
2 Ireland NNP:2 
2 Inv(16)(p13;q22) NN:2 
2 Intriguingly RB:2 
2 Intragenic JJ:2 
2 Intestinal JJ:2 
2 Interstitial JJ:2 
2 International NNP:2 
2 Interfollicular JJ:2 
2 Intercellular JJ:2 
2 Insertion NN:2 
2 Inorganic JJ:2 
2 Influence NN:2 
2 Infected JJ:2 
2 Inefficient JJ:2 
2 Indirect JJ:2 
2 Index NN:1 NNP:1 
2 Increases NNS:2 
2 Inasmuch RB:2 
2 Inactive JJ:2 
2 In-vitro FW:2 
2 Immunosuppression NN:2 
2 Immunoelectron NN:2 
2 Immunocytochemistry NN:2 
2 Immunocytochemical JJ:2 
2 Ile50 JJ:1 NN:1 
2 Ile NN:2 
2 IgM-secreting JJ:2 
2 IgH-enhancer JJ:1 NN:1 
2 Ig/EBP-1 NN:2 
2 Ig-expressing JJ:2 
2 Iepsilon NN:2 
2 Id1 NN:2 
2 Icenko- NN:2 
2 Ib-IX-V NN:2 
2 IX CD:2 
2 IV/Gr NN:2 
2 ITT NN:2 
2 ITF-2 NN:2 
2 ITF-1 NN:2 
2 ISH NN:2 
2 ISGF3gamma NN:2 
2 IRS NN:2 
2 IRF- NN:2 
2 IRBP NN:2 
2 ILT-mat NN:2 
2 IL4R NN:2 
2 IL15 NN:2 
2 IL-9Ralpha NN:2 
2 IL-9R NN:2 
2 IL-7- JJ:2 
2 IL-6R NN:2 
2 IL-6- NN:2 
2 IL-5- JJ:1 NN:1 
2 IL-4-induced JJ:2 
2 IL-2mRNA NN:2 
2 IL-2/ NN:2 
2 IL-1beta- JJ:1 NN:1 
2 IL-1R-associated JJ:2 
2 IL-12- JJ:1 NN:1 
2 IL-10- JJ:1 NN:1 
2 IIa NN:2 
2 IIIB NN:2 
2 III-dependent JJ:2 
2 II-deficient JJ:2 
2 IH NN:2 
2 IFN-responsive JJ:2 
2 IFN-induced JJ:2 
2 IFN-gamma-treated JJ:2 
2 IFN-alpha5 NN:2 
2 IEXL320G NN:2 
2 IEXC29S NN:2 
2 IE1 NN:2 
2 IDCs NNS:2 
2 IDBP NN:2 
2 ID50 NN:2 
2 ICR-27 NN:2 
2 I-kappa NN:2 
2 I-factor NN:2 
2 I-binding JJ:2 
2 I-III CD:2 
2 Hypoxic JJ:2 
2 Hypoxia NN:2 
2 Hypermethylation NN:2 
2 Hypercortisolaemia NN:2 
2 Hungary NNP:2 
2 Hum NNP:2 
2 HuT102 NN:2 
2 HsN3 NN:2 
2 HpaII NN:2 
2 How WRB:2 
2 Host NN:2 
2 Hormonal JJ:2 
2 Hirsutism NN:2 
2 Higher JJR:2 
2 High-dose JJ:2 
2 Heterogeneous JJ:2 
2 Heterogeneity NN:2 
2 Hepa-1 NN:2 
2 Hemoglobin NN:2 
2 Hemin NN:2 
2 Hematopoietic JJ:2 
2 Hematology NNP:2 
2 Helenalin NN:2 
2 Hela NN:2 
2 Heinz NN:2 
2 Heat-shock NN:2 
2 Heat NN:2 
2 HaCaT NN:2 
2 HTLV-I-transformed JJ:2 
2 HTLV-1-transformed JJ:2 
2 HTLV-1-infected JJ:2 
2 HSP NN:2 
2 HSI NN:2 
2 HSFE NN:2 
2 HSF-1 NN:2 
2 HNF3 NN:2 
2 HMG-box NN:2 
2 HMG-CoA NN:2 
2 HMG-1 NN:2 
2 HMDS NN:2 
2 HM NNS:2 
2 HLP-1 NN:2 
2 HLA-DR3 NN:2 
2 HLA-DMB NN:2 
2 HLA-DMA NN:2 
2 HL60R NN:2 
2 HIV-induced JJ:2 
2 HIV-enhancer JJ:1 NN:1 
2 HIV-_1 NN:2 
2 HIV-HD NN:2 
2 HIV-1-LTR NN:2 
2 HDN NN:2 
2 HDLM-1 NN:2 
2 HDL NN:2 
2 HCS NN:2 
2 H5sub304 NN:2 
2 H582 NN:2 
2 H-chain JJ:2 
2 H-2Kb NN:2 
2 H+-ATPase NN:2 
2 H(+)-ATPase NN:2 
2 Grb2-binding JJ:2 
2 Gram-positive JJ:2 
2 Go-6976 NN:2 
2 Gln NN:2 
2 Gi NN:2 
2 Germline NN:2 
2 Genomic JJ:2 
2 Gender NN:2 
2 GenBank NN:2 
2 Gen NN:2 
2 Gardnerella FW:2 
2 Galectin-3 NN:2 
2 Gal4- JJ:1 NN:1 
2 Gail NN:2 
2 Gag NN:2 
2 GRO-alpha NN:2 
2 GRIP-1 NN:2 
2 GPX NN:2 
2 GOS19 NN:2 
2 GM NN:2 
2 GLUT4 NN:2 
2 GLUT1 NN:2 
2 GLRP NN:2 
2 GIG10 NN:2 
2 GHF-1 NN:2 
2 GH-N NN:2 
2 GGGATTTCACC NN:2 
2 GCR-alpha NN:2 
2 GCA NN:2 
2 GC-rich JJ:2 
2 GATA-2/ER NN:2 
2 GASd/EBSd NN:2 
2 GASd NN:2 
2 GAM NN:2 
2 GAG NN:2 
2 G2 NN:2 
2 G1/S NN:2 
2 G1-to-S JJ:2 
2 G0S3 NN:2 
2 G-rich JJ:2 
2 G-protein NN:2 
2 Fy(b-) NN:2 
2 Fy(a-b-) NN:2 
2 Fv NN:2 
2 Full-length JJ:2 
2 Full JJ:2 
2 Fos-related JJ:2 
2 Forty CD:2 
2 Forced JJ:1 VBN:1 
2 Fine JJ:2 
2 Ficoll NN:2 
2 Fibroblast NN:2 
2 Fibrinogen NN:2 
2 Fewer JJR:2 
2 Ferriman-Gallwey JJ:2 
2 Feb NNP:2 
2 Fcgamma NN:2 
2 FcepsilonRIIb NN:2 
2 Fas- JJ:2 
2 Factors NNS:2 
2 Fabricius NN:2 
2 FY*A NN:2 
2 FVA NN:2 
2 FOG NN:2 
2 FLAP NN:2 
2 FL5.12 NN:2 
2 FK NN:2 
2 FICZ NN:2 
2 FC3 NN:2 
2 FAK NN:2 
2 FADD NN:2 
2 FACS NN:2 
2 FAB NN:2 
2 F774L NN:2 
2 F.R. NNP:2 
2 F. NNP:2 
2 Extracellular JJ:2 
2 Expressed VBN:2 
2 Exposing VBG:2 
2 Experimental JJ:2 
2 Exogenously RB:2 
2 Erythroid-specific JJ:2 
2 Epo-dependent JJ:2 
2 Epithelial JJ:2 
2 Ep NN:2 
2 Eosinophil NN:2 
2 Endotoxin NN:2 
2 Emphasis NN:2 
2 Eleven CD:2 
2 Element NN:2 
2 Electromobility NN:2 
2 El4 NN:2 
2 Eicosanoids NNS:2 
2 EcoRI NN:2 
2 EWS/FLI-1 NN:2 
2 ETS-domain JJ:1 NN:1 
2 ERbeta NN:2 
2 ERK-independent JJ:2 
2 ERG2 NN:2 
2 ER-negative JJ:2 
2 ER-alpha NN:2 
2 ELF1 NN:2 
2 EIA NN:2 
2 EC1 NN:2 
2 EBV-encoded JJ:2 
2 EBV-associated JJ:2 
2 EBNA1 NN:2 
2 EBNA-LP NN:2 
2 EB1-like JJ:2 
2 EA JJ:1 NN:1 
2 E4bp4 NN:2 
2 E4 NN:2 
2 E2F-I NN:2 
2 E214K JJ:1 NN:1 
2 E1a-_adenovirus NN:2 
2 E1B-19 NN:2 
2 E1B- JJ:2 
2 E1A- NN:2 
2 E12 NN:2 
2 E-proteins NNS:2 
2 E-protein NN:2 
2 E-boxes NNS:2 
2 Dysregulation NN:2 
2 Dual JJ:2 
2 Dr. NNP:2 
2 Downregulation NN:2 
2 Double JJ:2 
2 Dose-response JJ:2 
2 Domain NN:2 
2 Does VBZ:2 
2 Dithiocarbamates NNS:2 
2 Distinctive JJ:2 
2 Dissociation NN:2 
2 Disease NN:1 NNP:1 
2 Dimerization NN:2 
2 Dihydroxyvitamin NN:2 
2 Dezube NNP:2 
2 Deregulation NN:2 
2 Depletion NN:2 
2 Depending VBG:2 
2 Deoxycholate JJ:1 NN:1 
2 Dehydroepiandrosterone NN:2 
2 Daidzein NN:2 
2 DXM NN:2 
2 DTT NN:2 
2 DTC NN:2 
2 DST NN:2 
2 DQbeta NN:2 
2 DQA1*0501 NN:2 
2 DQA1*0201 NN:2 
2 DQ8 JJ:1 NN:1 
2 DQ3.3 NN:2 
2 DP2 NN:2 
2 DNaseI NN:2 
2 DNase-I NN:2 
2 DNAse NN:2 
2 DNA-PK(CS) NN:2 
2 DILs NN:1 NNS:1 
2 DFS NN:2 
2 DFC NN:2 
2 DEN NN:2 
2 DEM NN:2 
2 DE NN:2 
2 DCS NN:2 
2 DCR NN:2 
2 D5G6 NN:2 
2 D20S5 NN:2 
2 D10 NN:2 
2 D. NNP:2 
2 Cytotoxicity NN:2 
2 Cytogenetic JJ:2 
2 Cultured VBN:2 
2 Culture NN:2 
2 Crohn NN:2 
2 Critical JJ:2 
2 CpG-rich JJ:2 
2 Coupling NN:2 
2 Corticosteroids NNS:2 
2 Correspondingly RB:2 
2 Correlations NNS:2 
2 Cord NN:2 
2 Coordinate JJ:2 
2 Conserved VBN:2 
2 Confirmation NN:2 
2 Concanavalin NN:2 
2 Complete JJ:2 
2 Complementary JJ:2 
2 Combinations NNS:2 
2 Co-treatment NN:2 
2 Co-transfection NN:2 
2 Co-stimulation NN:2 
2 Clone NN:2 
2 Clonal JJ:2 
2 Cleavage NN:2 
2 Cis-acting JJ:2 
2 Circular JJ:2 
2 Circadian JJ:2 
2 Ciprofloxacin NN:2 
2 Ci-I NN:2 
2 Chlamydia NN:2 
2 Chicken NN:2 
2 Chen NNP:2 
2 Cgamma1 NN:2 
2 Cerami NNP:2 
2 Central JJ:2 
2 Cell-type-specific JJ:2 
2 Cbf NN:2 
2 Canventol NN:2 
2 Calmette-Guerin FW:2 
2 Callithrix FW:2 
2 Ca2+-ATPase NN:2 
2 Ca(2+)-independent JJ:1 NN:1 
2 Ca(2+)-activated JJ:2 
2 CYS NN:2 
2 CV-1 NN:2 
2 CTLL-R8 NN:2 
2 CTL-specific JJ:2 
2 CTG-motif NN:2 
2 CSFs NNS:2 
2 CRISP-3 NN:2 
2 CREM NN:2 
2 CREB/ATF-1 NN:2 
2 CREB- JJ:1 NN:1 
2 COS7 NN:2 
2 COOH-terminally RB:2 
2 COOH NN:2 
2 CMF NN:2 
2 CM NN:2 
2 CLs NN:1 NNS:1 
2 CLSM NN:2 
2 CLIP NN:1 NNS:1 
2 CHR NN:2 
2 CHO/CD14 NN:2 
2 CFP NN:1 NNS:1 
2 CESS NN:2 
2 CES-2 NN:2 
2 CEMx174 NN:2 
2 CD95/APO-1 NN:2 
2 CD8int/- JJ:2 
2 CD8-positive JJ:2 
2 CD8+CD18bright NN:2 
2 CD62 NN:2 
2 CD57+ JJ:2 
2 CD45- NN:2 
2 CD43/leukosialin JJ:1 NN:1 
2 CD41a NN:2 
2 CD40-specific JJ:2 
2 CD40-activated JJ:2 
2 CD35 NN:2 
2 CD30+ JJ:2 
2 CD3-stimulated JJ:2 
2 CD3- JJ:2 
2 CD28-responsive JJ:2 
2 CD27-_B NN:2 
2 CD27+ JJ:2 
2 CD1a- NN:1 NNS:1 
2 CD1a+ JJ:2 
2 CD14+ JJ:2 
2 CD11b+ JJ:2 
2 CD11C NN:2 
2 CCRF-CEM NN:2 
2 CCGCCC NN:2 
2 CCACC/Sp1 NN:2 
2 CCAAT-box NN:2 
2 CBL NN:2 
2 CAAX NN:2 
2 C5b6 NN:2 
2 C4 NN:2 
2 C3H-gld/gld JJ:2 
2 C2 NN:2 
2 C/EBPs NNS:2 
2 C/EBP- NN:2 
2 C- JJ:2 
2 Bukrinsky NNP:2 
2 Bruton NN:2 
2 Bp65 NN:2 
2 Borrelia FW:2 
2 Bloom NNP:2 
2 Blocking NN:1 VBG:1 
2 Bis NN:2 
2 Biphasic JJ:2 
2 Bianchi NNP:2 
2 Bcl6 NN:2 
2 Bad NN:2 
2 BRs NNS:2 
2 BRL49653 NN:2 
2 BP2 NN:2 
2 BP NN:2 
2 BK NN:2 
2 BAF3 NN:1 NNS:1 
2 B8+ JJ:2 
2 B10 NN:2 
2 B/c-Rel NN:2 
2 B/MAD3 NN:2 
2 B/ NN:2 
2 B-directed JJ:2 
2 B-cell-restricted JJ:2 
2 B-cell-derived JJ:2 
2 B-acute JJ:2 
2 B-LCL NN:2 
2 B-ALL NNS:2 
2 Avian JJ:2 
2 Autocrine NN:2 
2 Attenuation NN:2 
2 Assembly NN:2 
2 Assays NNS:2 
2 Assay NN:2 
2 Aspirin-like JJ:2 
2 Aspirin NN:2 
2 Arsenic JJ:2 
2 Arnica FW:2 
2 Arg551 NN:2 
2 Approximately RB:2 
2 Application NN:2 
2 Apoptotic JJ:2 
2 Apart RB:2 
2 Antioxidants NNS:2 
2 Antibody NN:2 
2 Amplified JJ:1 VBN:1 
2 Amino NN:2 
2 American NNP:2 
2 Alpha-tocopherol NN:2 
2 Allelic JJ:2 
2 Alagille NN:2 
2 Aggregation NN:2 
2 Agents NNS:2 
2 Age-related JJ:2 
2 Ag-3 NN:2 
2 Africans NNS:2 
2 African JJ:2 
2 Adherence NN:2 
2 Ad2/Ad12 NN:2 
2 Ad-infected JJ:2 
2 Activator NN:2 
2 Act-1 CD:1 NN:1 
2 Acquisition NN:2 
2 Acquired VBN:2 
2 According VBG:2 
2 Acanthamoeba NN:2 
2 Abl NN:2 
2 Aberrant JJ:2 
2 AVP NN:2 
2 AU-motif-directed JJ:2 
2 AU-DD NN:2 
2 ATTTGCAT NN:2 
2 ATL16T(-) JJ:2 
2 ATGs NNS:2 
2 ATF2 NN:2 
2 ATF/ NN:2 
2 AST/ALT NN:2 
2 ARRE-2 NN:2 
2 ARE-containing JJ:2 
2 APO-1/Fas NN:2 
2 APO-1 JJ:1 NN:1 
2 AP-1-related JJ:2 
2 AP-1-like JJ:2 
2 AP-1(I,II,III) NN:2 
2 ANH NN:2 
2 AMs NNS:2 
2 ALG-4 NN:2 
2 ALAS-E NN:2 
2 AL1 NN:2 
2 AIMS NNS:2 
2 AIM/CD69 NN:2 
2 AIM NN:2 
2 AIDS-associated JJ:2 
2 AIDS-GR NN:2 
2 AIDS-C NN:2 
2 AF-1 NN:2 
2 ADP-activated JJ:2 
2 ACH NN:2 
2 AAV NN:2 
2 AACAAAG NN:2 
2 A/T NN:2 
2 A.S.Fauci NNP:2 
2 A-induced JJ:2 
2 A-F NNS:2 
2 9S NN:2 
2 9J NN:2 
2 98059 CD:2 
2 98 CD:2 
2 97-kDa JJ:2 
2 96365 CD:2 
2 91 CD:2 
2 90-kDa JJ:2 
2 90- JJ:2 
2 9.5 CD:2 
2 9.36 CD:2 
2 88 CD:2 
2 87 CD:2 
2 83 CD:2 
2 814 CD:2 
2 8-bromo-cAMP NN:2 
2 79 CD:2 
2 77 CD:2 
2 75-kDa JJ:2 
2 720 CD:2 
2 70- CD:2 
2 7.6 CD:2 
2 7.4 CD:2 
2 7-fold JJ:1 RB:1 
2 69 CD:2 
2 64.6 CD:2 
2 60-kDa JJ:2 
2 6.1 CD:2 
2 6-h JJ:2 
2 5a NN:2 
2 591/EGR2 NN:2 
2 59-kDa JJ:2 
2 58 CD:2 
2 571 CD:2 
2 5637 CD:2 
2 56.1 CD:2 
2 56 CD:2 
2 543 CD:2 
2 53071 CD:2 
2 53 CD:2 
2 52-year-old JJ:2 
2 51.6 CD:2 
2 51 CD:2 
2 50K CD:2 
2 506 CD:2 
2 500-bp JJ:2 
2 5.9 CD:2 
2 5.8 CD:2 
2 5.5 CD:2 
2 5-hydroxyeicosatetraenoic JJ:2 
2 5-fluorouracil NN:2 
2 5-aminolevulinate JJ:1 NN:1 
2 5'HS NN:2 
2 4X NN:2 
2 48-hr JJ:2 
2 45.6 CD:2 
2 442 CD:2 
2 433-442A NN:2 
2 43 CD:2 
2 40S JJ:1 NN:1 
2 4.8 CD:2 
2 4.0 CD:2 
2 4. LS:2 
2 4-trifluoromethyl NN:2 
2 4-bp JJ:2 
2 4- CD:2 
2 3q27 NN:2 
2 3q26 NN:2 
2 3kb JJ:1 RB:1 
2 3H-thymidine JJ:1 NN:1 
2 3H-dexamethasone NN:2 
2 3D-NMR NN:2 
2 381 CD:2 
2 368 CD:2 
2 35S- NN:2 
2 350 CD:2 
2 3369 CD:2 
2 32P NN:2 
2 326 CD:2 
2 32.2 CD:2 
2 312 CD:2 
2 306 CD:2 
2 304G NN:2 
2 301.5 CD:2 
2 30-40 CD:2 
2 3/CRE NN:2 
2 3.6 CD:2 
2 3.3-fold RB:2 
2 3.2-fold JJ:1 RB:1 
2 3.2 CD:2 
2 3. LS:2 
2 3-methylcholanthrene JJ:1 NN:1 
2 3-like JJ:2 
2 3-deazaadenosine NN:2 
2 3-day JJ:2 
2 3-6 CD:2 
2 3- CD:2 
2 3,21-diacetoxy-5 NN:2 
2 3'-region NN:2 
2 3'-end NN:2 
2 2M-1 NN:2 
2 2B NN:2 
2 269 CD:2 
2 254 CD:2 
2 25-dihydroxyvitamin NN:2 
2 25-7386 CD:2 
2 245 CD:2 
2 242 CD:2 
2 24,25-dihydroxyvitamin NN:2 
2 23.3 CD:2 
2 23.1 CD:2 
2 225/EGR1 NN:2 
2 224 CD:2 
2 22-bp JJ:2 
2 210 CD:2 
2 21-acetoxy-11 NN:2 
2 207 CD:2 
2 20-methyl JJ:1 NN:1 
2 20-bp JJ:2 
2 20-base JJ:2 
2 20-50 CD:2 
2 20- CD:2 
2 2/core-binding JJ:2 
2 2.9 CD:2 
2 2.45 CD:2 
2 2. FW:1 LS:1 
2 2-kb JJ:2 
2 2-hydroxy-4-trifluoromethylbenzoic JJ:2 
2 2-globin NN:2 
2 2-6 CD:2 
2 2-451 CD:2 
2 2-3-fold JJ:1 RB:1 
2 2-3 CD:2 
2 1pk NN:2 
2 1b NN:2 
2 1G5 NN:2 
2 19D NN:2 
2 1990 CD:2 
2 1987 CD:2 
2 187 CD:2 
2 186 CD:2 
2 180 CD:2 
2 18-hydroxycorticosterone NN:2 
2 18-OH-B NN:2 
2 17beta-estradiol NN:2 
2 17beta-(3H)_estradiol NN:2 
2 172 CD:2 
2 169 CD:2 
2 168 CD:2 
2 16-bp JJ:2 
2 15B-7 NN:2 
2 158 CD:2 
2 155 CD:2 
2 154 CD:2 
2 15.5 CD:2 
2 15-deoxy-delta12,14-prostaglandin NN:2 
2 140-kDa JJ:2 
2 140 CD:2 
2 14.7 CD:2 
2 14-fold JJ:1 RB:1 
2 14-day JJ:2 
2 130-kD JJ:2 
2 13-fold RB:1 UNKNOWN:1 
2 13-cis JJ:2 
2 13-7410 CD:2 
2 12L NN:2 
2 12D NN:2 
2 129 CD:2 
2 1285 CD:2 
2 127 CD:2 
2 125 CD:2 
2 12/15-lipoxygenase NN:2 
2 12.1 CD:2 
2 12-fold JJ:1 RB:1 
2 12-day JJ:2 
2 12-O-tetradecanoyl-phorbol-13-acetate NN:2 
2 12-24 CD:2 
2 11alpha,13-dihydrohelenalin NN:2 
2 11.8 CD:2 
2 109 CD:2 
2 105K CD:2 
2 102 CD:1 NN:1 
2 1000 CD:2 
2 10.9 CD:2 
2 10-60 CD:2 
2 10-15 CD:2 
2 10-100 CD:2 
2 10,047 CD:2 
2 10,000-fold JJ:1 RB:1 
2 10(6) CD:2 
2 10(10) CD:2 
2 10(-9) CD:2 
2 10(-4) CD:2 
2 1.955-kb JJ:2 
2 1.4 CD:2 
2 1.17 CD:2 
2 1. LS:2 
2 1-bp JJ:2 
2 1-beta-D-arabinofuranosylcytosine NN:2 
2 1-60 CD:2 
2 1-10 CD:2 
2 1- CD:1 NN:1 
2 1,25-dihydroxy NN:2 
2 000 CD:2 
2 0.5-Gy JJ:2 
2 0.49 CD:2 
2 0.39 CD:2 
2 0.31 CD:2 
2 0.30 CD:2 
2 0.2-kb JJ:2 
2 0.15 CD:2 
2 0.1-0.5 CD:2 
2 0.09 CD:2 
2 0.03 CD:2 
2 0.0005 CD:2 
2 0.0004 CD:2 
2 /reporter NN:2 
2 /peptide NN:2 
2 /microg NN:2 
2 /extracellular JJ:2 
2 /enhancer NN:2 
2 /cell NN:1 NNS:1 
2 /calcium NN:2 
2 /calcineurin NN:2 
2 /c-Fos NN:2 
2 /RelA NN:2 
2 /PKA NN:2 
2 /OAP NN:2 
2 /NFAT NN:2 
2 /Mn2+ JJ:1 NN:1 
2 /IL-2 JJ:1 NN:1 
2 /GSH NN:2 
2 /GOS19 NN:2 
2 /Fos NN:2 
2 /Fas NN:2 
2 /Elf-1 JJ:2 
2 /ERK NN:2 
2 /CD40L NN:2 
2 /CD28RE NN:2 
2 /CD28 NN:2 
2 /CD25 NN:2 
2 /ATF NN:2 
2 /AP-1-specific JJ:2 
2 .03 CD:2 
2 .003 CD:2 
2 .0002 NN:2 
2 -type JJ:2 
2 -tolerant JJ:2 
2 -susceptible JJ:2 
2 -selective JJ:2 
2 -response JJ:2 
2 -resistance NN:2 
2 -replicative JJ:2 
2 -proteasome JJ:2 
2 -overexpressing JJ:2 
2 -nonresponsive JJ:2 
2 -mCD14 NN:2 
2 -interacting JJ:2 
2 -immunoreactive JJ:2 
2 -immortalized JJ:2 
2 -harboring JJ:2 
2 -group NN:2 
2 -globin NN:2 
2 -generating JJ:1 NN:1 
2 -endothelial JJ:2 
2 -deprived JJ:2 
2 -depleted JJ:2 
2 -deleted JJ:2 
2 -chloramphenicol JJ:2 
2 -catalysed JJ:2 
2 -biotin JJ:2 
2 -beta1 NN:2 
2 -VDR JJ:2 
2 -T NN:2 
2 -M1 NN:2 
2 -Fas JJ:2 
2 -DeltaSH2 NN:2 
2 -CD3 JJ:1 NN:1 
2 -97 CD:2 
2 -87 CD:2 
2 -83 CD:2 
2 -82 CD:2 
2 -78 CD:2 
2 -69 CD:2 
2 -67 CD:2 
2 -579 CD:2 
2 -500 CD:2 
2 -46 CD:2 
2 -45 CD:2 
2 -44 CD:2 
2 -42 CD:2 
2 -3alpha NN:2 
2 -35 CD:2 
2 -34 CD:2 
2 -326 CD:2 
2 -300 CD:2 
2 -295 CD:2 
2 -291 CD:2 
2 -2729 CD:2 
2 -267 CD:2 
2 -260 CD:2 
2 -257 CD:2 
2 -256 CD:2 
2 -24 CD:2 
2 -236 CD:2 
2 -220 CD:2 
2 -213 CD:2 
2 -206 CD:2 
2 -201/-184 CD:1 NN:1 
2 -200 CD:2 
2 -1beta NN:2 
2 -1alpha NN:2 
2 -195 CD:2 
2 -193 CD:2 
2 -187 CD:1 NN:1 
2 -186 CD:2 
2 -181 CD:2 
2 -180 CD:2 
2 -177 CD:2 
2 -160 CD:2 
2 -158 CD:2 
2 -153 CD:2 
2 -15 CD:2 
2 -145 CD:2 
2 -141 CD:2 
2 -139 CD:2 
2 -131 CD:2 
2 -13 CD:2 
2 -1280 CD:2 
2 -128 CD:2 
2 -121 CD:2 
2 -107 CD:2 
2 -105 CD:2 
2 -102 CD:2 
2 -/LT JJ:2 
2 +54 CD:2 
2 +240 CD:2 
2 +195 CD:2 
2 +15 CD:2 
2 +13 CD:2 
2 +/LT JJ:2 
2 +/CD3+ JJ:2 
2 (-)/syn-1(+) JJ:2 
2 (+)/ JJ:2 
2 (+)-pentazocine NN:2 
2 (+)-SKF NN:2 
1 zymosan- JJ:1 
1 zymography NN:1 
1 zygous JJ:1 
1 zoster NN:1 
1 zona NN:1 
1 zippers NNS:1 
1 zipper-like JJ:1 
1 zinc-inducible JJ:1 
1 zileuton NN:1 
1 zidovudine NN:1 
1 zero CD:1 
1 zebrafish NN:1 
1 zebra NN:1 
1 zap-70- JJ:1 
1 zVAD-FMK NN:1 
1 zVAD-fmk NN:1 
1 zDEVD-fmk NN:1 
1 ytokine NN:1 
1 yellow JJ:1 
1 yeasts NNS:1 
1 yang-deficiency NN:1 
1 xenotransplanted VBN:1 
1 xenoreactive JJ:1 
1 xenobiotics NNS:1 
1 xenobiotic JJ:1 
1 wt/vol NN:1 
1 written VBN:1 
1 wounds NNS:1 
1 world NN:1 
1 workload NN:1 
1 worked VBD:1 
1 words NNS:1 
1 wing NN:1 
1 wilfordii FW:1 
1 wildtype JJ:1 
1 wild-_type JJ:1 
1 wider JJR:1 
1 whilst IN:1 
1 wet-to-dry JJ:1 
1 well-standardized JJ:1 
1 well-recognized JJ:1 
1 well-established JJ:1 
1 well-documented JJ:1 
1 well-differentiated JJ:1 
1 weakness NN:1 
1 waves NNS:1 
1 water-soluble JJ:1 
1 wat VBD:1 
1 washout NN:1 
1 washing VBG:1 
1 wash NN:1 
1 warranted VBN:1 
1 warrant VBP:1 
1 warm JJ:1 
1 wanted VBD:1 
1 w VBD:1 
1 vulva NN:1 
1 vulnerable JJ:1 
1 vulnerability NN:1 
1 vol/vol NN:1 
1 vitronectin NN:1 
1 vitro-cultured JJ:1 
1 vitro-activated JJ:1 
1 vitality NN:1 
1 visually RB:1 
1 visual JJ:1 
1 visit NN:1 
1 visceral JJ:1 
1 vis-a-vis FW:1 
1 virus-uninfected JJ:1 
1 virus-type NN:1 
1 virus-transforming JJ:1 
1 virus-specific JJ:1 
1 virus-replicative JJ:1 
1 virus-negative JJ:1 
1 virus-host JJ:1 
1 virion-associated JJ:1 
1 virion NN:1 
1 viremia NN:1 
1 vincristine-selected JJ:1 
1 vii LS:1 
1 victimized VBN:1 
1 vice RB:1 
1 veterans NNS:1 
1 vesicle NN:1 
1 vertebral NN:1 
1 versa RB:1 
1 verprolin-homology JJ:1 
1 verify VB:1 
1 venules NNS:1 
1 ventral JJ:1 
1 velocity NN:1 
1 vector-mediated JJ:1 
1 vaso-occlusion NN:1 
1 vasculitic JJ:1 
1 vasculature NN:1 
1 vascular-rich JJ:1 
1 vascular-cell NN:1 
1 variously RB:1 
1 variably RB:1 
1 validity NN:1 
1 validate VB:1 
1 valid JJ:1 
1 vaginosis NN:1 
1 vaccinia NN:1 
1 vaccinated VBN:1 
1 v/v NN:1 
1 v-Myb NN:1 
1 v-Jun NN:1 
1 v- NN:1 
1 uv NN:1 
1 usurps VBZ:1 
1 usual JJ:1 
1 usion NN:1 
1 useless JJ:1 
1 urogenital JJ:1 
1 ureteral JJ:1 
1 ured VBN:1 
1 urea NN:1 
1 urban JJ:1 
1 up_-regulation NN:1 
1 upLNGFR NN:1 
1 up-modulation NN:1 
1 untransfected JJ:1 
1 untrained JJ:1 
1 unsynchronized JJ:1 
1 unsuppressed JJ:1 
1 unstable JJ:1 
1 unseparated JJ:1 
1 unresuscitated JJ:1 
1 unrestricted JJ:1 
1 unresolved JJ:1 
1 unregulated JJ:1 
1 unravel VB:1 
1 unquestionably RB:1 
1 unpublished JJ:1 
1 unphysiologically RB:1 
1 unnoticed JJ:1 
1 unmodified JJ:1 
1 unmasks VBZ:1 
1 unmasked VBD:1 
1 unmanipulated JJ:1 
1 unlabelled JJ:1 
1 units/ml NNS:1 
1 units-erythroid JJ:1 
1 unit-granulocyte-macrophage JJ:1 
1 unilateral JJ:1 
1 unifying JJ:1 
1 unexplored JJ:1 
1 uneven JJ:1 
1 unequivocally RB:1 
1 unequivocal JJ:1 
1 unequal JJ:1 
1 undissociable JJ:1 
1 undetected JJ:1 
1 underway JJ:1 
1 underscored VBN:1 
1 underrepresented JJ:1 
1 undernutrition NN:1 
1 undecylprodigiosin NN:1 
1 undecapeptide NN:1 
1 unde3r IN:1 
1 und CC:1 
1 uncovers VBZ:1 
1 uncoupling NN:1 
1 uncoupled VBD:1 
1 unconventional JJ:1 
1 uncontrolled JJ:1 
1 uncomplicated JJ:1 
1 uncommonly RB:1 
1 uncommon JJ:1 
1 uncharted JJ:1 
1 unavailable JJ:1 
1 unambiguously RB:1 
1 ultraviolet JJ:1 
1 ultrastructure NN:1 
1 ultrastructural JJ:1 
1 ultimate JJ:1 
1 ubiquitinylating VBG:1 
1 ubiquitinated VBN:1 
1 ubiquitin-protein JJ:1 
1 ubiquitin-carrier JJ:1 
1 ubiquitin-activating JJ:1 
1 ubiquitin- JJ:1 
1 ubiquination NN:1 
1 u.v. NN:1 
1 u VBN:1 
1 tyrosine-containing JJ:1 
1 typed VBN:1 
1 type-specificity NN:1 
1 type-pml/RAR NN:1 
1 type-C JJ:1 
1 type-2 JJ:1 
1 ty NNS:1 
1 two-thirds CD:1 
1 two-phase JJ:1 
1 two-layer JJ:1 
1 two-handed JJ:1 
1 twisted JJ:1 
1 twice/d RB:1 
1 twentyfold JJ:1 
1 twelve CD:1 
1 turnover-degradation NN:1 
1 turning VBG:1 
1 tuning NN:1 
1 tumoral JJ:1 
1 tumor/growth NN:1 
1 tumor-eradicating JJ:1 
1 tumor-bearing NN:1 
1 tumor-associated JJ:1 
1 tumeric JJ:1 
1 tubulointerstitium NN:1 
1 tubulointerstitial JJ:1 
1 tubular JJ:1 
1 tuberculin NN:1 
1 tubal JJ:1 
1 tu NN:1 
1 tt NN:1 
1 tsg101 NN:1 
1 ts VBZ:1 
1 try VB:1 
1 troublesome JJ:1 
1 tropisms NNS:1 
1 tropic JJ:1 
1 trophoblasts NNS:1 
1 trolox NN:1 
1 tritiated JJ:1 
1 trisubstituted JJ:1 
1 triplet NN:1 
1 triple-labellings NNS:1 
1 triphosphate NN:1 
1 tripartite JJ:1 
1 trilineage NN:1 
1 triidothyronine NN:1 
1 triglycerides NNS:1 
1 trifluoromethylketones NNS:1 
1 trifluoromethylketone NN:1 
1 trifluoperazine NN:1 
1 triepoxide NN:1 
1 tricyclic JJ:1 
1 trichostatin NN:1 
1 triangle NN:1 
1 triamcinolone NN:1 
1 trial NN:1 
1 tri-molecular JJ:1 
1 trends NNS:1 
1 trating VBG:1 
1 traps VBZ:1 
1 trapped VBN:1 
1 trapoxin NN:1 
1 transwell NN:1 
1 transversion NN:1 
1 transrepressor NN:1 
1 transplants NNS:1 
1 transplantations NNS:1 
1 transmitting VBG:1 
1 transmits VBZ:1 
1 transluminal JJ:1 
1 translocalization NN:1 
1 translation-dependent JJ:1 
1 transited VBN:1 
1 transient-cotransfection NN:1 
1 transglycosylase NN:1 
1 transglutaminase-dependent JJ:1 
1 transgenic-mouse JJ:1 
1 transgenesis NN:1 
1 transgenes NNS:1 
1 transformations NNS:1 
1 transformation-related JJ:1 
1 transformation-competent JJ:1 
1 transformation-associated JJ:1 
1 transformants NNS:1 
1 transformant NN:1 
1 transfection-cocultivation NN:1 
1 transfectin NN:1 
1 transfect VB:1 
1 transduction/ NN:1 
1 transcriptions NNS:1 
1 transcriptionally-active JJ:1 
1 transcription/translation NN:1 
1 transcription/repair NN:1 
1 transcription-regulating JJ:1 
1 transcription-enhancing JJ:1 
1 transcription-enhancer JJ:1 
1 transcription-activation JJ:1 
1 transcription-PCR-based JJ:1 
1 transcription-4 NN:1 
1 transcription-1alpha NN:1 
1 transcript-2/leukocyte NN:1 
1 transcribing VBG:1 
1 transaminase NN:1 
1 transactivator-induced JJ:1 
1 transactivator-independent JJ:1 
1 transactivator-encoding JJ:1 
1 transacting VBG:1 
1 trans-gene JJ:1 
1 trans-factor NN:1 
1 trans-disulfide NN:1 
1 trans-dimers NNS:1 
1 trans-dimer NN:1 
1 trans-cellular JJ:1 
1 trans-active JJ:1 
1 trans-activati JJ:1 
1 trans-_dominant JJ:1 
1 trans-_activator NN:1 
1 tranfection NN:1 
1 tran NN:1 
1 tramtrack NN:1 
1 traditionally RB:1 
1 traditional JJ:1 
1 tracts NNS:1 
1 tract-binding JJ:1 
1 tracking NN:1 
1 traces NNS:1 
1 toxin-I NN:1 
1 toxin-1 NN:1 
1 toxicities NNS:1 
1 toxic/septic JJ:1 
1 tow NN:1 
1 toto NN:1 
1 tosylphenylalanyl NN:1 
1 tosyl-phechloromethylketone NN:1 
1 topical JJ:1 
1 topic JJ:1 
1 top NN:1 
1 tonsil-_derived JJ:1 
1 tone NN:1 
1 tomography NN:1 
1 tolerization NN:1 
1 toler NN:1 
1 tobacco NN:1 
1 titre NN:1 
1 titration NN:1 
1 titrating VBG:1 
1 tissular JJ:1 
1 tissue-type NN:1 
1 tissue-infiltrating JJ:1 
1 tissue-damaging JJ:1 
1 tip NN:1 
1 time-response JJ:1 
1 time-frame NN:1 
1 tighter JJR:1 
1 tigenic JJ:1 
1 tie VB:1 
1 thyroids NNS:1 
1 thyroiditis NN:1 
1 thymuses NNS:1 
1 thymus-specific JJ:1 
1 thymus-dependent JJ:1 
1 throughput NN:1 
1 thrombomodulin NN:1 
1 thrombogenic JJ:1 
1 thrombogenesis NN:1 
1 thrombin-induced JJ:1 
1 thrombin-activated JJ:1 
1 three-layer JJ:1 
1 three- CD:1 
1 threatened VBN:1 
1 thoroughly RB:1 
1 thiol/disulfide NN:1 
1 thiol-containing JJ:1 
1 thioglycollate-activated JJ:1 
1 thioglucose NN:1 
1 thiobarbituric JJ:1 
1 thioanhydride NN:1 
1 thin-layer JJ:1 
1 thigh NN:1 
1 thick JJ:1 
1 thiazolidinedione JJ:1 
1 therapeutics NNS:1 
1 therapeutically RB:1 
1 therapeutical JJ:1 
1 theory NN:1 
1 theories NNS:1 
1 theme NN:1 
1 that. IN:1 
1 thalassemias NNS:1 
1 tha IN:1 
1 th DT:1 
1 tetraproline JJ:1 
1 tetraploid JJ:1 
1 tetrahydropapaveroline NN:1 
1 tetrahydrocortisone NN:1 
1 tetradecanoyl NN:1 
1 tetracycline-regulated JJ:1 
1 tetracycline-regulatable JJ:1 
1 tetra- JJ:1 
1 tethered VBN:1 
1 testis-determining JJ:1 
1 tertiary-butyl NN:1 
1 ternary JJ:1 
1 terminates VBZ:1 
1 terminals NNS:1 
1 teratogenic JJ:1 
1 tentatively RB:1 
1 tentative JJ:1 
1 teniposide NN:1 
1 tenfold JJ:1 
1 tends VBZ:1 
1 tending VBG:1 
1 tendency NN:1 
1 tended VBD:1 
1 tend VBP:1 
1 tenascin NN:1 
1 tenacious JJ:1 
1 temporary JJ:1 
1 tegument-specific JJ:1 
1 teceptor NN:1 
1 tautomycin NN:1 
1 tat/AS NN:1 
1 tasks NNS:1 
1 tartrate JJ:1 
1 targetted VBN:1 
1 target- NN:1 
1 tar-independent JJ:1 
1 tapered VBD:1 
1 tant JJ:1 
1 talking NN:1 
1 talk NN:1 
1 tal-15 NN:1 
1 tails NNS:1 
1 tag NN:1 
1 t_(1;14) NN:1 
1 t_(15;17) NN:1 
1 tRNA NN:1 
1 t-test NN:1 
1 t(Y;15)/45,X NN:1 
1 t(X;14)(q28;q11) NN:1 
1 t(9;22)(q34;q11) NN:1 
1 t(9;14)(p13;q32) NN:1 
1 t(7;14)(q35;q32.1) NN:1 
1 t(6;17)(q14;q24) NN:1 
1 t(3;3) NN:1 
1 t(3;21)(q26;q22) NN:1 
1 t(3;14)_(q27;q32) NN:1 
1 t(3;12) NN:1 
1 t(1;19) NN:1 
1 t(17;19)_(q22;p13) NN:1 
1 t(17;19)-bearing JJ:1 
1 t(17;19)(q22;p13) NN:1 
1 t(15;17)(q22;q21 NN:1 
1 t(14;14)(q11;q32.1) NN:1 
1 t(12;15) NN:1 
1 t(11;17)(q23;q21) NN:1 
1 t(11;17)(q13;121) NN:1 
1 t(11;17) NN:1 
1 t(10;11)(p13;q14) NN:1 
1 t(10;11)(p12-14;q13-21) NN:1 
1 systemically RB:1 
1 systematically RB:1 
1 system-derived JJ:1 
1 syphilitic JJ:1 
1 syphilis NN:1 
1 synthesizing VBG:1 
1 synoviocytes NNS:1 
1 syngeneic JJ:1 
1 synergist NN:1 
1 syncytium-forming JJ:1 
1 syncytium NN:1 
1 synchronization NN:1 
1 synaptic JJ:1 
1 symptomatic JJ:1 
1 symmetrical JJ:1 
1 symmetric JJ:1 
1 symbol NN:1 
1 symbiotic JJ:1 
1 syk NN:1 
1 swit NN:1 
1 swap NN:1 
1 sustaining VBG:1 
1 sustainably RB:1 
1 suspension NN:1 
1 suspect VBP:1 
1 survivor NN:1 
1 surveyed VBN:1 
1 surrogates NNS:1 
1 surgical JJ:1 
1 surfactants NNS:1 
1 suramin NN:1 
1 supratherapeutic JJ:1 
1 supraoptimal JJ:1 
1 supramaximal JJ:1 
1 suprachiasmatic JJ:1 
1 suppressor/cytotoxic JJ:1 
1 suppressor-inducer JJ:1 
1 supposedly RB:1 
1 suppose VBP:1 
1 supplementing VBG:1 
1 supershifts NNS:1 
1 supershifting VBG:1 
1 superinfection NN:1 
1 supercoiled JJ:1 
1 superaddition NN:1 
1 superactivation NN:1 
1 superactivates VBZ:1 
1 super-shift JJ:1 
1 super-induction NN:1 
1 super-induced VBD:1 
1 super JJ:1 
1 sunlight NN:1 
1 sun NN:1 
1 summarized VBN:1 
1 sum NN:1 
1 sulphate NN:1 
1 sulfoxide-induced JJ:1 
1 sulfated JJ:1 
1 sulfatase NN:1 
1 suited VBN:1 
1 suitably RB:1 
1 suicidal JJ:1 
1 suggestions NNS:1 
1 sugges VBZ:1 
1 suffices VBZ:1 
1 sudden JJ:1 
1 succinimide-containing JJ:1 
1 successes NNS:1 
1 success NN:1 
1 subvolumes NNS:1 
1 subverts VBZ:1 
1 subvert VB:1 
1 subtraction NN:1 
1 subtoxic JJ:1 
1 subtelomeric JJ:1 
1 substrate-1 NN:1 
1 substrata NNS:1 
1 substoichiometric JJ:1 
1 substantiates VBZ:1 
1 substantiate VB:1 
1 subst NNS:1 
1 subset-restricted JJ:1 
1 subserves VBZ:1 
1 subordinate JJ:1 
1 suboptimally RB:1 
1 submandibular JJ:1 
1 sublytic JJ:1 
1 sublines NNS:1 
1 subfragments NNS:1 
1 subepithelium NN:1 
1 subendothelium NN:1 
1 subdividing VBG:1 
1 subdiploid JJ:1 
1 subcytotoxic JJ:1 
1 subcloning NN:1 
1 subcloned VBN:1 
1 subclinically RB:1 
1 subclinical JJ:1 
1 subclassifying VBG:1 
1 subclassification NN:1 
1 sub-unit NN:1 
1 sub-optimal JJ:1 
1 structure/function NN:1 
1 structure-based JJ:1 
1 structure-activity JJ:1 
1 stromal-derived JJ:1 
1 stringently RB:1 
1 stressing VBG:1 
1 stress-responsive JJ:1 
1 stress-inducing JJ:1 
1 stress-dependent JJ:1 
1 stress- JJ:1 
1 streptoavidin JJ:1 
1 strengthen VBP:1 
1 strategic JJ:1 
1 stops VBZ:1 
1 stopped VBD:1 
1 stone-forming JJ:1 
1 stomach NN:1 
1 stochastic JJ:1 
1 stimulus-responsive JJ:1 
1 stimulus-mediated JJ:1 
1 stimuli-induced JJ:1 
1 stimulation-induced JJ:1 
1 stimulatio NN:1 
1 stimulat VB:1 
1 stimulants NNS:1 
1 stigmata NN:1 
1 sterol- NN:1 
1 steroidogram NN:1 
1 steroidal JJ:1 
1 steroid-thyroid JJ:1 
1 steroid-binding JJ:1 
1 steroid-MR JJ:1 
1 sterile JJ:1 
1 step-wise RB:1 
1 stem/progenitor NN:1 
1 stearic JJ:1 
1 stay VBP:1 
1 statistically-significant JJ:1 
1 stationary-phase-dependent JJ:1 
1 stationary-phase NN:1 
1 stated VBN:1 
1 starts VBZ:1 
1 staphylococci NNS:1 
1 stains NNS:1 
1 staging NN:1 
1 stages. UNKNOWN:1 
1 stage-specificity NN:1 
1 stabilizers NNS:1 
1 stabilised VBD:1 
1 ssp. FW:1 
1 ssion NN:1 
1 ssential JJ:1 
1 src-family NN:1 
1 squelches VBZ:1 
1 squelch VB:1 
1 sprue NN:1 
1 spreads VBZ:1 
1 spray NN:1 
1 spouse NN:1 
1 splice/polyadenylation NN:1 
1 spleen-cell JJ:1 
1 spinous JJ:1 
1 spice NN:1 
1 spi-B NN:1 
1 spermine NN:1 
1 spermatogonia NN:1 
1 spermatogenesis NN:1 
1 speculation NN:1 
1 spectroscopy NN:1 
1 spectrometry NN:1 
1 spectra NNS:1 
1 speckled JJ:1 
1 specified VBN:1 
1 specific-transcription NN:1 
1 species-specific JJ:1 
1 species-mediated JJ:1 
1 speaks VBZ:1 
1 sparingly RB:1 
1 spares VBZ:1 
1 spared VBN:1 
1 spacings NNS:1 
1 soundness NN:1 
1 sound JJ:1 
1 soot NN:1 
1 son NN:1 
1 solvent/media NN:1 
1 solved VBN:1 
1 solutions NNS:1 
1 sodium/proton-exchanger NN:1 
1 soccer NN:1 
1 so-far-unrecognized JJ:1 
1 sn-1 NN:1 
1 smear NN:1 
1 smallest JJS:1 
1 slot NN:1 
1 slope NN:1 
1 slipped JJ:1 
1 slides NNS:1 
1 slgM- JJ:1 
1 slg+B- NN:1 
1 skews VBZ:1 
1 skewer NN:1 
1 skewedness NN:1 
1 skew VB:1 
1 six-base-pair JJ:1 
1 situated JJ:1 
1 site/s NNS:1 
1 site-mediated JJ:1 
1 site-forming JJ:1 
1 site-binding JJ:1 
1 sinus NN:1 
1 singly RB:1 
1 single-residue NN:1 
1 single-positive JJ:1 
1 single-point JJ:1 
1 simulation NN:1 
1 simulating VBG:1 
1 simulated JJ:1 
1 simplifies VBZ:1 
1 silica NN:1 
1 silencers NNS:1 
1 silenced VBN:1 
1 significative JJ:1 
1 signal-transmitting JJ:1 
1 signal-related JJ:1 
1 signal-mediating JJ:1 
1 signal-mediated JJ:1 
1 signal-coupled JJ:1 
1 sign NN:1 
1 side-effects NNS:1 
1 sib-pair NN:1 
1 sialylated VBN:1 
1 sialoglycoprotein NN:1 
1 shuttles VBZ:1 
1 shutdown NN:1 
1 shut-down NN:1 
1 shut VBD:1 
1 short- JJ:1 
1 sheep NN:1 
1 shear- NN:1 
1 sharply RB:1 
1 shaping NN:1 
1 shaped VBN:1 
1 sham-exposed VBN:1 
1 shall MD:1 
1 sexually RB:1 
1 sex-reversed JJ:1 
1 sex-binding JJ:1 
1 seventeen CD:1 
1 seven-transmembrane-domain NN:1 
1 settled VBN:1 
1 settings NNS:1 
1 sessile NN:1 
1 serum-response JJ:1 
1 serum-independent JJ:1 
1 serum-grown JJ:1 
1 serum- NN:1 
1 serpentine NN:1 
1 serotype NN:1 
1 serological JJ:1 
1 seroconverted VBN:1 
1 seriously RB:1 
1 serine/threonine-specific JJ:1 
1 serine-specific JJ:1 
1 serine-phenylalanine JJ:1 
1 serine-727 NN:1 
1 serine-36 NN:1 
1 serine-32 NN:1 
1 serial JJ:1 
1 sequesters VBZ:1 
1 sequence-related JJ:1 
1 sequence- NN:1 
1 sepsis-associated JJ:1 
1 separations NNS:1 
1 sensorgrams NNS:1 
1 sensitize VB:1 
1 sensitively RB:1 
1 sensation NN:1 
1 semisolid JJ:1 
1 semiquantitate VB:1 
1 semipurified VBN:1 
1 semimature JJ:1 
1 semi-purified JJ:1 
1 semi-dominant JJ:1 
1 semen NN:1 
1 self-tolerance NN:1 
1 self-sustained JJ:1 
1 self-perpetuation NN:1 
1 self-perpetuating JJ:1 
1 self-perpetuated JJ:1 
1 self-limiting JJ:1 
1 self-distructed JJ:1 
1 self-antigen NN:1 
1 self-Ags NNS:1 
1 selenite NN:1 
1 selects VBZ:1 
1 selectins NNS:1 
1 selectable JJ:1 
1 segregate VBP:1 
1 sedimented VBD:1 
1 sed VBN:1 
1 secures VBZ:1 
1 sectioning NN:1 
1 section NN:1 
1 secretory/transport NN:1 
1 secretes VBZ:1 
1 secreted-type JJ:1 
1 secretable JJ:1 
1 secosterol NN:1 
1 secondarily RB:1 
1 second-site JJ:1 
1 second-degree JJ:1 
1 seborrheic JJ:1 
1 seasonal JJ:1 
1 sealing VBG:1 
1 scription NN:1 
1 screenings NNS:1 
1 scrambled VBN:1 
1 scientific JJ:1 
1 schizophrenic JJ:1 
1 schizophrenia NN:1 
1 scattered VBN:1 
1 scanty JJ:1 
1 scant JJ:1 
1 scan VB:1 
1 scaffold NN:1 
1 saturation NN:1 
1 satisfy VB:1 
1 satisfactorily RB:1 
1 sarcophytol NN:1 
1 sarcoma/leukemia NN:1 
1 sarco NN:1 
1 saphenous JJ:1 
1 sandwiched JJ:1 
1 sampling NN:1 
1 salt-transformed JJ:1 
1 salt-losing JJ:1 
1 salient JJ:1 
1 safer JJR:1 
1 sacrificed VBN:1 
1 sIg+ NN:1 
1 sCD8 NN:1 
1 sCD4 NN:1 
1 s.c. NN:1 
1 ruptured VBN:1 
1 runting NN:1 
1 runoff JJ:1 
1 run-off JJ:1 
1 run NN:1 
1 rules NNS:1 
1 rule NN:1 
1 routes NNS:1 
1 route NN:1 
1 rough JJ:1 
1 rotamers NNS:1 
1 rose VBD:1 
1 rom IN:1 
1 rol NN:1 
1 rodents NNS:1 
1 robustly RB:1 
1 risks NNS:1 
1 rises VBZ:1 
1 rigidly RB:1 
1 rigid JJ:1 
1 rightward JJ:1 
1 right JJ:1 
1 riend NN:1 
1 richly RB:1 
1 ribonucleoproteins NNS:1 
1 ribonucleoprotein NN:1 
1 rhythmic JJ:1 
1 rhombotin-2 NN:1 
1 rhodamine NN:1 
1 rhizome NN:1 
1 rhTNF-alpha NN:1 
1 rhIL-2 NN:1 
1 rexpression NN:1 
1 revisited VBN:1 
1 reverting VBG:1 
1 revertants NNS:1 
1 revertant NN:1 
1 reverse-transcription JJ:1 
1 reuptake NN:1 
1 returns VBZ:1 
1 retrovirus-transduced JJ:1 
1 retrovirus-mediated JJ:1 
1 retrovirus-like JJ:1 
1 retrovirally RB:1 
1 retrodifferentiated VBN:1 
1 retrievable JJ:1 
1 retinoid-resistant JJ:1 
1 retinoid-mediated JJ:1 
1 retinoid-X NN:1 
1 reticuloendotheliosis NN:1 
1 retargeting NN:1 
1 retarget VB:1 
1 retard VB:1 
1 resuscitation NN:1 
1 resurgence NN:1 
1 resumption NN:1 
1 resume VB:1 
1 resu NNS:1 
1 restrictive JJ:1 
1 restrict VB:1 
1 restitutes VBZ:1 
1 responsivity NN:1 
1 response-specific JJ:1 
1 respiration NN:1 
1 resorption NN:1 
1 residue-long JJ:1 
1 resected JJ:1 
1 reprogrammed VBN:1 
1 reprogramme VBP:1 
1 reproducing VBG:1 
1 reproducibly RB:1 
1 reproducible JJ:1 
1 reproducibility NN:1 
1 repressor/activator NN:1 
1 repressio NN:1 
1 representational JJ:1 
1 representating VBG:1 
1 repositioned VBN:1 
1 reporter-gene JJ:1 
1 repopulating VBG:1 
1 replicative/cytopathic JJ:1 
1 replication-incompetent JJ:1 
1 replenished VBN:1 
1 replating VBG:1 
1 replacing VBG:1 
1 replaces VBZ:1 
1 rephosphorylation NN:1 
1 rephosphorylated VBN:1 
1 repeatedly RB:1 
1 repeat-luciferase JJ:1 
1 repeat-chloramphenicol NN:1 
1 repeat-KB NN:1 
1 repeat-CAT JJ:1 
1 repair/transcription NN:1 
1 renewed JJ:1 
1 rendering VBG:1 
1 renamed VBN:1 
1 removing VBG:1 
1 remodel VB:1 
1 remedies NNS:1 
1 remainders NNS:1 
1 relocation NN:1 
1 relieving VBG:1 
1 relieves VBZ:1 
1 relieved VBN:1 
1 relieve VBP:1 
1 reliably RB:1 
1 reliability NN:1 
1 relaxing NN:1 
1 relations NNS:1 
1 relates VBZ:1 
1 relapses NNS:1 
1 rejecting VBG:1 
1 reinvestigated VBN:1 
1 reintroduction NN:1 
1 reinitiated VBD:1 
1 reinforcing VBG:1 
1 reinforce VB:1 
1 reinfection NN:1 
1 regulators/adapters NNS:1 
1 regulations NNS:1 
1 regional JJ:1 
1 region-specific JJ:1 
1 regime NN:1 
1 regeneration NN:1 
1 regarded VBN:1 
1 regained VBN:1 
1 regain VB:1 
1 reflex-tachycardia NN:1 
1 reflection NN:1 
1 refined VBD:1 
1 ref. NN:1 
1 reestablished VBD:1 
1 reentered VBD:1 
1 redundantly RB:1 
1 redox-regulatory JJ:1 
1 redox-dependent JJ:1 
1 redefining VBG:1 
1 recycling NN:1 
1 recurring VBG:1 
1 recultured VBN:1 
1 rectifier NN:1 
1 rectified VBD:1 
1 rectal JJ:1 
1 recovers VBZ:1 
1 recoverable JJ:1 
1 recorded VBN:1 
1 reconstructed VBN:1 
1 recommended VBN:1 
1 recombination-activating JJ:1 
1 recombinants NNS:1 
1 recombina JJ:1 
1 recognised VBN:1 
1 recloning VBG:1 
1 recipient NN:1 
1 recessiveness NN:1 
1 recessively RB:1 
1 receptor/toll-like JJ:1 
1 receptor/s NNS:1 
1 receptor/progesterone NN:1 
1 receptor-triggered JJ:1 
1 receptor-receptor JJ:1 
1 receptor-like JJ:1 
1 receptor-initiated JJ:1 
1 receptor-gamma NN:1 
1 receptor-effector-mechanisms NNS:1 
1 receptor-derived JJ:1 
1 receptor-coupled JJ:1 
1 receptor-containing JJ:1 
1 receptor-cDNA NN:1 
1 receptor-binding JJ:1 
1 receptor-beta NN:1 
1 receptor-activated JJ:1 
1 receptor-/- JJ:1 
1 receptor- NN:1 
1 receptivity NN:1 
1 recent-onset JJ:1 
1 receive VBP:1 
1 recall NN:1 
1 recalcitrant JJ:1 
1 rebound NN:1 
1 reassigned VBN:1 
1 reassembly NN:1 
1 reasonably RB:1 
1 rearranges VBZ:1 
1 reared VBN:1 
1 reappears VBZ:1 
1 really RB:1 
1 reality NN:1 
1 reaffirm VBP:1 
1 ready JJ:1 
1 readout NN:1 
1 readdressed VBN:1 
1 read VBN:1 
1 reactvation NN:1 
1 reaction-based JJ:1 
1 reaches VBZ:1 
1 re-establishes VBZ:1 
1 re NN:1 
1 rationalize VB:1 
1 rationale NN:1 
1 rational JJ:1 
1 ratio-dependent JJ:1 
1 ras-transformed JJ:1 
1 ras-induced JJ:1 
1 rapidity NN:1 
1 rapamycin-sensitive JJ:1 
1 rapamycin-resistant JJ:1 
1 rapamycin-regulated JJ:1 
1 ranking NN:1 
1 rampant JJ:1 
1 raf NN:1 
1 radixin NN:1 
1 radiometric JJ:1 
1 radiologic JJ:1 
1 radiolabelled JJ:1 
1 radioiodine NN:1 
1 radioimmunoassay NN:1 
1 radioimmune JJ:1 
1 radioactively RB:1 
1 radical-induced JJ:1 
1 radical-generating JJ:1 
1 rachitic JJ:1 
1 race- NN:1 
1 ra NN:1 
1 rNF-IL6 NN:1 
1 rIL-2 NN:1 
1 rIFN-alpha NN:1 
1 rCTLA4Ig NN:1 
1 r-h-TBP-1 NN:1 
1 r-h JJ:1 
1 quirement NN:1 
1 quinone NN:1 
1 quieiescent JJ:1 
1 quasispecies NNS:1 
1 quantity NN:1 
1 quantitation NN:1 
1 quantitate VB:1 
1 quantified VBN:1 
1 qi-invigorating JJ:1 
1 q27 NN:1 
1 q26 NN:1 
1 q23-31 NN:1 
1 q23 NN:1 
1 q13 NN:1 
1 q11 NN:1 
1 pyrrole-imidazole JJ:1 
1 pyrolidine NN:1 
1 puzzles NNS:1 
1 puzzle NN:1 
1 putatively RB:1 
1 put VBP:1 
1 purulent JJ:1 
1 purine-box/nuclear JJ:1 
1 purine-box/antigen NN:1 
1 purine-box/ARRE/NF-AT NN:1 
1 purine-box JJ:1 
1 purify VB:1 
1 puri NN:1 
1 purely RB:1 
1 pulsewise RB:1 
1 pulses NNS:1 
1 pulse-exposed JJ:1 
1 pulse-chase JJ:1 
1 pulp NN:1 
1 pull-down JJ:1 
1 pterin NN:1 
1 pseudohyperaldosteronism NN:1 
1 pseudogenes NNS:1 
1 pseudo-tumor NN:1 
1 pseudo-hypoaldosteronism NN:1 
1 prudence NN:1 
1 provocative JJ:1 
1 provocation NN:1 
1 provisional JJ:1 
1 proves VBZ:1 
1 protozoan NN:1 
1 protozoa NN:1 
1 protodrug NN:1 
1 proto NN:1 
1 prothrombinase NN:1 
1 proteolyzed VBN:1 
1 proteolysis-resisting JJ:1 
1 protein/protein NN:1 
1 protein/drug NN:1 
1 protein/activating NN:1 
1 protein. NN:1 
1 protein-responsive JJ:1 
1 protein-free JJ:1 
1 protein-beta NN:1 
1 protein-affinity JJ:1 
1 protein-3 NN:1 
1 protein-2- NN:1 
1 proteic JJ:1 
1 proteasomes NNS:1 
1 proteasome-mediated JJ:1 
1 proteasomal JJ:1 
1 protease-treated JJ:1 
1 prot NN:1 
1 prospectively RB:1 
1 proposing VBG:1 
1 proposes VBZ:1 
1 proposal NN:1 
1 propensity NN:1 
1 propel VB:1 
1 propagating VBG:1 
1 propagates VBZ:1 
1 prooxidants NNS:1 
1 proof-of-principle NN:1 
1 pronouncedly RB:1 
1 promyelomonocytic JJ:1 
1 promyelocytic/retinoic JJ:1 
1 promyelocyte-late JJ:1 
1 prompting VBG:1 
1 prompt VBP:1 
1 promoterless JJ:1 
1 promoter/enhancer-luciferase NN:1 
1 promoter/enhancer- NN:1 
1 promoter/5'-flank NN:1 
1 promoter/ NN:1 
1 promoter-specific JJ:1 
1 promoter-responsive JJ:1 
1 promoter-distal JJ:1 
1 promoter-bound JJ:1 
1 promoter-beta-galactosidase NN:1 
1 promoter-based JJ:1 
1 promot NN:1 
1 promonocyte JJ:1 
1 promises VBZ:1 
1 promise NN:1 
1 prominently RB:1 
1 promelocytic JJ:1 
1 prolines NNS:1 
1 proline- NN:1 
1 proliferators NNS:1 
1 proliferation/differentiation NN:1 
1 proliferation-specific JJ:1 
1 proliferation-associated JJ:1 
1 prolactin-responsive JJ:1 
1 prolactin-induced JJ:1 
1 projected VBN:1 
1 prohibited VBD:1 
1 progressing VBG:1 
1 progestin NN:1 
1 progesterone-mediated JJ:1 
1 progesterone-induced JJ:1 
1 progenitor/precursor NN:1 
1 progenitor-specific JJ:1 
1 profusely RB:1 
1 profilin-like JJ:1 
1 profilin NN:1 
1 profibrotic JJ:1 
1 proerythroblasts NNS:1 
1 production/oxidative JJ:1 
1 productio NN:1 
1 producers NNS:1 
1 producer NN:1 
1 prodrugs NNS:1 
1 prodigiosin NN:1 
1 procoagulant NN:1 
1 processivity NN:1 
1 probucol NN:1 
1 probable JJ:1 
1 pro-oxidative JJ:1 
1 pro-opiomelanocortin JJ:1 
1 pro-interleukin-1beta JJ:1 
1 pro-interleukin NN:1 
1 pro-coagulant JJ:1 
1 pro-/antiinflammatory JJ:1 
1 primordia NN:1 
1 primes VBZ:1 
1 prickle NN:1 
1 prevailing VBG:1 
1 presurgical JJ:1 
1 prestimulation NN:1 
1 pressures NNS:1 
1 press NN:1 
1 preservation NN:1 
1 presenters NNS:1 
1 prescription NN:1 
1 prescribed VBN:1 
1 prepartal JJ:1 
1 prepares VBZ:1 
1 prepare VB:1 
1 preovulatory JJ:1 
1 preosteoclast/ JJ:1 
1 preosteoclast JJ:1 
1 prematurely RB:1 
1 preleukemia NN:1 
1 preleukaemic JJ:1 
1 preinjured JJ:1 
1 pregerminal JJ:1 
1 preferably RB:1 
1 preexist VBP:1 
1 preeminent JJ:1 
1 predominate VBP:1 
1 precursers NNS:1 
1 precondition NN:1 
1 precluding VBG:1 
1 precluded VBD:1 
1 precipitating VBG:1 
1 preceeded VBD:1 
1 preceding VBG:1 
1 precede VBP:1 
1 precautions NNS:1 
1 precancerous JJ:1 
1 prebed JJ:1 
1 preadsorbed VBN:1 
1 pre-terminal JJ:1 
1 pre-term JJ:1 
1 pre-monocytic JJ:1 
1 pre-messenger NN:1 
1 pre-mRNA NN:1 
1 pre-leukemic JJ:1 
1 pre-incubation NN:1 
1 pre-formed JJ:1 
1 pre-culture JJ:1 
1 pre-bound JJ:1 
1 pre-Talpha JJ:1 
1 pre-B- JJ:1 
1 practically RB:1 
1 pp70(s6k) NN:1 
1 pp36-38 NN:1 
1 pp36 NN:1 
1 pp125FAK NN:1 
1 poxvirus NN:1 
1 pouch NN:1 
1 postvaccine JJ:1 
1 postulates VBZ:1 
1 posttreatment NN:1 
1 posttransplant JJ:1 
1 postreceptor NN:1 
1 postoperatively RB:1 
1 postinduction JJ:1 
1 postgerminal JJ:1 
1 postcapillary JJ:1 
1 postanoxic JJ:1 
1 postactivation NN:1 
1 post/pre JJ:1 
1 post-triggering JJ:1 
1 post-transcription JJ:1 
1 post-stimulation NN:1 
1 post-nuclear JJ:1 
1 post-inductive JJ:1 
1 post-dosing JJ:1 
1 post-PMA NN:1 
1 possibilities NNS:1 
1 positive/negative JJ:1 
1 positive-negative JJ:1 
1 positive- JJ:1 
1 positionally RB:1 
1 position- NN:1 
1 posit VBP:1 
1 porphobilinogen NN:1 
1 poromas NNS:1 
1 porcellus NN:1 
1 poorest JJ:1 
1 polyubiquitinylation NN:1 
1 polyubiquitinated VBN:1 
1 polysomy NN:1 
1 polysaccharides NNS:1 
1 polysaccharide NN:1 
1 polypyrimidine NN:1 
1 polypryrimidine-binding JJ:1 
1 polyoma NN:1 
1 polymyxin NN:1 
1 polymorphonucleate JJ:1 
1 polymerases NNS:1 
1 polymerase-associated JJ:1 
1 polymer NN:1 
1 polyether JJ:1 
1 polychlorinated VBN:1 
1 polyanionic JJ:1 
1 polyadenylylation NN:1 
1 polyadenylated JJ:1 
1 poly_(I).poly_(C) NN:1 
1 poly[d(I-C)] NN:1 
1 polyA+ JJ:1 
1 poly(I)-poly(C)-induced JJ:1 
1 poly(A)+ JJ:1 
1 poly( JJ:1 
1 poly NN:1 
1 pollution NN:1 
1 polarization NN:1 
1 poised VBN:1 
1 pointing VBG:1 
1 pneumonitis NN:1 
1 pneumoniae-mediated JJ:1 
1 pmol/mg NN:1 
1 pml/ NN:1 
1 pml NN:1 
1 plotted VBN:1 
1 ploidy NN:1 
1 plethora NN:1 
1 pleckstrin-homology JJ:1 
1 playing VBG:1 
1 players NNS:1 
1 plausible JJ:1 
1 plausibility NN:1 
1 platforms NNS:1 
1 platelet/endothelial JJ:1 
1 platelet-progenitor JJ:1 
1 platelet-endothelial JJ:1 
1 platelet-derived JJ:1 
1 platelet-activating-factor NN:1 
1 plated VBN:1 
1 plate-bound JJ:1 
1 plasticity NN:1 
1 plasminogen NN:1 
1 plasmide NN:1 
1 plasmic JJ:1 
1 plasmalemmal JJ:1 
1 plants NNS:1 
1 placement NN:1 
1 placebo-treated JJ:1 
1 placebo-controlled JJ:1 
1 pk NN:1 
1 pituitary-dependent JJ:1 
1 pituitary- JJ:1 
1 pits NNS:1 
1 pinpoints VBZ:1 
1 pinpointed VBN:1 
1 pinpoint VB:1 
1 pilot NN:1 
1 pills NNS:1 
1 pigs NNS:1 
1 pigmentation NN:1 
1 pigeon NN:1 
1 pieces NNS:1 
1 picornavirus NN:1 
1 picogram NN:1 
1 phytohemaglutinin NN:1 
1 phytohemagglutinin-stimulated JJ:1 
1 phytohemagglutin NN:1 
1 phyto-_hemagglutinin NN:1 
1 physiotherapy NN:1 
1 physiopathologic JJ:1 
1 physicochemical JJ:1 
1 physico-chemical JJ:1 
1 physician NN:1 
1 phrases NNS:1 
1 phox NN:1 
1 photoproducts NNS:1 
1 photoproduct NN:1 
1 photolabeled VBN:1 
1 photoactivatable JJ:1 
1 photic JJ:1 
1 phosphotyrosines NNS:1 
1 phosphotyrosine-based JJ:1 
1 phosphorylations NNS:1 
1 phosphorylation/proteolysis NN:1 
1 phosphorylation-defective JJ:1 
1 phosphorylation- JJ:1 
1 phosphoryl NN:1 
1 phosphopeptides NNS:1 
1 phosphopeptide NN:1 
1 phosphonoformic JJ:1 
1 phosphonoacetic JJ:1 
1 phosphonate-containing JJ:1 
1 phosphohydrolase NN:1 
1 phosphoform NN:1 
1 phosphatidylinositol-3-kinase NN:1 
1 phosphatidylinositol-3,4,5-trisphosphate NN:1 
1 phosphatidylinositides NNS:1 
1 phosphatidylethanolamine NN:1 
1 phosphatidylcholine NN:1 
1 phosphate-supplemented JJ:1 
1 phosphatase-positive JJ:1 
1 phosphatase-1 NN:1 
1 phorbolmyristate-acetate JJ:1 
1 phorbolester NN:1 
1 phorbol-myristate-acetate NN:1 
1 phoP/phoQ NN:1 
1 pheochromocytoma NN:1 
1 phenylpyrazolo JJ:1 
1 phenylpyrazol JJ:1 
1 phenyl NN:1 
1 phenotypical JJ:1 
1 phenol/chloroform NN:1 
1 phasing NN:1 
1 phased JJ:1 
1 phase-dependent JJ:1 
1 phase-2 NN:1 
1 pharmacophore NN:1 
1 pharmacology NN:1 
1 pharmacokinetic JJ:1 
1 pharmacok JJ:1 
1 pharmacogenetics NNS:1 
1 pharmacogenetic JJ:1 
1 pharmacodynamics NNS:1 
1 phagocyte/neutrophil NN:1 
1 phage NN:1 
1 pfu/animal NN:1 
1 pfu NN:1 
1 pets NN:1 
1 pes NNS:1 
1 pervanadate- JJ:1 
1 perturbed VBN:1 
1 pertaining VBG:1 
1 perspective NN:1 
1 personality NN:1 
1 perpetuating VBG:1 
1 perpetuated VBN:1 
1 peroxyl JJ:1 
1 peroxisome-proliferator NN:1 
1 peroxidase-antiperoxidase JJ:1 
1 permutation NN:1 
1 permissiveness NN:1 
1 permeate VB:1 
1 permeability NN:1 
1 peritoneum NN:1 
1 periplasmic JJ:1 
1 periovulatory JJ:1 
1 periodic JJ:1 
1 perihepatic JJ:1 
1 perfused VBN:1 
1 perfect JJ:1 
1 percutaneous JJ:1 
1 perception NN:1 
1 perceptible JJ:1 
1 percentages NNS:1 
1 percent-age NN:1 
1 peptidyl-prolyl JJ:1 
1 peptide/glycoprotein NN:1 
1 peptide-pulsed JJ:1 
1 peptide-mediated JJ:1 
1 peptide-affinity NN:1 
1 peptide-1 NN:1 
1 peptide- JJ:1 
1 people NN:1 
1 pentadecamer NN:1 
1 pedigree NN:1 
1 pedalled VBD:1 
1 peculiarly RB:1 
1 peculiarities NNS:1 
1 peculiar JJ:1 
1 paucity NN:1 
1 patterning NN:1 
1 patient/histopathology NN:1 
1 pathway-specific JJ:1 
1 pathway-dependent JJ:1 
1 pathogenetic JJ:1 
1 patency NN:1 
1 passaging NN:1 
1 passaged VBN:1 
1 parva-infected JJ:1 
1 participants NNS:1 
1 parenteral JJ:1 
1 parathyroidectomy NN:1 
1 parath NN:1 
1 parasitized VBN:1 
1 parasitism NN:1 
1 parasite-mediated JJ:1 
1 paraparesis/ JJ:1 
1 paralysis NN:1 
1 parallelled VBN:1 
1 parafollicular JJ:1 
1 paraffin NN:1 
1 paradox NN:1 
1 papio NN:1 
1 papillomavirus- NN:1 
1 papillomavirus NN:1 
1 papilloma NN:1 
1 papers NNS:1 
1 panoply NN:1 
1 panning NN:1 
1 panels NNS:1 
1 pan-T-lineage JJ:1 
1 pan- NN:1 
1 pan NN:1 
1 palmitic JJ:1 
1 pairwise JJ:1 
1 pagC NN:1 
1 paclitaxel-induced JJ:1 
1 packaging NN:1 
1 packaged VBN:1 
1 pace NN:1 
1 pUC NN:1 
1 pRPneo-SL3 NN:1 
1 pNF-kappa NN:1 
1 pMEP4 NN:1 
1 pIRE NN:1 
1 pI NN:1 
1 pHU-14 NN:1 
1 p97 NN:1 
1 p96 NN:1 
1 p91/84 NN:1 
1 p90RSK NN:1 
1 p8MTCP1 NN:1 
1 p84 NN:1 
1 p72 NN:1 
1 p70S6K NN:1 
1 p67SRF NN:1 
1 p65s NNS:1 
1 p65/ NN:1 
1 p65-p50 NN:1 
1 p65-RelA NN:1 
1 p65-50 NN:1 
1 p62 NN:1 
1 p56Lck NN:1 
1 p55/p75 NN:1 
1 p55/ NN:1 
1 p53-null JJ:1 
1 p53-mediated JJ:1 
1 p53-dependent JJ:1 
1 p53-/- JJ:1 
1 p52/ NN:1 
1 p50/p85 NN:1 
1 p50/p65/c-Rel NN:1 
1 p50/p65-NF-kappaB NN:1 
1 p50/p65- NN:1 
1 p50/p105-NF-kappa NN:1 
1 p50/65 NN:1 
1 p50/ NN:1 
1 p50.c-rel NN:1 
1 p50. NN:1 
1 p50-p56 NN:1 
1 p49/p52 NN:1 
1 p47 NN:1 
1 p46 NN:1 
1 p42/p44 NN:1 
1 p40-kappaB NN:1 
1 p38delta NN:1 
1 p37tax NN:1 
1 p300/CBP-type JJ:1 
1 p2l(ras) NN:1 
1 p27rex NN:1 
1 p27kip1 NN:1 
1 p26rex NN:1 
1 p21rex NN:1 
1 p21Ha-ras NN:1 
1 p210bcr-abl NN:1 
1 p21-activated JJ:1 
1 p14TCL1 NN:1 
1 p130/Rb2 NN:1 
1 p12.3 VB:1 
1 p11.23 NN:1 
1 p105/ NN:1 
1 p1-79 NN:1 
1 p.o. NN:1 
1 p.m. NN:1 
1 p-toluenesulfonic JJ:1 
1 p-nitrophenyl NN:1 
1 p-bromophenacyl-bromide NN:1 
1 p-145 NN:1 
1 oxygenation NN:1 
1 oxidoreductive JJ:1 
1 oxidizing VBG:1 
1 oxidant-rich JJ:1 
1 oxidant-initiated JJ:1 
1 overwhelming JJ:1 
1 overrepresentation NN:1 
1 overlying VBG:1 
1 overexpresses VBZ:1 
1 over-riding JJ:1 
1 over-representation NN:1 
1 over-lapping JJ:1 
1 over-expressing NN:1 
1 over-express VBP:1 
1 ove NN:1 
1 outside-in JJ:1 
1 output NN:1 
1 outpatient JJ:1 
1 outnumbered VBD:1 
1 outlines VBZ:1 
1 outlined VBN:1 
1 outgrow VB:1 
1 outcompeted VBD:1 
1 outcomes NNS:1 
1 ours PP:1 
1 oth DT:1 
1 osteosarcoma NN:1 
1 osteoprotegerin NN:1 
1 osteoporosis NN:1 
1 osteopontin NN:1 
1 osteolytic JJ:1 
1 osteoclastogenic JJ:1 
1 osteoclastic JJ:1 
1 osteocalcine NN:1 
1 osteoblasts NNS:1 
1 ostensibly RB:1 
1 ostensible JJ:1 
1 oscillatory JJ:1 
1 orthovanadate NN:1 
1 oropharynx NN:1 
1 oriented VBN:1 
1 orientations NNS:1 
1 orientation-specific JJ:1 
1 organizer NN:1 
1 organizational JJ:1 
1 organisation NN:1 
1 organic JJ:1 
1 organelles NNS:1 
1 organelle NN:1 
1 ordinarily RB:1 
1 order-dependent JJ:1 
1 orchestrate VBP:1 
1 option NN:1 
1 optimize VB:1 
1 optimization NN:1 
1 optimally RB:1 
1 oppose VB:1 
1 opportunity NN:1 
1 opportunistic JJ:1 
1 opioids NNS:1 
1 opinion NN:1 
1 operon NN:1 
1 operative JJ:1 
1 opens VBZ:1 
1 open-reading JJ:1 
1 open-label JJ:1 
1 oocyte NN:1 
1 onward RB:1 
1 one-third CD:1 
1 one-tenth CD:1 
1 one-sixth CD:1 
1 one-site JJ:1 
1 one-hybrid JJ:1 
1 one-half NN:1 
1 oncostatin NN:1 
1 oncology NN:1 
1 oncogenicity NN:1 
1 oncogenicities NNS:1 
1 oncogene-initiated JJ:1 
1 oncogene-expressing JJ:1 
1 once RB:1 
1 on/off JJ:1 
1 on-off JJ:1 
1 on-going JJ:1 
1 omitted VBN:1 
1 omega-monomethyl-L-arginine NN:1 
1 oligosaccharide NN:1 
1 oligoprobes NNS:1 
1 oligoprobe NN:1 
1 oligomerizing VBG:1 
1 oligomerized JJ:1 
1 oligodeoxyribonucleotides NNS:1 
1 oligodeoxyribonucleotide NN:1 
1 oligoclonal JJ:1 
1 oligoadenylate NN:1 
1 offersuggesting VBG:1 
1 off-rate JJ:1 
1 off RP:1 
1 of/or CC:1 
1 oestrogens NNS:1 
1 oedipus FW:1 
1 odds NNS:1 
1 october NN:1 
1 octanucleotide NN:1 
1 octamer-bound JJ:1 
1 octamer-associated JJ:1 
1 octamer-DNA NN:1 
1 octamer- JJ:1 
1 oct-2A NN:1 
1 occlusion NN:1 
1 occasions NNS:1 
1 obviated VBD:1 
1 oTAFII110 NN:1 
1 o-tetradecanoylphorbol NN:1 
1 o-phenanthroline NN:1 
1 o,o'-bismyristoyl NN:1 
1 nutritional JJ:1 
1 nullifies VBZ:1 
1 nucleosome-assembled JJ:1 
1 nucleosomal JJ:1 
1 nucleoporins NNS:1 
1 nucleoporin NN:1 
1 nucleoplasm NN:1 
1 nucleolus NN:1 
1 nucleoli JJ:1 
1 nucleocytoplasmic JJ:1 
1 nucleic JJ:1 
1 nucleation NN:1 
1 nucleates VBZ:1 
1 nuclease-hypersensitive JJ:1 
1 nuclease- JJ:1 
1 nuclearly RB:1 
1 nuclearity NN:1 
1 nuclear-located JJ:1 
1 nuclear-activating JJ:1 
1 nucl JJ:1 
1 novelty NN:1 
1 novelties NNS:1 
1 noteworthy JJ:1 
1 notch-1 NN:1 
1 not-self JJ:1 
1 northern JJ:1 
1 normoxic JJ:1 
1 normoxia NN:1 
1 normotensives NNS:1 
1 normalize VB:1 
1 norepinephrine NN:1 
1 nordihydroquairetic JJ:1 
1 nordihydroguiauretic JJ:1 
1 nordihydroguaiaretic JJ:1 
1 nontreated JJ:1 
1 nontranslated JJ:1 
1 nontranscribed JJ:1 
1 nontoxic JJ:1 
1 nontolerant JJ:1 
1 nonthymocyte JJ:1 
1 nonstructured JJ:1 
1 nonstimulating JJ:1 
1 nonstatic JJ:1 
1 nonspecifically RB:1 
1 nonsmoking JJ:1 
1 nonsense JJ:1 
1 nonselfness NN:1 
1 nonselective JJ:1 
1 nonsecreting JJ:1 
1 nonresident JJ:1 
1 nonrelated JJ:1 
1 nonrandomly RB:1 
1 nonrandom JJ:1 
1 nonpregnant JJ:1 
1 nonpilus JJ:1 
1 nonoptimal JJ:1 
1 nonmutational JJ:1 
1 nonmonocytic JJ:1 
1 nonmobilized JJ:1 
1 nonmatrix JJ:1 
1 nonmacrophage JJ:1 
1 nonlymphocytic JJ:1 
1 nonlinear JJ:1 
1 nonleukemogenic JJ:1 
1 noninvasively RB:1 
1 noninduction NN:1 
1 nonimmunocompromised JJ:1 
1 nonimmune JJ:1 
1 nonidentical JJ:1 
1 nonhomologous JJ:1 
1 nonhistone JJ:1 
1 nonhepatic JJ:1 
1 nonglucocorticoid NN:1 
1 nonfinger JJ:1 
1 nonexpression NN:1 
1 nonendocrine JJ:1 
1 nondividing JJ:1 
1 nondetectable JJ:1 
1 nondegradable JJ:1 
1 noncytoxic JJ:1 
1 noncycling JJ:1 
1 noncontiguous JJ:1 
1 noncleavable JJ:1 
1 noncatalytic JJ:1 
1 nonasthmatic JJ:1 
1 nonalcoholics NNS:1 
1 nonadherent JJ:1 
1 nonactive JJ:1 
1 nonactivating JJ:1 
1 non-voltage-gated JJ:1 
1 non-viral JJ:1 
1 non-tumorous JJ:1 
1 non-tumor JJ:1 
1 non-toxic JJ:1 
1 non-syntenic JJ:1 
1 non-steroidal JJ:1 
1 non-smokers NNS:1 
1 non-significant JJ:1 
1 non-recurrent JJ:1 
1 non-receptor JJ:1 
1 non-proliferating JJ:1 
1 non-polymorphic JJ:1 
1 non-polyadenylated JJ:1 
1 non-phlogistic JJ:1 
1 non-permissive JJ:1 
1 non-parametric JJ:1 
1 non-mammalian JJ:1 
1 non-lineage-specific JJ:1 
1 non-leukaemic JJ:1 
1 non-insulin-dependent JJ:1 
1 non-human JJ:1 
1 non-hematopoietic JJ:1 
1 non-heat JJ:1 
1 non-globin JJ:1 
1 non-genomically RB:1 
1 non-fusion JJ:1 
1 non-expressing JJ:1 
1 non-epithelial JJ:1 
1 non-dividing JJ:1 
1 non-cultured JJ:1 
1 non-cross-resisting JJ:1 
1 non-classic JJ:1 
1 non-cell-type-specific JJ:1 
1 non-applicable JJ:1 
1 non-acutely JJ:1 
1 non-abortive JJ:1 
1 non-T-lymphocytes NNS:1 
1 non-T-cells NNS:1 
1 non-PRL-secreting JJ:1 
1 non-Ig JJ:1 
1 non-DNA-binding JJ:1 
1 nomenclature NN:1 
1 node-positive JJ:1 
1 nodal JJ:1 
1 nocytic JJ:1 
1 nm23/NDP NN:1 
1 nm23-H2His NN:1 
1 nm23-H1 NN:1 
1 nitroso NN:1 
1 nitrofurantoin NN:1 
1 nitro NN:1 
1 night NN:1 
1 nicks NNS:1 
1 nickel NN:1 
1 ngal JJ:1 
1 ng/ml/h NN:1 
1 newest JJS:1 
1 newer JJR:1 
1 newborns NNS:1 
1 neutrophil-specific JJ:1 
1 neutrophil-mediated JJ:1 
1 neutrophil-like JJ:1 
1 neutropenia NN:1 
1 neutralizes VBZ:1 
1 neutralized VBD:1 
1 neuropeptides NNS:1 
1 neuropeptide NN:1 
1 neuropathogenic JJ:1 
1 neuron NN:1 
1 neuroglial JJ:1 
1 neuroectodermal JJ:1 
1 neurocutaneous JJ:1 
1 neuro-immuno JJ:1 
1 neurite NN:1 
1 neuraminidase NN:1 
1 neu-related JJ:1 
1 neu NN:1 
1 nephrotoxicity NN:1 
1 nephropathies NNS:1 
1 nephew NN:1 
1 neonate NN:1 
1 neomycin-resistance JJ:1 
1 neoglucogenesis NN:1 
1 neglect NN:1 
1 negativity NN:1 
1 needle NN:1 
1 necrotic JJ:1 
1 necessitate VBP:1 
1 near-perfect JJ:1 
1 near-basal JJ:1 
1 nd CC:1 
1 nausea NN:1 
1 naturally-occurring JJ:1 
1 native-Western JJ:1 
1 narrowly RB:1 
1 narrowing NN:1 
1 nanomolar JJ:1 
1 n-butyrate NN:1 
1 n-Acetyl-L-cysteine NN:1 
1 n-acetyl-L-cysteine NN:1 
1 myristylation NN:1 
1 myristoylated VBN:1 
1 myristate-induced JJ:1 
1 myristake NN:1 
1 myogenin NN:1 
1 myocytes NNS:1 
1 myocyte-enhancer NN:1 
1 myoblasts NNS:1 
1 myf6 NN:1 
1 myf5 NN:1 
1 myelopathy/tropical JJ:1 
1 myelomonoblasts NNS:1 
1 myelomocytic JJ:1 
1 myeloid/natural JJ:1 
1 myeloid/monocytic JJ:1 
1 myeloid/NK JJ:1 
1 myeloid-selective JJ:1 
1 myeloid-promyelocytic JJ:1 
1 myeloid- JJ:1 
1 myelofibrosis NN:1 
1 myeloblastoid JJ:1 
1 myeloblast-derived JJ:1 
1 myeloblast JJ:1 
1 myelin JJ:1 
1 mycoplasma-derived JJ:1 
1 mycoplasma NN:1 
1 mycoestrogens NNS:1 
1 myb-transformed JJ:1 
1 myb-like JJ:1 
1 muteins NNS:1 
1 mutation/deletion NN:1 
1 mutant-activated JJ:1 
1 muscles NNS:1 
1 muramyldipeptide NN:1 
1 mumol NN:1 
1 multivalent JJ:1 
1 multisubunit JJ:1 
1 multistep JJ:1 
1 multispecific JJ:1 
1 multiprotein JJ:1 
1 multipotent/erythroid/monocytic JJ:1 
1 multiplicity NN:1 
1 multiplex JJ:1 
1 multiples NNS:1 
1 multiparameter NN:1 
1 multinuclearity NN:1 
1 multimerizing VBG:1 
1 multimeric JJ:1 
1 multifocality NN:1 
1 multifocal JJ:1 
1 multidrug JJ:1 
1 multidishes NNS:1 
1 multicatalytic JJ:1 
1 multi-point JJ:1 
1 multi-organ JJ:1 
1 multi-functional JJ:1 
1 multi-agent JJ:1 
1 mucosa-associated JJ:1 
1 mucolytic JJ:1 
1 mucocutaneous JJ:1 
1 mucinous JJ:1 
1 mu/kappa NN:1 
1 mouse-repopulating JJ:1 
1 motion NN:1 
1 motif-rich JJ:1 
1 motif-1/lymphotactin NN:1 
1 motif-1 NN:1 
1 motheaten NN:1 
1 morning-to-afternoon JJ:1 
1 mor NN:1 
1 mood NN:1 
1 montana FW:1 
1 monosomy NN:1 
1 monosaccharide NN:1 
1 mononulear JJ:1 
1 mononucleated JJ:1 
1 mononitrosyl NN:1 
1 monomorphic JJ:1 
1 monocytic/myeloid JJ:1 
1 monocytic/myeloic JJ:1 
1 monocyte/neutrophil NN:1 
1 monocyte/macrophages NNS:1 
1 monocyte/macrophage-specific JJ:1 
1 monocyte-type JJ:1 
1 monocyte-mediated JJ:1 
1 monocyte-endothelial JJ:1 
1 monocyte-conditioned JJ:1 
1 monoctyes NNS:1 
1 monoclonicity NN:1 
1 monochloramine NN:1 
1 monoblast-like JJ:1 
1 monensine NN:1 
1 moment NN:1 
1 molecule/CD69 NN:1 
1 molarity NN:1 
1 mol/microgram NN:1 
1 moesin NN:1 
1 modulators NNS:1 
1 modulations NNS:1 
1 modular JJ:1 
1 modifier NN:1 
1 moderate/marked JJ:1 
1 modeling NN:1 
1 modeled VBD:1 
1 mobilizing VBG:1 
1 mo. NN:1 
1 mmon JJ:1 
1 mmHg NN:1 
1 mm NN:1 
1 mixing JJ:1 
1 mitomycin NN:1 
1 mitogenically RB:1 
1 mitogenic-activated JJ:1 
1 mitogen-induced JJ:1 
1 mite-specific JJ:1 
1 missense NN:1 
1 mispairing NN:1 
1 mismatch NN:1 
1 misleading JJ:1 
1 misfunction NN:1 
1 misdiagnosed JJ:1 
1 mirror VBP:1 
1 mink NN:1 
1 minimized VBN:1 
1 minimize VB:1 
1 mini- NN:1 
1 mineralo NN:1 
1 mineral JJ:1 
1 min/exposure NN:1 
1 milliliter NN:1 
1 milligram NN:1 
1 mild-moderate JJ:1 
1 mil. CD:1 
1 migration-promoting JJ:1 
1 mig NN:1 
1 middle-aged JJ:1 
1 midbrain JJ:1 
1 mid-late JJ:1 
1 mid-age JJ:1 
1 mid-S NN:1 
1 microvascular JJ:1 
1 microtubular JJ:1 
1 microsequence NN:1 
1 micron/ml NN:1 
1 micromol/ NN:1 
1 micrometer NN:1 
1 microgranular JJ:1 
1 micrograms/kg NNS:1 
1 micrograms/day NN:1 
1 micrograms/d NN:1 
1 microgram/mL NN:1 
1 microgram/day NNS:1 
1 microg/mL NN:1 
1 microg/g NN:1 
1 microg/100 NN:1 
1 microg/10 NN:1 
1 microg NN:1 
1 microenvironmental JJ:1 
1 microenvironment-directed JJ:1 
1 microdeletions NNS:1 
1 microdeletion NN:1 
1 micrococcal JJ:1 
1 microbiological JJ:1 
1 microbially RB:1 
1 microarrays NNS:1 
1 microarray NN:1 
1 microH NN:1 
1 microB-dependent JJ:1 
1 mgr NN:1 
1 mg/d NN:1 
1 metyrapone NN:1 
1 methyltransferase NN:1 
1 methylthiogliotoxin NN:1 
1 methylation-sensitive JJ:1 
1 methylation-free JJ:1 
1 methotrexate NN:1 
1 methane NN:1 
1 methallothionein NN:1 
1 metastasis-suppressor JJ:1 
1 metaphases NNS:1 
1 metaphase NN:1 
1 metamyelocytes NNS:1 
1 metamorphosis NN:1 
1 metalloproteinases-1 NN:1 
1 metalloproteinase-9 NN:1 
1 metabolize VB:1 
1 message-destabilizing JJ:1 
1 mesothelial JJ:1 
1 mesoderm NN:1 
1 mesenchyme NN:1 
1 mesenchymal JJ:1 
1 mesencephalon NN:1 
1 mesangial JJ:1 
1 merits NNS:1 
1 merit NN:1 
1 merging JJ:1 
1 mercury NN:1 
1 mentioned VBN:1 
1 mental JJ:1 
1 menstruations NNS:1 
1 menstruating VBG:1 
1 menarche NN:1 
1 menadione NN:1 
1 membrane-spanning JJ:1 
1 membrane-related JJ:1 
1 membrane-mediated JJ:1 
1 melanosis NN:1 
1 megakaryopoiesis/ NN:1 
1 megakaryopoiesis NN:1 
1 megakaryoblastic/erythroid JJ:1 
1 megadoses NNS:1 
1 meeting VBG:1 
1 mediterranean JJ:1 
1 medications NNS:1 
1 medial JJ:1 
1 media-stimulated JJ:1 
1 mechanistically RB:1 
1 mechanism-based JJ:1 
1 meas VBN:1 
1 meaning NN:1 
1 mean+/-SE NN:1 
1 mcl-1 NN:1 
1 maximize VB:1 
1 maxima NNS:1 
1 maxillary JJ:1 
1 maturity-onset JJ:1 
1 maturity NN:1 
1 matured VBD:1 
1 maturation/differentiation NN:1 
1 maturation-specific JJ:1 
1 matter NN:1 
1 matrix-bound JJ:1 
1 matrix-adherent JJ:1 
1 mating NN:1 
1 maternally RB:1 
1 matching VBG:1 
1 mastopathy NN:1 
1 mastocytic/basophilic JJ:1 
1 mastectomy NN:1 
1 massively RB:1 
1 mass-to-charge JJ:1 
1 mass-spectrometric JJ:1 
1 masked VBN:1 
1 mark VBP:1 
1 mannose NN:1 
1 manipulations NNS:1 
1 mangabey JJ:1 
1 mande NN:1 
1 managing VBG:1 
1 manage VBP:1 
1 maltose NN:1 
1 malignancy-associated JJ:1 
1 malfunction NN:1 
1 malformations NNS:1 
1 maleate NN:1 
1 malarial JJ:1 
1 makeup NN:1 
1 majorities NNS:1 
1 magnify VB:1 
1 mafK NN:1 
1 macroscopic JJ:1 
1 macrophages/ NNS:1 
1 macrophagelike JJ:1 
1 macrophage/monocyte JJ:1 
1 macrophage-specific JJ:1 
1 macrophage-restricted JJ:1 
1 macrophage-lymphocyte JJ:1 
1 macrophage-depleted JJ:1 
1 macrophage-competent JJ:1 
1 macrophage- NN:1 
1 macaque JJ:1 
1 mSin3 NN:1 
1 mRNA-type JJ:1 
1 mPRI NN:1 
1 mIL-2rE NN:1 
1 mAb/IL-2- NN:1 
1 mAb-stimulated JJ:1 
1 mAB NN:1 
1 m1 NN:1 
1 m/z NN:1 
1 m.w. NN:1 
1 lytically RB:1 
1 lysosomes NNS:1 
1 lysosomal-associated JJ:1 
1 lysophospholipids NNS:1 
1 lysoPE NN:1 
1 lyso-platelet-activating JJ:1 
1 lyso-phospholipids NNS:1 
1 lyso- JJ:1 
1 lysing VBG:1 
1 lyses VBZ:1 
1 lysate-synthesized JJ:1 
1 lyonization NN:1 
1 lymphycryptoviruses NNS:1 
1 lymphotoxin-alpha NN:1 
1 lymphoproliferation NN:1 
1 lymphomagenic JJ:1 
1 lymphoma/leukemia-2 NN:1 
1 lymphoma-derived JJ:1 
1 lymphoid/myeloid JJ:1 
1 lymphoid/ JJ:1 
1 lymphoid-enhancer JJ:1 
1 lymphoid-derived JJ:1 
1 lymphocyte-tropic JJ:1 
1 lymphocyte-mediated JJ:1 
1 lymphocyte-activating JJ:1 
1 lymphoblast NN:1 
1 lymphadenopathy NN:1 
1 lymph-node JJ:1 
1 lying VBG:1 
1 ly- JJ:1 
1 ly+ JJ:1 
1 luteinizing JJ:1 
1 lucigenin-enhanced JJ:1 
1 lts NNS:1 
1 ls NNS:1 
1 lpha NN:1 
1 lp NN:1 
1 lowers VBZ:1 
1 lowering NN:1 
1 low-stringency NN:1 
1 low-serum JJ:1 
1 low-potency JJ:1 
1 low-molecular-weight JJ:1 
1 low-mobility JJ:1 
1 low-ionic-strength JJ:1 
1 low-grade JJ:1 
1 lose VB:1 
1 losartan NN:1 
1 loosely RB:1 
1 looking VBG:1 
1 look NN:1 
1 longitudinal JJ:1 
1 longest JJS:1 
1 longer-term JJ:1 
1 longa FW:1 
1 long-terminal JJ:1 
1 long-standing JJ:1 
1 long-lived JJ:1 
1 log10MBC NN:1 
1 log10Kd NN:1 
1 log-fold JJ:1 
1 log NN:1 
1 locus-activating JJ:1 
1 locations NNS:1 
1 locate VB:1 
1 localize VB:1 
1 localizations NNS:1 
1 localisation NN:1 
1 lobules NNS:1 
1 lobes NNS:1 
1 loaded VBN:1 
1 lived VBN:1 
1 live-attenuated JJ:1 
1 live-HIV-1 NN:1 
1 liuwei FW:1 
1 littermates NNS:1 
1 listed VBN:1 
1 liquid-suspension NN:1 
1 liposomes NNS:1 
1 liposome-encapsulated JJ:1 
1 liposarcoma NN:1 
1 lipoprotein-lipopeptide- JJ:1 
1 lipopolysaccharide/interferon-gamma NN:1 
1 lipopolysaccharide-free JJ:1 
1 lipopolysaccharide- JJ:1 
1 lipid-mediated JJ:1 
1 lipid-lowering JJ:1 
1 lipid-laden JJ:1 
1 lipid-associated JJ:1 
1 linearly RB:1 
1 linearity NN:1 
1 lineage-positive JJ:1 
1 lineage-independent JJ:1 
1 lineage-determining JJ:1 
1 lin NN:1 
1 limiting-dilution JJ:1 
1 limiting-component JJ:1 
1 limbic-hippocampal JJ:1 
1 limbic JJ:1 
1 lights NNS:1 
1 light-regulated JJ:1 
1 light- JJ:1 
1 liganded JJ:1 
1 ligand-specific JJ:1 
1 ligand-receptor JJ:1 
1 ligand-occupied JJ:1 
1 ligand-independent JJ:1 
1 ligand-activatable JJ:1 
1 ligand-1 NN:1 
1 ligand+ JJ:1 
1 lifelong RB:1 
1 life-prolonging JJ:1 
1 life-long JJ:1 
1 liberated VBD:1 
1 leukopenia NN:1 
1 leukocyte-mediated JJ:1 
1 leukocyte-endothelium JJ:1 
1 leukocyte-derived JJ:1 
1 leukemogenicity NN:1 
1 leukemogenetic JJ:1 
1 leukemia/B NN:1 
1 leukemia-associated JJ:1 
1 leukemia-M3 NN:1 
1 leukaemia/lymphoma NN:1 
1 leukaemia-associated JJ:1 
1 leucocyte-activating JJ:1 
1 leucin-zipper NN:1 
1 lethally RB:1 
1 lesional JJ:1 
1 lesion-derived JJ:1 
1 lentiviruses NNS:1 
1 leishmania-infected JJ:1 
1 left JJ:1 
1 lecules NNS:1 
1 lectin-type JJ:1 
1 lectin-like JJ:1 
1 lectin-activated JJ:1 
1 leaves VBZ:1 
1 leave VBP:1 
1 learn VB:1 
1 leak NN:1 
1 layers NNS:1 
1 law NN:1 
1 latency-associated JJ:1 
1 latencies NNS:1 
1 late-onset JJ:1 
1 late-myeloblast-like JJ:1 
1 lasting JJ:1 
1 lasted VBD:1 
1 largest JJS:1 
1 large-cell JJ:1 
1 language NN:1 
1 lamps NNS:1 
1 laminin- JJ:1 
1 laminar JJ:1 
1 lag NN:1 
1 laevis NN:1 
1 ladder NN:1 
1 lacunae NNS:1 
1 lactose NN:1 
1 lactone NN:1 
1 lactoferrin NN:1 
1 labelling NN:1 
1 label VB:1 
1 l JJ:1 
1 knocked VBD:1 
1 kit NN:1 
1 kingdom NN:1 
1 kindred NN:1 
1 kinases/extracellular JJ:1 
1 kinase/c-Jun NN:1 
1 kinase/STAT NN:1 
1 kinase-specific JJ:1 
1 kinase-related JJ:1 
1 kinase-kinase NN:1 
1 kinase-3beta NN:1 
1 kinase-1-deficient JJ:1 
1 kinase- NN:1 
1 kilodalton JJ:1 
1 kidney-tonifying JJ:1 
1 kg/m2 NN:1 
1 keratoses NNS:1 
1 keratinocyte-derived JJ:1 
1 keratinocyte NN:1 
1 keratin NN:1 
1 kept VBN:1 
1 keep VB:1 
1 karyophilic JJ:1 
1 kappaB-regulated JJ:1 
1 kappaB-like JJ:1 
1 kappaB-binding JJ:1 
1 kappa3 NN:1 
1 kappa- JJ:1 
1 kDs NNS:1 
1 kDa/65 CD:1 
1 kDA NN:1 
1 juxtaposing VBG:1 
1 junctions NNS:1 
1 jun1 NN:1 
1 joined VBN:1 
1 jejunostomy NN:1 
1 jak NN:1 
1 ivalis NN:1 
1 isotonic JJ:1 
1 isoquinoline NN:1 
1 isopropylidine NN:1 
1 isomorphs NNS:1 
1 isomerization NN:1 
1 isomerases NNS:1 
1 isomerase-1 NN:1 
1 isoform-specific JJ:1 
1 isoflavones NNS:1 
1 isoelectric JJ:1 
1 islets NNS:1 
1 islands NNS:1 
1 ischemia/reperfusion NN:1 
1 ischemia NN:1 
1 is/are VBP:1 
1 irus NN:1 
1 irreversibly RB:1 
1 iron-sulfur JJ:1 
1 ionophore-induced JJ:1 
1 ionomycin-stimulated JJ:1 
1 ionomycin-evoked JJ:1 
1 ionomycin- JJ:1 
1 ionized VBN:1 
1 inward JJ:1 
1 invoking VBG:1 
1 invoked VBN:1 
1 investigates VBZ:1 
1 inverting VBG:1 
1 invertebrates NNS:1 
1 invertebrate JJ:1 
1 invariant-chain JJ:1 
1 invari RB:1 
1 invaginated JJ:1 
1 inv14(q11;q32.1) NN:1 
1 inv(3)(q21q26) NN:1 
1 inv(16)(p13q22) NN:1 
1 inv(16)(p13;q22) NN:1 
1 inv(14)(q11;q32) NN:1 
1 intron/exon NN:1 
1 intrinsically RB:1 
1 intricate JJ:1 
1 intrauterine JJ:1 
1 intrathymic JJ:1 
1 intraspecies NNS:1 
1 intraperitoneally RB:1 
1 intralymphocytic JJ:1 
1 intraluminal JJ:1 
1 intrahepatic JJ:1 
1 intracrine JJ:1 
1 intracranial JJ:1 
1 intracellularly RB:1 
1 intracellular-free JJ:1 
1 intrabody NN:1 
1 intraarterial JJ:1 
1 intra-cytoplasmic JJ:1 
1 intimate JJ:1 
1 intimal JJ:1 
1 intima NN:1 
1 interview NN:1 
1 interval NN:1 
1 interstitium NN:1 
1 interspecies NNS:1 
1 interrupts VBZ:1 
1 interrelationships NNS:1 
1 interrelationship NN:1 
1 interquartile JJ:1 
1 interpreted VBN:1 
1 interposed VBN:1 
1 intermediate-dependent JJ:1 
1 interleukin-beta NN:1 
1 interleukin-9 NN:1 
1 interleukin-4-dependent JJ:1 
1 interleukin-3-dependent JJ:1 
1 interleukin-2-independent JJ:1 
1 interleukin-2-gene JJ:1 
1 interleukin-2- JJ:1 
1 interleukin-15 NN:1 
1 interleukin-1-beta NN:1 
1 interior JJ:1 
1 interferon-y NN:1 
1 interferon-treated JJ:1 
1 interferon-responsive JJ:1 
1 interferon-gamma-activated JJ:1 
1 interferon-beta NN:1 
1 interface NN:1 
1 interdigitating NN:1 
1 interdependent JJ:1 
1 interconversion NN:1 
1 interconnected JJ:1 
1 intercept VB:1 
1 intercalating NN:1 
1 interbred VBD:1 
1 inter-relationship NN:1 
1 intentional JJ:1 
1 intensified VBN:1 
1 intend VBP:1 
1 integrin-mediated JJ:1 
1 integrin-containing JJ:1 
1 integratory JJ:1 
1 integrating VBG:1 
1 integer NN:1 
1 int-2 NN:1 
1 insulin-stimulated JJ:1 
1 insulin-like JJ:1 
1 insulin- JJ:1 
1 instrumental JJ:1 
1 instructive JJ:1 
1 instigated VBN:1 
1 insignificant JJ:1 
1 insertional JJ:1 
1 inserting JJ:1 
1 inquire VB:1 
1 input NN:1 
1 inositoltrisphosphate NN:1 
1 inositol-1,4,5-trisphosphate NN:1 
1 inosine-_5'-monophosphate NN:1 
1 inosine-5'-monophosphate NN:1 
1 injury/activation NN:1 
1 injections NNS:1 
1 initiator-like JJ:1 
1 initiative NN:1 
1 inhibitor-kappaB NN:1 
1 inherently RB:1 
1 inhalation NN:1 
1 ingredients NNS:1 
1 ingredient NN:1 
1 ingest VB:1 
1 infrequently RB:1 
1 infrequent JJ:1 
1 informed VBN:1 
1 influential JJ:1 
1 inflammatory-type JJ:1 
1 infitration NN:1 
1 inferring VBG:1 
1 inferred VBD:1 
1 infancy NN:1 
1 inexplicable JJ:1 
1 inetic JJ:1 
1 inefficiently RB:1 
1 ine NN:1 
1 inducibility/cell NN:1 
1 induced/inhibited VBN:1 
1 induced. VBN:1 
1 indolocarbazoles NNS:1 
1 individual-specific JJ:1 
1 indistinct JJ:1 
1 indigenous JJ:1 
1 indications NNS:1 
1 indication NN:1 
1 indexing NN:1 
1 independency NN:1 
1 indefinitely RB:1 
1 incrementally RB:1 
1 increment NN:1 
1 increase-ratios NN:1 
1 incorporating VBG:1 
1 incorporates VBZ:1 
1 incorporate VB:1 
1 inconsistencies NNS:1 
1 incompletely RB:1 
1 incompatibility NN:1 
1 inbred JJ:1 
1 in-vitro-translated JJ:1 
1 in-vitro FW:1 
1 in-leucyl-tRNA JJ:1 
1 improving VBG:1 
1 improves VBZ:1 
1 improvements NNS:1 
1 impromidine NN:1 
1 imprinting VBG:1 
1 impossible JJ:1 
1 imposes VBZ:1 
1 impor JJ:1 
1 implied VBD:1 
1 impinge VBP:1 
1 impermeable JJ:1 
1 imperfect JJ:1 
1 impending JJ:1 
1 impeded JJ:1 
1 impede VBP:1 
1 impairing VBG:1 
1 impacted JJ:1 
1 immunosuppression-inducing JJ:1 
1 immunosupershift NN:1 
1 immunostained VBN:1 
1 immunostainable JJ:1 
1 immunosenescence NN:1 
1 immunoregulation NN:1 
1 immunoreceptor NN:1 
1 immunoreactions NNS:1 
1 immunoradiometric JJ:1 
1 immunoprecipitate NN:1 
1 immunophilin-drug JJ:1 
1 immunoperoxidase NN:1 
1 immunopathology NN:1 
1 immunopathogenesis NN:1 
1 immunohistological JJ:1 
1 immunogold JJ:1 
1 immunoglobulin-like JJ:1 
1 immunogens NNS:1 
1 immunogenotypic JJ:1 
1 immunogenetic JJ:1 
1 immunofluorescent JJ:1 
1 immunoelectron NN:1 
1 immunodeficient JJ:1 
1 immunocytogenetic JJ:1 
1 immunocytochemically RB:1 
1 immunocytes NNS:1 
1 immunochemistry NN:1 
1 immunochemically RB:1 
1 immunoblastic JJ:1 
1 immunoassay NN:1 
1 immunoaffinity NN:1 
1 immunoadsorption NN:1 
1 immunoadsorbed VBN:1 
1 immuno-pathological JJ:1 
1 immuno-modulatory JJ:1 
1 immuno-deficiency NN:1 
1 immuno-cytochemistry NN:1 
1 immunmodulatory JJ:1 
1 immunizations NNS:1 
1 immune/inflammatory JJ:1 
1 immune-specific JJ:1 
1 immune-related JJ:1 
1 immune-modulating JJ:1 
1 immortal JJ:1 
1 immediate/early JJ:1 
1 immaturity NN:1 
1 imitated VBN:1 
1 imitate VB:1 
1 imbalanced JJ:1 
1 imaging NN:1 
1 image NN:1 
1 illustrating VBG:1 
1 illegitimate JJ:1 
1 ill-defined JJ:1 
1 ileostomized JJ:1 
1 ileal JJ:1 
1 ignificant JJ:1 
1 identifiable JJ:1 
1 ideal JJ:1 
1 ibuprofen NN:1 
1 hypothyroid JJ:1 
1 hypothetically RB:1 
1 hypothetical JJ:1 
1 hypothalamo-pituitary-adrenal JJ:1 
1 hypothalamic-pituitary-gonadal JJ:1 
1 hypothalamic JJ:1 
1 hypotetraploid JJ:1 
1 hypotension NN:1 
1 hyposialylated VBN:1 
1 hypophyseal NN:1 
1 hypomethylated VBN:1 
1 hypolipidaemic JJ:1 
1 hypocortisolemia NN:1 
1 hypocomplementemia NN:1 
1 hypo-acetylation NN:1 
1 hyperreactivity NN:1 
1 hyperreactive JJ:1 
1 hyperproliferative JJ:1 
1 hyperproliferate VBP:1 
1 hyperproduction NN:1 
1 hyperosmotic JJ:1 
1 hypermethylation-associated JJ:1 
1 hypermethylation NN:1 
1 hyperlipidemic JJ:1 
1 hyperglycemia NN:1 
1 hyperdemarcation NN:1 
1 hypercortisolemia NN:1 
1 hypercorticism NN:1 
1 hypercholesterolemic JJ:1 
1 hypercholesterolemia NN:1 
1 hypercholesteremia NN:1 
1 hypercellularity NN:1 
1 hypercalcemic JJ:1 
1 hyperadhesivity NN:1 
1 hyperactivity NN:1 
1 hyper-sensitivity NN:1 
1 hydroxyurea NN:1 
1 hydroxytoluene NN:1 
1 hydroxylases NNS:1 
1 hydroxylase NN:1 
1 hydroxylamine NN:1 
1 hydroxyl NN:1 
1 hydrophobicity NN:1 
1 hydrophilic JJ:1 
1 hydrolyze VB:1 
1 hydrolyses NNS:1 
1 hydrolyse VB:1 
1 hydrogenated VBN:1 
1 hydrocortisone-induced JJ:1 
1 hydrocarbons NNS:1 
1 hybridizations NNS:1 
1 humoral- JJ:1 
1 human-peripheral-blood JJ:1 
1 human-mouse JJ:1 
1 http://transfac.gbf.de/dbsearch/funsitep/s_comp.html NN:1 
1 http://compel.bionet.nsc.ru/FunSite/CompelScan.html NN:1 
1 hsp NN:1 
1 hosted VBN:1 
1 host-derived JJ:1 
1 hospital NN:1 
1 hormonocytes NNS:1 
1 hormone.2+o NN:1 
1 hormone-responsive JJ:1 
1 hormone-resistant JJ:1 
1 hormone-inducible JJ:1 
1 hormone- NN:1 
1 hormonally RB:1 
1 hope VBP:1 
1 homozygotic JJ:1 
1 homopolymer NN:1 
1 homologies NNS:1 
1 homogeneously RB:1 
1 homogeneity NN:1 
1 homodimerizing VBG:1 
1 hominid NN:1 
1 homeodomain-containing JJ:1 
1 holocomplex NN:1 
1 holo- NN:1 
1 holo NN:1 
1 histones NNS:1 
1 histogenetically RB:1 
1 histochemically RB:1 
1 histiocytoma NN:1 
1 histiocytes NNS:1 
1 histidine-rich JJ:1 
1 histidine NN:1 
1 his PRP$:1 
1 hirudin NN:1 
1 hip NN:1 
1 hindrance NN:1 
1 hinder VBP:1 
1 himself PRP:1 
1 hilar JJ:1 
1 highlighting VBG:1 
1 highlighted VBN:1 
1 higher-order JJ:1 
1 higher-affinity JJ:1 
1 high-titer JJ:1 
1 high-throughput JJ:1 
1 high-proliferative JJ:1 
1 high-molecular-weight JJ:1 
1 high-mobility JJ:1 
1 high-frequency VBP:1 
1 high-dose JJ:1 
1 hierarchical JJ:1 
1 hiding VBG:1 
1 hexasaccharide NN:1 
1 hexameric JJ:1 
1 heterozygotic JJ:1 
1 heterozygote NN:1 
1 heterotrans-activation NN:1 
1 heterotetramer NN:1 
1 heteromers NNS:1 
1 heterokaryon NN:1 
1 heterodimerizing VBG:1 
1 heterodimerizes VBZ:1 
1 heterodimerized JJ:1 
1 heterodimer-dependent JJ:1 
1 heterocomplex NN:1 
1 heteroaggregates NNS:1 
1 hetero-oligomeric JJ:1 
1 hesperidin NN:1 
1 herself PRP:1 
1 herpetic JJ:1 
1 herpesvirus-6 NN:1 
1 herpesviral JJ:1 
1 heritable JJ:1 
1 heretofore RB:1 
1 heredity NN:1 
1 hereby RB:1 
1 hereafter RB:1 
1 hepatotoxicity NN:1 
1 hepatoprotective JJ:1 
1 heparin-like JJ:1 
1 heparan NN:1 
1 hemostasis NN:1 
1 hemorrhagic JJ:1 
1 hemopoietic-specific JJ:1 
1 hemopoietic-derived JJ:1 
1 hemopoi-etic JJ:1 
1 hemolytic JJ:1 
1 hemoglobins NNS:1 
1 hemoglobinized VBN:1 
1 hemoglobin-producing JJ:1 
1 hemoglobin-positive JJ:1 
1 hemoglobin-encoding JJ:1 
1 hemizygous JJ:1 
1 hemizygotic JJ:1 
1 hemizygosity NN:1 
1 hemin-treated JJ:1 
1 hemin-induced JJ:1 
1 hemin- NN:1 
1 heme-responsive JJ:1 
1 hematopoletic JJ:1 
1 hematopoietin/cytokine NN:1 
1 hematopoietically RB:1 
1 hematopoietic/lymphoid JJ:1 
1 hematopoetic JJ:1 
1 hematolymphopoietrope NN:1 
1 hematological JJ:1 
1 helper-inducer JJ:1 
1 helper-induced JJ:1 
1 helpX?ed VBD:1 
1 helm NN:1 
1 helix-turn-helix JJ:1 
1 helix-loop-helix-zipper JJ:1 
1 helices NNS:1 
1 helical JJ:1 
1 held VBN:1 
1 heightened VBN:1 
1 heavy- JJ:1 
1 heated VBN:1 
1 heat-labile JJ:1 
1 heat-inactivated JJ:1 
1 heat-activated JJ:1 
1 heat- NN:1 
1 head-down JJ:1 
1 he DT:1 
1 hazardous JJ:1 
1 hat IN:1 
1 hastens VBZ:1 
1 harboured VBD:1 
1 harbour VBP:1 
1 harbored VBN:1 
1 haptenized VBN:1 
1 hampster NN:1 
1 hamartoma NN:1 
1 halted VBN:1 
1 haloperidol NN:1 
1 half-sites NNS:1 
1 half-lives NNS:1 
1 haemolytic JJ:1 
1 habitual JJ:1 
1 hStat5 NN:1 
1 hSIE-oligonucleotide NN:1 
1 hRXR NN:1 
1 hPRL NN:1 
1 hMRP8 NN:1 
1 hIL-5R NN:1 
1 hGRs NNS:1 
1 hGH NN:1 
1 hGATA-3-specific JJ:1 
1 hGATA-2 NN:1 
1 hGATA-1 NN:1 
1 hER NN:1 
1 hCaMKIV NN:1 
1 hBob1 NN:1 
1 h1-globin NN:1 
1 gynecomastias NNS:1 
1 gut-associated JJ:1 
1 guidelines NNS:1 
1 guardian NN:1 
1 guanylhydrazone NN:1 
1 guanylate NN:1 
1 gt11 NN:1 
1 gst- NN:1 
1 growth-transforming JJ:1 
1 growth-stimulating JJ:1 
1 growth-promoting JJ:1 
1 growth-modulating JJ:1 
1 growth-inhibition NN:1 
1 growth-inhibited VBN:1 
1 growth-factor-dependent JJ:1 
1 growth-factor NN:1 
1 growth-affecting JJ:1 
1 growth- NN:1 
1 grows VBZ:1 
1 grouped VBN:1 
1 grew VBD:1 
1 graphy NN:1 
1 granurocytes NNS:1 
1 granulosa NN:1 
1 granulopoietic JJ:1 
1 granulomonocytic JJ:1 
1 granulomonocyte-associated JJ:1 
1 granulomas NNS:1 
1 granulocytic/neutrophillic JJ:1 
1 granulocytic-neutrophilic JJ:1 
1 granulocyte/monocyte NN:1 
1 granulocyte/macrophage-colony-stimulating JJ:1 
1 granulocyte/macrophage-colony NN:1 
1 granulocyte/_macrophage NN:1 
1 granulocyte-monocyte JJ:1 
1 granulocyte-_macrophage JJ:1 
1 granulocyte- JJ:1 
1 granuloctyes NNS:1 
1 granulated JJ:1 
1 granularity NN:1 
1 gram-negative JJ:1 
1 grafts NNS:1 
1 graft-vs-host JJ:1 
1 graft-versus-host JJ:1 
1 gradient-gel JJ:1 
1 grades NNS:1 
1 graded VBN:1 
1 gpc91-phox JJ:1 
1 gp91-phox NN:1 
1 gp55 JJ:1 
1 gp39-CD8 JJ:1 
1 gp350/220 NN:1 
1 gp120-anti-gp120 NN:1 
1 gonadotropins NNS:1 
1 gonadotropin NN:1 
1 goat NN:1 
1 go VB:1 
1 glyocophorin NN:1 
1 glycosylphosphatidylinositol-linked JJ:1 
1 glycosylation NN:1 
1 glycosylated VBN:1 
1 glycosidase NN:1 
1 glycosaminoglycan NN:1 
1 glycolipid NN:1 
1 glycoconjugates NNS:1 
1 glycerophospholipid NN:1 
1 glycemic JJ:1 
1 glycation-induced JJ:1 
1 glycans NNS:1 
1 glutathione-S-transferase NN:1 
1 glutaminyl-tTG JJ:1 
1 glucose-stimulated JJ:1 
1 glucocorticoid-receptors NNS:1 
1 glucocorticoid-evoked JJ:1 
1 glucocorticoid-dependent JJ:1 
1 glucocorticoid-binding JJ:1 
1 glucocorticoid-based JJ:1 
1 gluco- JJ:1 
1 glomerulosa NN:1 
1 glomerulopathy NN:1 
1 glomerular JJ:1 
1 globulin NN:1 
1 globular JJ:1 
1 globins NNS:1 
1 globally RB:1 
1 glial-derived JJ:1 
1 gliadins NNS:1 
1 gld NN:1 
1 girl NN:1 
1 ging NN:1 
1 ghosts NNS:1 
1 getting VBG:1 
1 get VB:1 
1 gestation NN:1 
1 geometry NN:1 
1 genotoxic JJ:1 
1 genome-positive JJ:1 
1 genetics NNS:1 
1 generations NNS:1 
1 genera NN:1 
1 gene-suppressive JJ:1 
1 gene-specific JJ:1 
1 gene-proximal JJ:1 
1 gene-nonexpressing JJ:1 
1 gene-modified JJ:1 
1 gene-1 NN:1 
1 gene- JJ:1 
1 gender-specific JJ:1 
1 gender NN:1 
1 gelatinolytic JJ:1 
1 gel-retardation NN:1 
1 gel-mobility JJ:1 
1 gears NNS:1 
1 gcR NN:1 
1 gauge VB:1 
1 gastrointestinal JJ:1 
1 gas NN:1 
1 garlic JJ:1 
1 gaps NNS:1 
1 gammopathy NN:1 
1 gammaherpesvirus NN:1 
1 gammadelta-type JJ:1 
1 gammadelta NN:1 
1 gamma/delta+ JJ:1 
1 gamma-specific JJ:1 
1 gamma-rays NNS:1 
1 gamma-radiation NN:1 
1 gamma-positive JJ:1 
1 gamma-interferon- NN:1 
1 gamma-globin-expressing JJ:1 
1 gamma-activating JJ:1 
1 gamma(c)-positive JJ:1 
1 gamma'-chain NN:1 
1 gained VBN:1 
1 gag/pol NN:1 
1 gH NN:1 
1 gE-HSV NN:1 
1 gD2- JJ:1 
1 gD NN:1 
1 gC2- NN:1 
1 g/kg/h NN:1 
1 fusion/entry NN:1 
1 fuse VBP:1 
1 furnished JJ:1 
1 furnish VBP:1 
1 function-related JJ:1 
1 function-associated JJ:1 
1 funcion VB:1 
1 fulminant JJ:1 
1 full-sized JJ:1 
1 fulfil VBP:1 
1 freshly-isolated JJ:1 
1 free-radical JJ:1 
1 fragmentary JJ:1 
1 fractionated VBN:1 
1 fractional JJ:1 
1 four-subunit JJ:1 
1 four- CD:1 
1 foundation NN:1 
1 fos-related JJ:1 
1 forwarded VBN:1 
1 forth RB:1 
1 formylpeptides NNS:1 
1 formylated VBN:1 
1 formyl-met-leu-phe NN:1 
1 formamide NN:1 
1 formally RB:1 
1 formalin-resistant JJ:1 
1 formalin-fixed JJ:1 
1 forkhead NN:1 
1 foregoing JJ:1 
1 forcefully RB:1 
1 force NN:1 
1 follicle-center JJ:1 
1 follicle NN:1 
1 foliosa FW:1 
1 folds VBZ:1 
1 focussed VBD:1 
1 focal JJ:1 
1 fmol/10 CD:1 
1 fmol NN:1 
1 fly NN:1 
1 flurbiprofen NN:1 
1 fluorouracil NN:1 
1 fluorophosphate-thrombin NN:1 
1 fluorogenic JJ:1 
1 fluorochrome NN:1 
1 fluoride-resistant-_alpha-naphthyl-acetate-esterase NN:1 
1 fluorescence-activated JJ:1 
1 fluorescein-labeled JJ:1 
1 flunisolide NN:1 
1 flt-3 NN:1 
1 flowerheads NNS:1 
1 flow-induced JJ:1 
1 flow-cytometric JJ:1 
1 flos FW:1 
1 flora NN:1 
1 flies NNS:1 
1 flexibility NN:1 
1 flasks NNS:1 
1 flanked VBN:1 
1 fixative-sensitive JJ:1 
1 fixation NN:1 
1 five-fold JJ:1 
1 five- CD:1 
1 fits VBZ:1 
1 first-degree JJ:1 
1 first- JJ:1 
1 firmly RB:1 
1 finger/homeodomain NN:1 
1 finger/ NN:1 
1 finely RB:1 
1 filtrates NNS:1 
1 filopodia NN:1 
1 filaria-induced JJ:1 
1 figure NN:1 
1 fifty CD:1 
1 fication NN:1 
1 fibrous JJ:1 
1 fibrosarcomas NNS:1 
1 fibronectin- NN:1 
1 fibroblast-like JJ:1 
1 fibroadenomas NNS:1 
1 fibrinous JJ:1 
1 fibrinogen-binding JJ:1 
1 fibrin NN:1 
1 fibrils NNS:1 
1 fibrillar JJ:1 
1 fibers NNS:1 
1 fiberoptic JJ:1 
1 fferent JJ:1 
1 fever NN:1 
1 feto-maternal JJ:1 
1 fetal/neonatal JJ:1 
1 fetal-to-adult JJ:1 
1 fetal-calf JJ:1 
1 ferrous JJ:1 
1 ferric JJ:1 
1 ferredoxins NNS:1 
1 fermentans-derived JJ:1 
1 feel VBP:1 
1 feeds VBZ:1 
1 favours VBZ:1 
1 favourably RB:1 
1 favors VBZ:1 
1 fatigue NN:1 
1 fathered VBN:1 
1 fates NNS:1 
1 fat/lean JJ:1 
1 fast-migrating JJ:1 
1 fascinating JJ:1 
1 fas-ligand NN:1 
1 far-upstream JJ:1 
1 far-Western JJ:1 
1 false-positive JJ:1 
1 falling VBG:1 
1 fallen VBN:1 
1 faithfully RB:1 
1 faithful JJ:1 
1 factor/DNA NN:1 
1 factor/ NN:1 
1 factor.kappa NN:1 
1 factor-regulated JJ:1 
1 factor-mu NN:1 
1 factor-mediated JJ:1 
1 factor-kappaB/Rel NN:1 
1 factor-chi NN:1 
1 factor-associated JJ:1 
1 factor-activated JJ:1 
1 factor-a NN:1 
1 factor-KB NN:1 
1 factor-AT NN:1 
1 factor-90 NN:1 
1 factor-45 NN:1 
1 facet NN:1 
1 face NN:1 
1 fNF-E2 NN:1 
1 fMet-Leu-Phe NN:1 
1 ezrin NN:1 
1 exudate NN:1 
1 extrauterine JJ:1 
1 extrapituitary JJ:1 
1 extinguishing NN:1 
1 extinguished VBN:1 
1 extinguish VB:1 
1 externalization NN:1 
1 external JJ:1 
1 extents NNS:1 
1 extends VBZ:1 
1 exquisite JJ:1 
1 expression/repression NN:1 
1 expre NN:1 
1 exposes VBZ:1 
1 expose VBP:1 
1 exported VBN:1 
1 exploration NN:1 
1 exploit VB:1 
1 explanations NNS:1 
1 experiencing VBG:1 
1 experiences NNS:1 
1 experienced VBN:1 
1 expense NN:1 
1 expectation NN:1 
1 expect VB:1 
1 expands NNS:1 
1 expand VB:1 
1 exotoxin NN:1 
1 exophthalmos NNS:1 
1 exonic JJ:1 
1 exon:intron NN:1 
1 exon-intron JJ:1 
1 exogeneous JJ:1 
1 existing VBG:1 
1 exerting VBG:1 
1 exemplify VBP:1 
1 exemplifies VBZ:1 
1 execution NN:1 
1 excludes VBZ:1 
1 excisional JJ:1 
1 exceptions NNS:1 
1 excep NN:1 
1 excellently RB:1 
1 exceeded VBD:1 
1 examinations NNS:1 
1 exacerbated JJ:1 
1 evolves VBZ:1 
1 evoke VB:1 
1 evidently RB:1 
1 evidencing VBG:1 
1 ever RB:1 
1 eventuating NN:1 
1 event-free RB:1 
1 evening NN:1 
1 evaluates VBZ:1 
1 evaluable JJ:1 
1 evaginate VBP:1 
1 euthyroidism NN:1 
1 eu JJ:1 
1 etoposide- NN:1 
1 etiologies NNS:1 
1 etiologically RB:1 
1 ethyl-methanesulfonate-treated JJ:1 
1 ethyl-methanesulfonate-derived JJ:1 
1 ethidium NN:1 
1 ether NN:1 
1 estrone NN:1 
1 estrogen/progesterone JJ:1 
1 estrogen-mediated JJ:1 
1 estrogen-dependent JJ:1 
1 estrogen- NN:1 
1 estriol NN:1 
1 estradiol-dependent JJ:1 
1 estimation NN:1 
1 estimates VBZ:1 
1 esterified VBN:1 
1 esterification NN:1 
1 ester/IL-2 NN:1 
1 ester-sensitive JJ:1 
1 ester- JJ:1 
1 essays NNS:1 
1 escapes VBZ:1 
1 escaped VBD:1 
1 escape VB:1 
1 esc NNS:1 
1 es NNS:1 
1 erythropoietin-dependent JJ:1 
1 erythropoietin- JJ:1 
1 erythropoeitin NN:1 
1 erythroleukaemia NN:1 
1 erythroid-lineage JJ:1 
1 erythroid-expressed JJ:1 
1 erythroid-enriched JJ:1 
1 erythrocyte-binding JJ:1 
1 erythroblastosis NN:1 
1 erk1 NN:1 
1 erentiation NN:1 
1 erected JJ:1 
1 ere VBD:1 
1 erbstatin NN:1 
1 erbA NN:1 
1 eradication NN:1 
1 era NN:1 
1 er NN:1 
1 equipotent JJ:1 
1 equi-effective JJ:1 
1 epsilonRII NN:1 
1 epsilon-globin NN:1 
1 epitope-tagged JJ:1 
1 epitope-labeled JJ:1 
1 epitope-encoded JJ:1 
1 episomes NNS:1 
1 episome NN:1 
1 episodes NNS:1 
1 epipodophyllotoxin NN:1 
1 epidermis NN:1 
1 epidemiological JJ:1 
1 epidemiologic JJ:1 
1 epidemic JJ:1 
1 epicardium NN:1 
1 epicardin/capsulin/Pod-1 NN:1 
1 epends VBZ:1 
1 eosinophlic JJ:1 
1 eosinophilopoiesis NN:1 
1 eosinophil-associated JJ:1 
1 eosinophil-activating JJ:1 
1 enzyme-generated JJ:1 
1 enzymatically RB:1 
1 enucleated VBN:1 
1 entrance NN:1 
1 entities NNS:1 
1 entirety NN:1 
1 enters VBZ:1 
1 ensures VBZ:1 
1 ensues VBZ:1 
1 enrolled VBN:1 
1 enough RB:1 
1 enolase NN:1 
1 enlarging VBG:1 
1 enlarged JJ:1 
1 enkephalin NN:1 
1 enigmatic JJ:1 
1 enigma NN:1 
1 enhanson NN:1 
1 enhancer-mediated JJ:1 
1 enhancer- NN:1 
1 enhanceosome NN:1 
1 engrafted VBN:1 
1 engineering VBG:1 
1 enfeebled JJ:1 
1 energy NN:1 
1 eneanalogues NN:1 
1 endpoints NNS:1 
1 endotoxemia NN:1 
1 endothelium-derived JJ:1 
1 endothelia NN:1 
1 endothall NN:1 
1 endosomes NNS:1 
1 endosomal/lysosomal JJ:1 
1 endosomal JJ:1 
1 endonuclease NN:1 
1 endometria NN:1 
1 endolysosomial JJ:1 
1 endoglycosidase NN:1 
1 endogeneous JJ:1 
1 endodermal JJ:1 
1 endocytosed VBN:1 
1 endocrine-lineage NN:1 
1 endo NN:1 
1 end-labelled JJ:1 
1 end-end JJ:1 
1 end-effectors NNS:1 
1 encourage VBP:1 
1 encountering VBG:1 
1 encompasses VBZ:1 
1 encephalomyocarditis NN:1 
1 emulsion NN:1 
1 empty JJ:1 
1 employees NNS:1 
1 emphasizing VBG:1 
1 emotional JJ:1 
1 emitting VBG:1 
1 emigration NN:1 
1 embryocarcinoma NN:1 
1 elutriated VBN:1 
1 eluted VBN:1 
1 elucidation NN:1 
1 elucidates VBZ:1 
1 elsewhere RB:1 
1 elf-1 NN:1 
1 elevations NNS:1 
1 element/ NN:1 
1 element-specific JJ:1 
1 element-regulated JJ:1 
1 element-like JJ:1 
1 element-driven JJ:1 
1 element-1 NN:1 
1 electrostatic JJ:1 
1 electron-transport JJ:1 
1 electron-dense JJ:1 
1 electrochemistry NN:1 
1 electro NN:1 
1 elbow NN:1 
1 elastatinal JJ:1 
1 elaboration NN:1 
1 ein NN:1 
1 eighteen CD:1 
1 eight-fold JJ:1 
1 eiconsanoids NNS:1 
1 ehrlichial JJ:1 
1 egulatory JJ:1 
1 egr-3 NN:1 
1 egr-2 NN:1 
1 eg FW:1 
1 efficiencies NNS:1 
1 efficacious JJ:1 
1 editorial NN:1 
1 edema NN:1 
1 ed VBN:1 
1 ectoderm NN:1 
1 ecdysone-inducible JJ:1 
1 eccrine JJ:1 
1 eccentrically RB:1 
1 easy JJ:1 
1 ease NN:1 
1 early-stage JJ:1 
1 early-response JJ:1 
1 early-phase JJ:1 
1 early-onset JJ:1 
1 early-lytic-cycle JJ:1 
1 early-late-class JJ:1 
1 ear JJ:1 
1 eage NN:1 
1 dysrhythmia NN:1 
1 dysmenorrhoea NN:1 
1 dysfunctions NNS:1 
1 dysfunctional JJ:1 
1 dys JJ:1 
1 dynes/cm2 NNS:1 
1 dynamically RB:1 
1 dynamic JJ:1 
1 dyn/cm2 NN:1 
1 durable JJ:1 
1 duplications NNS:1 
1 ducts NNS:1 
1 dual-target JJ:1 
1 dual-specific JJ:1 
1 dual-function JJ:1 
1 drove VBD:1 
1 dropped VBD:1 
1 drop-mediated JJ:1 
1 drift NN:1 
1 drawn VBN:1 
1 draining VBG:1 
1 drained VBD:1 
1 dp65 NN:1 
1 doxycycline NN:1 
1 doxepin-sensitive JJ:1 
1 doxepin NN:1 
1 downmodulating VBG:1 
1 down-regulating VBG:1 
1 double-labeling JJ:1 
1 double-labeled JJ:1 
1 double-immunogold JJ:1 
1 double- JJ:1 
1 dot-like JJ:1 
1 dose-sparing JJ:1 
1 dose-related JJ:1 
1 dosages NNS:1 
1 dominate VB:1 
1 dominant-active JJ:1 
1 dominant-acting JJ:1 
1 dominance NN:1 
1 domain-helix-loop-helix JJ:1 
1 domain-binding JJ:1 
1 documents VBZ:1 
1 dl337-infected JJ:1 
1 dl312 NN:1 
1 dl-NF NN:1 
1 diversified JJ:1 
1 diverse, JJ:1 
1 divergences NNS:1 
1 diverge VBP:1 
1 dithiocarbarmate NN:1 
1 dithiocarbamates NNS:1 
1 diterpene JJ:1 
1 disuse NN:1 
1 distinctions NNS:1 
1 distinction NN:1 
1 distance NN:1 
1 distally RB:1 
1 dissolved VBN:1 
1 dissimilar JJ:1 
1 disruptions NNS:1 
1 disrupters NNS:1 
1 disordered VBN:1 
1 dishes NNS:1 
1 disease-susceptible JJ:1 
1 disease-activated JJ:1 
1 discriminatory JJ:1 
1 discriminates VBZ:1 
1 discrepancies NNS:1 
1 discourse NN:1 
1 discordance NN:1 
1 discontinuation NN:1 
1 disclosed VBD:1 
1 disclose VBP:1 
1 discharged VBN:1 
1 discharge NN:1 
1 discernible JJ:1 
1 discern VB:1 
1 disappointing JJ:1 
1 disappears VBZ:1 
1 disappear VB:1 
1 disadvantageous JJ:1 
1 directions NNS:1 
1 direct-repeat JJ:1 
1 dipropionate NN:1 
1 diphosphonate NN:1 
1 diphenylhexatriene NN:1 
1 dioxin-mediated JJ:1 
1 dioctanoyl NN:1 
1 dimorphism NN:1 
1 diminishing VBG:1 
1 dimethylpimelimidate NN:1 
1 dimethyldithiocarbamate NN:1 
1 dimerizing VBG:1 
1 dimerized JJ:1 
1 dimerizations NNS:1 
1 diisopropyl NN:1 
1 dihydrochloride NN:1 
1 dihydro NN:1 
1 dihuang FW:1 
1 digoxigenin-labeled JJ:1 
1 digital JJ:1 
1 diffusion NN:1 
1 diffusible JJ:1 
1 difficult-to-control JJ:1 
1 differentiation/retrodifferentiation NN:1 
1 differentiation/maturation NN:1 
1 differentiation/activation JJ:1 
1 differentiation-related JJ:1 
1 differentiation-linked JJ:1 
1 differentiation-blocked JJ:1 
1 differentiation- JJ:1 
1 differentiate/mature VB:1 
1 diff NN:1 
1 diferuoylmethane NN:1 
1 dies VBZ:1 
1 dideoxy JJ:1 
1 dicysteine NN:1 
1 dictates VBZ:1 
1 dicoumarol NN:1 
1 dichroism NN:1 
1 dichotomy NN:1 
1 dichloromethylene NN:1 
1 dicarba-closo-dodecaborane NN:1 
1 dibutyric JJ:1 
1 dibutyrate/calcium NN:1 
1 diacetate NN:1 
1 di-butyryl NN:1 
1 di JJ:1 
1 dextran-coated JJ:1 
1 dexamethasone-treated JJ:1 
1 devised VBN:1 
1 deviation NN:1 
1 deviate VB:1 
1 developments NNS:1 
1 determinations NNS:1 
1 deteriorations NNS:1 
1 deterioration NN:1 
1 detergent-insoluble JJ:1 
1 detects VBZ:1 
1 detecting VBG:1 
1 detecte VBD:1 
1 detached VBD:1 
1 desulfation NN:1 
1 desulfate VBP:1 
1 destructive JJ:1 
1 destroy VBP:1 
1 destabilized VBD:1 
1 destabilization NN:1 
1 designation NN:1 
1 deserve VBP:1 
1 descript NN:1 
1 describing VBG:1 
1 des-Arg JJ:1 
1 dermis NN:1 
1 dermatomyositis/polymyositis NN:1 
1 deriving VBG:1 
1 derivates NNS:1 
1 derepression NN:1 
1 derepress VB:1 
1 deregulates VBZ:1 
1 derangements NNS:1 
1 deprivation-induced JJ:1 
1 depolarization NN:1 
1 depleting VBG:1 
1 departure NN:1 
1 deoxyribonucleic JJ:1 
1 deoxynucleotidyl NN:1 
1 deoxyguanosine NN:1 
1 deoxycytidine NN:1 
1 deoxycorticosterone NN:1 
1 deoxycholate NN:1 
1 deoxidizing NN:1 
1 dentified VBN:1 
1 density-gradient JJ:1 
1 densities NNS:1 
1 denotes VBZ:1 
1 denied VBN:1 
1 denatured VBN:1 
1 demons VBG:1 
1 demethylation NN:1 
1 demethylated VBN:1 
1 dementia NN:1 
1 demarcation NN:1 
1 deltaSpi-B NN:1 
1 deltaspi-B NN:1 
1 deltaNFkappaBdeltaSpl234 NN:1 
1 deltaNFkappaBdeltaSpl NN:1 
1 deltaNFkappaBdeltaSp1 NN:1 
1 deltaDNA-binding JJ:1 
1 delta418 NN:1 
1 delta-opioid JJ:1 
1 delivering VBG:1 
1 delineating VBG:1 
1 delimited VBN:1 
1 delimitation NN:1 
1 delicate JJ:1 
1 deletion/substitution NN:1 
1 deleting VBG:1 
1 deleteriously RB:1 
1 del(17)(q25) NN:1 
1 deiodination NN:1 
1 dehydroascorbate NN:1 
1 dehydratase NN:1 
1 degranulation NN:1 
1 degranulated VBN:1 
1 degenerative JJ:1 
1 deflazacort NN:1 
1 definitively RB:1 
1 definitions NNS:1 
1 deficiencies NNS:1 
1 deeply RB:1 
1 deepen VB:1 
1 deduce VBP:1 
1 decidual/lymphoid JJ:1 
1 decayed VBD:1 
1 debate NN:1 
1 deamidated VBN:1 
1 deal NN:1 
1 deactivation NN:1 
1 deacetylation NN:1 
1 deacetylases NNS:1 
1 dbcAMP NN:1 
1 daunomycin NN:1 
1 databases NNS:1 
1 dapsone NN:1 
1 dansylcadaverine NN:1 
1 dampened JJ:1 
1 damaged VBN:1 
1 dUMP NN:1 
1 dNTPs NNS:1 
1 d1a NN:1 
1 cytosolic-anchoring JJ:1 
1 cytoskeleton-binding JJ:1 
1 cytosins NNS:1 
1 cytosine NN:1 
1 cytoprotection NN:1 
1 cytoplasmically RB:1 
1 cytoplasmic/nuclear JJ:1 
1 cytoplasmic-to-nuclear JJ:1 
1 cytolytically RB:1 
1 cytologically RB:1 
1 cytokine-producing JJ:1 
1 cytokine-inducible JJ:1 
1 cytokine-encoding JJ:1 
1 cytokine-driven JJ:1 
1 cytokine-binding JJ:1 
1 cytokine- JJ:1 
1 cytokeratins NNS:1 
1 cytogenetics NNS:1 
1 cytogenetically RB:1 
1 cytofluorometry NN:1 
1 cytodifferentiation NN:1 
1 cytochemistry NN:1 
1 cytochemical JJ:1 
1 cytoadhesin NN:1 
1 cystine NN:1 
1 cysteine- NN:1 
1 cystatin NN:1 
1 cyst NN:1 
1 cys22-gly22 NN:1 
1 cyproterone NN:1 
1 cyclotetrapeptide NN:1 
1 cyclophosphamide NN:1 
1 cyclophilin/calcineurin NN:1 
1 cyclooxygenase/5-lipoxygenase NN:1 
1 cycloheximide/polyinosinic-polycytidylic JJ:1 
1 cycloheximide-sensitive JJ:1 
1 cyclized JJ:1 
1 cyclin-dependent-kinase- NN:1 
1 cycle-related JJ:1 
1 cycle-induced JJ:1 
1 cycle- JJ:1 
1 cut/CDP NN:1 
1 cut-off JJ:1 
1 culturing NN:1 
1 culture-adapted JJ:1 
1 ctivator NN:1 
1 csk NN:1 
1 cryptococcosis NN:1 
1 cryostat NN:1 
1 crux NN:1 
1 cruciform JJ:1 
1 crossreactivity NN:1 
1 crossreactions NNS:1 
1 crossover JJ:1 
1 crosslinker NN:1 
1 crosslinkage NN:1 
1 crosslink VB:1 
1 crossbred VBN:1 
1 cross-talking NN:1 
1 cross-species JJ:1 
1 cross-reacts VBZ:1 
1 cross-reactivity NN:1 
1 cross-reacting VBG:1 
1 cross-reacted VBD:1 
1 cross-react VB:1 
1 cross-prime VB:1 
1 cross-over JJ:1 
1 cross-competition JJ:1 
1 cross-competed VBD:1 
1 cripples VBZ:1 
1 creation NN:1 
1 creatininemia NN:1 
1 creatinine NN:1 
1 creates VBZ:1 
1 cre-loxP JJ:1 
1 covariant JJ:1 
1 courses NNS:1 
1 couples VBZ:1 
1 country NN:1 
1 counterbalance NN:1 
1 counteracts VBZ:1 
1 counteracted VBN:1 
1 counter-receptor NN:1 
1 counter-anion JJ:1 
1 counted VBN:1 
1 cotton NN:1 
1 cotranslated VBN:1 
1 cotransfections NNS:1 
1 cotransfecting VBG:1 
1 costimulation-induced JJ:1 
1 cosmids NNS:1 
1 cosmid NN:1 
1 coselected VBN:1 
1 cortisol-resistant JJ:1 
1 cortisol-dependent JJ:1 
1 corticosteroid-treated JJ:1 
1 corticosteroid-sensitive JJ:1 
1 corticosteroid-resistant JJ:1 
1 corticosensitivity NN:1 
1 corroborate VBP:1 
1 correspondent JJ:1 
1 correspondence NN:1 
1 correlative JJ:1 
1 coregulators NNS:1 
1 core- NN:1 
1 copurifies VBZ:1 
1 coproporphyrinogen NN:1 
1 coprecipitate VBP:1 
1 copied VBD:1 
1 cope VB:1 
1 coordinating VBG:1 
1 cooperativities NNS:1 
1 cooperating VBG:1 
1 conveying VBG:1 
1 convertase NN:1 
1 converging VBG:1 
1 convergent JJ:1 
1 controversies NNS:1 
1 controller NN:1 
1 control-transduced JJ:1 
1 contributor NN:1 
1 contransfection NN:1 
1 contradiction NN:1 
1 contraception NN:1 
1 continuum NN:1 
1 continual JJ:1 
1 contingent JJ:1 
1 continental JJ:1 
1 contexts NNS:1 
1 context-specific JJ:1 
1 context-restricted JJ:1 
1 contention NN:1 
1 contaminating NN:1 
1 contacting VBG:1 
1 contact-delivered JJ:1 
1 consuming JJ:1 
1 consumed VBN:1 
1 constituting VBG:1 
1 constellation NN:1 
1 consolidating VBG:1 
1 consistency NN:1 
1 consistence NN:1 
1 considerations NNS:1 
1 consent NN:1 
1 consecutively RB:1 
1 consanguinous JJ:1 
1 connecting VBG:1 
1 conjunctival JJ:1 
1 conjunctiva NN:1 
1 conjugates NNS:1 
1 conjugated VBN:1 
1 congruence NN:1 
1 congestive JJ:1 
1 conformers NNS:1 
1 conformer NN:1 
1 confluency NN:1 
1 confirms VBZ:1 
1 conducts VBZ:1 
1 conducive JJ:1 
1 conditions-concentration NN:1 
1 condensation NN:1 
1 concurrence NN:1 
1 concordant JJ:1 
1 concordance NN:1 
1 conclusively RB:1 
1 conclusive JJ:1 
1 conclusions NNS:1 
1 concisely RB:1 
1 concilliate VB:1 
1 concentratios NNS:1 
1 concentration- NN:1 
1 concentrating VBG:1 
1 concentrated VBD:1 
1 concentrate VB:1 
1 conceivable JJ:1 
1 concatamers NNS:1 
1 concatameric JJ:1 
1 computerized VBN:1 
1 computer-assisted JJ:1 
1 computational JJ:1 
1 compromise VB:1 
1 compose VBP:1 
1 components/pathways NNS:1 
1 complexing VBG:1 
1 complex-associated JJ:1 
1 complex, UNKNOWN:1 
1 completion NN:1 
1 completed VBN:1 
1 complements VBZ:1 
1 complementarity NN:1 
1 complement-opsonized JJ:1 
1 competitions NNS:1 
1 competes VBZ:1 
1 compensation NN:1 
1 compensating VBG:1 
1 compensated VBN:1 
1 compartmentalization NN:1 
1 compares VBZ:1 
1 comparatively RB:1 
1 comparably RB:1 
1 communications NNS:1 
1 communicates VBZ:1 
1 commit VB:1 
1 commetns NNS:1 
1 comigrating VBG:1 
1 colour NN:1 
1 colonizing VBG:1 
1 colocalize VB:1 
1 colocalization NN:1 
1 collinear NN:1 
1 collective JJ:1 
1 colleagues NNS:1 
1 collagens NNS:1 
1 collagen-coated JJ:1 
1 collaborate VBP:1 
1 colimycin NN:1 
1 coli-binding JJ:1 
1 colectomy NN:1 
1 cold-shock-induced JJ:1 
1 coinfected VBN:1 
1 coinducer NN:1 
1 coincubating VBG:1 
1 coinciding VBG:1 
1 coincide VBP:1 
1 coimmunoadsorption NN:1 
1 coimmunoadsorbed VBN:1 
1 coiled-coil JJ:1 
1 cohorts NNS:1 
1 coherent JJ:1 
1 cofilin-homology JJ:1 
1 coexpress VBP:1 
1 coenzyme NN:1 
1 codon-initiated JJ:1 
1 cocktails NNS:1 
1 cobalt NN:1 
1 coated JJ:1 
1 coassociated JJ:1 
1 coamplification NN:1 
1 coagulopathy NN:1 
1 coagulate VB:1 
1 coadsorbed VBN:1 
1 coactivation NN:1 
1 coactivating VBG:1 
1 coactivated VBN:1 
1 coa NN:1 
1 co-treatment NN:1 
1 co-repressors NNS:1 
1 co-renaturation NN:1 
1 co-ordinates VBZ:1 
1 co-ordinate JJ:1 
1 co-opted VBN:1 
1 co-operativity NN:1 
1 co-operative JJ:1 
1 co-operate VBP:1 
1 co-localizes VBZ:1 
1 co-localization NN:1 
1 co-immunoprecipitated VBN:1 
1 co-immobilized VBN:1 
1 co-expressed VBD:1 
1 co-cultures NNS:1 
1 co-activators NNS:1 
1 co JJ:1 
1 clues NNS:1 
1 clonotype NN:1 
1 clonogenicity NN:1 
1 clonogenetic JJ:1 
1 clonogenesis NN:1 
1 clone-13 NN:1 
1 clomiphene NN:1 
1 clipping JJ:1 
1 clinicopathological JJ:1 
1 clinical/histological JJ:1 
1 cleaves VBZ:1 
1 classify VB:1 
1 clarified VBN:1 
1 clarification NN:1 
1 claims NNS:1 
1 claimed VBN:1 
1 cis_-regulatory JJ:1 
1 cis_-acting JJ:1 
1 cis-inactivating JJ:1 
1 cis-encoded JJ:1 
1 cis-dominant JJ:1 
1 cis-cloned JJ:1 
1 circumstance NN:1 
1 circularizes VBZ:1 
1 circularize VB:1 
1 circular JJ:1 
1 circuits NNS:1 
1 cimetidine NN:1 
1 ciglitazone NN:1 
1 chronological JJ:1 
1 chronicity NN:1 
1 chromosome-specific JJ:1 
1 chromosome-containing JJ:1 
1 chromosomally RB:1 
1 chromogenic JJ:1 
1 chromium-release NN:1 
1 chromatinized VBN:1 
1 chromatin-assembled JJ:1 
1 choriocarcinoma-induced JJ:1 
1 cholesteryl NN:1 
1 cholecystokinin NN:1 
1 chloram-phenicol NN:1 
1 chimpanzee NN:1 
1 childbearing JJ:1 
1 chemists NNS:1 
1 chemiluminescent JJ:1 
1 chemiluminescence NN:1 
1 chemicals NNS:1 
1 chemically-reactive JJ:1 
1 chemically-exposed JJ:1 
1 chemically- JJ:1 
1 chemical-induced JJ:1 
1 chelating NN:1 
1 charybdotoxin-resistant JJ:1 
1 charge NN:1 
1 characterizations NNS:1 
1 characterisation NN:1 
1 chaperoning VBG:1 
1 chancre NN:1 
1 chan'su NN:1 
1 chamissonis FW:1 
1 chain-specific JJ:1 
1 chain-derived JJ:1 
1 chain- JJ:1 
1 ch NN:1 
1 cfms NN:1 
1 cf. VBP:1 
1 cf NN:1 
1 cerulein-induced JJ:1 
1 ceroid-lypofuscinosis NN:1 
1 ceramides NNS:1 
1 cepharantha FW:1 
1 centuries NNS:1 
1 centromeric JJ:1 
1 centrocytes NNS:1 
1 centroblasts NNS:1 
1 centrifugations NNS:1 
1 centrifugation NN:1 
1 centipoise NN:1 
1 centimorgan NN:1 
1 cent NN:1 
1 cellularly RB:1 
1 cellular/molecular JJ:1 
1 cellular- JJ:1 
1 cells/tube NNS:1 
1 cells/ml NNS:1 
1 cells/cm2 NNS:1 
1 cells-family NN:1 
1 cell/monocyte NN:1 
1 cell-type-independent JJ:1 
1 cell-type-dependent JJ:1 
1 cell-tropic JJ:1 
1 cell-target JJ:1 
1 cell-specifically RB:1 
1 cell-sorted JJ:1 
1 cell-receptor-induced JJ:1 
1 cell-receptor NN:1 
1 cell-monocyte NN:1 
1 cell-matrix JJ:1 
1 cell-line JJ:1 
1 cell-intrinsic JJ:1 
1 cell-initiated JJ:1 
1 cell-independent JJ:1 
1 cell-extracellular JJ:1 
1 cell-enriched JJ:1 
1 cell-encoded JJ:1 
1 cell-deficient JJ:1 
1 cell-cycle-regulated JJ:1 
1 cell-based JJ:1 
1 cell-T-cell NN:1 
1 cell-B NN:1 
1 cel NNS:1 
1 ced-3 NN:1 
1 ceases VBZ:1 
1 cdk4 NN:1 
1 cdc10/ankyrin JJ:1 
1 cdc-2 NN:1 
1 cdc NN:1 
1 cavities NNS:1 
1 caution NN:1 
1 category NN:1 
1 catecholamine NN:1 
1 catalyze VB:1 
1 caspase-dependent JJ:1 
1 caspase-6 JJ:1 
1 caspase-3/CPP32 NN:1 
1 caspase-1 JJ:1 
1 case-oriented JJ:1 
1 carrier NN:1 
1 carriage NN:1 
1 carefully RB:1 
1 care NN:1 
1 cardiomyocytes NNS:1 
1 carcinoma-derived JJ:1 
1 carcinogens NNS:1 
1 carboxylic JJ:1 
1 carboxyl- JJ:1 
1 carboranes NNS:1 
1 carborane NN:1 
1 carbonic JJ:1 
1 carbon-20 NN:1 
1 carbazole NN:1 
1 caps NNS:1 
1 capacitance NN:1 
1 candidiasis NN:1 
1 cancerous JJ:1 
1 cancelled VBD:1 
1 canceled VBN:1 
1 campomelic JJ:1 
1 camp NN:1 
1 came VBD:1 
1 calycin NN:1 
1 calphostin NN:1 
1 calmodulin-regulated JJ:1 
1 calmodulin-binding JJ:1 
1 calmodulin- JJ:1 
1 calcium/calmodulin-dependent JJ:1 
1 calcium-stimulated JJ:1 
1 calcium-modulator NN:1 
1 calcium-mobilizing JJ:1 
1 calcium-mediated JJ:1 
1 calcium-ionophore JJ:1 
1 calcium-independent JJ:1 
1 calcium-calmodulin-dependent JJ:1 
1 calcium-activated JJ:1 
1 calcitropic JJ:1 
1 calcitonin NN:1 
1 calcineurin-nuclear JJ:1 
1 cadmium- JJ:1 
1 cM NN:1 
1 cJun NN:1 
1 cGMP- JJ:1 
1 cGMP NN:1 
1 cGATA-3 NN:1 
1 cDNA-transfected JJ:1 
1 cDNA-library NN:1 
1 cD3H12 NN:1 
1 cAMP-response-element-binding JJ:1 
1 cAMP-phosphodiesterase NN:1 
1 cAMP-activated JJ:1 
1 c6.1B/MTCP1 NN:1 
1 c-rel-specific JJ:1 
1 c-raf NN:1 
1 c-mim NN:1 
1 c-jun/ NN:1 
1 c-fos-two NN:1 
1 c-fgr NN:1 
1 c-erbA/thyroid NN:1 
1 c-erbA/T3 NN:1 
1 c-cerbA/thyroid NN:1 
1 c-abl NN:1 
1 c-_fos NN:1 
1 c-Rel/p50 NN:1 
1 c-Rel-p65 NN:1 
1 c-Rel-like JJ:1 
1 c-Kit/Epo-R NNS:1 
1 c-Jun- NN:1 
1 c-Cbl NN:1 
1 c-Akt NN:1 
1 c-ABL NN:1 
1 bypasses VBZ:1 
1 butyric-acid JJ:1 
1 buttock NN:1 
1 bursal JJ:1 
1 built VBN:1 
1 buffy JJ:1 
1 buds NNS:1 
1 bud VBP:1 
1 brushing NN:1 
1 broths NNS:1 
1 brothers NNS:1 
1 bronchoscopy NN:1 
1 bronchiale NN:1 
1 bromide NN:1 
1 broken VBN:1 
1 broadly RB:1 
1 bring VBP:1 
1 bright JJ:1 
1 bridging VBG:1 
1 bridge NN:1 
1 breaking NN:1 
1 branchpoints NNS:1 
1 branching VBG:1 
1 branchial JJ:1 
1 brainstem NN:1 
1 box1 NN:1 
1 box-like JJ:1 
1 box-dependent JJ:1 
1 box-deleted JJ:1 
1 border NN:1 
1 boost VB:1 
1 bone-sparing JJ:1 
1 bone-resorbing JJ:1 
1 bodily JJ:1 
1 blurring VBG:1 
1 blunt VB:1 
1 blr1 NN:1 
1 bloodstream NN:1 
1 blood-thyroid JJ:1 
1 blood-glucose NN:1 
1 blood-brain JJ:1 
1 blockage NN:1 
1 bleeding JJ:1 
1 blastogenic JJ:1 
1 blastogenesis NN:1 
1 blastocysts NNS:1 
1 blastocyst-derived JJ:1 
1 blastic JJ:1 
1 blast-crisis JJ:1 
1 bladder NN:1 
1 bivalent JJ:1 
1 bisdioxopiperazine NN:1 
1 bis[4-[2,4-dioxo-5-thiazolidinyl)methyl]phenyl] NN:1 
1 bis(maltolato)oxovanadium-IV NN:1 
1 birth NN:1 
1 biotin- NN:1 
1 biopsy-derived JJ:1 
1 biologists NNS:1 
1 bioinactivation NN:1 
1 biogenesis NN:1 
1 bioflavonoids NNS:1 
1 biodisposal NN:1 
1 biochemistry NN:1 
1 bioassay NN:1 
1 binding-protein NN:1 
1 bindin NN:1 
1 bimodally RB:1 
1 bilateral JJ:1 
1 bigger JJR:1 
1 big JJ:1 
1 bifurcates VBZ:1 
1 bicycle NN:1 
1 bicarbonates NNS:1 
1 bi-directional JJ:1 
1 between-subject JJ:1 
1 betaherpesvirus NN:1 
1 betagamma NN:1 
1 beta-tubulin NN:1 
1 beta-sheet JJ:1 
1 beta-phenyl NN:1 
1 beta-methyl NN:1 
1 beta-lipoproteins NNS:1 
1 beta-glucan NN:1 
1 beta-globin/alpha-globin NN:1 
1 beta-globin-expressing JJ:1 
1 beta-gene NN:1 
1 beta-bound JJ:1 
1 beta-binding JJ:1 
1 beta-amyloid NN:1 
1 beta-adrenoreceptor JJ:1 
1 beta-_chain NN:1 
1 beta-MYH11 NN:1 
1 beta-Catenin NN:1 
1 beta-(1,6)-branched JJ:1 
1 beta-(1,3)-linked JJ:1 
1 beta,19-epoxypregn-5-ene-4,20-dione NN:1 
1 beta,19-epoxy-4-hydroxypregnane-3,20-dione NN:1 
1 beta,19-epoxy-4,21-dihydroxypregn-4-ene-3,20-dione NN:1 
1 beta,19-epoxy-3-hydroxypregnan-20-one NN:1 
1 beta,19-cyclopregna-2,9(11)-diene-4,20-dione NN:1 
1 beta,19-cyclopregn-5-ene-4,20-dione NN:1 
1 benzoic JJ:1 
1 bent JJ:1 
1 beneath IN:1 
1 bends VBZ:1 
1 bending/flexure NN:1 
1 bending NN:1 
1 belonged VBD:1 
1 belies VBZ:1 
1 behaviours NNS:1 
1 behaviour NN:1 
1 behaviors NNS:1 
1 begun VBN:1 
1 beclomethasone NN:1 
1 bear VB:1 
1 bead NN:1 
1 bcl2 NN:1 
1 bcl-xs NN:1 
1 bcl-xl NN:1 
1 bcl-2-transduced JJ:1 
1 bb NN:1 
1 bax NN:1 
1 basosophilic JJ:1 
1 basophilic JJ:1 
1 basic-leucine NN:1 
1 base-substitution NN:1 
1 base-pair NN:1 
1 basal-level JJ:1 
1 barriers NNS:1 
1 barbed JJ:1 
1 bank NN:1 
1 banerofti FW:1 
1 balances NNS:1 
1 bak NN:1 
1 bad NN:1 
1 bacteriophage NN:1 
1 bacterially-produced JJ:1 
1 bacterially RB:1 
1 bacillus FW:1 
1 bacille FW:1 
1 baby NN:1 
1 baboons NNS:1 
1 baT NN:1 
1 bHLH-PAS JJ:1 
1 bHLH- JJ:1 
1 bFGF NN:1 
1 azurophilic JJ:1 
1 axin NN:1 
1 away RB:1 
1 awareness NN:1 
1 awaiting VBG:1 
1 avoiding VBG:1 
1 avoid VB:1 
1 avirulent JJ:1 
1 avidly RB:1 
1 avidin-biotin NN:1 
1 avenue NN:1 
1 avascular JJ:1 
1 autostimulatory JJ:1 
1 autostimulate VB:1 
1 autoradiographic JJ:1 
1 autoradio NN:1 
1 autopsy- NN:1 
1 autopsy NN:1 
1 autopresentation NN:1 
1 autokinase NN:1 
1 autoinduced VBN:1 
1 autoimmune/inflammatory JJ:1 
1 autofluoresence NN:1 
1 autoantibody-producing JJ:1 
1 auto/transphosphorylation NN:1 
1 auto-regulates VBZ:1 
1 auto-inhibitory JJ:1 
1 auto JJ:1 
1 aunt NN:1 
1 augmentative JJ:1 
1 attributing VBG:1 
1 attracting NN:1 
1 attract VB:1 
1 attenuation NN:1 
1 attendant JJ:1 
1 attempting VBG:1 
1 attainable JJ:1 
1 attach VB:1 
1 atopics NNS:1 
1 atmospheric JJ:1 
1 ation NN:1 
1 atherosclerosis-promoting JJ:1 
1 atheogenic JJ:1 
1 athat WDT:1 
1 atent JJ:1 
1 at-Xq28 NN:1 
1 asymptomatically RB:1 
1 astroglioma NN:1 
1 astrocytic JJ:1 
1 astrocyte NN:1 
1 assumptions NNS:1 
1 assumes VBZ:1 
1 associated-antigen-1 NN:1 
1 assisted JJ:1 
1 assist VBP:1 
1 assign VB:1 
1 assemblies NNS:1 
1 aspirin-like JJ:1 
1 aspirations NNS:1 
1 aspirates NNS:1 
1 ask VB:1 
1 ascribable JJ:1 
1 ascertained VBN:1 
1 artifactually RB:1 
1 artifact NN:1 
1 arthrogenic JJ:1 
1 arthritic JJ:1 
1 artery-SCID NN:1 
1 arteritis-SCID NN:1 
1 arrests VBZ:1 
1 armamentarium NN:1 
1 arguments NNS:1 
1 argued VBN:1 
1 arginine-glycine-aspartate NN:1 
1 architectural JJ:1 
1 archetypal JJ:1 
1 arbitrary JJ:1 
1 approximation NN:1 
1 approx RB:1 
1 approved JJ:1 
1 appropriates VBZ:1 
1 approached VBN:1 
1 apprehend VB:1 
1 appreciated VBN:1 
1 applying VBG:1 
1 applicable JJ:1 
1 applicability NN:1 
1 apparatus NN:1 
1 appa NN:1 
1 apoptosisprone JJ:1 
1 apoptosis-resistant JJ:1 
1 apoptosis-mediating JJ:1 
1 apoptosis-linked JJ:1 
1 apoptose VBP:1 
1 apoplexic JJ:1 
1 apolipoprotein NN:1 
1 apolar JJ:1 
1 apoaldosterone NN:1 
1 apical JJ:1 
1 anytime RB:1 
1 anxiety NN:1 
1 anucleated JJ:1 
1 antitumour JJ:1 
1 antituberculous JJ:1 
1 antiseras NN:1 
1 antirheumatic NN:1 
1 antiretroviral JJ:1 
1 antiprogestagens NNS:1 
1 antiport NN:1 
1 antipeptide JJ:1 
1 antipaternal JJ:1 
1 antiparallel JJ:1 
1 antioxidative JJ:1 
1 antioxidant-dependent JJ:1 
1 antioxidant-based JJ:1 
1 antioncogenic JJ:1 
1 antineoplastic JJ:1 
1 antimouse JJ:1 
1 antimicrovascular JJ:1 
1 antiinfectious JJ:1 
1 antihuman JJ:1 
1 antigenes NNS:1 
1 antigen/chemokine NN:1 
1 antigen-stimulated JJ:1 
1 antigen-responsive JJ:1 
1 antigen-receptor NN:1 
1 antigen-processing JJ:1 
1 antigen-derived JJ:1 
1 antigen-dependent JJ:1 
1 antigen-activated JJ:1 
1 antigen-B8 NN:1 
1 antifungal JJ:1 
1 antiestrogenic JJ:1 
1 antidsDNA JJ:1 
1 antidiabetic JJ:1 
1 antidepressants NNS:1 
1 antidepressant JJ:1 
1 anticancer JJ:1 
1 antibody-mediated JJ:1 
1 antibody-encoding JJ:1 
1 antibody-dependent JJ:1 
1 antibody-MR JJ:1 
1 antiandrogen- JJ:1 
1 antiallergic JJ:1 
1 anti-tumour JJ:1 
1 anti-tumoral JJ:1 
1 anti-thrombotic JJ:1 
1 anti-thrombin NN:1 
1 anti-tax1 JJ:1 
1 anti-tag JJ:1 
1 anti-silencer NN:1 
1 anti-sera NNS:1 
1 anti-runt JJ:1 
1 anti-rabbit JJ:1 
1 anti-porcine JJ:1 
1 anti-pml/ JJ:1 
1 anti-peptide JJ:1 
1 anti-p65 JJ:1 
1 anti-p-145 NN:1 
1 anti-oxidative JJ:1 
1 anti-onco-genic JJ:1 
1 anti-mouse JJ:1 
1 anti-microbial JJ:1 
1 anti-lambda JJ:1 
1 anti-kappa JJ:1 
1 anti-infective JJ:1 
1 anti-immunoglobulin-treated JJ:1 
1 anti-immunoglobulin JJ:1 
1 anti-hsp JJ:1 
1 anti-hapten JJ:1 
1 anti-hGH JJ:1 
1 anti-estrogens NNS:1 
1 anti-estrogenic JJ:1 
1 anti-early JJ:1 
1 anti-diabetic JJ:1 
1 anti-class JJ:1 
1 anti-choleretic JJ:1 
1 anti-capsular JJ:1 
1 anti-cancer JJ:1 
1 anti-calla-FITC NN:1 
1 anti-atherogenic JJ:1 
1 anti-allergy JJ:1 
1 anti-allergic JJ:1 
1 anti-Z JJ:1 
1 anti-VLA-5 JJ:1 
1 anti-VCAM JJ:1 
1 anti-Tat JJ:1 
1 anti-TR55 JJ:1 
1 anti-TNF JJ:1 
1 anti-SSB JJ:1 
1 anti-P-selectin JJ:1 
1 anti-P JJ:1 
1 anti-NF-ATc JJ:1 
1 anti-MBP JJ:1 
1 anti-M-CSF JJ:1 
1 anti-JunD JJ:1 
1 anti-IFN-alpha/beta JJ:1 
1 anti-I JJ:1 
1 anti-HLA-DR JJ:1 
1 anti-Fc JJ:1 
1 anti-ERK JJ:1 
1 anti-DNP JJ:1 
1 anti-DNA JJ:1 
1 anti-Class JJ:1 
1 anti-CD95 JJ:1 
1 anti-CD8-FITC NN:1 
1 anti-CD8 JJ:1 
1 anti-CD70 JJ:1 
1 anti-CD4-FITC NN:1 
1 anti-CD3epsilon JJ:1 
1 anti-CD3/anti-CD28 JJ:1 
1 anti-CD29 JJ:1 
1 anti-CD28- JJ:1 
1 anti-CD2-activated JJ:1 
1 anti-CD2-FITC NN:1 
1 anti-CD14 JJ:1 
1 anti-C/EBPdelta JJ:1 
1 anti-C/EBPbeta JJ:1 
1 anti-C/EBP-epsilon JJ:1 
1 anti-BCR1/25 CD:1 
1 anti-38,000-M(r) JJ:1 
1 anthropometric NN:1 
1 anthracyclines NNS:1 
1 antenatal JJ:1 
1 antecedent JJ:1 
1 antagonizing VBG:1 
1 antagonization NN:1 
1 antagonistically RB:1 
1 antagonic JJ:1 
1 ant JJ:1 
1 anoxia/reoxygenation-induced JJ:1 
1 anorexic JJ:1 
1 anonymous JJ:1 
1 anomalous JJ:1 
1 anomalies NNS:1 
1 annular JJ:1 
1 annexin-V JJ:1 
1 annealing NN:1 
1 ankyrin-rich JJ:1 
1 anisotropy NN:1 
1 anisomycin NN:1 
1 anion-exchange JJ:1 
1 anhydrase NN:1 
1 angle NN:1 
1 angioplasty NN:1 
1 aneusomy NN:1 
1 anetholdithiolthione NN:1 
1 anemia-inducing JJ:1 
1 androgen-sensitive JJ:1 
1 androgen-responsive JJ:1 
1 androgen-regulated JJ:1 
1 androgen-modulated JJ:1 
1 androgen-dependent JJ:1 
1 androgen-binding JJ:1 
1 androgen- NN:1 
1 ancillary NN:1 
1 anchored VBN:1 
1 anatomy NN:1 
1 anatomic JJ:1 
1 anaplastic JJ:1 
1 anaphylaxis NN:1 
1 anaphylatoxin NN:1 
1 analyzes VBZ:1 
1 analysing VBG:1 
1 anabolism NN:1 
1 anabolic/catabolic JJ:1 
1 amyloid-beta NN:1 
1 amplifications NNS:1 
1 amphipatic JJ:1 
1 amp NN:1 
1 amongst IN:1 
1 amoebocyte NN:1 
1 aminotriazole NN:1 
1 aminoterminal JJ:1 
1 aminolaevulinic JJ:1 
1 aminoguanidine NN:1 
1 aminoacid JJ:1 
1 amiloride NN:1 
1 amidst IN:1 
1 amide-containing JJ:1 
1 amide NN:1 
1 amenorrhoeic JJ:1 
1 amenable JJ:1 
1 ameliorate VBP:1 
1 ambiguous JJ:1 
1 ambiguities NNS:1 
1 ambient JJ:1 
1 altruistic JJ:1 
1 altogether RB:1 
1 alternating VBG:1 
1 alternate JJ:1 
1 alphoid JJ:1 
1 alphas NNS:1 
1 alphaCD28 NN:1 
1 alpha403 NN:1 
1 alpha4 NN:1 
1 alpha/MAD-3 NN:1 
1 alpha/GABP NN:1 
1 alpha/AML-1-related JJ:1 
1 alpha-tubulin NN:1 
1 alpha-tosylphenylalanyl JJ:1 
1 alpha-tosyl-L-lysine NN:1 
1 alpha-tocopheryl NN:1 
1 alpha-methyl-1 NN:1 
1 alpha-methyl NN:1 
1 alpha-locus NN:1 
1 alpha-lipoate NN:1 
1 alpha-induced JJ:1 
1 alpha-hydroxyprogesterone NN:1 
1 alpha-hydroxymethyl NN:1 
1 alpha-hydroxylase NN:1 
1 alpha-herpesviruses NNS:1 
1 alpha-helix JJ:1 
1 alpha-fluoromethyl NN:1 
1 alpha-dihydroxycholecalciferol NN:1 
1 alpha-dihydrotestosterone NN:1 
1 alpha-chloromethyl NN:1 
1 alpha-chemokine NN:1 
1 alpha-Tocopheryl NN:1 
1 alpha-Rb NN:1 
1 alpha-Dihydroxicholecalciferol NN:1 
1 alpha-(2-hydroxyethyl NN:1 
1 alpha,alpha'-dipyridyl NN:1 
1 alpha,_25-dihydroxyvitamin NN:1 
1 alpha,_25-dihydroxy NN:1 
1 alpha,_25-Dihydroxyvitamin NN:1 
1 alpha,25-dihydroxycholecalciferol NN:1 
1 alpha,25-OH)2D3 NN:1 
1 alpha,25-(OH) NN:1 
1 allosterically RB:1 
1 allografts NNS:1 
1 allogen-specific JJ:1 
1 alloantigens NNS:1 
1 alloantigenic JJ:1 
1 allo NN:1 
1 allergy-driven JJ:1 
1 alkylation NN:1 
1 alkylaryl NN:1 
1 alkaloids NNS:1 
1 alike RB:1 
1 alfa NN:1 
1 aldosteronism NN:1 
1 aldehyde NN:1 
1 alcoholics NNS:1 
1 alcohol NN:1 
1 alanine-rich JJ:1 
1 airflow NN:1 
1 aided VBN:1 
1 agreed VBD:1 
1 agree VBP:1 
1 agonist-dependent JJ:1 
1 ago RB:1 
1 aggressivity NN:1 
1 ages NNS:1 
1 agarose NN:1 
1 ag NN:1 
1 afterwards RB:1 
1 afternoon NN:1 
1 afforded VBD:1 
1 affirmed VBN:1 
1 affinity-binding JJ:1 
1 aetiology NN:1 
1 aetiologies NNS:1 
1 advantages NNS:1 
1 advantageous JJ:1 
1 advancing VBG:1 
1 advancement NN:1 
1 adult-type JJ:1 
1 adult-progenitor JJ:1 
1 adult-onset JJ:1 
1 adult-T-cell-leukemia JJ:1 
1 adsorption NN:1 
1 adrenergic JJ:1 
1 adrenalectomy NN:1 
1 administrations NNS:1 
1 administering VBG:1 
1 adjustments NNS:1 
1 adjusted VBN:1 
1 adjunctive JJ:1 
1 adjunct NN:1 
1 adjoining JJ:1 
1 adipogenesis NN:1 
1 adhesins NNS:1 
1 adherence/contact NN:1 
1 adherence-dependent JJ:1 
1 adherence-associated JJ:1 
1 adhered JJ:1 
1 adhere VB:1 
1 adequately RB:1 
1 adequate JJ:1 
1 adequacy NN:1 
1 adenovirus-transformed JJ:1 
1 adenovirus-mediated JJ:1 
1 adenovirus- JJ:1 
1 adenomyotic JJ:1 
1 adenomyosis NN:1 
1 adenoids NNS:1 
1 adenoidal JJ:1 
1 adducts NNS:1 
1 additively RB:1 
1 activity-stimulating JJ:1 
1 activity-alpha NN:1 
1 activin- JJ:1 
1 activation/translocation NN:1 
1 activation/repression NN:1 
1 activation-specific JJ:1 
1 activation-responsive JJ:1 
1 activation-related JJ:1 
1 activation-inducer JJ:1 
1 activation-driven JJ:1 
1 activatable JJ:1 
1 actinomycin-D NN:1 
1 acquires VBZ:1 
1 acquire VBP:1 
1 acidosis NN:1 
1 acidification NN:1 
1 acid-synthesizing JJ:1 
1 acid-rich JJ:1 
1 acid-response JJ:1 
1 acid-reactive JJ:1 
1 acid-induced JJ:1 
1 acid-binding JJ:1 
1 acid-alpha NN:1 
1 acid-Schiff NN:1 
1 acetylsalicylic JJ:1 
1 acetylsalicylate NN:1 
1 acetic JJ:1 
1 acetate-A23187 NN:1 
1 acetate- NN:1 
1 acetaminophen- NN:1 
1 accrued VBN:1 
1 accord VBP:1 
1 accomplish VB:1 
1 accompany VBP:1 
1 accommodate VB:1 
1 accessible JJ:1 
1 access NN:1 
1 acceleration NN:1 
1 accelerates VBZ:1 
1 abutting VBG:1 
1 abusers NNS:1 
1 absorbance NN:1 
1 abruptly RB:1 
1 abrupt JJ:1 
1 abovesaid VBN:1 
1 abortive JJ:1 
1 aborting VBG:1 
1 ably RB:1 
1 ablation/supershift NN:1 
1 abbreviated VBN:1 
1 aa565-647 NN:1 
1 a.m. RB:1 
1 [3H]testosterone NN:1 
1 [3H]pyrilamine NN:1 
1 [3H]progesterone-MBP-HBD NN:1 
1 [3H]glycosaminoglycan NN:1 
1 [3H]dihydrotestosterone NN:1 
1 [3H]calcitriol NN:1 
1 [3H]VD3 NN:1 
1 [3H]Thymidine NN:1 
1 [3H]RU-1881 NN:1 
1 [3H]1 NN:1 
1 [3H]-Dexamethasone NN:1 
1 [3H]-DEX-binding JJ:1 
1 [35S]methionine NN:1 
1 [32P]orthophosphate NN:1 
1 [2-pyridylmethyl]ethylenediamine NN:1 
1 [125I]T3 NN:1 
1 [125I]-labeled JJ:1 
1 [125I]-aldosterone NN:1 
1 [(TRE)3-tk-Luc] NN:1 
1 ZpCat NN:1 
1 Zn2+ NN:1 
1 Zn++ NN:1 
1 Zn NN:1 
1 Zinc NN:1 
1 Zimmerman NNP:1 
1 Zif-268 NN:1 
1 Zfp36 NN:1 
1 Zfh-1 NN:1 
1 Zfh NN:1 
1 Zap70 NN:1 
1 Zalani NNP:1 
1 ZXDB NN:1 
1 ZXDA NN:1 
1 ZLF-1 NN:1 
1 ZI NN:1 
1 ZB-4 NN:1 
1 Z/R NN:1 
1 Z-VAD-fmk NN:1 
1 Z-29 NN:1 
1 Yoshida NNP:1 
1 Yang-deficiency NN:1 
1 Yang NN:1 
1 YY-Bu NN:1 
1 YM-268 NN:1 
1 YLPA NN:1 
1 YACS NNS:1 
1 YACs NNS:1 
1 Y;15 NN:1 
1 Y731EAM NN:1 
1 Y731EAC NN:1 
1 Y701 NN:1 
1 Y519 NN:1 
1 Y518 NN:1 
1 Y440 NN:1 
1 Y341 NN:1 
1 Y196A NN:1 
1 Y145 NN:1 
1 Y. NNP:1 
1 Y-peptide NN:1 
1 Xq28 NN:1 
1 Xq13 NN:1 
1 Xa NN:1 
1 XPG NN:1 
1 XPA NN:1 
1 XP11BE NN:1 
1 XP/ NN:1 
1 XLA NN:1 
1 XIST-specific JJ:1 
1 XIC NN:1 
1 X50-7 NN:1 
1 X2- NNS:1 
1 X1-specific JJ:1 
1 X1- NN:1 
1 X. NNP:1 
1 X-rays JJ:1 
1 X-ray-treated JJ:1 
1 X-chromosomes NNS:1 
1 X-Thr-Pro NN:1 
1 Wyeth NN:1 
1 Wy14 NN:1 
1 Wuchereria FW:1 
1 Workshop NNP:1 
1 Working NNP:1 
1 Work NN:1 
1 Without IN:1 
1 Wingless/Wnt NN:1 
1 Wiley-Liss NNP:1 
1 Wide NN:1 
1 WiDr NN:1 
1 Where WRB:1 
1 What WP:1 
1 Western-blot JJ:1 
1 Web NN:1 
1 Warren NNP:1 
1 Wakim NNP:1 
1 Waf1 NN:1 
1 WY14643 NN:1 
1 WT19 NN:1 
1 WT-19 NN:1 
1 WP-34 NN:1 
1 WEHI-3B/D+ NN:1 
1 WEHI-231 NN:1 
1 WEHI IN:1 
1 WEB NN:1 
1 WD-40 NN:1 
1 W.Q. NNP:1 
1 W.C.Greene NNP:1 
1 W. NNP:1 
1 VpreB1 NN:1 
1 VpreB NN:1 
1 Vogel NNP:1 
1 Visualization NN:1 
1 Visceral JJ:1 
1 Viruses NNS:1 
1 Virol. NNP:1 
1 Vignoli NNP:1 
1 Vietnam NN:1 
1 Very RB:1 
1 Verdin NNP:1 
1 Vegeto NNP:1 
1 Values NNS:1 
1 Val837 NN:1 
1 Val50 NN:1 
1 Val10-Gln22 NN:1 
1 Vaccination NN:1 
1 Va NN:1 
1 VP-16-derived JJ:1 
1 VLA-4/ NN:1 
1 VII/VIIa NN:1 
1 VII NN:1 
1 VI NN:1 
1 VH-to-DHJH JJ:1 
1 VDRs NNS:1 
1 VDREs NNS:1 
1 VDR-RXR- NN:1 
1 VDJ NN:1 
1 VASP NN:1 
1 V.cholera. FW:1 
1 V.Wendel-Hansen NNP:1 
1 V.M. NNP:1 
1 V.J. NNP:1 
1 V.B. NNP:1 
1 V-J JJ:1 
1 V-IX NN:1 
1 Urine NN:1 
1 Urinary JJ:1 
1 Up-regulates VBZ:1 
1 Up IN:1 
1 Untreated JJ:1 
1 Until IN:1 
1 Unstimulated JJ:1 
1 Unresponsiveness NN:1 
1 University NNP:1 
1 United NNP:1 
1 Unique JJ:1 
1 Uninduced JJ:1 
1 Unicellular-unilineage JJ:1 
1 Unexpected JJ:1 
1 Uneven JJ:1 
1 Uncontrolled JJ:1 
1 Ultrastructurally RB:1 
1 Ultrastructural JJ:1 
1 Ubiquitinylation NN:1 
1 Ubiquitin-mediated JJ:1 
1 UVB NN:1 
1 UV-irradiated JJ:1 
1 UV- NN:1 
1 UT-7/ NN:1 
1 USF2 NN:1 
1 USF1 NN:1 
1 USF/ NN:1 
1 USF-related JJ:1 
1 USF- NN:1 
1 URS NN:1 
1 UPS NN:1 
1 UL75 NN:1 
1 UL55 NN:1 
1 UL50 NN:1 
1 UL49 NN:1 
1 UL44 NN:1 
1 UL21 NN:1 
1 UC NN:1 
1 UBP NN:1 
1 U937-derived JJ:1 
1 U5 NN:1 
1 U4A NN:1 
1 U1RNP NN:1 
1 U1B NN:1 
1 U1A NN:1 
1 U.Smola NNP:1 
1 U.R.Rapp NNP:1 
1 U. NNP:1 
1 U-Test NN:1 
1 Tyrphostin NN:1 
1 Tyrosines NNS:1 
1 Tyr477 NN:1 
1 Tyr427 NN:1 
1 Tyr396 NN:1 
1 Tyr374 NN:1 
1 Tyr-705 NN:1 
1 Tyr-128 NN:1 
1 Tyr-113 NN:1 
1 Two-site JJ:1 
1 Two-color JJ:1 
1 Twenty-seven CD:1 
1 Twenty-four CD:1 
1 Twelve CD:1 
1 Tumors NNS:1 
1 Tumor-derived JJ:1 
1 Trx-expressing NN:1 
1 Triptolide NN:1 
1 Tripterygium FW:1 
1 Triplex JJ:1 
1 Triflusal NN:1 
1 Trifluoromethylketones NNS:1 
1 Trapoxin NN:1 
1 Translocated VBN:1 
1 Translational JJ:1 
1 Transgene NN:1 
1 Transformation NN:1 
1 Transfer NN:1 
1 Transfections NNS:1 
1 Transfected VBN:1 
1 Transcription-independent JJ:1 
1 Trans-activation NN:1 
1 Tpp47 NN:1 
1 Tpp17 NN:1 
1 Toxicity NN:1 
1 Towards IN:1 
1 Tortolani NNP:1 
1 Toronto NNP:1 
1 Tolerant JJ:1 
1 Tolerance NN:1 
1 Tis-8 NN:1 
1 Tip-associated JJ:1 
1 Thymocyte-thymic JJ:1 
1 Thymocyte NN:1 
1 Thymic JJ:1 
1 Thy-tax NN:1 
1 Throughout IN:1 
1 Thromboxane NN:1 
1 Threonine NN:1 
1 Thr729-Lys984 NN:1 
1 Thr729 NN:1 
1 Thr-15 NN:1 
1 Thirty CD:1 
1 Thereby RB:1 
1 Thereafter RB:1 
1 Therapy NN:1 
1 Therapeutic JJ:1 
1 Theileria-infected JJ:1 
1 Th2-selective JJ:1 
1 Th2-restricted JJ:1 
1 Th2-associated JJ:1 
1 Th1/Th2-like JJ:1 
1 Th1/Th0 NN:1 
1 Th1-type JJ:1 
1 Th1-developing NN:1 
1 Th0-type JJ:1 
1 Th0-like JJ:1 
1 Testing VBG:1 
1 Tesmer NNP:1 
1 Tenen NNP:1 
1 Tenascin NN:1 
1 Ten-day JJ:1 
1 Temperature-induced JJ:1 
1 Tef NN:1 
1 Tec NN:1 
1 Tcl-5 NN:1 
1 Tcf-responsive JJ:1 
1 Tcf-mediated JJ:1 
1 Tcf-dependent JJ:1 
1 Tcf-controlled JJ:1 
1 Tcf NN:1 
1 TcR-beta NN:1 
1 TcR- NN:1 
1 Tc2 NN:1 
1 Taxol NN:1 
1 TaxREB NN:1 
1 Tax-mediated JJ:1 
1 Tat1-72 CD:1 
1 Tat-expressing JJ:1 
1 Tat-activated JJ:1 
1 Tat-_human JJ:1 
1 Tat-_HIV-1 NN:1 
1 Tat- NN:1 
1 Targeting NN:1 
1 Tal1 NN:1 
1 Taking VBG:1 
1 Takahashi NNP:1 
1 Tai NNP:1 
1 Tac NN:1 
1 TZDs NNS:1 
1 TXA2 NN:1 
1 TTTCC NN:1 
1 TTP NN:1 
1 TTCTTCTAATTAA NN:1 
1 TTCC NN:1 
1 TTCAAAG NN:1 
1 TTCA NN:1 
1 TT4 NN:1 
1 TSST-1 NN:1 
1 TRX NN:1 
1 TRH NN:1 
1 TRAP-positive JJ:1 
1 TRAP+ JJ:1 
1 TRANCE NN:1 
1 TR2RE-SV40 NN:1 
1 TPEN NN:1 
1 TPA/Ca(2+)-induced JJ:1 
1 TPA-treated JJ:1 
1 TPA-induced JJ:1 
1 TPA-dependent JJ:1 
1 TPA-GR NN:1 
1 TPA- NN:1 
1 TP2 NN:1 
1 TNFalpha- NN:1 
1 TNFRp55-deficient JJ:1 
1 TNFRp55-/-mutant JJ:1 
1 TNFRII NN:1 
1 TNF/neuron NN:1 
1 TNF-related JJ:1 
1 TNF-mediated JJ:1 
1 TNF-beta NN:1 
1 TNF-alpha-activity NN:1 
1 TNF-_alpha NN:1 
1 TLR4 NN:1 
1 TLR-dependent JJ:1 
1 TLR NN:1 
1 TLC NN:1 
1 TL20/12RS NN:1 
1 TL-OmI NN:1 
1 TL-Mor NN:1 
1 TK-3 NN:1 
1 TIS11 NN:1 
1 TIMP-2 NN:1 
1 THP-1-hGH-transfected JJ:1 
1 THP-1-hGH NN:1 
1 THP-1- JJ:1 
1 THE DT:1 
1 TH2-regulated JJ:1 
1 TH1-to-TH2 JJ:1 
1 TGTGGTCA NN:1 
1 TGGAAATTCC NN:1 
1 TGF-beta2 NN:1 
1 TGF-beta1-transcribing JJ:1 
1 TGF-beta-inducible JJ:1 
1 TGCGCATGCGCA NN:1 
1 TFIIIA NN:1 
1 TFIIDs NNS:1 
1 TFIID-dependent JJ:1 
1 TFIIB NN:1 
1 TFG-beta NN:1 
1 TF-specific JJ:1 
1 TF-h5R NN:1 
1 TF-1 NN:1 
1 TCRs NNS:1 
1 TCRgamma NN:1 
1 TCR/ JJ:1 
1 TCR-stimulated JJ:1 
1 TCR-dependent JJ:1 
1 TCR-beta/TCR-delta NN:1 
1 TCR-associated JJ:1 
1 TCF1 NN:1 
1 TCCCCTCCCCT NN:1 
1 TC-II NN:1 
1 TC NN:1 
1 TBP-associated JJ:1 
1 TBG NN:1 
1 TBARS NNS:1 
1 TATAAA NN:1 
1 TATA-like JJ:1 
1 TAR-deleted JJ:1 
1 TAP1-/- JJ:1 
1 TAP-independent JJ:1 
1 TAP-deficient JJ:1 
1 TAM-treated JJ:1 
1 TAL1/SCL NN:1 
1 TAL1- NN:1 
1 TAL-2 NN:1 
1 TAG NN:1 
1 TAFII250 NN:1 
1 TAFII NN:1 
1 TAB NN:1 
1 TAAT NN:1 
1 TA1 NN:1 
1 TA-rich JJ:1 
1 T47D NN:1 
1 T3/T4 NN:1 
1 T3-unresponsive JJ:1 
1 T3-responsive JJ:1 
1 T3-responses NNS:1 
1 T24 NN:1 
1 T1/2 NN:1 
1 T/natural JJ:1 
1 T.Folks NNP:1 
1 T.-W.Chun NNP:1 
1 T-tropic JJ:1 
1 T-prolymphocytic JJ:1 
1 T-lymphotrophic JJ:1 
1 T-lymphoma NN:1 
1 T-lymphocyte-depleted JJ:1 
1 T-lymphoblastoid JJ:1 
1 T-derived JJ:1 
1 T-cell-specifically RB:1 
1 T-cell-restricted JJ:1 
1 T-cell-line-expressing JJ:1 
1 T-cell-derived JJ:1 
1 T-cell- NN:1 
1 T-antigen-expressing JJ:1 
1 T-_cell NN:1 
1 T-Cell NN:1 
1 T-C NN:1 
1 Synergy NN:1 
1 Synchronous JJ:1 
1 Syk/Zap-70-family NN:1 
1 Syk-deficient JJ:1 
1 Sustained JJ:1 
1 Surrogate NN:1 
1 Surgically RB:1 
1 Suppressive JJ:1 
1 Supplementing VBG:1 
1 Supershifts NNS:1 
1 Superoxide NN:1 
1 Supernatants NNS:1 
1 Super-shift JJ:1 
1 SupT1 NN:1 
1 SupT NN:1 
1 Sudan NN:1 
1 Sucrose NN:1 
1 Succinate NN:1 
1 Subunit NN:1 
1 Subnuclear JJ:1 
1 Subcloning NN:1 
1 Subcellular JJ:1 
1 Sub NN:1 
1 Stuber NNP:1 
1 Stuart NNP:1 
1 Structure/function NN:1 
1 Structure-function JJ:1 
1 Stronger JJR:1 
1 Strong JJ:1 
1 Strober NNP:1 
1 Strict JJ:1 
1 Stress NN:1 
1 Strength NN:1 
1 Strasser NNP:1 
1 Strains NNS:1 
1 Stimulated NN:1 
1 Still RB:1 
1 Steroid-resistant JJ:1 
1 Stepwise JJ:1 
1 Stephania FW:1 
1 Steady-state JJ:1 
1 Stauro NN:1 
1 Statl NN:1 
1 Statistically RB:1 
1 Statistical JJ:1 
1 States NNPS:1 
1 Stat5b NN:1 
1 Stat4-independent JJ:1 
1 Stat4-dependent JJ:1 
1 Stat3EE NN:1 
1 Stat3-like JJ:1 
1 Stat1-dependent JJ:1 
1 Stat-specific JJ:1 
1 Stat-related JJ:1 
1 Starting VBG:1 
1 Stanley NNP:1 
1 Stably RB:1 
1 Stability NN:1 
1 Sry NN:1 
1 Squirrel NN:1 
1 Squamous JJ:1 
1 Spontaneous JJ:1 
1 Splitting VBG:1 
1 Spi-1/PU.1-family NN:1 
1 Sp100 NN:1 
1 Sp1/NF-AT NN:1 
1 Sp1/ NN:1 
1 Sp-deficient JJ:1 
1 Sox4 NN:1 
1 Somewhat RB:1 
1 Somatic JJ:1 
1 Solubilization NN:1 
1 Smu/Sepsilon NN:1 
1 Smu NN:1 
1 Small-bowel JJ:1 
1 Small JJ:1 
1 Smad2 NN:1 
1 Smad1/Smad5 NN:1 
1 Smad NN:1 
1 Slp-76 NN:1 
1 Slight JJ:1 
1 SlVmac239 NN:1 
1 Skeletal JJ:1 
1 Sixty-six CD:1 
1 Sixteen CD:1 
1 Single-cell JJ:1 
1 Singh NNP:1 
1 Simultaneously RB:1 
1 Simon NNP:1 
1 Similarities NNS:1 
1 Silencing NN:1 
1 Silastic JJ:1 
1 Significance NN:1 
1 Side-chain NN:1 
1 Shared JJ:1 
1 Sh- NN:1 
1 Sexual JJ:1 
1 Sex-related JJ:1 
1 Serum-equilibrated JJ:1 
1 Serine NN:1 
1 Serial JJ:1 
1 Ser616 NN:1 
1 Ser551 NN:1 
1 Ser5 NN:1 
1 Ser386-Val525 NN:1 
1 Ser23-Ala49 NN:1 
1 Ser-36 NN:1 
1 Ser-32 NN:1 
1 Sequential JJ:1 
1 Sephadex NN:1 
1 Sephacryl NN:1 
1 Separation NN:1 
1 Sentman NNP:1 
1 Senescent JJ:1 
1 Seminoma NN:1 
1 Self NN:1 
1 Selenium JJ:1 
1 Selected VBN:1 
1 Seiki NNP:1 
1 Secondly RB:1 
1 Secondarily RB:1 
1 Searching NN:1 
1 Scya3r2 NN:1 
1 Scya3r NN:1 
1 Screening NN:1 
1 Sci. NNP:1 
1 Schreiber NNP:1 
1 Scholl NN:1 
1 Schindler NNP:1 
1 Scheuermann NNP:1 
1 Sch. FW:1 
1 Sc170 NN:1 
1 Saos-2 NN:1 
1 Saos NN:1 
1 Salahuddin NNP:1 
1 Said NN:1 
1 Saguinus FW:1 
1 Safety NN:1 
1 SUBJECTS NNS:1 
1 STP-A11 NN:1 
1 STATI NN:1 
1 STAT6-DNA NN:1 
1 STAT5a/b NN:1 
1 STAT3beta NN:1 
1 STAT3-containing JJ:1 
1 STAT3- NN:1 
1 STAT1s1 NN:1 
1 STAT1-containing JJ:1 
1 STAT-related JJ:1 
1 STAT-dependent JJ:1 
1 STAT-6-binding JJ:1 
1 STAT-3 NN:1 
1 SSI/CIS NN:1 
1 SSE-like JJ:1 
1 SRF/NFkappaB-like JJ:1 
1 SRF/ NN:1 
1 SRE/CArG NN:1 
1 SRC-related JJ:1 
1 SRA1 NN:1 
1 SQ NN:1 
1 SPXX NN:1 
1 SP6 NN:1 
1 SP1-box NN:1 
1 SP1-binding JJ:1 
1 SOCS3 NN:1 
1 SOCS/CIS/SSI NN:1 
1 SOCS/ NN:1 
1 SOCS NN:1 
1 SNP NN:1 
1 SNEs NNS:1 
1 SN-50 NN:1 
1 SMX-NO NN:1 
1 SMX-NHOH NN:1 
1 SMAD3 NN:1 
1 SLP-76-deficient JJ:1 
1 SLP-76-associated JJ:1 
1 SLEDAI NN:1 
1 SLB-I NN:1 
1 SLA-DRA NN:1 
1 SL3-3 NN:1 
1 SKIPs NNS:1 
1 SIVs NNS:1 
1 SIV-infected JJ:1 
1 SIR NN:1 
1 SIL NN:1 
1 SIE NN:1 
1 SHP2-interacting JJ:1 
1 SHP2-DeltaSH2 NN:1 
1 SHBG NN:1 
1 SH3-interacting JJ:1 
1 SH3-deleted JJ:1 
1 SH3-binding JJ:1 
1 SH3-SH2-SH3 NN:1 
1 SH2/SH3 NN:1 
1 SH2-containing JJ:1 
1 SH-groups NNS:1 
1 SH-SY5Y NN:1 
1 SFS NNS:1 
1 SFLLRNP NN:1 
1 SFFV NN:1 
1 SF2 NN:1 
1 SF-2 NN:1 
1 SER NN:1 
1 SEK/ NN:1 
1 SDS-stable JJ:1 
1 SDS-gel NN:1 
1 SDS NN:1 
1 SCM-1beta NN:1 
1 SCM-1alpha NN:1 
1 SCL/tal-1 NN:1 
1 SCID-HU-_INT JJ:1 
1 SCCs NNS:1 
1 SBE NNS:1 
1 SAPKs NNS:1 
1 SAP-1 NN:1 
1 SAF-like JJ:1 
1 S727 NN:1 
1 S49.1 NN:1 
1 S3 NN:1 
1 S2' NN:1 
1 S2 NN:1 
1 S1T NN:1 
1 S186A NN:1 
1 S._cerevisiae FW:1 
1 S.M.Schnittman NNP:1 
1 S.L.Zeichner NNP:1 
1 S.Henderson NNP:1 
1 S.E.DeRocco NNP:1 
1 S.D.Hayward NNP:1 
1 S.D. NN:1 
1 S.Benn NNP:1 
1 S-transferase- NN:1 
1 S-transferase NN:1 
1 S-nitrosylation NN:1 
1 S-G2/M JJ:1 
1 S-100 NN:1 
1 Rs NN:1 
1 Rp-cAMP- JJ:1 
1 Rowe NNP:1 
1 Rothman NNP:1 
1 Rosen NNP:1 
1 Ro5-3335 NN:1 
1 Ro47-5944 NN:1 
1 Rights NNS:1 
1 Rhombotin-2 NN:1 
1 Rhom-3 NN:1 
1 RhoA NN:1 
1 Rhabdomyosarcomas NNS:1 
1 Rh- NN:1 
1 Reynolds NNP:1 
1 Review NN:1 
1 Reversions NNS:1 
1 Reversing VBG:1 
1 Reversible JJ:1 
1 Reversed VBN:1 
1 Reversal NN:1 
1 Retrospective JJ:1 
1 Retinoidal JJ:1 
1 Retinoid-like JJ:1 
1 Reticuloendotheliosis NN:1 
1 Reticulocyte NN:1 
1 Retention NN:1 
1 Restimulation NN:1 
1 Responsiveness NN:1 
1 Resorption NN:1 
1 Residues NNS:1 
1 Reserved VBN:1 
1 Rescue NN:1 
1 Res. NNP:1 
1 Requirements NNS:1 
1 Representative JJ:1 
1 Representational JJ:1 
1 Repertoire JJ:1 
1 Renesto NNP:1 
1 Renal JJ:1 
1 Remixing NN:1 
1 Relief NN:1 
1 RelA/NFkappaB1 JJ:1 
1 RelA.p50 NN:1 
1 Rel/nuclear NN:1 
1 Rel/STAT NN:1 
1 Rel/NFkappaB NN:1 
1 Rel/NF-kB NN:1 
1 Rel-deficient JJ:1 
1 Rel-/- JJ:1 
1 Reinsertion NN:1 
1 Regulated VBN:1 
1 Regrettably RB:1 
1 Regression NN:1 
1 Region NN:1 
1 Recruitment NN:1 
1 Reciprocally RB:1 
1 Receptor/Stat NN:1 
1 Rearrangement NN:1 
1 Reactivation NN:1 
1 Reactions NNS:1 
1 Rch1/importin NN:1 
1 Rb-transformed JJ:1 
1 Rb-related JJ:1 
1 Rb-defective JJ:1 
1 Rb- NN:1 
1 Ray-Gallet NNP:1 
1 Raw NN:1 
1 RasN17 NN:1 
1 Ras/Raf/ERK NN:1 
1 Ras-like JJ:1 
1 Ras-Raf-1-MAP NN:1 
1 Rapl NN:1 
1 Rap1GTP NN:1 
1 Rap1GDP NN:1 
1 Rao NNP:1 
1 Random JJ:1 
1 Rando NNP:1 
1 Raloxifene NN:1 
1 RalGDS NN:1 
1 Raif NN:1 
1 Raghavan NNP:1 
1 Raf1/MEK1/ NN:1 
1 Raf1 NN:1 
1 Rael NN:1 
1 Radioreceptor NN:1 
1 Rac1 NN:1 
1 Rabbit NN:1 
1 Raabe NNP:1 
1 RXR-specific JJ:1 
1 RXR-beta NN:1 
1 RXR-RARalpha403 NN:1 
1 RVLPs NNS:1 
1 RU43044 NN:1 
1 RU24858 NN:1 
1 RU-38486 NN:1 
1 RSKFRQIV NN:1 
1 RRLPIF NN:1 
1 RRKYKQII NN:1 
1 ROS-dependent JJ:1 
1 ROI-dependent JJ:1 
1 ROI- NN:1 
1 RO13-7410 NN:1 
1 RO NN:1 
1 RNAzol NN:1 
1 RNAase NN:1 
1 RNA-protein JJ:1 
1 RNA-positive JJ:1 
1 RNA-packaging JJ:1 
1 RKGSSSNEPSSD NN:1 
1 RI-gamma NN:1 
1 REX NN:1 
1 REVs NNS:1 
1 REH NN:1 
1 REF52 NN:1 
1 RD NN:1 
1 RCGCRYGCGY NN:1 
1 RBTN2 NN:1 
1 RAW264 NN:1 
1 RAS NN:1 
1 RARalpha403 NN:1 
1 RAR/RXR NN:1 
1 RAR-specific JJ:1 
1 RAP74 NN:1 
1 RAP30 NN:1 
1 RAKFKQLL NN:1 
1 RAG-2 NN:1 
1 RA-resistant JJ:1 
1 RA-mediated JJ:1 
1 RA-independent JJ:1 
1 RA- JJ:1 
1 R294A NN:1 
1 R272A NN:1 
1 R24571 NN:1 
1 R217A NN:1 
1 R/U5 NN:1 
1 R.W.Crowley NNP:1 
1 R.Leonard NNP:1 
1 R.L. NNP:1 
1 R.F.Siliciano NNP:1 
1 R.Cheynier NNP:1 
1 R.C. NNP:1 
1 R-dependent JJ:1 
1 R-activating JJ:1 
1 R-_inducible JJ:1 
1 R-394 NN:1 
1 R-3-hydroxymyristate NN:1 
1 R-276 NN:1 
1 Quantification NN:1 
1 Qualitatively RB:1 
1 Qi-invigorating JJ:1 
1 QUK NN:1 
1 QAKWRLQTL NN:1 
1 Pyrrolidinedithiocarbamate NN:1 
1 Pulse-field JJ:1 
1 Pulse NN:1 
1 PuB2 NN:1 
1 PuB1 NN:1 
1 Pterin NN:1 
1 PstI NN:1 
1 Pseudo-hypoaldosteronism NN:1 
1 Proximal JJ:1 
1 Proteolytic JJ:1 
1 Proteolysis NN:1 
1 Protein-tyrosine JJ:1 
1 Protein-1 NN:1 
1 Protective JJ:1 
1 Protection NN:1 
1 Proteasome-dependent JJ:1 
1 Prostaglandins NNP:1 
1 Propylthiouracil NN:1 
1 Proper JJ:1 
1 Propagation NN:1 
1 Prompted VBN:1 
1 Promiscuous JJ:1 
1 Prominent JJ:1 
1 Proliferative JJ:1 
1 Progressive JJ:1 
1 Programmed VBN:1 
1 Proerythroblasts NNS:1 
1 Processing NN:1 
1 Proc.Natl.Acad.Sci.USA NNP:1 
1 Proc.Natl.Acad.Sci. NNP:1 
1 Proc. NNP:1 
1 Probucol NN:1 
1 Problems NNS:1 
1 Pro641 NN:1 
1 Pro639 NN:1 
1 Pro24Leu NN:1 
1 Pro-X-Pro NN:1 
1 Prion NN:1 
1 Primed VBN:1 
1 Prevalence NN:1 
1 Presenting NN:1 
1 Presentation NN:1 
1 Presence NN:1 
1 Preparation NN:1 
1 Prenatal JJ:1 
1 Premenopausal JJ:1 
1 Pregnancy-induced JJ:1 
1 Preferential JJ:1 
1 Predicted VBN:1 
1 Precursors NNS:1 
1 Preclinical JJ:1 
1 Preassociation NN:1 
1 Preactivation NN:1 
1 Pre-incubation NN:1 
1 Posttranscriptional JJ:1 
1 Postoperatively RB:1 
1 Post IN:1 
1 Positive-pressure JJ:1 
1 Position NN:1 
1 Polyunsaturated JJ:1 
1 Polyubiquitinylated VBN:1 
1 Polymyxin NN:1 
1 Polymorphism NN:1 
1 Polymorphic JJ:1 
1 Polyclonal JJ:1 
1 Polyaromatic NN:1 
1 Pollio NNP:1 
1 Pol NN:1 
1 Pleural JJ:1 
1 Platelet/endothelium NN:1 
1 Platelet/endothelial JJ:1 
1 Platelet-induced JJ:1 
1 Plasmids NNS:1 
1 Pivotal JJ:1 
1 Pit-Oct-Unc NN:1 
1 Pip/LSIRF NN:1 
1 Pindolol NN:1 
1 Pills NNS:1 
1 Pili NNS:1 
1 Physiol. NNP:1 
1 Photoaffinity NN:1 
1 Phosphotyrosine NN:1 
1 Phosphorylated VBN:1 
1 Phospholipid NN:1 
1 Phospholipase NN:1 
1 Phosphoinositide NN:1 
1 Phosphoamino NN:1 
1 Phosphatidylserine NN:1 
1 Phosphatidylinositides NNS:1 
1 Phosphatidyl NN:1 
1 Phorbol-myristate-acetate NN:1 
1 Phorbol-12-myristate-13-acetate NN:1 
1 PhoPc NN:1 
1 Philips NN:1 
1 Phe774 NN:1 
1 Phe50-Tyr65 NN:1 
1 Phase-2 NN:1 
1 Pharmacokinetic JJ:1 
1 Pharmacodynamic JJ:1 
1 Phagocytosis NN:1 
1 Phagocyte NN:1 
1 PhK NN:1 
1 Ph NN:1 
1 PgR-EIA NN:1 
1 Persistent JJ:1 
1 Peroxisomal JJ:1 
1 Pernis NNP:1 
1 Permissiveness NN:1 
1 Permanently RB:1 
1 Permanent JJ:1 
1 Peritoneal JJ:1 
1 Periductal JJ:1 
1 Percentage NN:1 
1 Perceived VBN:1 
1 Per-Arnt-Sim NN:1 
1 Peptidoglycan NN:1 
1 Pellicciari NNP:1 
1 Peculiarly RB:1 
1 Pebp2beta NN:1 
1 Pebp2/Cbf NN:1 
1 Peak JJ:1 
1 Pbeta NN:1 
1 Pax-gene NN:1 
1 Pax-b NN:1 
1 Pax-258 NN:1 
1 Pax-1 NN:1 
1 Paul NN:1 
1 Patterns NN:1 
1 Pathological JJ:1 
1 Paternal JJ:1 
1 Passaging NN:1 
1 Partitioning NN:1 
1 Part NN:1 
1 Parental JJ:1 
1 Parasites NNS:1 
1 Paramyxovirus NN:1 
1 Paradoxical JJ:1 
1 Papillomas NNS:1 
1 Pancreas NN:1 
1 Pan/E2A NN:1 
1 Pan-2 NN:1 
1 Pan-1 NN:1 
1 Palpha NN:1 
1 Paget NN:1 
1 Paclitaxel NN:1 
1 Packaging NN:1 
1 PXQXT/S-containing JJ:1 
1 PXP NN:1 
1 PU.1/Pip NN:1 
1 PU.1-/- JJ:1 
1 PU.1- NN:1 
1 PU-1 NN:1 
1 PTH NN:1 
1 PTF-Oct-1-DNA NN:1 
1 PSPTSPT NN:1 
1 PSI NN:1 
1 PRL-inducible JJ:1 
1 PRIP NN:1 
1 PRE NN:1 
1 PRD NN:1 
1 PPs NNS:1 
1 PPARbeta NN:1 
1 PPAR-gamma NN:1 
1 PPAR-alpha NN:1 
1 PP2B NN:1 
1 PP1/PP2A NN:1 
1 PP-1 NN:1 
1 POZ/zinc-finger NN:1 
1 POZ/Zinc NN:1 
1 POZ-mediated JJ:1 
1 POU[S] JJ:1 
1 POU[H] NN:1 
1 POU-domain NN:1 
1 POU-dependent JJ:1 
1 POU(S) JJ:1 
1 POU(H) NN:1 
1 POS-1b NN:1 
1 POS-1a NN:1 
1 POMC JJ:1 
1 PODs NNS:1 
1 PMNL NN:1 
1 PMN-mediated JJ:1 
1 PMLRARalpha NN:1 
1 PML-retinoic JJ:1 
1 PML-containing JJ:1 
1 PMI-1 NN:1 
1 PMA/ionomycin NN:1 
1 PMA/anti-CD28 JJ:1 
1 PMA/PHA NN:1 
1 PMA/Ca2+ NN:1 
1 PMA/Bt2cAMP-treated JJ:1 
1 PMA/A23187 NN:1 
1 PMA-stimulated JJ:1 
1 PLL NN:1 
1 PLCgamma1 NN:1 
1 PL/IM NN:1 
1 PKC/Ras- NN:1 
1 PKC/Ras JJ:1 
1 PKC-independent JJ:1 
1 PKC-dependent JJ:1 
1 PKB/PI3-kinase NN:1 
1 PIP2 NN:1 
1 PIN*POINT NN:1 
1 PI-3 NN:1 
1 PHKA1 NN:1 
1 PHD/TTC NN:1 
1 PHA-p NN:1 
1 PGI2 NN:1 
1 PGG-glucan NN:1 
1 PGF2 NN:1 
1 PG-B6p NN:1 
1 PG-B6 NN:1 
1 PFGE NN:1 
1 PEF NN:1 
1 PEBP-2alpha NN:1 
1 PEA3 NN:1 
1 PEA1 NN:1 
1 PDX-1/IPF1/STF-1 NN:1 
1 PDP NN:1 
1 PDGF[B] NN:1 
1 PDGF-B NN:1 
1 PDBu/iono NN:1 
1 PD195599 NN:1 
1 PD098059 NN:1 
1 PD-98059 NN:1 
1 PCL NN:1 
1 PC60 NN:1 
1 PC2 NN:1 
1 PC12 NN:1 
1 PBYF NN:1 
1 PBX1 NN:1 
1 PBR NN:1 
1 PBC.M2 NN:1 
1 PB-697 NN:1 
1 PAX1 NN:1 
1 PA6-neo JJ:1 
1 P9 NN:1 
1 P8 NN:1 
1 P65/p50 NN:1 
1 P6 NN:1 
1 P53 NN:1 
1 P4501A1 NN:1 
1 P45 NN:1 
1 P41 NN:1 
1 P3A2 NN:1 
1 P388D1 NN:1 
1 P388 NN:1 
1 P288S NN:1 
1 P16 NN:1 
1 P.S.Sarin NNP:1 
1 P.M.Lieberman NNP:1 
1 P-selectin-specific JJ:1 
1 P-glycoprotein NN:1 
1 P-4501A1 NN:1 
1 P-450 NN:1 
1 Oxypurinol NN:1 
1 Oxidoreductive JJ:1 
1 Oxidizing JJ:1 
1 Oxidized VBN:1 
1 Oxidant-regulation NN:1 
1 Owen NNP:1 
1 Overproduction NN:1 
1 Overproduced JJ:1 
1 Over-expression NN:1 
1 Ovarian JJ:1 
1 Osteoclast NN:1 
1 OspB NN:1 
1 Orkin NNP:1 
1 Organizational JJ:1 
1 Order NN:1 
1 Oral JJ:1 
1 Opposite JJ:1 
1 Opposing JJ:1 
1 One-hybrid NN:1 
1 Oncogenicity NN:1 
1 Oncogenic JJ:1 
1 Olomoucine NN:1 
1 Oligonucleotide NN:1 
1 Oligoclonal JJ:1 
1 Oleic JJ:1 
1 Oleate NN:1 
1 Okamura NNP:1 
1 Oestrogen-dependent JJ:1 
1 Oestradiol NN:1 
1 Octamer-dependent JJ:1 
1 Oct2ba NN:1 
1 Oct2B NN:1 
1 Oct2-positive JJ:1 
1 Oct1.2 NN:1 
1 Oct-binding JJ:1 
1 Oct-6 NN:1 
1 Oct-4 NN:1 
1 Oct- NN:1 
1 Occurrence NN:1 
1 Observations NNS:1 
1 OX-OX40 JJ:1 
1 OVTAL NN:1 
1 OTFs NNS:1 
1 ORI1yt NN:1 
1 ORF1 NN:1 
1 OR NN:1 
1 OPGL NN:1 
1 OKT3/PMA NN:1 
1 OKM5 NN:1 
1 OFT-2 NN:1 
1 OFT-1 NN:1 
1 ODN NN:1 
1 OCT-1p NN:1 
1 OCT-1/OAF NN:1 
1 OCT-1-binding JJ:1 
1 OCT NN:1 
1 OAS NN:1 
1 OAP/octamer NN:1 
1 O2- NN:1 
1 O2 CD:1 
1 O.Long NNP:1 
1 O.J. NNP:1 
1 O-linked JJ:1 
1 Nup475 NN:1 
1 Nucleotide NN:1 
1 Nuclease NN:1 
1 Nov NNP:1 
1 Noteborn NNP:1 
1 Notch1/TAN-1 NN:1 
1 Norepinephrine NN:1 
1 Nor CC:1 
1 Nonsteroidal JJ:1 
1 Nonspecific JJ:1 
1 Nonresponders NNS:1 
1 Nonradioactive JJ:1 
1 Nonpituitary JJ:1 
1 Nonopsonic JJ:1 
1 Nonmitogenic JJ:1 
1 Nonimmunoglobulin JJ:1 
1 Nonhuman JJ:1 
1 Nondividing JJ:1 
1 Nonadherent JJ:1 
1 Non-steroidal JJ:1 
1 Non-genomic JJ:1 
1 Nip-2 NN:1 
1 Ninety-seven CD:1 
1 Nicoletti NN:1 
1 Ni2+-blockable JJ:1 
1 Nfil3/ NN:1 
1 Nfil3 NN:1 
1 Newly RB:1 
1 Neuronal JJ:1 
1 Neurath NNP:1 
1 Neo(r) NN:1 
1 Neighbouring VBG:1 
1 Neg-2 NN:1 
1 Neg-1 NN:1 
1 Nefs NNS:1 
1 Nef-expressing JJ:1 
1 Necrosis NN:1 
1 Naturally RB:1 
1 Natural JJ:1 
1 Natl. NNP:1 
1 Nat.Med.1 NNP:1 
1 Naringenin NN:1 
1 Nalm-6 NN:1 
1 Nakao NNP:1 
1 Naive JJ:1 
1 Nacetylcysteine NN:1 
1 NaF-R-NSE NN:1 
1 Na+/H(+)-exchanger NN:1 
1 Na(+)-H+ JJ:1 
1 Na(+)-H(+)-antiport NN:1 
1 NTPs NNS:1 
1 NSAID NN:1 
1 NRF-1/alpha-Pal NN:1 
1 NREs NNS:1 
1 NRE-2a NN:1 
1 NRAS NNS:1 
1 NP-TCII NN:1 
1 NP-5 NN:1 
1 NP-2 NN:1 
1 NM23.H1 NN:1 
1 NLSs NNS:1 
1 NK: NN:1 
1 NK92 NN:1 
1 NK/T NN:1 
1 NK/LGL NN:1 
1 NK/ NN:1 
1 NK-like JJ:1 
1 NK-derived JJ:1 
1 NK-chi NN:1 
1 NK-cell NN:1 
1 NK-_kappa NN:1 
1 NH(2)-termini NNS:1 
1 NGFI-B/nur77-related JJ:1 
1 NGFI-A NN:1 
1 NGF-R NN:1 
1 NFs NNS:1 
1 NFkappaB1 NN:1 
1 NFkB-like JJ:1 
1 NFeB NN:1 
1 NFS-60 NN:1 
1 NFKappaB NN:1 
1 NFKB NN:1 
1 NFATx4 NN:1 
1 NFATx3 NN:1 
1 NFATp/c- JJ:1 
1 NFATp/c NN:1 
1 NFATp/AP-1 NN:1 
1 NFATp- NN:1 
1 NFATd NN:1 
1 NFATc.alpha NN:1 
1 NFATc- JJ:1 
1 NFATC NN:1 
1 NFAT4/x NN:1 
1 NFAT4/NFATx/NFATc3 NN:1 
1 NFAT1/ NN:1 
1 NFAT/AP-1 NN:1 
1 NFAT-sensitive JJ:1 
1 NFAT-dependent JJ:1 
1 NFAT-controlled JJ:1 
1 NFAT-DNA NN:1 
1 NF45 NN:1 
1 NF1 NN:1 
1 NF-muE3 NN:1 
1 NF-microB-binding JJ:1 
1 NF-microB NN:1 
1 NF-kappaBp65 NN:1 
1 NF-kappaB-p105/p50 NN:1 
1 NF-kappaB-like JJ:1 
1 NF-kappaB-dependent JJ:1 
1 NF-kappaB-controlled JJ:1 
1 NF-kappa-B NN:1 
1 NF-kB2/p52 NN:1 
1 NF-k NN:1 
1 NF-activated JJ:1 
1 NF-_kappaB/ NN:1 
1 NF-_kappa NN:1 
1 NF-KB2 NN:1 
1 NF-KB-related JJ:1 
1 NF-IL2A NN:1 
1 NF-IL-2B NN:1 
1 NF-ATs NNS:1 
1 NF-ATc/p NN:1 
1 NF-ATc.alpha NN:1 
1 NF-AT/AP-1- JJ:1 
1 NF-AT/AP-1 NN:1 
1 NF-AT/ JJ:1 
1 NF-AT- JJ:1 
1 NF-(kappa)B NN:1 
1 ND10s NNS:1 
1 NC2.10 NN:1 
1 NADPH-oxidase NN:1 
1 N17Rac NN:1 
1 N17-mutated JJ:1 
1 N.Ringertz NNP:1 
1 N.P.Salzman NNP:1 
1 N.Israel NNP:1 
1 N.G. NNP:1 
1 N.Engl.J. NNP:1 
1 N. NN:1 
1 N-tosylphenylalanine NN:1 
1 N-terminus NN:1 
1 N-myc NN:1 
1 N-hydroxy NN:1 
1 N-formyl-methionine-leucine-phenyl-alanine NN:1 
1 N-ethylmaleimide NN:1 
1 N-end JJ:1 
1 N-alpha-tosyl-L-phenylalanine NN:1 
1 N-alpha-tosyl-L-lysine NN:1 
1 N-acetylglucosaminyl-1,6-anhydro-N-acetylmuramyl-L-alanyl-D-_isoglutamyl-m-diaminopimelyl-D-alanine NN:1 
1 N-acetyl-leu-leu-norleucinal NN:1 
1 N-acetyl-L-leucinyl-L-leucinyl-L-norleucinal NN:1 
1 N-acetyl JJ:1 
1 N-Terminal JJ:1 
1 N-Tera2 NN:1 
1 N-Oct-factors NNS:1 
1 N-Myc NN:1 
1 N-IRAK NN:1 
1 N-CoR NN:1 
1 N-Ac-Leu-Leu-norleucinal NN:1 
1 N,N,N',N'-tetrakis JJ:1 
1 Myc-Max NN:1 
1 Myb-transformed JJ:1 
1 Myb-Ets NN:1 
1 MyD NN:1 
1 Mutually RB:1 
1 Mutated JJ:1 
1 Mutants NNS:1 
1 Musculin NN:1 
1 Multifactor JJ:1 
1 Multicolor JJ:1 
1 Mucosal JJ:1 
1 Mosaicism NN:1 
1 Morphological JJ:1 
1 Morphologic JJ:1 
1 Moreau-Gachelin NNP:1 
1 Monolayers NNS:1 
1 Monofactorial JJ:1 
1 Monocyte/macrophages NNS:1 
1 Monocyte-macrophage JJ:1 
1 Monitoring VBG:1 
1 Monick NNP:1 
1 Molt4 NN:1 
1 Molt NN:1 
1 Molecular-biologic JJ:1 
1 Mol.Med.1 NNP:1 
1 Mol.Cell.Biol.15 NNP:1 
1 Modulatory JJ:1 
1 Modifications NNS:1 
1 Models NNS:1 
1 Mobilization NN:1 
1 Mn-dependent JJ:1 
1 Mls NN:1 
1 Mitogen-mediated JJ:1 
1 Mitochondrial JJ:1 
1 Missense NN:1 
1 Minimizing VBG:1 
1 Minimally RB:1 
1 Minimal JJ:1 
1 MiniMACS NN:1 
1 Mineralocorticoids NNPS:1 
1 Microtubules NNS:1 
1 Michael NNP:1 
1 Mi-2-HDAC NN:1 
1 Mg2+ NN:1 
1 Methylprednisolone NN:1 
1 Methods NNS:1 
1 Metabolic JJ:1 
1 Mesnier NNP:1 
1 Mental JJ:1 
1 Menopause NN:1 
1 Membrane-associated JJ:1 
1 Membrane NN:1 
1 MelanA/MART1+ JJ:1 
1 MelanA/MART-1-specific JJ:1 
1 Meistrell NNP:1 
1 Megakaryocytic JJ:1 
1 Megakaryocyte/Platelet-specific JJ:1 
1 Mediterranean JJ:1 
1 Med.324 NNP:1 
1 Mechanical JJ:1 
1 Mean NN:1 
1 Mc NN:1 
1 May NN:1 
1 Mature JJ:1 
1 Mass JJ:1 
1 Markus NNP:1 
1 Markedly RB:1 
1 Maria NNP:1 
1 Marek NN:1 
1 Mantel-Cox NN:1 
1 Manogue NNP:1 
1 Mann-Whitney JJ:1 
1 Maniatis NNP:1 
1 Mammography NN:1 
1 Mammalian JJ:1 
1 Mammal JJ:1 
1 Maltose NN:1 
1 Malignant JJ:1 
1 Males NNS:1 
1 Maggi NNP:1 
1 Maeda NNP:1 
1 Macrophage-differentiation NN:1 
1 Macrophage-colony-stimulating JJ:1 
1 Macrophage NN:1 
1 Mac-6 NN:1 
1 Mac-2 NN:1 
1 MZF1 NN:1 
1 MZF NN:1 
1 MYC NN:1 
1 MW NN:1 
1 MTS1 NN:1 
1 MTCP1/c6.1B NN:1 
1 MT4 NN:1 
1 MSB NN:1 
1 MS2-HBx NN:1 
1 MS-5 NN:1 
1 MRP8 NN:1 
1 MRP NN:1 
1 MRL-Ipr/Ipr NN:1 
1 MR-count NN:1 
1 MPO NN:1 
1 MOLT4 NN:1 
1 MOLT NN:1 
1 MODY3 NN:1 
1 MODY1 NN:1 
1 MN NN:1 
1 MMPs NNS:1 
1 MMP-1 NN:1 
1 MLVs NNS:1 
1 MLL/ NN:1 
1 MLA NN:1 
1 ML-3 NN:1 
1 MKK6 NN:1 
1 MKK4 NN:1 
1 MIX NN:1 
1 MIP1 NN:1 
1 MIP-2 NN:1 
1 MIP-1alpha-R NN:1 
1 MIP NN:1 
1 MIB-1 NN:1 
1 MHC/superantigen NN:1 
1 MHC/peptide NN:1 
1 MHC-class NN:1 
1 MGF-STAT5-like JJ:1 
1 MG132 NN:1 
1 META(P) NN:1 
1 META(D-) NN:1 
1 MEKK1 NN:1 
1 MEK2 NN:1 
1 MEK1S218/222A NN:1 
1 MEK1/MEK2 NN:1 
1 MEF2 NN:1 
1 MEDLINE NN:1 
1 ME1a1 NN:1 
1 MDS1- NN:1 
1 MCP NN:1 
1 MCF13 NN:1 
1 MC38 NN:1 
1 MC1627 NN:1 
1 MC1288 NN:1 
1 MBP- NN:1 
1 MAbs NNS:1 
1 MATERIAL NN:1 
1 MAR-binding JJ:1 
1 MAPKS NNS:1 
1 MAPKs NNS:1 
1 MAPK/ERK-specific JJ:1 
1 MAP- JJ:1 
1 MALT NN:1 
1 M67 NN:1 
1 M5 NN:1 
1 M44 NN:1 
1 M41 NN:1 
1 M3 NN:1 
1 M0/M1 NN:1 
1 M/l NN:1 
1 M.Tremblay NNP:1 
1 M.S.Malnati NNP:1 
1 M.Rothe NNP:1 
1 M.Nugeyre NNP:1 
1 M.Malnati NNP:1 
1 M.M.Lightfoote NNP:1 
1 M.M. NNP:1 
1 M.LaPlaca NNP:1 
1 M.Hall NN:1 
1 M.Feldman NNP:1 
1 M.C.Re NNP:1 
1 M.C.Psallidopoulos NNP:1 
1 M.Bina NNP:1 
1 M.Baseler NNP:1 
1 M-TAT/SCF NN:1 
1 Lytic JJ:1 
1 Lysophosphatidylethanolamine NN:1 
1 Lysis NN:1 
1 Lysates NNS:1 
1 Lysate NN:1 
1 Lymphotoxin-alpha NN:1 
1 Lymphocytic JJ:1 
1 Lymphocytes-1 NNS:1 
1 Lyme NN:1 
1 LyF-1 NN:1 
1 Luciw NNP:1 
1 Ltd NNP:1 
1 Low-density JJ:1 
1 Louckes NN:1 
1 Loss- NN:1 
1 Long-term JJ:1 
1 Long-lasting JJ:1 
1 Long JJ:1 
1 London NNP:1 
1 Lobular JJ:1 
1 Lmo2 NN:1 
1 Liver NN:1 
1 Live-attenuated JJ:1 
1 Liuwei FW:1 
1 Liu NNP:1 
1 Listeria NN:1 
1 Liposomes NNS:1 
1 Liposomal JJ:1 
1 Linked VBN:1 
1 Lineage- NN:1 
1 Lin-_murine JJ:1 
1 Limulus JJ:1 
1 Limited JJ:1 
1 Ligand-induced JJ:1 
1 Ligand-dependent JJ:1 
1 Life-table JJ:1 
1 Liberated VBN:1 
1 Level NN:1 
1 Leukocytes NNS:1 
1 Leukemic JJ:1 
1 Leu765 NN:1 
1 Leu42-Pro49 NN:1 
1 Leu122 NN:1 
1 Leu-7+ JJ:1 
1 Lethality NN:1 
1 Lesions NNS:1 
1 Length NN:1 
1 Leiomyosarcoma NN:1 
1 Leger NNP:1 
1 Lef/Tcf NN:1 
1 LeR NN:1 
1 Ldb-1 NN:1 
1 Lck/Fyn- NN:1 
1 Lck-negative JJ:1 
1 Lck- JJ:1 
1 Lavage NN:1 
1 Latency NN:1 
1 Last RB:1 
1 Langerhans NN:1 
1 Lane NNP:1 
1 Lac- JJ:1 
1 LZ NN:1 
1 LUF NN:1 
1 LTR-CAT NN:1 
1 LTR- NN:1 
1 LT-producing JJ:1 
1 LSP-1 NN:1 
1 LRR NN:1 
1 LPS-treated JJ:1 
1 LPS-free JJ:1 
1 LPS-LPS NN:1 
1 LMPs NNS:1 
1 LMP2B NN:1 
1 LMP2 NN:1 
1 LMP1- NN:1 
1 LMP1+ JJ:1 
1 LMP-2A NN:1 
1 LMO- JJ:1 
1 LKLF NN:1 
1 LIP NN:1 
1 LIM-domain JJ:1 
1 LIM-Hox NN:1 
1 LH-20 NN:1 
1 LH-2 NN:1 
1 LDL-receptor NN:1 
1 LD78 NN:1 
1 LCRs NNS:1 
1 LCR/gamma-globin NN:1 
1 LCK NN:1 
1 LBF4- JJ:1 
1 LAP NN:1 
1 LAM- NN:1 
1 L753F NN:1 
1 L540 NN:1 
1 L428 NN:1 
1 L397 NN:1 
1 L389- JJ:1 
1 L128G NN:1 
1 L.Thompson NNP:1 
1 L.Szekely NNP:1 
1 L.Flamand NNP:1 
1 L.E. NNP:1 
1 L.Chene NNP:1 
1 L-shaped JJ:1 
1 L-cystine NN:1 
1 L-cells NNS:1 
1 L-PK JJ:1 
1 L-N-monomethyl-arginine NN:1 
1 L-659 NN:1 
1 L-34 NN:1 
1 L-29 NN:1 
1 L-2 NN:1 
1 L- NN:1 
1 Kv1.3 NN:1 
1 Kruskal-Wallis NN:1 
1 Krox-24 NN:1 
1 Krox-20 NN:1 
1 Kr NN:1 
1 Korsmeyer NNP:1 
1 Ko NN:1 
1 Klug NN:1 
1 Kit NN:1 
1 Kirito NNP:1 
1 Kim NNP:1 
1 Kidney-tonifying JJ:1 
1 Ki NN:1 
1 Kenney NNP:1 
1 Kennedy NN:1 
1 Kd-values NNS:1 
1 Kd-restricted JJ:1 
1 Karyotypic JJ:1 
1 Karsenty NNP:1 
1 Kappa-B NN:1 
1 KU812F NN:1 
1 KU812 NN:1 
1 KT-3 NN:1 
1 KRAB-containing JJ:1 
1 KOS NN:1 
1 KN NN:1 
1 KMT NN:1 
1 KMO NN:1 
1 KM-H2 NN:1 
1 KIAA0144 NN:1 
1 KG1a NN:1 
1 KCl NN:1 
1 KBF NN:1 
1 KB-enhancer NN:1 
1 KAs NNS:1 
1 K44M NN:1 
1 K3T NN:1 
1 K197S NN:1 
1 K.R. NNP:1 
1 K.Chadwick NNP:1 
1 Jurkat-tat NN:1 
1 Jurkat-derived JJ:1 
1 Jurkat-TAg NN:1 
1 June NNP:1 
1 Jun/Jun NN:1 
1 Jun/AP-1 NN:1 
1 Jun-Fos NN:1 
1 Jun-D NN:1 
1 Jun-B NN:1 
1 Jun- NN:1 
1 Jnk NN:1 
1 Jijoye NN:1 
1 Jiang NNP:1 
1 Jews NNS:1 
1 Jewish JJ:1 
1 Jay NNP:1 
1 Japan NNP:1 
1 Jan NNP:1 
1 Jalaguier NNP:1 
1 Jaks/Stats NN:1 
1 Jak-3 CD:1 
1 Jak-1 NN:1 
1 Jak- NN:1 
1 JY NN:1 
1 JRFL NNP:1 
1 JR-St NN:1 
1 JPX9 NN:1 
1 JNK2 NN:1 
1 JM NN:1 
1 JH4 NN:1 
1 JH2 NN:1 
1 JH NN:1 
1 JEG-3 NN:1 
1 JCam/ NN:1 
1 JCT6 NN:1 
1 J774 NN:1 
1 J6 NN:1 
1 J.Y.H. NNP:1 
1 J.Virol.72 NNP:1 
1 J.Virol.70 NNP:1 
1 J.Virol.67 NNP:1 
1 J.Virol.65 NNP:1 
1 J.Virol.64 NNP:1 
1 J.Virol.63 NNP:1 
1 J.T.Bruder NNP:1 
1 J.Steroid NNP:1 
1 J.Menezes NNP:1 
1 J.Margolick NNP:1 
1 J.Leahy NNP:1 
1 J.L. NNP:1 
1 J.Exp.Med.183 NNP:1 
1 J.Exp.Med. NNP:1 
1 J.Corbeil NNP:1 
1 J.C.Alwine NNP:1 
1 J.Babin NNP:1 
1 J.16 NNP:1 
1 J-C JJ:1 
1 Israel NNP:1 
1 Isolated VBN:1 
1 Isoflavones NNS:1 
1 Isoelectric JJ:1 
1 Irreversible JJ:1 
1 Irish/German NNP:1 
1 Irish NNP:1 
1 Ionomycin NN:1 
1 Iono NN:1 
1 Ionizing VBG:1 
1 Investigation NN:1 
1 Investigating VBG:1 
1 Invariably RB:1 
1 Intron-exon JJ:1 
1 Intratracheal JJ:1 
1 Intranuclear JJ:1 
1 Intrahepatic JJ:1 
1 Intimate JJ:1 
1 Interspecies JJ:1 
1 Interrelations NNS:1 
1 Interphase NN:1 
1 International-Toxicity NN:1 
1 Interleukin-9 NN:1 
1 Interleukin-8 NN:1 
1 Interleukin-13 NN:1 
1 InterleUkin NN:1 
1 Interferon-gamma-induced JJ:1 
1 Interferon-beta NN:1 
1 Interfering VBG:1 
1 Interference NN:1 
1 Interdomain NN:1 
1 Integrin-mediated JJ:1 
1 Integration NN:1 
1 Int-2 NN:1 
1 Insulin NN:1 
1 Injection NN:1 
1 Initially RB:1 
1 Inhibitors NNS:1 
1 Inhibitor NN:1 
1 Inflammatory JJ:1 
1 Inflammation NN:1 
1 Inducibility NN:1 
1 Indomethacin NN:1 
1 Individually RB:1 
1 Individual JJ:1 
1 Increase NN:1 
1 Inclusion NN:1 
1 Incidentally RB:1 
1 Incidence NN:1 
1 Inc NNP:1 
1 Inactivation NN:1 
1 In-situ FW:1 
1 Improvement NN:1 
1 Implication NN:1 
1 Impairments NNS:1 
1 Immunosuppressant JJ:1 
1 Immunostained VBN:1 
1 Immunophenotype NN:1 
1 Immunological JJ:1 
1 Immunohistochemically RB:1 
1 Immunoglobulin NN:1 
1 Immunofluorescent JJ:1 
1 Immunodepletion NN:1 
1 Immunodeficiency NN:1 
1 Immunochemical JJ:1 
1 Immunoblotting NN:1 
1 Immuno-histochemical JJ:1 
1 Immunity NN:1 
1 Immortalized VBN:1 
1 Immortalization NN:1 
1 Immobilization NN:1 
1 Immediately RB:1 
1 Immediate JJ:1 
1 Immature JJ:1 
1 Imbalanced JJ:1 
1 Imbalance NN:1 
1 Ile761 NN:1 
1 Ile50Val NN:1 
1 Ikaros-null JJ:1 
1 IkappaBs NNS:1 
1 IkappaBepsilon NN:1 
1 IkBalpha NN:1 
1 Ii-expressing JJ:1 
1 Igkappa NN:1 
1 IgM+ JJ:1 
1 IgH-luciferase JJ:1 
1 IgGk NN:1 
1 IgG-positive JJ:1 
1 IgG-AECA NN:1 
1 IgG+ JJ:1 
1 IgE/allergen JJ:1 
1 IgE-binding JJ:1 
1 IgD- NN:1 
1 IgD+ JJ:1 
1 IgA1 NN:1 
1 IgA+ JJ:1 
1 Ig/TcR NN:1 
1 Ig-silenced JJ:1 
1 Ig-secreting JJ:1 
1 Ig-mediated JJ:1 
1 Ig-like JJ:1 
1 Id-bHLH JJ:1 
1 IcsA- NN:1 
1 IVS1-10TC NN:1 
1 IV-VII CD:1 
1 ISG54 NN:1 
1 ISG15-LTR-IFN JJ:1 
1 IRS-2 NN:1 
1 IRS-1 NN:1 
1 IRF-1/ISGF2 NN:1 
1 IRAK2 NN:1 
1 IP9 NN:1 
1 ING-1 NN:1 
1 INF-gamma NN:1 
1 ILF NN:1 
1 IL5 NN:1 
1 IL2s NNS:1 
1 IL2Rbeta NN:1 
1 IL13R NN:1 
1 IL1-induced JJ:1 
1 IL1-RA NN:1 
1 IL-beta NN:1 
1 IL-6/interferon-gamma NN:1 
1 IL-6-type JJ:1 
1 IL-6-induced JJ:1 
1 IL-4STAT NN:1 
1 IL-4-producing JJ:1 
1 IL-4-independent JJ:1 
1 IL-4-binding JJ:1 
1 IL-3-mediated JJ:1 
1 IL-3- NN:1 
1 IL-2rE NN:1 
1 IL-2r NN:1 
1 IL-2Rgamma NN:1 
1 IL-2R-alpha NN:1 
1 IL-2E NN:1 
1 IL-2A NN:1 
1 IL-2/IL-15 NN:1 
1 IL-2-inducible JJ:1 
1 IL-2-induced JJ:1 
1 IL-2-independent JJ:1 
1 IL-2-gene JJ:1 
1 IL-2-deprived JJ:1 
1 IL-2-dependent JJ:1 
1 IL-2-alpha NN:1 
1 IL-2+ JJ:1 
1 IL-1Rs NNS:1 
1 IL-1RI-associated JJ:1 
1 IL-1RA NN:1 
1 IL-18- JJ:1 
1 IL-15R NN:1 
1 IL-13Ralpha1 NN:1 
1 IL-13-induced JJ:1 
1 IL-13- JJ:1 
1 IL-12p40 NN:1 
1 IL-12/10 NN:1 
1 IL-10-activated JJ:1 
1 IL-1/tumor NN:1 
1 IL-1/ NN:1 
1 IL-1-induced JJ:1 
1 IL-1-RA NN:1 
1 IL-1- NN:1 
1 IL- NN:1 
1 IKKs NNS:1 
1 IKK-gamma NN:1 
1 IKB NN:1 
1 IKAROS/LYF-1 NN:1 
1 IIbright/CD83+/CD86+/ JJ:1 
1 IIIB-infected JJ:1 
1 IID NN:1 
1 IIA NN:1 
1 II-specific JJ:1 
1 II-restricted JJ:1 
1 II-peptide NN:1 
1 II-constitutive JJ:1 
1 II-associated JJ:1 
1 II- NN:1 
1 II+ JJ:1 
1 IGF2 NN:1 
1 IFP53 NN:1 
1 IFNgamma-driven JJ:1 
1 IFNalpha-stimulated JJ:1 
1 IFNA2 NN:1 
1 IFN-regulated JJ:1 
1 IFN-inducible JJ:1 
1 IFN-gammaRalpha NN:1 
1 IFN-gamma-primed JJ:1 
1 IFN-gamma-inducible JJ:1 
1 IFN-gamma-induced JJ:1 
1 IFN-alpha/beta-induced JJ:1 
1 IFN-alpha/B-stimulated JJ:1 
1 IFN-alpha-stimulated JJ:1 
1 IFN-alpha-activated JJ:1 
1 IFN-alpha- JJ:1 
1 IFN-activated JJ:1 
1 IFN-_gamma NN:1 
1 IEF-1 NN:1 
1 IE62-HSV NN:1 
1 IE-2 NN:1 
1 ICSAT/Pip/LSIRF NN:1 
1 ICR27 NN:1 
1 ICP36 NN:1 
1 ICP27 NN:1 
1 ICK-1A NN:1 
1 ICE-like JJ:1 
1 ICAM1 NN:1 
1 ICAM-3 NN:1 
1 ICAM-1LUC NN:1 
1 ICAM NN:1 
1 ICA-positive JJ:1 
1 IC50S NN:1 
1 IC50) NN:1 
1 IC NN:1 
1 IBMX NN:1 
1 I2 NN:1 
1 I/L NN:1 
1 I.Stefanescu NNP:1 
1 I-transformed JJ:1 
1 I-kappaBbeta NN:1 
1 I-kappaBalpha NN:1 
1 I-kB NN:1 
1 I-II CD:1 
1 I-Ek NN:1 
1 I+/ JJ:1 
1 Hypothetically RB:1 
1 Hypertension NN:1 
1 Hyperplastic JJ:1 
1 Hydroxyurea NN:1 
1 Hydrogen NN:1 
1 Hydrochlorothiazide NN:1 
1 Hut102 NN:1 
1 Hut-78 NN:1 
1 Hunninghake NNP:1 
1 Hungarian JJ:1 
1 Humara NN:1 
1 Huh7 NN:1 
1 Hsp NN:1 
1 Hox NN:1 
1 Hospital NNP:1 
1 Hormones NNS:1 
1 Hormone-induced JJ:1 
1 Hormone NN:1 
1 Hook FW:1 
1 Homozygotes NNS:1 
1 Homology NN:1 
1 Homodimerization NN:1 
1 Holley-Guthrie NNP:1 
1 Hogan NNP:1 
1 Hoffmeyer NNP:1 
1 Hlf NN:1 
1 Histopathological JJ:1 
1 Histological JJ:1 
1 Histologic JJ:1 
1 Hinrichs NNP:1 
1 Higher-molecular-weight JJ:1 
1 High-risk JJ:1 
1 Hha NN:1 
1 Hetherington NNP:1 
1 Heterokaryons NNS:1 
1 Heterodimerization NN:1 
1 Herpesviruses NNS:1 
1 Herein RB:1 
1 Hepatocytes NNS:1 
1 Hepatocyte NN:1 
1 Hepatic JJ:1 
1 Heparin NN:1 
1 Hemorrhagic JJ:1 
1 Helix-loop-helix JJ:1 
1 Helix NN:1 
1 Helices NNS:1 
1 HeLaS3 NN:1 
1 HeLa-tat JJ:1 
1 HeLa-cell JJ:1 
1 Hdg-1 NN:1 
1 Hayata FW:1 
1 Having VBG:1 
1 Hardy-Weinberg JJ:1 
1 Haplotypes NNS:1 
1 Haplotype NN:1 
1 Hans NNP:1 
1 Hanging VBG:1 
1 Half-maximal JJ:1 
1 Half-life NN:1 
1 Haemopoietic JJ:1 
1 Ha-ras NN:1 
1 HX630 NN:1 
1 HUT78 NN:1 
1 HUT NN:1 
1 HTLV-infected JJ:1 
1 HTLV-IIIB NN:1 
1 HTLV-III NN:1 
1 HTLV-I-negative JJ:1 
1 HTLV-I-LTR-CAT NN:1 
1 HTLV-I(-) JJ:1 
1 HTLV-1-transfected JJ:1 
1 HTLV NN:1 
1 HTH NN:1 
1 HTC NN:1 
1 HT93A NN:1 
1 HT-29 NN:1 
1 HSV/VZV NN:1 
1 HSV-1-mediated JJ:1 
1 HSV-1-activated JJ:1 
1 HSP70B NN:1 
1 HSFs NNS:1 
1 HSCs NNS:1 
1 HSC/ NN:1 
1 HSC NN:1 
1 HSB-2 NN:1 
1 HS4 NN:1 
1 HPV-18 NN:1 
1 HPV-16 NN:1 
1 HPP-CFCs NNS:1 
1 HPP-CFC NN:1 
1 HPP- CD:1 
1 HPB.ALL NN:1 
1 HPB-ALL NN:1 
1 HOX NN:1 
1 HOG-1 NN:1 
1 HOCI NN:1 
1 HNP-1 NNP:1 
1 HNFs NNS:1 
1 HNF-6 NN:1 
1 HNF-4alpha NN:1 
1 HNF-3alpha NN:1 
1 HNF-1alpha NN:1 
1 HNF NN:1 
1 HMG1B NN:1 
1 HMG-Y NN:1 
1 HMG-88 CD:1 
1 HMBA-induced JJ:1 
1 HLADQ NN:1 
1 HLA/peptide NN:1 
1 HLA-restricting JJ:1 
1 HLA-molecules NNS:1 
1 HLA-DRbeta NN:1 
1 HLA-DRalpha NN:1 
1 HLA-DR4 NN:1 
1 HLA-DR11 NN:1 
1 HLA-DR/-DQ NN:1 
1 HLA-DR-restricted JJ:1 
1 HLA-DR-constitutive JJ:1 
1 HLA-DR- JJ:1 
1 HLA-DR+ JJ:1 
1 HLA-DQB1 NN:1 
1 HLA-DQB NN:1 
1 HLA-DQA1*0501/DQB1*0302 NN:1 
1 HLA-DQ3.2 NN:1 
1 HLA-DP NN:1 
1 HLA-C NN:1 
1 HLA-B8 NN:1 
1 HLA-B27 NN:1 
1 HLA-A2-restricted JJ:1 
1 HLA-A2+ JJ:1 
1 HLA-A2 NN:1 
1 HL-60Egr-1 NN:1 
1 HL-60- NN:1 
1 HK666 NN:1 
1 HIV1_-infected JJ:1 
1 HIV/SIV NN:1 
1 HIV-seronegative JJ:1 
1 HIV-protease NN:1 
1 HIV-long JJ:1 
1 HIV-LTR/tat NN:1 
1 HIV-LTR-kappaB NN:1 
1 HIV-1/SIV NN:1 
1 HIV-1-infected JJ:1 
1 HIV-1-encoded JJ:1 
1 HIV-1- NN:1 
1 HIT-T15 NN:1 
1 HIT NN:1 
1 HIC1 NN:1 
1 HHT NN:1 
1 HH514-16 NN:1 
1 HGMW-approved JJ:1 
1 HGFs NNS:1 
1 HGF NN:1 
1 HES-1 NN:1 
1 HEK NN:1 
1 HEB-1 NN:1 
1 HDL-cholesterol NN:1 
1 HDAC-containing JJ:1 
1 HDAC NN:1 
1 HD1 NN:1 
1 HCl NN:1 
1 HCV-positive JJ:1 
1 HCO3- JJ:1 
1 HC11 NN:1 
1 HBx-antigen NN:1 
1 HBG1 NN:1 
1 HAuCl3 NN:1 
1 HAT NN:1 
1 HA1004 NN:1 
1 HA-1004 NN:1 
1 H7-inhibitable JJ:1 
1 H3-antagonist NN:1 
1 H2O2- JJ:1 
1 H2B-2 NN:1 
1 H2B NN:1 
1 H2A-2 NN:1 
1 H292 NN:1 
1 H287A NN:1 
1 H2.0 NN:1 
1 H2-antagonist NN:1 
1 H19 NN:1 
1 H1285 NN:1 
1 H1-histamine JJ:1 
1 H1-antagonists NNS:1 
1 H1-agonists NNS:1 
1 H1 NN:1 
1 H/C NN:1 
1 H.M. NNP:1 
1 H.C. NNP:1 
1 H.-M.Chen NNP:1 
1 H-gene NN:1 
1 H-CAM NN:1 
1 H-8 NN:1 
1 H-2k NN:1 
1 H-2d NN:1 
1 H-2b NN:1 
1 H- TO:1 
1 Gzero/G1 NN:1 
1 Gy/min NN:1 
1 Gupta NNP:1 
1 Gudmundsson NN:1 
1 Gs(alpha) NN:1 
1 Gs NN:1 
1 Growing VBG:1 
1 Groups NNS:1 
1 Gribben NNP:1 
1 Grb2-related JJ:1 
1 Grb2-like JJ:1 
1 Grb2-associated JJ:1 
1 Grave NN:1 
1 Granzyme NN:1 
1 Granulosa NN:1 
1 Granulocyte/macrophage NN:1 
1 Gr NN:1 
1 Gq/G11 NN:1 
1 Gonzalez NNP:1 
1 Gonadotropin-releasing JJ:1 
1 Gollob NNP:1 
1 Golgi NN:1 
1 Goldberg NNP:1 
1 Gold NN:1 
1 Go NN:1 
1 GnRH-stimulated JJ:1 
1 Glycoprotein NN:1 
1 Glycation-dependent JJ:1 
1 Glutathione-S-transferase NN:1 
1 Glucocorticosteroids NNS:1 
1 Glucocorticosteroid NN:1 
1 Glucocorticoid-induced JJ:1 
1 Glu30-Leu41 NN:1 
1 Glu-Asp-Gly-Lys-Lys-Phe-Asp NN:1 
1 Gliotoxin NN:1 
1 Giant JJ:1 
1 Gi/Go NN:1 
1 Germinal JJ:1 
1 Germany NNP:1 
1 German NNP:1 
1 Germ NN:1 
1 Gerald NNP:1 
1 General JJ:1 
1 Genbank NNP:1 
1 Gel-retardation JJ:1 
1 Geist NNP:1 
1 Geha NN:1 
1 Garfein NNP:1 
1 Garcia-Cozar NNP:1 
1 Gallo NNP:1 
1 Gal4-binding JJ:1 
1 Gal4-Elf-1 NN:1 
1 Gal/ER NN:1 
1 G_+_C NN:1 
1 GTT NN:1 
1 GTP-cyclohydrolase NN:1 
1 GTP-GDP JJ:1 
1 GTGGGAA NN:1 
1 GST-pi- JJ:1 
1 GST-construct NN:1 
1 GRs NNS:1 
1 GRE-dependent JJ:1 
1 GPIbalpha NN:1 
1 GPIb- JJ:1 
1 GPIIb-IIIa NN:1 
1 GPIIIa NN:1 
1 GPI-1 NN:1 
1 GP+E-86 NN:1 
1 GOS19.1 NN:1 
1 GM2/GC-box NN:1 
1 GM1 NN:1 
1 GM-CSFR NN:1 
1 GM-CSF- JJ:1 
1 GHF-1/Pit-1 NN:1 
1 GH4C1 NN:1 
1 GH/PRL- NN:1 
1 GH-V NN:1 
1 GGTAGTTCCC NN:1 
1 GGGGGCTTTCCC NN:1 
1 GGGGCTGTCCC NN:1 
1 GGGGACTTTCCG NN:1 
1 GGGGACTTTCC NN:1 
1 GGGGACGTCCCC NN:1 
1 GGGGAATCTCCC NN:1 
1 GGGACTTTCC NN:1 
1 GGGAACTACC NN:1 
1 GGGAAATTCC NN:1 
1 GGACTACAG NN:1 
1 GGAAs NNS:1 
1 GGAAAGTCCC NN:1 
1 GGAAAA NN:1 
1 GGAA NN:1 
1 GF-1 NN:1 
1 GDP NN:1 
1 GD1a NN:1 
1 GC-sensitive JJ:1 
1 GC-motif NN:1 
1 GATA/ER NN:1 
1 GATA-responsive JJ:1 
1 GATA-like JJ:1 
1 GATA-factor NN:1 
1 GATA-dependent JJ:1 
1 GATA-associated JJ:1 
1 GATA-3/ER NN:1 
1 GATA-2/estrogen NN:1 
1 GATA-1/lacZ NN:1 
1 GATA-1(d) NN:1 
1 GATA-1(c) NN:1 
1 GATA- JJ:1 
1 GAS-like JJ:1 
1 GAS-binding JJ:1 
1 GALdbd- NN:1 
1 GALA NN:1 
1 GAL4-substituted JJ:1 
1 GAL4-p65 NN:1 
1 GAL4-EBNA3C NN:1 
1 GAD-CREB NN:1 
1 G76:GPLTPLPV NN:1 
1 G75:AES1/2 NN:1 
1 G61:_AES1/2 NN:1 
1 G60:_AES1/2 NN:1 
1 G3AG4AG3 NN:1 
1 G3 NN:1 
1 G2715T NN:1 
1 G2/M- NN:1 
1 G10-2/ NN:1 
1 G10-2 NN:1 
1 G1/G0 NN:1 
1 G1-regulating JJ:1 
1 G1-S-associated JJ:1 
1 G1- NN:1 
1 G0-G1 JJ:1 
1 G.Visani NNP:1 
1 G.Peters NN:1 
1 G.Nabel NNP:1 
1 G.Klein NNP:1 
1 G.Furlini NNP:1 
1 G.A. NNP:1 
1 G-seropositive JJ:1 
1 G-actin NN:1 
1 G-200 NN:1 
1 Fyn NN:1 
1 Fyb NN:1 
1 Fya NN:1 
1 Furthermore, UNKNOWN:1 
1 Fura-2-loaded JJ:1 
1 Functions NNS:1 
1 Functionally RB:1 
1 French-American-British JJ:1 
1 Fragments NNS:1 
1 Fragmentation NN:1 
1 Fragment NN:1 
1 Fr35-II NN:1 
1 Fp NN:1 
1 Fourth RB:1 
1 Fourteen CD:1 
1 Fourier NN:1 
1 Fos/Jun-containing JJ:1 
1 Fos-B NN:1 
1 Forty-one CD:1 
1 Forty-five CD:1 
1 Forty-eight CD:1 
1 Formulation NNP:1 
1 Formalin-fixed JJ:1 
1 Footprinting NN:1 
1 Follow-up NN:1 
1 Flt-3 NN:1 
1 Flavonoids NNS:1 
1 Finapres NN:1 
1 Finally, UNKNOWN:1 
1 Fifty-three CD:1 
1 Fifteen CD:1 
1 Fibronectin NN:1 
1 Fibrin NN:1 
1 Fes NN:1 
1 Fenton NN:1 
1 Female JJ:1 
1 Fe2+ JJ:1 
1 FcepsilonRI NN:1 
1 FcRFgamma NN:1 
1 Fast-Green/Neutral-Red NN:1 
1 Fast JJ:1 
1 FasL/CD95 NN:1 
1 FasL- NN:1 
1 Fas/APO-1/CD95- NN:1 
1 Fas/APO-1 NN:1 
1 Fas/ NN:1 
1 Factor-1 NN:1 
1 Faber NNP:1 
1 Fab NN:1 
1 FVC NN:1 
1 FT4 NN:1 
1 FR NN:1 
1 FP4-3' NN:1 
1 FOSB/G0S3 NN:1 
1 FOS/G0S7 NN:1 
1 FLRGRAYGL NN:1 
1 FLICE NN:1 
1 FKHRL1P2 NN:1 
1 FKHRL1 NN:1 
1 FKBP54 NN:1 
1 FK506.FKBP12 NN:1 
1 FK506-sensitive JJ:1 
1 FITC-dextran NN:1 
1 FITC- NN:1 
1 FIGURE NN:1 
1 FI NN:1 
1 FGFs NNS:1 
1 FDCP-mix NN:1 
1 FDCP-2 NN:1 
1 FDC-P1-derived JJ:1 
1 FCS(-)-culture JJ:1 
1 FC-derived JJ:1 
1 FC NN:1 
1 FACS-isolated JJ:1 
1 F9 NN:1 
1 F6T NN:1 
1 F.Wang NNP:1 
1 F.Massari NNP:1 
1 F.M NN:1 
1 F.Lori NNP:1 
1 F.Barre-Sinoussi NNP:1 
1 F-actin NN:1 
1 F(ab')2 NN:1 
1 Extrarenal JJ:1 
1 Extracts NNS:1 
1 Extract NN:1 
1 Extracellular-regulated JJ:1 
1 Extinction NN:1 
1 External JJ:1 
1 Extensive JJ:1 
1 Expressions NNS:1 
1 Exploration NN:1 
1 Experimentally RB:1 
1 Exp.Cell NNP:1 
1 Exp. NNP:1 
1 Exons NNS:1 
1 Exclusive JJ:1 
1 Excess JJ:1 
1 Ex FW:1 
1 Evil NN:1 
1 Evi-1 NN:1 
1 Every DT:1 
1 Europe NN:1 
1 Eur.J.Immunol.1994.24 NN:1 
1 Eur NNP:1 
1 Ets1 NN:1 
1 Ets-like JJ:1 
1 Ets-family NN:1 
1 Ets-2 NN:1 
1 Ets-1-containing JJ:1 
1 Ets- JJ:1 
1 Estrone NN:1 
1 Establishment NN:1 
1 Essential JJ:1 
1 Escape NN:1 
1 Erythrocyte NN:1 
1 Eryf-1 NN:1 
1 Erbstatin NN:1 
1 ErbB NN:1 
1 Equivalencies NN:1 
1 Epstein NN:1 
1 Epitope NN:1 
1 Eotaxin NN:1 
1 Eosinophil-depleted JJ:1 
1 Eo NN:1 
1 Enzymatic JJ:1 
1 Environmental JJ:1 
1 Env NN:1 
1 Entamoeba FW:1 
1 Enhancing NN:1 
1 Enhancers NNS:1 
1 English-language JJ:1 
1 Enforced VBN:1 
1 Energy NN:1 
1 Endonuclease NN:1 
1 Endocrine JJ:1 
1 Encephalomyocarditis NN:1 
1 Employing VBG:1 
1 Elsevier NNP:1 
1 Eligible JJ:1 
1 Elf-2b NN:1 
1 Elf-2 NN:1 
1 Elevation NN:1 
1 Elements NNS:1 
1 Electrophoretically RB:1 
1 Electrophoresis NN:1 
1 Electron NN:1 
1 Elastatinal NN:1 
1 Either CC:1 
1 Eighteen CD:1 
1 Ehrlichia FW:1 
1 Egr-1/ NN:1 
1 Efforts NNS:1 
1 Effector NN:1 
1 Edman NN:1 
1 Eckhard NNP:1 
1 East JJ:1 
1 Earlier JJR:1 
1 EWG NN:1 
1 ETV6- JJ:1 
1 ESb-L NN:1 
1 ES-derived JJ:1 
1 ERalpha NN:1 
1 ERK-dependent JJ:1 
1 ER27191 NN:1 
1 ER-positive JJ:1 
1 ER-beta NN:1 
1 ER-_cells NNS:1 
1 EP4 NN:1 
1 EMBO NNP:1 
1 EIB19K NN:1 
1 EGFP NN:1 
1 EGF-gp130 NN:1 
1 EDTA NN:1 
1 ED-40515(+) NN:1 
1 ECS-dependent JJ:1 
1 EBV-mediated JJ:1 
1 EBV-infected JJ:1 
1 EBV-induced JJ:1 
1 EBV-immortalized JJ:1 
1 EBV-immortalised JJ:1 
1 EBV-BHRF1 NN:1 
1 EBV-B NN:1 
1 EBNAI NN:1 
1 EBNA2-deficient JJ:1 
1 EBNA2-EBNA6 NN:1 
1 EBNA-2A NN:1 
1 EBNA-1 NN:1 
1 EBI1 NN:1 
1 EBER-1 NN:1 
1 EBER NN:1 
1 EB1089 NN:1 
1 EA-R NN:1 
1 EA-D/BHLF1/NotI NN:1 
1 E74-like JJ:1 
1 E6-AP NN:1 
1 E3-dependent JJ:1 
1 E2a NN:1 
1 E2Fs NNS:1 
1 E2F-dependent JJ:1 
1 E2F-DNA NN:1 
1 E2F-1/DP1 NN:1 
1 E29.1 NN:1 
1 E232K NN:1 
1 E2-treated JJ:1 
1 E2-F1 NN:1 
1 E1a-specific JJ:1 
1 E1a-positive JJ:1 
1 E1a-_replication-deficient JJ:1 
1 E1a- NN:1 
1 E1A-region NN:1 
1 E1A-immortalized JJ:1 
1 E1A-binding JJ:1 
1 E15 CD:1 
1 E14 NN:1 
1 E1-binding JJ:1 
1 E.Ramazzotti NNP:1 
1 E.Kieff NNP:1 
1 E.Hara NN:1 
1 E.Flory NNP:1 
1 E.C.3.1.4.12 NN:1 
1 E-stained JJ:1 
1 E-dependent JJ:1 
1 E-cadherin NN:1 
1 E-box-binding JJ:1 
1 E-Cdk2- NN:1 
1 E-CM NN:1 
1 E(spl) NN:1 
1 Dupuytren NN:1 
1 Duhring NNP:1 
1 Ducy NNP:1 
1 Ductal JJ:1 
1 Drops NN:1 
1 Dramatic JJ:1 
1 Downstream JJ:1 
1 Double-stranded JJ:1 
1 Double-stimulation NN:1 
1 Dose-dependent JJ:1 
1 Dose-dependence JJ:1 
1 Dorsal NN:1 
1 Dopamine NN:1 
1 Donnelley NNP:1 
1 Dithiothreitol NN:1 
1 Disturbance NN:1 
1 Displacement NN:1 
1 Dimethyldithiocarbamate NN:1 
1 Dimers NNS:1 
1 Dihuang FW:1 
1 Diffusible JJ:1 
1 Differentiation-dependent JJ:1 
1 Differentiation-associated JJ:1 
1 Dicarba-closo-dodecaboranes NNS:1 
1 Dibutyryl NN:1 
1 Diamide NN:1 
1 Dexter-type JJ:1 
1 Development NN:1 
1 Dev. NNP:1 
1 Description NN:1 
1 Deregulated JJ:1 
1 Deranged VBN:1 
1 Dependence NN:1 
1 Department NN:1 
1 Deoxycorticosterone NN:1 
1 Deltorphin NN:1 
1 DeltaSpi-B NN:1 
1 Delta-opioid JJ:1 
1 Delineation NN:1 
1 Deleted JJ:1 
1 Delayed VBN:1 
1 Degenerate NN:1 
1 Defining VBG:1 
1 Defensin NN:1 
1 Decidual JJ:1 
1 December NNP:1 
1 Death-inducing NN:1 
1 Deactivation NN:1 
1 Dd-restricted JJ:1 
1 Dd NN:1 
1 Dbp NN:1 
1 Damage NN:1 
1 Dalton NN:1 
1 Da NN:1 
1 DU528 NN:1 
1 DU NN:1 
1 DT-40 NN:1 
1 DSM-III-R NN:1 
1 DSL NN:1 
1 DRIP205 NN:1 
1 DRA/DQB NN:1 
1 DR3-type JJ:1 
1 DR11-restricted JJ:1 
1 DR11(+) JJ:1 
1 DR11 NN:1 
1 DR1 NN:1 
1 DR+4 NN:1 
1 DR+2 NN:1 
1 DQalpha NN:1 
1 DQB1*0201 NN:1 
1 DQB1 NN:1 
1 DQB-W NN:1 
1 DQA1*0501/DQB1*0302 NN:1 
1 DQ3.1 NN:1 
1 DQ2.1 NN:1 
1 DQ2-restricted JJ:1 
1 DQ2-anchor NN:1 
1 DPH NN:1 
1 DP-I NN:1 
1 DOX-treated JJ:1 
1 DOC NN:1 
1 DO- JJ:1 
1 DNasel NN:1 
1 DNase-I-hypersensitive JJ:1 
1 DND-41 NN:1 
1 DNA-unwinding NN:1 
1 DNA-transfected JJ:1 
1 DNA-swap NN:1 
1 DNA-streptavidin NN:1 
1 DNA-relaxing JJ:1 
1 DNA-recognition NN:1 
1 DNA-probe NN:1 
1 DNA-mobility-shift JJ:1 
1 DNA-mobility JJ:1 
1 DNA-laddering NN:1 
1 DNA-dependent JJ:1 
1 DNA-binding/immunoprecipitation JJ:1 
1 DNA-binding/dimerization JJ:1 
1 DNA-associated JJ:1 
1 DMS NN:1 
1 DMP NN:1 
1 DM+ JJ:1 
1 DIL NN:1 
1 DHL-9 NN:1 
1 DH42 NN:1 
1 DG75 NN:1 
1 DG/SA NN:1 
1 DFR NN:1 
1 DEVD-pNA NN:1 
1 DEVD-p-nitroanilide NN:1 
1 DEVD-cleavable JJ:1 
1 DEVD-CHO NN:1 
1 DEPs NNS:1 
1 DEP-PAH-activated JJ:1 
1 DEG5 NN:1 
1 DCoH-HNF-1 NN:1 
1 DCFH-DA NN:1 
1 DC-T-cell NN:1 
1 DBF-sites NNS:1 
1 DAPI NN:1 
1 D584AQPQAGR NN:1 
1 D3-responsive JJ:1 
1 D3- NN:1 
1 D20Z1 NN:1 
1 D20S58 NN:1 
1 D20S57 NN:1 
1 D20S56 NN:1 
1 D20S42 NN:1 
1 D20S41 NN:1 
1 D20S18 NN:1 
1 D20S17 NN:1 
1 D1/CDR3-loop NN:1 
1 D1/CDR2-loop NN:1 
1 D1/ NN:1 
1 D07 RB:1 
1 D.Zagury NNP:1 
1 D.V.Ablashi NNP:1 
1 D.Schwartz NNP:1 
1 D.M.Powell NNP:1 
1 D.G.Tenen NNP:1 
1 D.G. NNP:1 
1 D.Finzi NNP:1 
1 D.E. NNP:1 
1 D.D.Richman NNP:1 
1 D.Baltimore NNP:1 
1 D.A. NNP:1 
1 D.-E.Zhang NNP:1 
1 D.-E. NNP:1 
1 D-type JJ:1 
1 D-resistant JJ:1 
1 D-mediated JJ:1 
1 D-box NN:1 
1 D-binding JJ:1 
1 D-associated JJ:1 
1 Cytosols NNS:1 
1 Cytokine-stimulated JJ:1 
1 Cytokine-induced JJ:1 
1 Cystic JJ:1 
1 Cysteine NN:1 
1 Cysteamine NN:1 
1 Cys2-Xaa12-His2 NN:1 
1 Cys NN:1 
1 Cyclosporine NN:1 
1 Cyclic JJ:1 
1 Cycles NNS:1 
1 CyP-40 NN:1 
1 Cy1 NN:1 
1 Cushingoid JJ:1 
1 Curiously RB:1 
1 Curcumin NN:1 
1 Curcuma FW:1 
1 Cupric JJ:1 
1 Cu NN:1 
1 CstF-64 NN:1 
1 Crossreactive JJ:1 
1 Cross-priming NN:1 
1 Cross-competition NN:1 
1 CrmA NN:1 
1 Crkl NN:1 
1 Crabtree NNP:1 
1 Cp/Wp NN:1 
1 Cowan NN:1 
1 Coupled JJ:1 
1 Costimulatory JJ:1 
1 Costar NN:1 
1 Cosmid NN:1 
1 Cortisone-resistant JJ:1 
1 Corticoids NNS:1 
1 Core-specific JJ:1 
1 Core NN:1 
1 Coproporphyrinogen NN:1 
1 Copeland NNP:1 
1 Coordination NN:1 
1 Conversion NN:1 
1 Convergence NN:1 
1 Contribution NN:1 
1 Continuous JJ:1 
1 Constructs NNS:1 
1 Construction NN:1 
1 Considerably RB:1 
1 Consensus NN:1 
1 Consecutive JJ:1 
1 Congruous JJ:1 
1 Confirmed VBN:1 
1 Conditioned JJ:1 
1 Concerning VBG:1 
1 Concentration NN:1 
1 Concanavalin-A NN:1 
1 ConA NN:1 
1 Computer-assisted JJ:1 
1 Computer NN:1 
1 Compounds NNS:1 
1 Composite JJ:1 
1 Complications NNS:1 
1 Competent JJ:1 
1 Comparing VBG:1 
1 Communication NN:1 
1 Common JJ:1 
1 Combined JJ:1 
1 Colinear JJ:1 
1 Coligation NN:1 
1 Coincidentally RB:1 
1 Coincident JJ:1 
1 Cohen NNP:1 
1 Coffman NNP:1 
1 Cockayne NN:1 
1 Cobalt NN:1 
1 Coactivator NN:1 
1 Coactivation NN:1 
1 Co-transfections NNS:1 
1 Co-ligation NN:1 
1 Co-infection NN:1 
1 Co-immunoprecipitation NN:1 
1 Co-culture NN:1 
1 Closer JJR:1 
1 Clones NNS:1 
1 Cloned VBN:1 
1 Clone-13 NN:1 
1 Clinicians NNS:1 
1 Clinically RB:1 
1 Clevers NNP:1 
1 Clathrin NN:1 
1 Classification NN:1 
1 Cl- NN:1 
1 Circumvention NN:1 
1 Circularization NN:1 
1 Ciprofibrate NN:1 
1 Cipro NN:1 
1 Cip1 NN:1 
1 Churg-Strauss JJ:1 
1 Chrysotile NN:1 
1 CholecystokininB NN:1 
1 Chlorinated VBN:1 
1 Chimeric JJ:1 
1 Chignard NNP:1 
1 Chesney NNP:1 
1 Chemoattractants NNS:1 
1 Chemical JJ:1 
1 Chem. NNP:1 
1 Charybdotoxin-sensitive JJ:1 
1 Charcot-Leyden NN:1 
1 Characterisation NN:1 
1 Chang NNP:1 
1 Challenges NNS:1 
1 Cgamma NN:1 
1 Cell. NNP:1 
1 Cell-mediated JJ:1 
1 Cell-cycle JJ:1 
1 Ceanorhabditis FW:1 
1 Cdk2-dependent JJ:1 
1 Cdk2 NN:1 
1 Cdk-2-dependent JJ:1 
1 Cavia NN:1 
1 Category NN:1 
1 Categories NNS:1 
1 Caspase-3 NN:1 
1 Caspase NN:1 
1 Carter NN:1 
1 Cardiac JJ:1 
1 Carboxylesterases NNS:1 
1 Carboxyl-terminal JJ:1 
1 Capacitance NN:1 
1 Cao NNP:1 
1 Can/Nup214 NN:1 
1 Campomelic JJ:1 
1 Calyculin NN:1 
1 Calpha NN:1 
1 Calmodulin NN:1 
1 Calcium/calmodulin-dependent JJ:1 
1 Calcitriol NN:1 
1 CaMKIV/ NN:1 
1 CaMK NN:1 
1 CaM/CN- JJ:1 
1 CaI NN:1 
1 Ca2+/calmodulin-regulated JJ:1 
1 Ca2+-mediated JJ:1 
1 Ca2+-dependent JJ:1 
1 Ca2+-binding JJ:1 
1 Ca2+- JJ:1 
1 Ca-ATPase NN:1 
1 Ca(2+)-transport NN:1 
1 Ca(2+)-stimulated JJ:1 
1 Ca(2+)-regulated JJ:1 
1 Ca(2+)-mobilizing NN:1 
1 Ca(2+)-ionophore NN:1 
1 Ca(2+)-ATPases NNS:1 
1 Ca NN:1 
1 C[AT]6GG NN:1 
1 CYC1 NN:1 
1 CV3988 NN:1 
1 CTTGG NN:1 
1 CTLL2 NN:1 
1 CTLL-2/ NN:1 
1 CTL-mediated JJ:1 
1 CTGTG NN:1 
1 CTG-monomer NN:1 
1 CTG-dimer NN:1 
1 CTF/NF-1 NN:1 
1 CTF/CBP NN:1 
1 CTCACNTNC NN:1 
1 CST3 NN:1 
1 CRT NN:1 
1 CRP1 NN:1 
1 CREB/activating JJ:1 
1 CREB/ATF-1/CREM NN:1 
1 CREB-1 NN:1 
1 CRC NN:1 
1 CR2/CD21 NN:1 
1 CR2 NN:1 
1 CPRE NN:1 
1 CPP32/Yama/apopain NN:1 
1 CPP32 NN:1 
1 CP-2 NN:1 
1 COX-2-mediated JJ:1 
1 COUP NN:1 
1 COOH- JJ:1 
1 CNS-derived JJ:1 
1 CNI-_1493 NN:1 
1 CNBr NN:1 
1 CMMoL NN:1 
1 CMML NN:1 
1 CLB-CD28/1 NN:1 
1 CL-induced JJ:1 
1 CK-1/CK-2 NN:1 
1 CINC NN:1 
1 CHOtsH1-1 NN:1 
1 CHO-DR/ JJ:1 
1 CHO-DR NN:1 
1 CH NN:1 
1 CFU-M NN:1 
1 CFU-IL6 NNS:1 
1 CFU-GM NN:1 
1 CFU-GEMM/ NN:1 
1 CEM-ICR NN:1 
1 CEM-C1 NN:1 
1 CEM-4R4 NN:1 
1 CEM-3R43 NN:1 
1 CDNA NN:1 
1 CDIIa NN:1 
1 CDC42 NN:1 
1 CD95-dependent JJ:1 
1 CD8alpha/IL-4Ralpha NN:1 
1 CD8-negative JJ:1 
1 CD8+CD56+/CD57+ JJ:1 
1 CD8+CD28null NN:1 
1 CD79b NN:1 
1 CD68-_APC NN:1 
1 CD68- JJ:1 
1 CD68(+) JJ:1 
1 CD68 NN:1 
1 CD65s+ JJ:1 
1 CD62L NN:1 
1 CD61 NN:1 
1 CD5+) JJ:1 
1 CD5+ JJ:1 
1 CD49f NN:1 
1 CD49d/CD29 NN:1 
1 CD45R0+ JJ:1 
1 CD45-negative JJ:1 
1 CD45-deficient JJ:1 
1 CD437 NN:1 
1 CD41 NN:1 
1 CD40: NN:1 
1 CD40-CD40 JJ:1 
1 CD40- NN:1 
1 CD4/CD8 NN:1 
1 CD4-bearing JJ:1 
1 CD4-IgG NN:1 
1 CD4-CD8-_murine JJ:1 
1 CD4-CD8-_T NN:1 
1 CD4-CD8- JJ:1 
1 CD4+CD45RO- JJ:1 
1 CD4+CD45RO+ JJ:1 
1 CD4+CD45R0+CD45RA-CD29highCD11a+ JJ:1 
1 CD4+CD45R0+ JJ:1 
1 CD4+CD28null NN:1 
1 CD4+/CD45RO JJ:1 
1 CD4(-)CD8(-)CD3(-) JJ:1 
1 CD3R NN:1 
1 CD39- NN:1 
1 CD38(-) JJ:1 
1 CD37 NN:1 
1 CD367 NN:1 
1 CD34+Thy-l-CD45RA+ JJ:1 
1 CD34+Thy-1-CD45RA- JJ:1 
1 CD34+CD71+ JJ:1 
1 CD34+/CD38(2+) JJ:1 
1 CD34+/- JJ:1 
1 CD34(2+)/CD38- JJ:1 
1 CD336 NN:1 
1 CD30L NN:1 
1 CD3/TCR NN:1 
1 CD3/T-cell NN:1 
1 CD3/T NN:1 
1 CD3/CD4+ JJ:1 
1 CD3/ JJ:1 
1 CD3.TcR NN:1 
1 CD3-T-cell NN:1 
1 CD3+CD28-induced JJ:1 
1 CD3(+) JJ:1 
1 CD29 NN:1 
1 CD28-induced JJ:1 
1 CD28+ JJ:1 
1 CD2019 NN:1 
1 CD20/B1 NN:1 
1 CD20-CAT NN:1 
1 CD20+ JJ:1 
1 CD2/CD4-positive JJ:1 
1 CD2-mediated JJ:1 
1 CD19-expressing JJ:1 
1 CD19+ JJ:1 
1 CD16+ JJ:1 
1 CD15lo JJ:1 
1 CD14-transfected JJ:1 
1 CD14- NN:1 
1 CD14(+) JJ:1 
1 CD13lo JJ:1 
1 CD138/syndecan-1 NN:1 
1 CD138/ NN:1 
1 CD13/APN NN:1 
1 CD11c/CD18 NN:1 
1 CD11a+ JJ:1 
1 CD11B NN:1 
1 CD102 NN:1 
1 CD1+relB+DC NN:1 
1 CD1+RelB+ JJ:1 
1 CD1+relB+ JJ:1 
1 CD-40 NN:1 
1 CD+8 JJ:1 
1 CCl4- JJ:1 
1 CCR-1 NN:1 
1 CCGAAACTGAAAAGG NN:1 
1 CCATATATGG NN:1 
1 CCACC NN:1 
1 CCAAT-binding JJ:1 
1 CCAAG NN:1 
1 CCAAC NN:1 
1 CC(A/T)6GG NN:1 
1 CC NN:1 
1 CBP35 NN:1 
1 CBG NN:1 
1 CBFalpha2 NN:1 
1 CBFA2 NN:1 
1 CB77O-DR/ NN:1 
1 CB50 NN:1 
1 CAX NN:1 
1 CATGTGGC NN:1 
1 CANNTG NN:1 
1 CAK NN:1 
1 CAGs NNS:1 
1 CAGGTG NN:1 
1 CAGATG NN:1 
1 CAAT/enhancer NN:1 
1 C8-C7 NN:1 
1 C5b-8 NN:1 
1 C57MG NN:1 
1 C57BL/10SnJ NN:1 
1 C57BL/10 NN:1 
1 C57 NN:1 
1 C3HeB/FeJ NN:1 
1 C3H NN:1 
1 C2H2-type NN:1 
1 C196 NN:1 
1 C/EBPdelta NN:1 
1 C/EBPa NN:1 
1 C/EBP-binding JJ:1 
1 C.botulinum FW:1 
1 C.J.Hetherington NNP:1 
1 C.J. NNP:1 
1 C.H.R. NNP:1 
1 C.H.Fox NNP:1 
1 C.Gregory NNP:1 
1 C-zeta NN:1 
1 C-ring NN:1 
1 C-reactive JJ:1 
1 C-myb NN:1 
1 C-gamma1 NN:1 
1 C-fos NN:1 
1 C-depleted JJ:1 
1 C-Jun NN:1 
1 C-FMS NN:1 
1 C-235 NN:1 
1 C-11-substituted JJ:1 
1 C(H) NN:1 
1 Butyric JJ:1 
1 Bufalin NN:1 
1 Bucala NNP:1 
1 Bt2 NN:1 
1 BsmI NN:1 
1 Bsm NN:1 
1 Bs NNS:1 
1 Bronchoalveolar JJ:1 
1 Briefly RB:1 
1 Brief JJ:1 
1 Breast NN:1 
1 Brazilian JJ:1 
1 Boyden NN:1 
1 Box1 NN:1 
1 Bound VBN:1 
1 Boston NNP:1 
1 Bone NN:1 
1 Body NN:1 
1 Bob1/OBF-1/OCA-B NN:1 
1 Bob-1 NN:1 
1 Blot NN:1 
1 Block NN:1 
1 Blast NN:1 
1 Bivalent JJ:1 
1 Bipotential JJ:1 
1 Biosynthesis NN:1 
1 Biopsies NNS:1 
1 Biophys NNP:1 
1 Biomarkers NNS:1 
1 Biological JJ:1 
1 Biologic JJ:1 
1 Biochim NNP:1 
1 Biochemistry NNP:1 
1 Biochemically RB:1 
1 Biochem.Mol.Biol.57 NNP:1 
1 Bioactivation NN:1 
1 Bicoid NN:1 
1 BglII NN:1 
1 Bfl-1/A1 NN:1 
1 Bfl-1 NN:1 
1 Beyond IN:1 
1 Between IN:1 
1 Better JJR:1 
1 Beth NNP:1 
1 Beta-catenin NN:1 
1 Bernard NNP:1 
1 Beres NN:1 
1 Benzene NN:1 
1 Being VBG:1 
1 Bcl6+/CD3+/CD20-/CD57- JJ:1 
1 Bcl-X(L) NN:1 
1 Bcl-2-overexpressed JJ:1 
1 BcLF1 NN:1 
1 Bb NN:1 
1 Basophils NNS:1 
1 Basing VBG:1 
1 Basically RB:1 
1 Basement NN:1 
1 Baseler NNP:1 
1 Base-pair JJ:1 
1 Barrier NN:1 
1 Barr NN:1 
1 Bare NN:1 
1 Bandshift NN:1 
1 BamHI-A NN:1 
1 Balb/c3T3 NN:1 
1 Balachandran NNP:1 
1 BaL NN:1 
1 Bal NN:1 
1 Baf-3 NN:1 
1 Bacterially RB:1 
1 BaF3 NN:1 
1 BZLF1-encoded JJ:1 
1 BXB NN:1 
1 BW5147 NN:1 
1 BV173 NN:1 
1 BUN NN:1 
1 BUD NN:1 
1 BU/mL NN:1 
1 BU NN:1 
1 BTEB2 NN:1 
1 BSLF2 NN:1 
1 BSAP/PAX5 NN:1 
1 BSAP-binding JJ:1 
1 BSA NN:1 
1 BRTAL NNS:1 
1 BRLF1/BZLF1 NN:1 
1 BRLF-1 NN:1 
1 BRL NN:1 
1 BRK NN:1 
1 BR4 NN:1 
1 BPV NN:1 
1 BPI NN:1 
1 BP- NN:1 
1 BMS2.4 NN:1 
1 BLUC NN:1 
1 BLR2/EBI1 NN:1 
1 BLK NN:1 
1 BL60 NN:1 
1 BL41-P3HR1 NN:1 
1 BL30 NN:1 
1 BL2 NN:1 
1 BHLF1/NotI NN:1 
1 BH3 NN:1 
1 BH2 NN:1 
1 BH10 NN:1 
1 BH1 NN:1 
1 BFU-E/CFU-M NN:1 
1 BFRF3 NN:1 
1 BF24 NN:1 
1 BF-kappa NN:1 
1 BCR1/9 NN:1 
1 BCR-ABL NN:1 
1 BCL2+ JJ:1 
1 BCL-XL NN:1 
1 BCL-2+ JJ:1 
1 BCG NN:1 
1 BCCs NNS:1 
1 BCC NN:1 
1 BB-94 NN:1 
1 BB NN:1 
1 BAt NN:1 
1 BASED NN:1 
1 BASC NN:1 
1 BAPTA-AM NN:1 
1 BALL1 NN:1 
1 BALF2 NN:1 
1 BALB/cByJ NN:1 
1 BAL-17 NN:1 
1 BAF170 NN:1 
1 BAF155 NN:1 
1 BA92 NN:1 
1 BA/F3 NN:1 
1 B95.8 NN:1 
1 B8-restricted JJ:1 
1 B7-transfected JJ:1 
1 B7-positive JJ:1 
1 B7-negative JJ:1 
1 B7-independent JJ:1 
1 B6D2F1 NN:1 
1 B1/p50 NN:1 
1 B1/ NN:1 
1 B/Sp1 NN:1 
1 B/Rel/NFAT NN:1 
1 B.pertussis FW:1 
1 B-subunit JJ:1 
1 B-site NN:1 
1 B-responsive JJ:1 
1 B-reporter JJ:1 
1 B-lymphotropic JJ:1 
1 B-lymphopoiesis NN:1 
1 B-lymphoma NN:1 
1 B-lymphoid-specific JJ:1 
1 B-lineage-specific JJ:1 
1 B-lineage NN:1 
1 B-inducible JJ:1 
1 B-fos-CAT NN:1 
1 B-driven JJ:1 
1 B-chronic JJ:1 
1 B-cell-mediated JJ:1 
1 B-cell-and NN:1 
1 B-cell- JJ:1 
1 B-binding-proteins NNS:1 
1 B-beta NN:1 
1 B-alpha/MAD-3 NN:1 
1 B-LAIp NN:1 
1 B-4 NN:1 
1 B-3 NN:1 
1 Auzou NNP:1 
1 Autosome/ NN:1 
1 Autoregulation NN:1 
1 Autoreactive JJ:1 
1 Autologous JJ:1 
1 Authentic JJ:1 
1 August NNP:1 
1 Augmented JJ:1 
1 Attenuated VBN:1 
1 Atopy NN:1 
1 Astrocytes NNS:1 
1 Assuming VBG:1 
1 Associations NNS:1 
1 Asp838 NN:1 
1 Asp584 NN:1 
1 Asp5 NN:1 
1 Asn240-Leu335 NN:1 
1 Asn NN:1 
1 Aside IN:1 
1 Ascorbic JJ:1 
1 Ascorbate NN:1 
1 Arrested VBN:1 
1 Arnicae FW:1 
1 Armadillo NN:1 
1 Arg91 NN:1 
1 Arg271Trp NN:1 
1 Arg143Gln NN:1 
1 Arg-Gly-Asp NN:1 
1 Are VBP:1 
1 Aramburu NNP:1 
1 Arai NNP:1 
1 Appraisal NN:1 
1 Appearance NN:1 
1 Apparently RB:1 
1 Apo-1/CD95 NN:1 
1 ApaI NN:1 
1 Ap2 NN:1 
1 Ap1 NN:1 
1 Antiserum NN:1 
1 Antisera NN:1 
1 Antiphosphotyrosine JJ:1 
1 Antioxidant-mediated JJ:1 
1 Antioxidant JJ:1 
1 Antigenic JJ:1 
1 Antigen-specific JJ:1 
1 Antiandrogens NNS:1 
1 Anti-rheumatic JJ:1 
1 Anti-intercellular JJ:1 
1 Anti-immunoglobulin NN:1 
1 Anti-TR55 JJ:1 
1 Anti-TNF-alpha JJ:1 
1 Anti-Ro(SSA) JJ:1 
1 Anti-Ehrlichia FW:1 
1 Anti-CD40 NN:1 
1 Anti-CD2 JJ:1 
1 Anoxia/reoxygenation-induced JJ:1 
1 AnnexinV NN:1 
1 Animals NNS:1 
1 Animal NN:1 
1 Angiotensin NN:1 
1 Anetholdithiolthione NN:1 
1 Anergy NN:1 
1 Anergic JJ:1 
1 And CC:1 
1 Anaphylatoxins NNS:1 
1 Analyzed VBN:1 
1 Analogs NNS:1 
1 Analogous JJ:1 
1 Anaerobic JJ:1 
1 Aminoenhancer NN:1 
1 Amelioration NN:1 
1 Am80 NN:1 
1 Am. NNP:1 
1 Alternate JJ:1 
1 Alpha-lipoic JJ:1 
1 Alpha NN:1 
1 Along IN:1 
1 Almost RB:1 
1 All-trans-retinoic JJ:1 
1 Alignment NN:1 
1 Aldosterone-specific JJ:1 
1 Alcoholic JJ:1 
1 Alcohol-induced JJ:1 
1 Albuminemia NN:1 
1 Alanine NN:1 
1 Ala618 NN:1 
1 Ala5 NN:1 
1 Ala-X-Ala NN:1 
1 Akata NN:1 
1 Aims NNS:1 
1 Ah-receptor NN:1 
1 Agonistic JJ:1 
1 Agonist-induced JJ:1 
1 Agonist NN:1 
1 Aging NN:1 
1 Aggarwal NNP:1 
1 Agamma- NN:1 
1 Again RB:1 
1 Ag-pulsed JJ:1 
1 Ag-induced JJ:1 
1 Ag-activated JJ:1 
1 Afternoon NN:1 
1 Africa NNP:1 
1 Affinity-driven JJ:1 
1 Advances NNS:1 
1 Adherent JJ:1 
1 Adherence-isolated JJ:1 
1 Adherence-dependent JJ:1 
1 Adenoviruses NNS:1 
1 Adding VBG:1 
1 Add-back JJ:1 
1 Adaptor NN:1 
1 Ad5wt NN:1 
1 Ad5E1A234-243 NN:1 
1 Ad5E1A-peptide NN:1 
1 Ad5E1A-expressing JJ:1 
1 Ad5-induced JJ:1 
1 Ad3 NN:1 
1 Ad-transformed JJ:1 
1 Acylation NN:1 
1 Activation-dependent JJ:1 
1 Activating VBG:1 
1 Acta NNP:1 
1 Aclacinomycin NN:1 
1 Acetylsalicylic JJ:1 
1 Acetylation NN:1 
1 Accumulation NN:1 
1 Accumulating JJ:1 
1 Accompanying VBG:1 
1 Accessory JJ:1 
1 Accessing VBG:1 
1 Access NN:1 
1 Acad. NNP:1 
1 Ac-DEVD-fmk NN:1 
1 Ac-DEVD-CHO NN:1 
1 Abundant JJ:1 
1 Absorptive JJ:1 
1 Absolute JJ:1 
1 Absent JJ:1 
1 Absence NN:1 
1 Abnormality NN:1 
1 Ablation NN:1 
1 Abbott NN:1 
1 Ab-associated JJ:1 
1 Ab- NN:1 
1 AU-rich JJ:1 
1 AU NN:1 
1 ATp NN:1 
1 ATTTA NN:1 
1 ATT NN:1 
1 ATRA-induced JJ:1 
1 ATPase NN:1 
1 ATP/Mg2+ NN:1 
1 ATP-depleted JJ:1 
1 ATP-dependent JJ:1 
1 ATL-derived JJ:1 
1 ATL-1K NN:1 
1 ATL-1k NN:1 
1 ATF4/CREB2 NN:1 
1 ATF1- NN:1 
1 ATF-2/JUN NN:1 
1 ATA NN:1 
1 AT464 NN:1 
1 AT2.5 NN:1 
1 AT1 NN:1 
1 ARRE/NF-AT NN:1 
1 ARRE-1 NN:1 
1 ARRE NN:1 
1 ARH77 NN:1 
1 AREs NNS:1 
1 AR/TR2/AR NN:1 
1 AR-CRE NN:1 
1 APC-independent JJ:1 
1 AP3-like JJ:1 
1 AP3 NN:1 
1 AP1/c-jun NN:1 
1 AP1-binding JJ:1 
1 AP-5 NN:1 
1 AP-3 NN:1 
1 AP-2- NN:1 
1 AP-1/Octamer NN:1 
1 AP-1/octamer NN:1 
1 AP-1/ets NN:1 
1 AP-1/c-jun NN:1 
1 AP-1/TPA NN:1 
1 AP-1/ATF/CREB NN:1 
1 AP-1/ NN:1 
1 AP-1(III)/ NN:1 
1 AP-1(III) NN:1 
1 ANX5 NN:1 
1 ANAE NN:1 
1 AMLCG86/92 NN:1 
1 AML1/CBF NN:1 
1 AML1-related JJ:1 
1 AML1- NN:1 
1 AML-M7 NN:1 
1 AML-M5 NN:1 
1 AML-M2 NN:1 
1 ALG-4F NN:1 
1 ALDs NNS:1 
1 AGGTCATGACCT NN:1 
1 AGGC NN:1 
1 AGATAA NN:1 
1 AF-10 NN:1 
1 AES1/2 NN:1 
1 AECA NNS:1 
1 ADP-ribose NN:1 
1 ADP- JJ:1 
1 AD2 NN:1 
1 AD1 NN:1 
1 ACT-1-activating JJ:1 
1 ACT-1 NN:1 
1 ACLA-treated JJ:1 
1 ACE NN:1 
1 ABF-1 NN:1 
1 ABC NN:1 
1 AAGTGA NN:1 
1 AA2 NN:1 
1 A549 NN:1 
1 A4 NN:1 
1 A2.01 NN:1 
1 A10 NN:1 
1 A1/Bfl-1 NN:1 
1 A1.1 NN:1 
1 A/G NN:1 
1 A.Rickinson NNP:1 
1 A.Rajadhyaksha NNP:1 
1 A.L. NNP:1 
1 A.J. NNP:1 
1 A.I. NNP:1 
1 A.Garzino-Demo NNP:1 
1 A.De NNP:1 
1 A-treated JJ:1 
1 A-to-G JJ:1 
1 A-ring NN:1 
1 A-related JJ:1 
1 A-inducible JJ:1 
1 A-binding JJ:1 
1 A-Cdk2- JJ:1 
1 A- JJ:1 
1 9Q33-34.1 NN:1 
1 9q33-34.1 NN:1 
1 9p21 NN:1 
1 991.9 CD:1 
1 99.0 CD:1 
1 99-bp JJ:1 
1 99+/-15 CD:1 
1 989 CD:1 
1 984 CD:1 
1 97.6 CD:1 
1 97.1 CD:1 
1 969-bp JJ:1 
1 969-base JJ:1 
1 968 CD:1 
1 962 CD:1 
1 95.6 CD:1 
1 95.57 CD:1 
1 95.5 CD:1 
1 95-kDa JJ:1 
1 95-bp JJ:1 
1 95-100 CD:1 
1 940-984 CD:1 
1 94.4 CD:1 
1 937 CD:1 
1 92.9 CD:1 
1 92-kD JJ:1 
1 92-bp JJ:1 
1 9194-9199 CD:1 
1 918 CD:1 
1 910 CD:1 
1 902 CD:1 
1 9011 CD:1 
1 90.8 CD:1 
1 90-120 CD:1 
1 9/19 CD:1 
1 9.9 CD:1 
1 9.6 CD:1 
1 9.5+/-0.3 CD:1 
1 9.4 CD:1 
1 9.1 CD:1 
1 9.0 CD:1 
1 9-mer NN:1 
1 9-dideoxy JJ:1 
1 9-cis-retinoic JJ:1 
1 9-bp JJ:1 
1 9-CIS JJ:1 
1 9-29 CD:1 
1 9,11-dihydro NN:1 
1 8q24 NN:1 
1 8p12 NN:1 
1 8;21 NN:1 
1 880 CD:1 
1 88.6+/-11.5 CD:1 
1 869 CD:1 
1 86002 CD:1 
1 86-nucleotide JJ:1 
1 86-amino NN:1 
1 86-265 CD:1 
1 852 CD:1 
1 850-853 CD:1 
1 85-90 CD:1 
1 85- JJ:1 
1 8421 CD:1 
1 8402 CD:1 
1 84-kDa JJ:1 
1 83/95 CD:1 
1 83-kDa JJ:1 
1 8226 CD:1 
1 82+/-6 CD:1 
1 8154 CD:1 
1 813-bp JJ:1 
1 803 CD:1 
1 800-base JJ:1 
1 800 CD:1 
1 80/60 CD:1 
1 80.5 CD:1 
1 80.2 CD:1 
1 80- CD:1 
1 8.98 CD:1 
1 8.9+/-1.2 CD:1 
1 8.8 CD:1 
1 8.7 CD:1 
1 8.5-fold JJ:1 
1 8.5 CD:1 
1 8.3S NN:1 
1 8.3 CD:1 
1 8.20 CD:1 
1 8.1 NN:1 
1 8.0 CD:1 
1 8-fold JJ:1 
1 8-15 CD:1 
1 8-(diethylamino)-octyl-3,4,5-trimethoxybenzoate NN:1 
1 7q21q22 NN:1 
1 7q21-q22 NN:1 
1 7a NN:1 
1 798+/-67 CD:1 
1 792 CD:1 
1 79/95 CD:1 
1 79.1 CD:1 
1 782 CD:1 
1 78-nucleotide JJ:1 
1 775 CD:1 
1 773-785 CD:1 
1 7687 CD:1 
1 768-bp JJ:1 
1 75.3 CD:1 
1 75-kD JJ:1 
1 75-80 CD:1 
1 742 CD:1 
1 74 CD:1 
1 735 CD:1 
1 7347 CD:1 
1 734 CD:1 
1 7298-7302 CD:1 
1 729-766 CD:1 
1 729-6 CD:1 
1 72.3 CD:1 
1 72-kilodalton JJ:1 
1 72-hr JJ:1 
1 72-hour JJ:1 
1 7131 CD:1 
1 711-717 CD:1 
1 711 CD:1 
1 710 CD:1 
1 71-100 CD:1 
1 70Z/3-derived JJ:1 
1 7085 CD:1 
1 707-base JJ:1 
1 7050+/-1122 CD:1 
1 703 CD:1 
1 70/Z3-derived JJ:1 
1 70.6 CD:1 
1 70-kDa JJ:1 
1 70-base-pair JJ:1 
1 7/8 CD:1 
1 7/20 CD:1 
1 7.9 CD:1 
1 7.5-fold RB:1 
1 7.5 CD:1 
1 7.30 CD:1 
1 7.27 CD:1 
1 7.2 CD:1 
1 7.1 CD:1 
1 7.03 CD:1 
1 7.0 CD:1 
1 7. LS:1 
1 7-bp JJ:1 
1 7-base-pair JJ:1 
1 7-O- NNS:1 
1 7-16 CD:1 
1 7- CD:1 
1 6q26-27 NN:1 
1 6F11 NN:1 
1 6C2 NN:1 
1 697 CD:1 
1 692 CD:1 
1 690 CD:1 
1 69.1 CD:1 
1 69-bp JJ:1 
1 688 CD:1 
1 6821 CD:1 
1 68.5-kb JJ:1 
1 68.28 CD:1 
1 68-kDa JJ:1 
1 68-amino-acid JJ:1 
1 6790-6799 CD:1 
1 6768-6777 CD:1 
1 671 CD:1 
1 67-kDa JJ:1 
1 67-bp JJ:1 
1 6625 CD:1 
1 66.6 CD:1 
1 65K CD:1 
1 6576 CD:1 
1 651 CD:1 
1 6500+/-1001 CD:1 
1 65-year-old JJ:1 
1 65-kilodalton JJ:1 
1 65-75 CD:1 
1 65,000 CD:1 
1 6498 CD:1 
1 648 CD:1 
1 647 CD:1 
1 643 CD:1 
1 642 CD:1 
1 64,000-M(r) JJ:1 
1 64 CD:1 
1 6352+/-1697 CD:1 
1 633 CD:1 
1 63-kDa JJ:1 
1 627-bp JJ:1 
1 627-637 CD:1 
1 6234 CD:1 
1 620-bp JJ:1 
1 62-97 CD:1 
1 61058 CD:1 
1 61.0 CD:1 
1 61-80 CD:1 
1 60b NN:1 
1 607 CD:1 
1 606-611 CD:1 
1 600-602 CD:1 
1 60.7 CD:1 
1 60-min JJ:1 
1 60,000 CD:1 
1 6/20 CD:1 
1 6.8 CD:1 
1 6.7+/-0.5 CD:1 
1 6.7 CD:1 
1 6.61 CD:1 
1 6.6 CD:1 
1 6.5- CD:1 
1 6.41 CD:1 
1 6.25 CD:1 
1 6.22 CD:1 
1 6.2 CD:1 
1 6.18 CD:1 
1 6.05 CD:1 
1 6.04 CD:1 
1 6. LS:1 
1 6-week JJ:1 
1 6-keto-PGF1 NN:1 
1 6-k-PGF1 NN:1 
1 6-induced JJ:1 
1 6-formylindolo JJ:1 
1 6-fold RB:1 
1 6-cis-locked JJ:1 
1 6-8-fold RB:1 
1 6-24 CD:1 
1 6-15 CD:1 
1 6- CD:1 
1 6,7-3H NN:1 
1 5q31.1 NN:1 
1 5q23-31 NN:1 
1 5X NN:1 
1 5S NN:1 
1 59.6 CD:1 
1 59.5 CD:1 
1 5869-bp JJ:1 
1 5852-5861 CD:1 
1 580 CD:1 
1 58.3 CD:1 
1 57.3 CD:1 
1 57.1 CD:1 
1 57- CD:1 
1 569 CD:1 
1 5669 CD:1 
1 563 CD:1 
1 5622 CD:1 
1 560 CD:1 
1 56-kDa JJ:1 
1 56-59-kilodalton JJ:1 
1 56,000 CD:1 
1 5581-5587 CD:1 
1 551 CD:1 
1 55.3 CD:1 
1 55-kDa JJ:1 
1 55- CD:1 
1 548 CD:1 
1 546-nucleotide JJ:1 
1 542 CD:1 
1 54.3 CD:1 
1 54-year-old JJ:1 
1 533-535 CD:1 
1 532 CD:1 
1 5306-5309 CD:1 
1 53.4 CD:1 
1 53-kD JJ:1 
1 528-777 CD:1 
1 5269-5275 CD:1 
1 524 CD:1 
1 52-kDa JJ:1 
1 515 CD:1 
1 5101 CD:1 
1 51,659 CD:1 
1 50nM NN:1 
1 503-amino-acid-long JJ:1 
1 5028 CD:1 
1 5007+2insA NN:1 
1 50000 CD:1 
1 500-fold JJ:1 
1 50-75 CD:1 
1 50-500 CD:1 
1 50,000 CD:1 
1 5/24 CD:1 
1 5/20 CD:1 
1 5/18 CD:1 
1 5/12 CD:1 
1 5.86-6.74 CD:1 
1 5.7-fold JJ:1 
1 5.7+/-0.3 CD:1 
1 5.66-10 CD:1 
1 5.6 CD:1 
1 5.54 CD:1 
1 5.53 CD:1 
1 5.5-kilobase JJ:1 
1 5.5-fold RB:1 
1 5.33 CD:1 
1 5.25 CD:1 
1 5.13 CD:1 
1 5.1-fold RB:1 
1 5.1 CD:1 
1 5. LS:1 
1 5-dihydroxyvitamin NN:1 
1 5-bromo-2'-deoxyuridine NN:1 
1 5-based JJ:1 
1 5-azacytidine NN:1 
1 5-[p-methoxyphenyl]-3H-1,2-dithiol-3-thione NN:1 
1 5-Aminolevulinate NN:1 
1 5-80 CD:1 
1 5-8 CD:1 
1 5-60 CD:1 
1 5-25 CD:1 
1 5-20 CD:1 
1 5-13 CD:1 
1 5-10-fold RB:1 
1 5-10 CD:1 
1 5'_-flanking JJ:1 
1 5'NF-E2/AP1 NN:1 
1 5'HS1-5 NN:1 
1 5'-upstream JJ:1 
1 5'-truncations NNS:1 
1 5'-serially RB:1 
1 5'-region NN:1 
1 5'-positive JJ:1 
1 5'-noncoding JJ:1 
1 5'-TTGTCCcgtGGACAAaTGTCC-3' NN:1 
1 5'-TGCGTCA-3' NN:1 
1 5'-Rapid JJ:1 
1 5'-RACE NNS:1 
1 5'-PyCTTTG-3' NN:1 
1 5'-NT NN:1 
1 5'-GTTACGTAAT-3' NN:1 
1 5'-GTTAAGGTTCGTAGGTCATGGA-3' NN:1 
1 5'-GGGCGG NN:1 
1 5'-GGCCAATGGG-3' NN:1 
1 5'-GGCACCCTTTGA-3' NN:1 
1 5'-GGAACCTCCCCC-3' NN:1 
1 5'-GGAA-3' NN:1 
1 5'-CTCAGGA-3' NN:1 
1 5'-CGGAGTTTCC-3' NN:1 
1 5'-CGAAAATTTCC-3' NN:1 
1 5'-CC(A_+_T)6GG-3' NN:1 
1 5'-ATGCAAAG-3' NN:1 
1 5'-3' JJ:1 
1 5'-(N-ethyl)-carboxamido NN:1 
1 5'- JJ:1 
1 4c NN:1 
1 4S NN:1 
1 4G10 NN:1 
1 499 CD:1 
1 4986 CD:1 
1 4982 CD:1 
1 4978+/-391 CD:1 
1 49653 CD:1 
1 496 CD:1 
1 4922 CD:1 
1 492/493 CD:1 
1 491-amino-acid NN:1 
1 488 CD:1 
1 4855 CD:1 
1 4851 CD:1 
1 4816 CD:1 
1 48.6 CD:1 
1 48-kDa JJ:1 
1 48-h JJ:1 
1 48,000 CD:1 
1 4766 CD:1 
1 4737-4745 CD:1 
1 4701 CD:1 
1 47-kDa JJ:1 
1 47-kD JJ:1 
1 47-bp JJ:1 
1 4681 CD:1 
1 465 CD:1 
1 4631 CD:1 
1 463 CD:1 
1 4623 CD:1 
1 462 CD:1 
1 46.6 CD:1 
1 46.26 CD:1 
1 46,XY NN:1 
1 46,XX NN:1 
1 46,X,-Y,t(Y;15)(q12;p13)/45,X NN:1 
1 46,X,-Y,t(Y;15)(q12;p13) NN:1 
1 46 CD:1 
1 458-462 CD:1 
1 455-bp JJ:1 
1 4545 CD:1 
1 4524 CD:1 
1 4519 CD:1 
1 451.4+/-45.4 CD:1 
1 450 CD:1 
1 45.8 CD:1 
1 45-nucleotide JJ:1 
1 45-50 CD:1 
1 45,X/46,X,r(X) NN:1 
1 45,X NN:1 
1 4494 CD:1 
1 4490 CD:1 
1 4484-5643 CD:1 
1 4481 CD:1 
1 4462 CD:1 
1 446 CD:1 
1 444 CD:1 
1 4433 CD:1 
1 442A NN:1 
1 4419 CD:1 
1 440 CD:1 
1 44-55 CD:1 
1 44- JJ:1 
1 438 CD:1 
1 437 CD:1 
1 436 CD:1 
1 435 CD:1 
1 434 CD:1 
1 433 CD:1 
1 432 CD:1 
1 431 CD:1 
1 43044 CD:1 
1 430-444,442A NN:1 
1 430 CD:1 
1 43.5 CD:1 
1 43-mer NN:1 
1 43-50 CD:1 
1 43-47 CD:1 
1 426 CD:1 
1 425 CD:1 
1 421-486 CD:1 
1 42.6 CD:1 
1 42.2 CD:1 
1 42-nucleotide JJ:1 
1 42- CD:1 
1 419 CD:1 
1 418 CD:1 
1 4131+/-321 CD:1 
1 413 CD:1 
1 41.0 CD:1 
1 41-kDa JJ:1 
1 40mer JJ:1 
1 409 CD:1 
1 4021-4033 CD:1 
1 4021 CD:1 
1 402 CD:1 
1 400-fold JJ:1 
1 400-base JJ:1 
1 40-kd JJ:1 
1 40-bp JJ:1 
1 40-50 CD:1 
1 40-48 CD:1 
1 40,000 CD:1 
1 4/5 CD:1 
1 4/17 CD:1 
1 4/12 CD:1 
1 4.9S NN:1 
1 4.93 CD:1 
1 4.6 CD:1 
1 4.55 CD:1 
1 4.5-kilobase NN:1 
1 4.5-fold RB:1 
1 4.49+/-0.71 CD:1 
1 4.43 CD:1 
1 4.4 CD:1 
1 4.3-fold JJ:1 
1 4.27 CD:1 
1 4.04 CD:1 
1 4.00 CD:1 
1 4-year JJ:1 
1 4-week-old JJ:1 
1 4-phorbol NN:1 
1 4-octylphenol NN:1 
1 4-month JJ:1 
1 4-hydroxytamoxifen NN:1 
1 4-hour JJ:1 
1 4-h JJ:1 
1 4-exon JJ:1 
1 4-carboranyl-substituted JJ:1 
1 4-acetoxy NN:1 
1 4-9 CD:1 
1 4-5.13 CD:1 
1 4-24 CD:1 
1 4-(4-fluorophenyl)-2-(4-methylsulphinylphenyl)-5-(4-pyridyl)_1H-imidazole NN:1 
1 4,757 CD:1 
1 4,5-dihydro NN:1 
1 4,215.4 CD:1 
1 4,21-diacetoxy-11 NN:1 
1 4,19-substituted JJ:1 
1 4,19-disubstituted JJ:1 
1 4,111 CD:1 
1 3rd JJ:1 
1 3q21-24 NN:1 
1 3H-triamcinolone NN:1 
1 3H-labelled JJ:1 
1 3H-aldosterone NN:1 
1 3H-TdR NN:1 
1 3H-R1881 NN:1 
1 3H-E2 NN:1 
1 3H-Dex NN:1 
1 3H NN:1 
1 3C NN:1 
1 3B NN:1 
1 3A NN:1 
1 3;21 NN:1 
1 399 CD:1 
1 393 CD:1 
1 39.9 CD:1 
1 39-48 CD:1 
1 39,000 CD:1 
1 3863 CD:1 
1 386 CD:1 
1 385 CD:1 
1 383-bp JJ:1 
1 382/EC1 NN:1 
1 380 CD:1 
1 38.9 CD:1 
1 38-kD JJ:1 
1 38,000-M(r) JJ:1 
1 38,000 CD:1 
1 378 CD:1 
1 3775 CD:1 
1 373-381 CD:1 
1 370 CD:1 
1 37.8 CD:1 
1 37.5 CD:1 
1 37,745 CD:1 
1 3696-bp JJ:1 
1 368-389 CD:1 
1 367 CD:1 
1 3632 CD:1 
1 362 CD:1 
1 3610 CD:1 
1 360-d JJ:1 
1 36.6 CD:1 
1 36-kDa JJ:1 
1 36-41 CD:1 
1 35S-methionine NN:1 
1 35S-TR NN:1 
1 35S NN:1 
1 359-370 CD:1 
1 352 CD:1 
1 350/microliters NNS:1 
1 35.5 CD:1 
1 35.2 CD:1 
1 35-year-old JJ:1 
1 35-fold JJ:1 
1 35-amino NN:1 
1 35-55 CD:1 
1 349 CD:1 
1 3473 CD:1 
1 345 CD:1 
1 342 CD:1 
1 3413 CD:1 
1 34-fold RB:1 
1 339 CD:1 
1 33705 CD:1 
1 335 CD:1 
1 333 CD:1 
1 332-342 CD:1 
1 332 CD:1 
1 331 CD:1 
1 33-kDa JJ:1 
1 33-47 CD:1 
1 33-39 CD:1 
1 32Pi-labeled JJ:1 
1 32P-probe NN:1 
1 32P-labelled JJ:1 
1 327 CD:1 
1 322-relaxation-assay NN:1 
1 320-kDa CD:1 
1 32.2-kDa JJ:1 
1 32-kDa JJ:1 
1 32-36 CD:1 
1 32-34 CD:1 
1 319LL-RS NN:1 
1 3183-4450 CD:1 
1 318 CD:1 
1 31747A-binding JJ:1 
1 317-1130 CD:1 
1 315 CD:1 
1 3131-3139 CD:1 
1 313-321 CD:1 
1 313 CD:1 
1 311 CD:1 
1 310 CD:1 
1 31/33 CD:1 
1 31.90 CD:1 
1 31-8425 CD:1 
1 31-55 CD:1 
1 308-317 CD:1 
1 3070 CD:1 
1 305-308 CD:1 
1 305 CD:1 
1 3040-3050 CD:1 
1 304 CD:1 
1 302 CD:1 
1 300-fold RB:1 
1 300-bp JJ:1 
1 30.5 CD:1 
1 30.3+/-2.5 CD:1 
1 30.3 CD:1 
1 30-kD JJ:1 
1 30-bp JJ:1 
1 30-90 CD:1 
1 30-50 CD:1 
1 30-36 CD:1 
1 3/5 CD:1 
1 3.93+/-0.89 CD:1 
1 3.8-kb JJ:1 
1 3.8-7.0 CD:1 
1 3.8 CD:1 
1 3.5-10 CD:1 
1 3.49 CD:1 
1 3.44 CD:1 
1 3.4-fold RB:1 
1 3.4+/-0.3 CD:1 
1 3.3 CD:1 
1 3.20 CD:1 
1 3.16 CD:1 
1 3.15 CD:1 
1 3.1+/-0.2 CD:1 
1 3.0 CD:1 
1 3-week JJ:1 
1 3-hydroxy-3-methylglutaryl NN:1 
1 3-carboranyl-substituted JJ:1 
1 3-bp JJ:1 
1 3-O-methyl-D JJ:1 
1 3-5-fold RB:1 
1 3-4 JJ:1 
1 3-10 CD:1 
1 3,605 CD:1 
1 3,5-dichloro-2-hydroxy-4-methoxy-6-n-propylbenzoic JJ:1 
1 3,5,3'-triiodothyronine NN:1 
1 3,4-dichloroisocoumarin NN:1 
1 3,4-diacetoxy NN:1 
1 3,339 CD:1 
1 3'untranslated JJ:1 
1 3'NF-E2/AP1 NN:1 
1 3'-untranslated JJ:1 
1 3'-most JJ:1 
1 3'-flanking JJ:1 
1 3'-azido-3'-deoxythymidine NN:1 
1 3'-CAGGTG NN:1 
1 3'- NNS:1 
1 2xNFkappaB NN:1 
1 2x NN:1 
1 2nd JJ:1 
1 2c NN:1 
1 2D3 NN:1 
1 2A-sensitive JJ:1 
1 29CP-AS NN:1 
1 297+/-54 CD:1 
1 296 CD:1 
1 294 CD:1 
1 293T NN:1 
1 29038 CD:1 
1 29/33 CD:1 
1 29.9 CD:1 
1 29.8 CD:1 
1 29.2 CD:1 
1 2884-2894 CD:1 
1 285+/-100 CD:1 
1 2849 CD:1 
1 284 CD:1 
1 283 CD:1 
1 281 CD:1 
1 280 CD:1 
1 28-bp JJ:1 
1 28,000 CD:1 
1 27th JJ:1 
1 279 CD:1 
1 276 CD:1 
1 275 CD:1 
1 271 CD:1 
1 27.8 CD:1 
1 27.7 CD:1 
1 27-amino JJ:1 
1 27-30 CD:1 
1 26988 CD:1 
1 269.0 CD:1 
1 268 CD:1 
1 26721 CD:1 
1 267 CD:1 
1 260 CD:1 
1 26.5 CD:1 
1 26.4 CD:1 
1 26-kDa JJ:1 
1 26-137 CD:1 
1 2594-3979 CD:1 
1 259 CD:1 
1 258 CD:1 
1 257.7 CD:1 
1 255 CD:1 
1 254-266 CD:1 
1 253 CD:1 
1 252 CD:1 
1 250-fold JJ:1 
1 250,000 CD:1 
1 25.0 CD:1 
1 25-mer NN:1 
1 25-kDa JJ:1 
1 25-OHD NN:1 
1 25-79 CD:1 
1 25-77 CD:1 
1 25-50 CD:1 
1 25-140 CD:1 
1 25- CD:1 
1 25(OH)D3-24-hydroxylase NN:1 
1 25(OH)2D3 NN:1 
1 24p3 NN:1 
1 24R-hydroxylase NN:1 
1 24R,25_(OH)2D3 NN:1 
1 248-263 CD:1 
1 246 CD:1 
1 244B NN:1 
1 244-bp JJ:1 
1 2436-2444 CD:1 
1 2430 CD:1 
1 2400 CD:1 
1 24.6+/-2.4 CD:1 
1 24-hydroxylated JJ:1 
1 24-h JJ:1 
1 24-58 CD:1 
1 24,25-dihydroxy-vitamin NN:1 
1 24,25-(OH)2D3 NN:1 
1 24,25(OH)2D3 NN:1 
1 24,000 CD:1 
1 23:00-24:00 CD:1 
1 237 CD:1 
1 236 CD:1 
1 2351 CD:1 
1 2345 CD:1 
1 2343 CD:1 
1 234 CD:1 
1 233 CD:1 
1 2300 CD:1 
1 229-bp JJ:1 
1 227.0 CD:1 
1 2260-_2268 CD:1 
1 22536 CD:1 
1 225 CD:1 
1 223-amino NN:1 
1 223 CD:1 
1 22/S NN:1 
1 22-kDa JJ:1 
1 22-60 CD:1 
1 218 CD:1 
1 216 CD:1 
1 214 CD:1 
1 213 CD:1 
1 2126 CD:1 
1 211 CD:1 
1 2100 CD:1 
1 21/10(3) CD:1 
1 21.7 CD:1 
1 21.5 CD:1 
1 21.4-kb JJ:1 
1 21-base-pair JJ:1 
1 21-base JJ:1 
1 21-66 CD:1 
1 21-50 CD:1 
1 20_-_100-fold RB:1 
1 209 CD:1 
1 2086 CD:1 
1 207.9+/-31.5 CD:1 
1 2061 CD:1 
1 206 CD:1 
1 204 CD:1 
1 203580 CD:1 
1 2015 CD:1 
1 201-bp JJ:1 
1 201 CD:1 
1 200B NN:1 
1 2000-3000 CD:1 
1 2000 CD:1 
1 200-bp JJ:1 
1 200-500 CD:1 
1 20.9 CD:1 
1 20.7 CD:1 
1 20.4 CD:1 
1 20-methyl-23- NN:1 
1 20-methyl- NN:1 
1 20-mer JJ:1 
1 20-kDa JJ:1 
1 20-Epi-22-oxa-24a,26a,27a-trihomo-1alpha,2 NN:1 
1 20-Epi-22-oxa-24a,26a,27a,-trihomo-1alpha,25(OH)2- NN:1 
1 20-Epi NN:1 
1 20-70 CD:1 
1 20-30 CD:1 
1 2/73 CD:1 
1 2/7 CD:1 
1 2/6 CD:1 
1 2/3 CD:1 
1 2.92 CD:1 
1 2.89 CD:1 
1 2.8-fold RB:1 
1 2.7+/-2.0 CD:1 
1 2.6-kilobase JJ:1 
1 2.6-fold JJ:1 
1 2.5-kilobase JJ:1 
1 2.5- CD:1 
1 2.35 CD:1 
1 2.32 CD:1 
1 2.31 CD:1 
1 2.24 CD:1 
1 2.1 CD:1 
1 2.02 CD:1 
1 2.0-kb JJ:1 
1 2-yr JJ:1 
1 2-week JJ:1 
1 2-type JJ:1 
1 2-phase JJ:1 
1 2-microglobulin NN:1 
1 2-methylhistamine NN:1 
1 2-mediated JJ:1 
1 2-integrin JJ:1 
1 2-deoxyguanosine-treated JJ:1 
1 2-deoxyglucose NN:1 
1 2-day JJ:1 
1 2-bp JJ:1 
1 2-b JJ:1 
1 2-acetoxy-4-trifluoromethyl-benzoic JJ:1 
1 2-ME NN:1 
1 2-Gy JJ:1 
1 2-99 CD:1 
1 2-8 CD:1 
1 2-7 CD:1 
1 2-50 CD:1 
1 2-5 CD:1 
1 2-4-fold JJ:1 
1 2,738 CD:1 
1 2,7 CD:1 
1 2,6 CD:1 
1 2,3,7,8-TCDD NN:1 
1 2,250 CD:1 
1 2,000 CD:1 
1 2'-deoxy-3'-adenosine JJ:1 
1 2'-5' JJ:1 
1 1st JJ:1 
1 1q12 NN:1 
1 1p21-22 NN:1 
1 1beta,25-dihydroxyvitamin NN:1 
1 1alpha,25-dihydroxyvitamin NN:1 
1 1alpha,25-dihydroxy-lumisterol3 NN:1 
1 1alpha,25(OH)2-lumisterol3 NN:1 
1 1alpha,25(OH)2-d5-previtamin NN:1 
1 1a NN:1 
1 1H NN:1 
1 1G11 NN:1 
1 1:77,040 CD:1 
1 1:230,250 CD:1 
1 1:115,000 CD:1 
1 1:103,034 CD:1 
1 19p13.3 NN:1 
1 1992 CD:1 
1 199 CD:1 
1 1983 CD:1 
1 198 CD:1 
1 1956 CD:1 
1 195-kD JJ:1 
1 193-bp JJ:1 
1 1907 CD:1 
1 190-fold RB:1 
1 190 CD:1 
1 19.2+/-2.4 CD:1 
1 19.0 CD:1 
1 19-noraldosterone NN:1 
1 19-chloro-4,21-dihydroxypregna-4,9(11)-diene-3,20-dione NN:1 
1 1858-1869 CD:1 
1 185+/-38 CD:1 
1 184 CD:1 
1 1830 CD:1 
1 183-bp JJ:1 
1 183 CD:1 
1 181 CD:1 
1 18/10(3) CD:1 
1 18.9 CD:1 
1 18.5 CD:1 
1 18.0 CD:1 
1 18-hydroxyprogesterone NN:1 
1 18-hydroxy-corticosterone NN:1 
1 18-fold-lower JJ:1 
1 18-fold RB:1 
1 18-deoxyaldosterone NN:1 
1 18-deoxy-19-noraldosterone NN:1 
1 18-bp JJ:1 
1 18-20 CD:1 
1 18- CD:1 
1 18,_19-chloro-21-acetoxypregn-9(11)-en-20-one NN:1 
1 18,21-anhydroaldosterone NN:1 
1 17p13.3 NN:1 
1 17p NN:1 
1 17beta-hydroxysteroid NN:1 
1 1796 CD:1 
1 179.7 CD:1 
1 1753-bp JJ:1 
1 1750 CD:1 
1 173 CD:1 
1 171.3 CD:1 
1 1709 CD:1 
1 170-kD JJ:1 
1 170-fold RB:1 
1 170 CD:1 
1 17.5+/-1.7 CD:1 
1 17.4 CD:1 
1 17-isoaldosterone NN:1 
1 17-hydroxy-progesterone NN:1 
1 17-amino NN:1 
1 17-29 CD:1 
1 16p12-16p13.3 NN:1 
1 16HBE NN:1 
1 16983 CD:1 
1 1695 CD:1 
1 166 CD:1 
1 16507 CD:1 
1 165-fold RB:1 
1 1634delT NN:1 
1 163 CD:1 
1 1600 CD:1 
1 16.5 CD:1 
1 16.2 CD:1 
1 16.1 CD:1 
1 16-hour JJ:1 
1 16-96 CD:1 
1 16-27 CD:1 
1 16-18 CD:1 
1 15q21.1-21.2 NN:1 
1 15N NN:1 
1 158-176 CD:1 
1 157.6+/-25.1 CD:1 
1 157 CD:1 
1 1568 CD:1 
1 1566 CD:1 
1 156.7+/-27.3 CD:1 
1 155+/-31 CD:1 
1 1549-1560 CD:1 
1 153 CD:1 
1 1523 CD:1 
1 151-bp JJ:1 
1 150-200 CD:1 
1 15.5+/-1.8 CD:1 
1 15-mer JJ:1 
1 15-lox NN:1 
1 15-fold JJ:1 
1 15-deoxy-Delta NN:1 
1 15-base NN:1 
1 15-HETE NN:1 
1 15-30 CD:1 
1 15- CD:1 
1 15,000 CD:1 
1 14q32 NN:1 
1 149 CD:1 
1 148 CD:1 
1 14643 CD:1 
1 146 CD:1 
1 144 CD:1 
1 142+/-12 CD:1 
1 142 CD:1 
1 1419 CD:1 
1 140+/-25 CD:1 
1 14.7-18.7 CD:1 
1 14.6 CD:1 
1 14.5 CD:1 
1 14.3-kDa JJ:1 
1 14.3 CD:1 
1 14.2 CD:1 
1 14.1 CD:1 
1 14.0 CD:1 
1 14-kD JJ:1 
1 14-amino-acid JJ:1 
1 14-amino NN:1 
1 14-18 CD:1 
1 13q14 NN:1 
1 13S NN:1 
1 13B8-2 NN:1 
1 139-144 CD:1 
1 1389 CD:1 
1 137Cs NN:1 
1 1367 CD:1 
1 135 CD:1 
1 1333 CD:1 
1 1321-1326 CD:1 
1 132 CD:1 
1 1311-base JJ:1 
1 130TL-AS NN:1 
1 13.9 CD:1 
1 13.8 CD:1 
1 13.6 CD:1 
1 13.51 CD:1 
1 13.3 CD:1 
1 13.2 CD:1 
1 13.1 CD:1 
1 13-myristate NN:1 
1 13-kilobase-pair NN:1 
1 13-kb JJ:1 
1 13-acetate/phytohemagglutinin-stimulated JJ:1 
1 13,000 CD:1 
1 12p12-p13 NN:1 
1 1284-1290 CD:1 
1 127-137 CD:1 
1 1264 CD:1 
1 12611 CD:1 
1 126+/-11 CD:1 
1 126 CD:1 
1 125I-IL-4 NN:1 
1 125I- NN:1 
1 1256 CD:1 
1 1255-1266 CD:1 
1 125.6 CD:1 
1 125-135 CD:1 
1 125-133 CD:1 
1 123+/-9 CD:1 
1 123 CD:1 
1 122 CD:1 
1 1211 CD:1 
1 1206 CD:1 
1 120-kDa JJ:1 
1 120-h JJ:1 
1 120-amino-acid JJ:1 
1 120-125 CD:1 
1 120,000-140,000 CD:1 
1 12/12 CD:1 
1 12.91 CD:1 
1 12.5-kb JJ:1 
1 12.2+/-1.6 CD:1 
1 12-phorbol NN:1 
1 12-myristate_-13-_acetate NN:1 
1 12-myristate-13 JJ:1 
1 12-O-tetradecanoyl-phorbol-13 NN:1 
1 12-25 CD:1 
1 12-0- NN:1 
1 12,13-phorbol NN:1 
1 11q14 NN:1 
1 11p14-15.1 NN:1 
1 1199 CD:1 
1 118 CD:1 
1 116 CD:1 
1 115 CD:1 
1 114 CD:1 
1 112+/-28 CD:1 
1 1107-1115 CD:1 
1 110-130-kDa JJ:1 
1 110,000-molecular-weight JJ:1 
1 11.5+/-7.1 CD:1 
1 11.4 CD:1 
1 11.1 CD:1 
1 11.0 CD:1 
1 11-fold JJ:1 
1 11-base-pair JJ:1 
1 11-42 CD:1 
1 11- CD:1 
1 11+/CD4+ JJ:1 
1 10:00 CD:1 
1 1091 CD:1 
1 108 CD:1 
1 1071 CD:1 
1 107.8 CD:1 
1 107 CD:1 
1 10631 CD:1 
1 106-kDa JJ:1 
1 1056 CD:1 
1 1054 CD:1 
1 1053 CD:1 
1 105.3 CD:1 
1 105-kD JJ:1 
1 105,000- CD:1 
1 104-bp JJ:1 
1 104-522 CD:1 
1 104 CD:1 
1 103-amino-acid JJ:1 
1 103 CD:1 
1 101bp JJ:1 
1 10182 CD:1 
1 100B NN:1 
1 10000-fold JJ:1 
1 10000 CD:1 
1 100-500 CD:1 
1 10/53 CD:1 
1 10/19 CD:1 
1 10.5 CD:1 
1 10.4S NN:1 
1 10.3 CD:1 
1 10.0 CD:1 
1 10-d-pregnant JJ:1 
1 10-amino JJ:1 
1 10-50 CD:1 
1 10-23 CD:1 
1 10-12 CD:1 
1 10,_047 CD:1 
1 10,11-dihydroxyaporphine NN:1 
1 10,000 CD:1 
1 10(7.0) CD:1 
1 10(6.1) CD:1 
1 10(6)-fold JJ:1 
1 10(5.2) CD:1 
1 10(5)- CD:1 
1 10(5) CD:1 
1 10(4.4) CD:1 
1 10(2.9) CD:1 
1 10(2) CD:1 
1 10(-4)/bp NN:1 
1 10(-15)-10(-12) CD:1 
1 10(-14) CD:1 
1 10(-11)-10(-10) CD:1 
1 10(-10)-(-6) CD:1 
1 1/octamer-binding JJ:1 
1 1/Oct NN:1 
1 1/Kd NN:1 
1 1/3 CD:1 
1 1/15,000 CD:1 
1 1/15 CD:1 
1 1.95 CD:1 
1 1.87+/-0.36 CD:1 
1 1.77 CD:1 
1 1.73 CD:1 
1 1.72 CD:1 
1 1.7-kb JJ:1 
1 1.62 CD:1 
1 1.55 CD:1 
1 1.54 CD:1 
1 1.5-2.6 CD:1 
1 1.5-1.6 CD:1 
1 1.46 CD:1 
1 1.42 CD:1 
1 1.4-kb JJ:1 
1 1.4-fold RB:1 
1 1.4+/-0.8 CD:1 
1 1.39 CD:1 
1 1.38 CD:1 
1 1.37 CD:1 
1 1.35 CD:1 
1 1.34 CD:1 
1 1.32 CD:1 
1 1.3-kb JJ:1 
1 1.3-fold RB:1 
1 1.3-7.6 CD:1 
1 1.3-1.5 CD:1 
1 1.25 CD:1 
1 1.23 CD:1 
1 1.2-kb JJ:1 
1 1.2-3.3 CD:1 
1 1.16 CD:1 
1 1.13 CD:1 
1 1.120 CD:1 
1 1.07 CD:1 
1 1-wk JJ:1 
1 1-type JJ:1 
1 1-oleoyl-2-acetyl-sn-glycerol NN:1 
1 1-mg JJ:1 
1 1-long JJ:1 
1 1-beta-D-arabino-furanosylcytosine NN:1 
1 1-beta NN:1 
1 1-8 CD:1 
1 1-5 CD:1 
1 1-450 CD:1 
1 1-421 CD:1 
1 1-42 CD:1 
1 1-32 CD:1 
1 1-180 CD:1 
1 1-1.5 CD:1 
1 1-(5-isoquinolinyl-sulfonyl)-2-methylpiperazine NN:1 
1 1-(5-chloronaphthalene-1-sulfonyl)-1H-hexahydro-1,4-diazepine NN:1 
1 1-(5-Isoquinolinylsulphonyl)-2-methylpiperazine NN:1 
1 1-(5-Isoquinolinyl_sulfonyl)-2-methylpiperazine NN:1 
1 1,_25-dihydroxyvitamin NN:1 
1 1,794 CD:1 
1 1,458 CD:1 
1 1,4,5-trisphosphate NN:1 
1 1,25-dihydroxy-vitamin NN:1 
1 1,25-Dihydroxy NN:1 
1 1,25-(OH)2 NN:1 
1 1,25(OH)2D2 NN:1 
1 1,25(OH)2)D3 NN:1 
1 1,24-dihydroxy-22-ene-24-cyclopropyl-vitamin NN:1 
1 1,24(OH)2-22-ene-24-cyclopropyl-vitamin NN:1 
1 1,2-bis(o-aminophenoxy)-ethane-N,N,N',N'-tetraacetic JJ:1 
1 1,148.0 CD:1 
1 1,100 CD:1 
1 098,059 CD:1 
1 0800 CD:1 
1 06 CD:1 
1 04:00-08:00 CD:1 
1 0400 CD:1 
1 02 CD:1 
1 0000 CD:1 
1 0/8 CD:1 
1 0/33 CD:1 
1 0/1 CD:1 
1 0.95 CD:1 
1 0.9356 CD:1 
1 0.935 CD:1 
1 0.92+/-0.42 CD:1 
1 0.92 CD:1 
1 0.91 CD:1 
1 0.89 CD:1 
1 0.84 CD:1 
1 0.82 CD:1 
1 0.817 CD:1 
1 0.799 CD:1 
1 0.79 CD:1 
1 0.77 CD:1 
1 0.75 CD:1 
1 0.74 CD:1 
1 0.72 CD:1 
1 0.703 CD:1 
1 0.70 CD:1 
1 0.6895 CD:1 
1 0.66 CD:1 
1 0.6204 CD:1 
1 0.60 CD:1 
1 0.592 CD:1 
1 0.59 CD:1 
1 0.58-fold JJ:1 
1 0.58 CD:1 
1 0.551 CD:1 
1 0.53 CD:1 
1 0.52 CD:1 
1 0.5-fold JJ:1 
1 0.5-2.5 CD:1 
1 0.5- CD:1 
1 0.47 CD:1 
1 0.46 CD:1 
1 0.44 CD:1 
1 0.41 CD:1 
1 0.4-fold JJ:1 
1 0.4-1.9 CD:1 
1 0.37 CD:1 
1 0.34 CD:1 
1 0.316 CD:1 
1 0.304 CD:1 
1 0.3-2.6 CD:1 
1 0.2979 CD:1 
1 0.29 CD:1 
1 0.25-2.0 CD:1 
1 0.25 CD:1 
1 0.24 CD:1 
1 0.21-0.33 CD:1 
1 0.20 CD:1 
1 0.2-4 CD:1 
1 0.2-1.6 CD:1 
1 0.2-1.2 CD:1 
1 0.18 CD:1 
1 0.17 CD:1 
1 0.16 CD:1 
1 0.154 CD:1 
1 0.14 CD:1 
1 0.139 CD:1 
1 0.136 CD:1 
1 0.131 CD:1 
1 0.13 CD:1 
1 0.10 CD:1 
1 0.1-10 CD:1 
1 0.095 CD:1 
1 0.08 CD:1 
1 0.068 CD:1 
1 0.06 CD:1 
1 0.045 CD:1 
1 0.0354 CD:1 
1 0.0291 CD:1 
1 0.016 CD:1 
1 0.0126 CD:1 
1 0.0112 CD:1 
1 0.010 CD:1 
1 0.01-5 CD:1 
1 0.009 CD:1 
1 0.0081 CD:1 
1 0.007 CD:1 
1 0.006 CD:1 
1 0.0023 CD:1 
1 0.0008 CD:1 
1 0.0006 CD:1 
1 0.00009 CD:1 
1 0.00005 CD:1 
1 0-125 CD:1 
1 0- NNS:1 
1 /zymosan NN:1 
1 /translation NN:1 
1 /stress NN:1 
1 /signal NN:1 
1 /rex NN:1 
1 /reoxygenation NN:1 
1 /rel NN:1 
1 /receptor NN:1 
1 /precursors NNS:1 
1 /p24rex NN:1 
1 /p21rex NN:1 
1 /p130 NN:1 
1 /octamer NN:1 
1 /nuclear JJ:1 
1 /nm23 NN:1 
1 /nerve NN:1 
1 /monocytic JJ:1 
1 /macrophage NN:1 
1 /lymphotactin NN:1 
1 /lymphomas NNS:1 
1 /lymphoma NN:1 
1 /luciferase NN:1 
1 /ionomycin NN:1 
1 /inhibitor-kappaB NN:1 
1 /hypereosinophilic JJ:1 
1 /glioblastomas NNS:1 
1 /degradation NN:1 
1 /cyclosporin NN:1 
1 /chloramphenicol NN:1 
1 /calmodulin NN:1 
1 /beta-induced JJ:1 
1 /anti-CD3+ JJ:1 
1 /anti-CD28 JJ:1 
1 /animal NN:1 
1 /alphaCD28 NN:1 
1 /alpha- NN:1 
1 /alpha NN:1 
1 /adenovirus NN:1 
1 /activating VBG:1 
1 /XIST NN:1 
1 /Vav/phosphatidylinositol-3 NN:1 
1 /VD NN:1 
1 /Thr NN:1 
1 /TRAF2 NN:1 
1 /TCR NN:1 
1 /Syk-deficient JJ:1 
1 /Syk NN:1 
1 /Stat NN:1 
1 /SV40 NN:1 
1 /STAT5a/b NN:1 
1 /STAT5B NN:1 
1 /SRA1 NN:1 
1 /SAPK NN:1 
1 /RANK NN:1 
1 /PU.1 NN:1 
1 /PML NN:1 
1 /PKB/Akt NN:1 
1 /PKB NN:1 
1 /PHA NN:1 
1 /PEBP2/CBF NN:1 
1 /OCA-B NN:1 
1 /NF-kappaB1 NN:1 
1 /NF-AT NN:1 
1 /MEK NN:1 
1 /MAC-1 NN:1 
1 /LPS NNS:1 
1 /KBF1 NN:1 
1 /Jun NN:1 
1 /JNK NN:1 
1 /Iono-stimulated JJ:1 
1 /Iono NN:1 
1 /IkappaBalpha NN:1 
1 /IkappaB NN:1 
1 /HLA NN:1 
1 /HEB NN:1 
1 /GTP NN:1 
1 /GM-CSF NN:1 
1 /GAL4 NN:1 
1 /FK506 NN:1 
1 /Ets NN:1 
1 /ERK-2 NN:1 
1 /EIC NN:1 
1 /EBV NN:1 
1 /DRIP NN:1 
1 /Cu2+ JJ:1 
1 /CsA NN:1 
1 /Ca2+ NN:1 
1 /CD57 NN:1 
1 /CD40 NN:1 
1 /CD20 NN:1 
1 /CD18 NN:1 
1 /C-EBP NN:1 
1 /C NN:1 
1 /B NN:1 
1 /Apo-1 NN:1 
1 /ATF-1 NN:1 
1 /AP-1-DNA NN:1 
1 /A1 NN:1 
1 /A NN:1 
1 /9-cis NN:1 
1 .H1 NN:1 
1 .Cell. NNP:1 
1 .3 NN:1 
1 .2 NN:1 
1 .04 CD:1 
1 .011 CD:1 
1 .01-.02 CD:1 
1 .005 NN:1 
1 .0048 CD:1 
1 .0035 CD:1 
1 .0014 CD:1 
1 .0009 CD:1 
1 .0007 CD:1 
1 .0001 CD:1 
1 ... ::1 
1 -vitamin NN:1 
1 -virus NN:1 
1 -viral JJ:1 
1 -values NNS:1 
1 -untreated JJ:1 
1 -unresponsive JJ:1 
1 -ubiquitinylated JJ:1 
1 -transduced JJ:1 
1 -transcribed JJ:1 
1 -to-tumor JJ:1 
1 -to-oxidized JJ:1 
1 -to TO:1 
1 -thymidine NN:1 
1 -terminal JJ:1 
1 -targeted JJ:1 
1 -synthesizing JJ:1 
1 -suppressed JJ:1 
1 -supplemented JJ:1 
1 -subjects NNS:1 
1 -stimulatory JJ:1 
1 -stimulation NN:1 
1 -status NN:1 
1 -sized JJ:1 
1 -silenced JJ:1 
1 -signalling JJ:1 
1 -selectivity NN:1 
1 -ribosylates VBZ:1 
1 -ribose) JJ:1 
1 -retinoic JJ:1 
1 -responsiveness NN:1 
1 -repressible JJ:1 
1 -release NN:1 
1 -regulatory JJ:1 
1 -reducing JJ:1 
1 -red JJ:1 
1 -receptive JJ:1 
1 -proximal JJ:1 
1 -proton-antiport NN:1 
1 -prostaglandin NN:1 
1 -promoted JJ:1 
1 -production NN:1 
1 -priming JJ:1 
1 -pretreated JJ:1 
1 -prestimulated JJ:1 
1 -phoQ JJ:1 
1 -peptide NN:1 
1 -p65(286-551)-mediated JJ:1 
1 -p65 NN:1 
1 -p100 NN:1 
1 -overexpressed JJ:1 
1 -opposing JJ:1 
1 -null JJ:1 
1 -nucleotide JJ:1 
1 -nonsupplemented JJ:1 
1 -neutralizing JJ:1 
1 -mutant JJ:1 
1 -motif NN:1 
1 -modified JJ:1 
1 -mobilizing JJ:1 
1 -macrophages NNS:1 
1 -lymphoid JJ:1 
1 -luc NN:1 
1 -lipopeptides NNS:1 
1 -ligand+ JJ:1 
1 -leucine JJ:1 
1 -less JJ:1 
1 -kB NN:1 
1 -irradiation NN:1 
1 -inuced JJ:1 
1 -interfering JJ:1 
1 -interactor NN:1 
1 -interaction JJ:1 
1 -inhibited JJ:1 
1 -inhibitable JJ:1 
1 -inductive JJ:1 
1 -inducer NN:1 
1 -generation NN:1 
1 -forming JJ:1 
1 -exposed JJ:1 
1 -evoked JJ:1 
1 -estrogen NN:1 
1 -erythroid JJ:1 
1 -double-negative JJ:1 
1 -dose NN:1 
1 -diverse JJ:1 
1 -derivative NN:1 
1 -depleting JJ:1 
1 -dependent-genes NNS:1 
1 -cyclohydrolase NN:1 
1 -cross-linking NN:1 
1 -costimulated JJ:1 
1 -converting JJ:1 
1 -control NN:1 
1 -contaminated JJ:1 
1 -contact JJ:1 
1 -conserved JJ:1 
1 -conjugating NN:1 
1 -conditioned JJ:1 
1 -competed VBD:1 
1 -compatible JJ:1 
1 -coated JJ:1 
1 -chelating JJ:1 
1 -chaperoned JJ:1 
1 -cells NNS:1 
1 -catalyzed JJ:1 
1 -carrier JJ:1 
1 -body NN:1 
1 -beta-catenin NN:1 
1 -b NN:1 
1 -assisted JJ:1 
1 -assembly JJ:1 
1 -angiotensin JJ:1 
1 -alpha-inducible JJ:1 
1 -adherent JJ:1 
1 -activation JJ:1 
1 -_receptor NN:1 
1 -_kappa NN:1 
1 -_concentration NN:1 
1 -_59 CD:1 
1 -_245 CD:1 
1 -_188 CD:1 
1 -_184 CD:1 
1 -VLA-5 NN:1 
1 -TRE NN:1 
1 -TRAF2 JJ:1 
1 -TCR NN:1 
1 -Stat JJ:1 
1 -STAT5a NN:1 
1 -STAT5B NN:1 
1 -STAT3 NN:1 
1 -SLP-76 NN:1 
1 -S-transferase NN:1 
1 -RARalpha403 NN:1 
1 -PhoQ JJ:1 
1 -PU.1 JJ:1 
1 -PHA JJ:1 
1 -PCR JJ:1 
1 -Ox NN:1 
1 -NFAT JJ:1 
1 -NF-Y NN:1 
1 -Mediated JJ:1 
1 -MBP-HBD NN:1 
1 -M3v NN:1 
1 -M2 NN:1 
1 -M0 NN:1 
1 -LTR JJ:1 
1 -LP NN:1 
1 -LBD NN:1 
1 -K1 NN:1 
1 -Induced JJ:1 
1 -Ig/EBP-1 NN:1 
1 -Ig NN:1 
1 -IL6 NN:1 
1 -II CD:1 
1 -IFNA2 NN:1 
1 -HSF3 NN:1 
1 -HLA NN:1 
1 -HCMV NN:1 
1 -H2 NN:1 
1 -H1 NN:1 
1 -Grb2 NN:1 
1 -GGAT- NN:1 
1 -GGAA- NN:1 
1 -EVI1 NN:1 
1 -EIA NN:1 
1 -E2F NN:1 
1 -DO NN:1 
1 -D421A NN:1 
1 -CSF NN:1 
1 -CRH JJ:1 
1 -CK1 NN:1 
1 -CD8 NN:1 
1 -CD40L NN:1 
1 -CD40 NN:1 
1 -CD30L JJ:1 
1 -CD25+ JJ:1 
1 -CAT+ NN:1 
1 -C-C NN:1 
1 -BSA-induced JJ:1 
1 -BSA-FITC NN:1 
1 -BSA NN:1 
1 -BHRF1 NN:1 
1 -Aiolos NN:1 
1 -AT NN:1 
1 -A23187 JJ:1 
1 -98 CD:1 
1 -93 CD:1 
1 -90/-82 CD:1 
1 -90/-79 CD:1 
1 -9-mediated JJ:1 
1 -875 CD:1 
1 -870 CD:1 
1 -850 CD:1 
1 -80 CD:1 
1 -795 CD:1 
1 -7.0 CD:1 
1 -685 CD:1 
1 -66-bp JJ:1 
1 -650 CD:1 
1 -643 CD:1 
1 -63 CD:1 
1 -620 CD:1 
1 -62 CD:1 
1 -615 CD:1 
1 -61 CD:1 
1 -605 CD:1 
1 -59/-54 CD:1 
1 -585 CD:1 
1 -58 CD:1 
1 -571 CD:1 
1 -570 CD:1 
1 -57-positive JJ:1 
1 -57 CD:1 
1 -559 CD:1 
1 -557 CD:1 
1 -552 CD:1 
1 -550 CD:1 
1 -55 CD:1 
1 -540 CD:1 
1 -533 CD:1 
1 -53 CD:1 
1 -516 CD:1 
1 -512 CD:1 
1 -510 CD:1 
1 -51 CD:1 
1 -509 CD:1 
1 -508 CD:1 
1 -502 CD:1 
1 -501 CD:1 
1 -49/-41 CD:1 
1 -49 CD:1 
1 -487 CD:1 
1 -47 CD:1 
1 -460 CD:1 
1 -459 CD:1 
1 -454 CD:1 
1 -445/-366 CD:1 
1 -440 CD:1 
1 -429 CD:1 
1 -413 CD:1 
1 -41 CD:1 
1 -408 CD:1 
1 -404/-220 CD:1 
1 -40/-32 CD:1 
1 -4-phosphate NN:1 
1 -395 CD:1 
1 -392 CD:1 
1 -386 CD:1 
1 -38 CD:1 
1 -3757 CD:1 
1 -37 CD:1 
1 -365/-264 CD:1 
1 -353 CD:1 
1 -352 CD:1 
1 -351 CD:1 
1 -345 CD:1 
1 -319 CD:1 
1 -317/-288 CD:1 
1 -311CTCCCTTCT-303 NN:1 
1 -3110 CD:1 
1 -31 CD:1 
1 -3090 CD:1 
1 -3079 CD:1 
1 -306 CD:1 
1 -304 CD:1 
1 -301 CD:1 
1 -300bp NN:1 
1 -2A NN:1 
1 -299 CD:1 
1 -2987 CD:1 
1 -294 CD:1 
1 -293 CD:1 
1 -288CTTTTTGCTT-TGC-300 NN:1 
1 -285/-254 CD:1 
1 -285 CD:1 
1 -277 CD:1 
1 -275 CD:1 
1 -271 CD:1 
1 -264 CD:1 
1 -261 CD:1 
1 -258 CD:1 
1 -255 CD:1 
1 -254 CD:1 
1 -253 CD:1 
1 -251 CD:1 
1 -248 CD:1 
1 -246 CD:1 
1 -244 CD:1 
1 -240 CD:1 
1 -236/-145 JJ:1 
1 -233 CD:1 
1 -228 CD:1 
1 -226 CD:1 
1 -224 CD:1 
1 -223 CD:1 
1 -219 CD:1 
1 -214 CD:1 
1 -210 CD:1 
1 -21/-12 CD:1 
1 -203 CD:1 
1 -2010 CD:1 
1 -2-stimulated JJ:1 
1 -2-receptor NN:1 
1 -196 CD:1 
1 -1954 CD:1 
1 -183/-166 CD:1 
1 -18 CD:1 
1 -178 CD:1 
1 -175 CD:1 
1 -173 CD:1 
1 -172 CD:1 
1 -170/+108 CD:1 
1 -170 CD:1 
1 -16T JJ:1 
1 -166 CD:1 
1 -165/-148 NN:1 
1 -165 CD:1 
1 -163 CD:1 
1 -162 CD:1 
1 -1609 CD:1 
1 -16 CD:1 
1 -158/-90 CD:1 
1 -155 CD:1 
1 -152 CD:1 
1 -147/-130 NN:1 
1 -147 CD:1 
1 -146 CD:1 
1 -135 CD:1 
1 -132/+170 CD:1 
1 -131/+15 CD:1 
1 -124 CD:1 
1 -119 CD:1 
1 -118 CD:1 
1 -117 CD:1 
1 -1168 CD:1 
1 -110 CD:1 
1 -11 CD:1 
1 -109 CD:1 
1 -1053/+34 CD:1 
1 -104 CD:1 
1 -1011 CD:1 
1 -101 CD:1 
1 -100 CD:1 
1 -1.7 CD:1 
1 -1-triggered JJ:1 
1 -1-linked JJ:1 
1 -1-/- JJ:1 
1 -1,065 CD:1 
1 -1,056 CD:1 
1 -0.821 CD:1 
1 -0.791 CD:1 
1 -0.784 NN:1 
1 -0.63 CD:1 
1 -0.568 CD:1 
1 -0.2 CD:1 
1 -/ST JJ:1 
1 -/ JJ:1 
1 +89 CD:1 
1 +74 CD:1 
1 +655 CD:1 
1 +646 CD:1 
1 +60 CD:1 
1 +55 CD:1 
1 +50bp NN:1 
1 +50 CD:1 
1 +45 CD:1 
1 +448 CD:1 
1 +44 CD:1 
1 +42 CD:1 
1 +40 CD:1 
1 +34 CD:1 
1 +33 CD:1 
1 +3 CD:1 
1 +27 CD:1 
1 +265 CD:1 
1 +22 CD:1 
1 +178 CD:1 
1 +16 CD:1 
1 +157 CD:1 
1 +11 CD:1 
1 +/EBV- JJ:1 
1 +/EBV+ JJ:1 
1 +/CD10-/CD5- JJ:1 
1 * SYM:1 
1 (q11;q32) NN:1 
1 (p13;q14) NN:1 
1 (Z) NN:1 
1 (Ca2+)i NN:1 
1 (CT)19/(CA)16 NN:1 
1 (A/T)GATA(G/_A) NN:1 
1 (A/T)GATA(A/G) NN:1 
1 (8;21)(q22;q22) NN:1 
1 (3H)-thymidine NN:1 
1 (3H)-E2 NN:1 
1 (3;21)(q26;q22) NN:1 
1 (2E)-3-[5-(2,3-Dimethoxy-6-methyl-1,4-benzoquinoyl)]-2-nonyl-2-_propenoic JJ:1 
1 (2-Amino-3'-methoxyphenyl)oxanaphthalen-4-one NN:1 
1 (13) CD:1 
1 (-)-SKF NN:1 
1 (+/-) JJ:1 
